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ABSTRACT
The regulation of the temporal and spatial location of proteins is paramount in
maintaining a properly-functioning cell. The control of protein abundance and
localization is mediated, in part, by post-translational modifications. One such notable
modification is protein ubiquitination. Protein ubiquitination involves the covalent
attachment of the small, ubiquitously-expressed and highly-conserved protein ubiquitin
(Ub) to a substrate protein. The function of the Ub tag is dependent on the type and
topology of the Ub chain, and can direct proteins for degradation by the 26S proteasome,
or may serve other non-proteolytic functions.
Protein ubiquitination is achieved by three enzyme complexes: the E1 Ubactivating enzyme, the E2 Ub-conjugating enzyme, and the E3 Ub ligase enzyme. A
particular subclass of E3 ligases is the SCF subclass, a multi-subunit complex comprising
at least four components. Of these components, the variable F-box protein is responsible
for substrate specificity of the SCF. Interestingly, the genome of the plant model species
Arabidopsis thaliana is known or predicted to encode for roughly 700 F-box proteins, in
contrast to the yeast and human genomes that encode for only 11 and 69 F-box proteins,
respectively. In addition, more than 5% of the Arabidopsis genome encodes for
components for the Ub-proteasome pathway (UPS).
Given this potential complexity, it is surprising that the catalogue of known
ubiquitinated proteins in Arabidopsis is very small. The most high-throughput approaches
thus far have only identified about a thousand candidate proteins. Furthermore, unbiased
genetic surveys of mutants with impaired plant-specific patterning and development have
identified alleles of genes involved in the UPS.
iv

To address the complexity of the ubiquitination machinery in Arabidopsis, a more
comprehensive list of ubiquitinated proteins must be obtained. To that end, the major
objective of this work is to expand this catalogue, through the adaptation and use of
approaches employed in other systems for the high-throughput identification of
ubiquitinated proteins. Using a diglycine-scanning-based approach, we have identified
over 600 novel candidate ubiquitinated proteins with their associated ubiquitination sites.
Of the candidates identified in this study, we further studied PATL1, a novel cellplate associated protein, whose expression was found to be modulated by auxin. Our
studies towards the characterization of PATL1 suggests that its degradation is sensitive to
26S proteasome inhibition, but not to inhibition of the vacuole. Further, BiFC and co-IP
experiments suggest that PATL1 may act as a homodimer.
Lastly, I worked towards adapting the BioID system for biotin-based proximity
labeling in plant. My results suggest that the plant system is amenable to the use of this
system for study, though further work is required for its full-scale implementation in
Arabidopsis.
With further refinement, the tools described in this study may prove to be useful
in expanding the catalogue of ubiquitinated proteins in Arabidopsis, and shed light on the
prominence of protein ubiquitination as a key regulator of plant patterning and
development.
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reference to lysine residues of substrate proteins, and in all other contexts, so as to avoid
confusion when referring to lysine residues within ubiquitin and other proteins.
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CHAPTER 1
AN INTRODUCTION TO PROTEIN UBIQUITINATION

1

PROTEIN UBIQUITINATION AS A POST-TRANSLATIONAL
MODIFICATION
Protein ubiquitination is a post-translational modification that signals various
fates for the modified protein, dependent on the length of the polyUb chain, and the way
in which the chain is formed (reviewed in [1]). Ub is a small protein (8.5 kDa),
ubiquitously found in eukaryotes. Ub contains seven lysine (Lys, K) residues—namely
K6, K11, K27, K29 K33, K48, and K63—which contribute to the function of
ubiquitination in the diverse regulatory networks with which the Ub tag and signals are
involved. These Lys residues serve as an anchor point at which a subsequent Ub moiety
can become conjugated. This process involves the formation of an isopeptide bond
between the ε-amino group of a Lys within the first Ub moiety and the carboxyl group of
the C-terminal glycine (Gly) residue of another Ub moiety thereby forming polyubiquitin chains. Chains of varying lengths can be produced as further isopeptide bonds
form with subsequent Ub moieties, and can be both homogenous and heterogeneous in
nature; that is, they can be composed of Ub moieties linked together through the same or
different Lys linkage types throughout the chain [2, 3]. Atypically, the N-terminal
methionine (Met1) residue can be used in the formation of linear polyUb chains by the
linear Ub chain assembly complex (LUBAC) [4].
Ub is generally conjugated to the target protein through a Lys residue, forming an
isopeptide bond in the same manner as the formation of polyUb chains. Nonetheless,
there are rare cases of ubiquitination occurring at other sites, including cysteine (Cys),
serine (Ser), and threonine (Thr) residues (reviewed in [5]; [6]).

2

The chain-length and the linkage-type of the chain dictate the fate of the
ubiquitinated protein. Most commonly, ubiquitination has been described as a means for
targeting proteins for degradation by the 26S proteasome, and this function has been
attributed primarily to chains formed through the K48 residue of Ub. However,
developments in Ub biology suggest that this long-standing view may be an
oversimplification.
Firstly, proteins modified with Ub chains formed through K63 residues are not
targeted for proteasomal degradation; they are generally sent to the lysosome for
degradation. Alternative, non-proteolytic functions may be extant (reviewed in [7]), such
as K63-linked chains directing endocytosis of the modified protein [8], or activation of
the protein, as in the case of the TAK1 kinase [9] and the IκB kinase complex [10]. K63linked chains have also been shown to play a central role in DNA damage repair [11].
Secondly, while most reports to date show that K48-ubiquitinated proteins are targeted
for proteasomal degradation, it is not the only chain-type that dictates this fate. Substrates
of the anaphase promoting complex/cyclosome (APC/C), which are generally involved in
cell cycle regulation, have been shown to be modified with K11-linked chains and are
also degraded by the proteasome [12]. Further, studies of the proteasomal degradation of
DELLA proteins in plants have reported that these proteins are modified with chains
linked through the K29 residue [13]. As it stands, the more contemporary view of
polyubiquitin (polyUb) chains is that all chains that are not linked through K63 residues
can target the modified protein for degradation via the 26S proteasome, a view supported
by quantitative proteomics [14]. Finally, proteins that are modified only with a single Ub
moiety—and are said to be monoubiquitinated—are generally not targeted for
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proteasomal degradation, though there are still instances of monoubiquitinated proteins
being targeted to the 26S proteasome [15]. Rather, monoubiquitination can play a
regulatory role in, for example, inhibiting Ub-binding domain (UBD) interaction with a
ubiquitinated protein [16, 17] as discussed further in this chapter. Among other functions,
monoubiquitination has been associated with transcriptional regulation through histone
ubiquitination [18] and modification of transcription factors themselves [19]. Multiple
monoubiquitination events involving receptor tyrosine kinases (RTKs) have also been
shown to promote receptor endocytosis and degradation [20].
In this chapter, I describe the process by which protein ubiquitination is achieved,
the current state of Ub biology, and the apparent importance of this post-translational
modification in the plant model species Arabidopsis thaliana.

4

UBIQUITIN
Ubiquitin Genes
Mature Ub is a highly conserved 76-amino acid residue protein which is
expressed ubiquitously in eukaryotes. The Arabidopsis genome encodes 14 members of
the Ub gene family, which are divided into three subtypes: (i) the polyUb genes; (ii) the
Ub-like (Ubl) genes; and (iii) the Ub extension genes [21] (Fig. 1.1). The polyUb
family—composed of UBQ3, 4, 10, 11, and 14—is characterized by an open reading
frame (ORF) encoding multiple identical tandem repeats of the Ub coding sequence,
resulting in the expression of a single pre-polypeptide containing multiple Ub repeats,
where each of the different genes encodes a varying number of non-Ub residues at the Cterminus [21, 22]. Genes of the Ubl subtype—describing those genes comprising Ub
repeats with at least one amino acid substitution—includes UBQ7, 8, 9, and 12. These
genes also encode for Ub repeats that contain additional non-Ub residues at their Ctermini which are thought to inhibit incorporation of premature Ub moieties into the
ubiquitination cascade. UBQ1, 2, 5, and 6 form the last subtype, the Ub extension protein
genes, where each gene contains a single Ub ORF followed by one or two ribosomal
protein ORFs [23]; Ub in this context has been described as a co-translational chaperone,
in yeast, wherein Ub facilitates the formation of nascent ribosomes [24] (Fig. 1.1).
In comparison, four polyUb genes are expressed in yeast (UBI1, 2, 3, and 4) [25].
Similarly, the human genome encodes a family of Ub genes, including those that are
expressed with C-terminal fusions, and as polyUb peptides.
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Figure 1.1. Schematic diagram of UBQ coding sequences.
The schematic diagram of each UBQ polypeptide (adapted from [21]). For convenience,
only the coding sequences are represented in the schematic. Dark blocks represent wildtype Ub sequences, while lighter blocks represent Ubl sequences. 52- and 72-residue
ribosomal protein fusions are depicted in striped and dotted boxes, respectively. Single
amino acid codes indicate additional residues in the polypeptide C-terminal to the last
Ub/Ubl repeat.
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Ubiquitin Structure
The crystal structure of Ub, determined at 1.8 Å resolution, reveals a number of
secondary structures including 3.5 α-helices, a short portion of a 310 helix, a mixed βsheet, and seven reverse turns [26] (Fig. 1.2).
The primary sequence of Ub is highly conserved across all eukaryotes and all
tissues therein, with the exception of calf thymus Ub where the mature form is only 74
residues in length and lacks the canonical C-terminal Gly-Gly residues [27]. In addition
to primary sequence similarity, the structure of Ub is conserved across different
kingdoms. For instance, the crystal structures of human, yeast, and oat Ub suggest that
Ub structure is similar in each of these organisms [28]. The crystal structures of the Ubls
NEDD8 [29], RUB1 [30], SUMO-1 [31], and ISG-15 [32] have also been determined,
and likewise exhibit a high degree of tertiary structure similarity.
Ub contains seven Lys residues that are necessary for the formation of polyUb
chains (Fig. 1.3A). The Ub crystal structure shows that six of these Lys residues are
surface-exposed (K29 being the exception), which is presumably advantageous for the
conjugation of a subsequent Ub molecule in polyUb chain formation. Conjugation
through K29 is expected to require a conformational change within Ub to expose the
residue.
Most mature Ub (and Ubl) proteins terminate in Gly (Fig. 1.2B), which is
necessary for the covalent attachment of Ub to its substrate protein, or to an acceptor Ub
in the case of polyUb chain formation. In either case, an isopeptide bond forms between
the ε-amino group of a Lys group within the acceptor protein/Ub and the C-terminal
carboxyl group of the donor Ub.
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Figure 1.2. Tertiary structure of ubiquitin.
A structural representation of Ub based on the crystal structure resolved at 1.8 Å [33]. An
α-helix is indicated in pink, a short 310-turn in purple, and the mixed β-sheet in gold. The
C-terminal tail is seen to the right of the structure. Retrieved from the RCSB PDB
(http://www.rcsb.org/, 1UBQ).
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A

B

Figure 1.3. Important residues in ubiquitin.
The structure of Ub based on crystal structure resolved at 1.8 Å [33], rendered using
Swiss PDB Viewer and PDB file 1UBQ. (A) Lysine residues 6, 11, 29, 33, 48, and 63,
and glycine residues 75 and 76 are indicated (left), and all seven lysine residues
(including K27) are indicated in the rotated structure (right). (B) The C-terminal tail with
the Gly75 and 76 residues indicated.
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Post-translational Modification of Ubiquitin
Most Ub polypeptides are expressed as fusions to several additional amino acids
or a ribosomal protein at its C-terminal, or as a single polypeptide containing multiple
tandem repeats. The transition to mature Ub requires post-translational processing by
deubiquitinating enzymes (DUBs), and will be discussed in detail later. In addition to this
post-translational modification, Ub has also been found to be modified through
phosphorylation.
Multiple studies have reported that Ub is phosphorylated on Ser65 by the kinase
PINK1 (PTEN-induced putative kinase 1), which is important for the allosteric activation
of the E3 ligase Parkin [34-36]. Previous studies also identified a PINK1
autophosphorylation event occurring on its equivalent Ser65 residue within the PINK1
Ubl (Ub-like) domain [37]. The dependence of Parkin activation on phospho-Ser65
(UbpSer65) was confirmed through the use of a phosphomimetic UbS65E isoform, and the
use of purified UbpSer65 in the absence of PINK1, which were both able to activate Parkin
[36].
A later study has shown that PINK1 is also able to phosphorylate UbSer65
assembled in K63-linked polyUb chains (Fig. 1.4) where Ser65 is believed to be
amenable to phosphorylation in this chain because of the “open confirmation” adopted by
K63-linked chains [38]. The same study further supports the hypothesis that UbpSer65 is an
allosteric regulator of Parkin activity in that Parkin is unable to efficiently assemble
polyUb chains on its substrates when the free Ub pool contains only free UbpSer65. This
group also undertook nuclear magnetic resonance (NMR) studies to ascertain the effect of
the modification on Ub structure, where the results suggested that UbpSer65 adopts two
10

non-identical conformations, the major one of which shares a similar resonance to
wildtype (unmodified) Ub, except for perturbations in resonances surrounding pSer65.
The group also reported that the structure of the minor species has not yet been
previously shown, which displays significant perturbations in comparison with wildtype
Ub. Their solution NMR studies suggest that phosphorylation does not induce unfolding
of Ub N- or C-termini, as evidenced by only small changes to the prediction of the
secondary structure.
Taken together, it appears that the function of Ub phosphorylation is still largely
unknown, although it seems clear that it plays an important role in the activation of the
E3 ligase Parkin.

11

Figure 1.4. Structure of K63-linked diUb with phosphorylated Ser65.
Ribbon diagram of K63-linked diUbpSer65 rendered using Swiss PDB Viewer and PDB
file 4WZP [38]. One Ub moiety is coloured in yellow, and the other in blue. pSer65 is
indicated in both units.
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DEUBIQUITINATING ENZYMES (DUBs)
While the process of ubiquitinating a protein is of utmost importance, equally
important is the reverse modification—that is, protein deubiquitination. Deubiquitinating
enzymes (DUBs) play an important role in regulating ubiquitination through the removal
of the Ub tag. In most cases, proteasomal degradation of ubiquitinated proteins first
requires removal of the Ub tags from substrates (DUBs are also a part of the 19S
regulatory unit of the 26S proteasome), and DUBs can be involved in chain-editing.
Further, the processing of Ub pre-proteins requires DUB activity (reviewed in [39]).
DUBs are divided into the Cys-protease and metalloprotease classes, the former
of which is further subdivided into four subclasses on the basis of their Ub-protease
domains: (i) Ub-specific proteases (USP); (ii) Ub C-terminal hydrolases (UCH); (iii)
Otubain Ubal-binding proteases (OTU); and (iv) Machado-Joseph disease proteases
(MJD; reviewed in [40]). The lone member of the metalloprotease class of DUBs are the
JAMM/MPN+ motif proteases.
Ub-Specific Proteases (USPs)
USPs are capable of cleaving after the C-terminal Gly residue of Ub, regardless of
the identity of the subsequent residue be it the N-terminal Met of the next Ub repeat in a
polyUb polypeptide, or the N-terminus of a ribosomal fusion [41]. Because of this
activity, USPs are thought to be mainly responsible for the cleavage of precursor polyUb
polypeptides or Ub–ribosomal fusions, to generate mature Ub with the exposed Nterminus (reviewed in [42]).
In addition to the role of USPs in maintaining the free Ub pool, they have been
implicated in the direct regulation of ubiquitinated proteins. For example, short-hairpin
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RNA (shRNA) studies in mammalian cells have shown that USP28 is important in
regulating the stability of the oncoprotein, MYC [43]. In this role, USP28 acts to localize
MYC to the nucleus through an interaction with FBW7α. This interaction protects MYC
from ubiquitination by FBW7γ and subsequent degradation in the nucleolus.
Ub C-terminal Hydrolases (UCHs)
The UCHs are thought to be involved in the removal and recycling of Ub from
tagged substrates during protein degradation, as well as in the processing of the Ub
precursors. As their name suggests, UCHs are able to cleave peptide or isopeptide bonds
that form between the C-terminal Gly carboxyl group and α- or ε-amino groups of other
proteins, respectively; the former is the case with the co-translational processing of
polyUb repeats and ribosomal fusions [44].
UCHs have also been implicated in the development of Parkinson’s disease. In
particular, a missense mutation in UCH-L1 was identified that partially impaired catalytic
activity [45]. At a molecular level, Parkinson’s disease is characterized by the
aggregation of α-synuclein, and cells possessing a dysregulated UPS are thought to be
unable to facilitate the removal of these proteins [46].
Otubain Ubiquitin-aldehyde (OTU) Proteases
Enrichment of biotin-conjugated Ub-aldehyde (Ubal) using streptavidin–agarose
resulted in the co-enrichment of a number of Cys proteases, the most predominant of
which were UCH-L3 as well as two proteins containing OTU domains—otubain 1 and
otubain 2 [47]. These proteins are Cys proteases sharing homology with Drosophilia
ovarian tumour gene products [48]. Distinct from USP activity, OTU1 was unable to
cleave peptide bonds between artificial substrates (Ub–GFP or LRGG–7-amido-414

methylcoumarin) but was able to cleave tetraUb at the isopeptide bonds. OTU2 was not
found to have any proteolytic activity, but was similarly sensitive to Cys protease
inhibitors [47]. The study reported that OTU2 contained a short C-terminal extension
that, upon removal, conferred isopeptidase activity to OTU2; this suggests that the Cterminal extension plays a regulatory role in OTU2 activity.
OTU1 has been shown to have specific activity towards K48-linked chains—both
free and anchored to substrate proteins and activity towards K48-diUb was inhibited by
both free Ub as well as diUb of any other topology [49]. OTU1 has been implicated in
regulating protein abundance of the E3 ligase GRAIL, and OTU1 was presumed to act as
a DUB towards GRAIL because these two proteins were found to interact. However,
downregulation of OTU1 corresponded to a decrease in GRAIL autoubiquitination,
which was contrary to expectations if OTU1 exhibits DUB activity towards GRAIL [50].
Indeed, the study showed that OTU1 and GRAIL also interacted with USP8, which
instead is responsible for GRAIL deubiquitination. In this context, OTU1 was believed to
compete with USP8 binding to GRAIL in order to regulate its deubiquitination, and is to
be a positive regulator of GRAIL protein levels.
OTU DUBs are also able to act on other chain types; for instance, TRABID
(TRAF binding domain) has been shown to predominantly act on K29-linked chains,
even though it has been shown to act on both K48- and K63-linked chains [51].
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Machado-Joseph Disease (MJD) Proteases
Thus far, ataxin-3 (AT3) is the only described member of the Josephin domaincontaining proteases, where mutant alleles of AT3 are associated with spinocerebellar
ataxia. The mutations encompassed a polyglutamine (polyQ) expansion between the
second and third Ub-interacting motifs (UIMs) in AT3, thus abrogating Ub chain binding
[52].
NMR solution structures of the Josephin domain suggest that it is similar to
papain-like Cys proteases despite low primary sequence similarity, and that the common
tertiary structure domain may facilitate protein-protein interactions [53].
AT3 exhibits DUB activity in typical assays testing DUB activity, and binds Ub
chains four or more in length [54]. In its capacity as a DUB, AT3 can bind Ub chains
linked both through K48 and K63 with preference towards the latter, and AT3 has been
shown to edit K63 linkages in mixed-linkage chains [55]. The UIMs within AT3 were
found to be essential for AT3 ubiquitination, but not in controlling AT3 abundance [52].
JAB/MPN/Mov34 Metalloenzyme (JAMM)/MPN+ Proteases
The JAMM/MPN+ proteases are DUBs found to be insensitive to most inhibitors
of the Cys-proteases such as Ubal and Ub-vinyl sulfone (UbVS) [56], suggesting that
these DUBs are not Cys-proteases. Indeed, what was coined a cryptic protease by Yao, et
al., in 2002, was later described to be a JAMM motif-containing protease, whose activity
is metal ion-dependent [57]. The subjects of these studies were the yeast and human
JAMM/MPN+ proteases Rpn11 and POH1, respectively. These proteases are found in the
19S proteasome lid complex.
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Other notable JAMM/MPN+ DUBs include AMSH (associated molecule with
SH3 domain of STAM), which is involved in multivesicular body sorting. AMSH
specifically cleaves K48- and K63-linked chains and is involved in regulating ESCRTmediated endosomal–lysosomal sorting [58]. BRCC36, which is part of the BRCA1–
RAP80 complex, has also been found to cleave K63-linked chains [59].
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PROTEIN UBIQUITINATION IS ACHIEVED BY THE SEQUENTIAL EFFORT
OF (AT LEAST) THREE ENZYME COMPLEXES
The process of ubiquitination involves the concerted effort of at least three
enzyme complexes. In an ATP-dependent manner, the E1 Ub-activating enzyme charges
the free Ub molecule, which is then transferred to the E2 Ub-conjugating enzyme. This
enzyme then interacts with the E3 Ub ligase enzyme, which is generally thought to
regulate both substrate specificity as well as facilitating the transfer of the charged Ub
moiety to the substrate. The qualifier “at least” has been used here to describe this
process because many studies have shown that the efficient polyubiquitination of some
proteins is dependent on a fourth factor, known as an E4 ligase. Here, I describe in detail
the enzymes involved in this process.
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E1 UBIQUITIN-ACTIVATING ENZYMES
The E1 Ub-activating enzyme is the first enzyme in the ubiquitination cascade.
Ub activation is an ATP-dependent process whereby an acyl phosphoanhydride bond is
formed between the Ub carboxy-terminus and the AMP moiety of ATP which is
subsequently displaced upon the formation of a thioester linkage between an E1 internal
Cys residue and the activated Ub [60].
Mechanism of E1 Activity
Ub-activating enzymes function similarly between Ub and other Ubls. This
section will refer to the Ub E1s specifically, but I will also discuss any differences
between Ub and Ubl activation.
The mechanism of E1 action in the activation of Ub and Ubls such as Nedd8 and
SUMO was revealed through studies of the mechanism of activation of the bacterial
protein MoaD by MoeB [61]. MoeB and MoaD are involved in the biosynthesis of the
molybdenum cofactor (MoCo), and MoaD contains a C-terminal GlyGly motif [62],
similar to Ub and Ubls. The activation of MoaD was shown to involve the acyladenylation of its C-terminus by MoeB [63], which suggested that elucidating the
mechanism of the MoeB-dependent activation of MoaD could shed light on the
mechanism of Ub/Ubl activation by E1.
The E1 enzyme contains two active sites: an adenylation site, and the catalytic
Cys cite. In the first step of Ub activation, Ub non-covalently occupies the former active
site, and in an ATP/Mg2+-dependent manner, the Ub C-terminus is adenylated [64]. In the
next step, the AMP-Ub conjugate is attacked by the E1 catalytic Cys, forming a thioester
bond between the E1 Cys and AMP-Ub in the catalytic site. Before the activated Ub is
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ejected from the E1, another free Ub molecule occupies the adenylation site (Fig. 1.5).
The transfer of the activated Ub to the E2 is facilitated by binding of E2 to E1, wherein a
transthiolation event occurs and the activated Ub molecule becomes covalently bound to
E2, and the activation cascade within E1 continues. While the general mechanism of
activation is similar between Ub and Ubls (specifically, SUMO and Nedd8/RUB1), Ub
E1s function as monomers, whereas Ubl E1s function as heterodimeric complexes [65].
E1–E2 binding and dissociation is made possible through the differential affinities
between E2 and E1, not only in terms of cognate pairings but also in the state of
occupation of the E1. That is, E2s have a higher affinity for E1s conjugated to Ub
compared to unoccupied E1s (reviewed in [66]). This allows for the binding of E2 to E1–
Ub, and the subsequent dissociation of E2 from E1 upon ejection of the activated Ub and
Ub transfer to E2.
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Figure 1.5. Mechanism of ubiquitin activation by the E1 activating enzyme.
(1) The E1 binds ATP in the adenylation site. (2) Ub is then adenylated in the
adenylation site. (3) Inorganic phosphate (PPi) is removed, and Ub forms a conjugate
with AMP. (4) The thiol group from the catalytic Cys residue attacks the C-terminus of
Ub. (5) AMP is ejected from the adenylation site and (6) a new ATP molecule binds the
adenylation site. (7,8) A second Ub moiety is adenylated.
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E1 Proteins in Different Systems
Previous literature suggested that humans and yeast express only a single E1
enzyme, UBA1. However, a recent report has shown that a second E1 enzyme, UBE1L2,
is expressed in humans (particularly in testis) and functionally serves to activate Ub [67].
Plants appear to contain more E1 proteins than their metazoan counterparts. For
instance, wheat expresses at least three E1 isozymes [68], whereas in A. thaliana two E1
enzymes are encoded in the genome: AtUBA1 and AtUBA2. The protein products of these
two Arabidopsis genes were submitted to functional studies, and both E1 enzymes could
form β-mercaptoethanol-sensitive intermediates with Ub, suggesting the formation of
thioester bonds and thus E1 function for both AtUBA1 and AtUBA2 [69].
E1 Enzymes as Therapeutic Targets
While therapeutic inhibitors have been developed and employed mainly against
E3 Ub ligases, some groups have begun the development of inhibitors for E1 enzymes in
the treatment of cancer [70]. One compound, PYR-41, was shown to inhibit E1 Ubactivating activity in cells and has been shown to generally block protein degradation.
Though the mechanism of inhibition was not elucidated in this study, the results suggest
that the molecule acts as a competitive inhibitor of the E1 active site, although the
specific active site involved was not specified.
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E2 UBIQUITIN-CONJUGATING ENZYMES
E2 Ub-conjugating enzymes are responsible for transferring charged Ub-AMP
from the E1 Ub-activing enzyme to the substrate protein. The activated Ub is conjugated
to an E2 Cys residue, which resides in the conserved ~150 residue UBC (ubiquitinconjugating) domain. The Arabidopsis genome encodes 34 E2 Ub-conjugating enzymes,
while the human and yeast genomes code for about 50 and 11 E2s, respectively [71, 72].
For years, E3 ligases were thought to direct much of the ubiquitination of their
substrates (i.e., chain linkage type and length); however, in vitro and in vivo studies have
shown that E2 Ub-conjugating enzymes are capable of monoubiquitinating substrates in
the absence of an E3 ligase [17]. For example, the E2 enzyme E2-25K was shown to
modify its substrate protein with a K48-linked Ub chain without the involvement of an
E3 enzyme [73]. Furthermore, E2s in different E2–E3 pairs have been shown to direct the
length and chain type conjugated to substrates (as reviewed in [74]). Studies also suggest
that E2s determine the specific substrate Lys to be ubiquitinated [75].
Mechanism of E2 Activity
The E2 catalytic Cys residue resides within a shallow groove, which also contains
many other conserved residues believed to interact with the donor Ub in order to properly
orient Ub for conjugation to the substrate or acceptor Ub molecule (reviewed in [76]).
For instance, while a study by Wu, et al., showed that a conserved E2 Arg residue is not
necessary for E2 folding or formation of the E2–Ub thioester, the Arg residue is required
for isopeptide bond formation between Ub Gly76 and the substrate Lys e-amino group
[77].
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E2s must bind both E1 and E3 enzymes, but at separate times. This is, in part,
because the E2 uses the same binding interface for interaction with E1 and E3 such that
E1 binding to E2 precludes E3 binding, and vice versa.
In the transfer of activated Ub from the E1 to the E2, a transthiolation occurs
resulting in the formation of a thioester between the E2 catalytic Cys and the C-terminus
of Ub (Fig. 1.6).
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Recruitment of E2s to E3s
The next step in the ubiquitination cascade requires the association between the
E2 Ub-conjugating enzyme and E3 Ub ligase. An in vitro study by Kawakami, et al.,
showed that CUL1 neddylation was required and sufficient for recruitment of the E2
Ubc4 to the E3 SCFβ-TrCP [78].

E2 Enzymes Dictate Chain-type
The human E2 Ube2S is responsible for modifying proteins with K11-linked
polyUb chains. In addition to its interaction with the donor Ub through its catalytic Cys,
Ube2S non-covalently interacts with and orients the donor Ub in such a way that it may
attack the acceptor Ub at K11 [79].
The essentiality of Ube2S in the formation of K11-linked chains was determined
through knockdown experiments using small-interfering RNAs (siRNAs) directed against
Ube2S [79]. It was found that K11-linked chains were undetectable in cells depleted in
Ube2S, suggesting that not only is Ube2S a major contributor to the pool of K11 chainmodified proteins, but also, that the E2 plays a substantial role in dictating the chain type.
It is also possible that the cognate E3 of Ube2S is responsible for determining the chain
type, but can only associate with Ube2S to do so. In either case, the functional and
mechanistic data suggest that the E2 is important in chain-type determination.
E2 Enzymes can Pre-assemble Polyubiquitin Chains
There are two models that seek to explain how polyUb chains are formed on
substrates. In the “sequential model,” Ub molecules are added one at time, forming a
growing chain and I will elaborate on this model in a later section. In the “pre-assembly
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model,” polyUb chains are first formed within the E2 enzyme, and are transferred en bloc
to the substrate.
The E2 conjugating enzyme Ube2g2 was found to dimerize, and it is proposed
that one protomer is bound to the acceptor Ub molecule, while the other is bound to the
donor. The donor Ub is conjugated to the acceptor Ub (still bound to its cognate E2), and
chains are formed through subsequent rounds of conjugation ([80]; Fig. 1.7). Ube2g2 is
able to form K48-linked chains in this manner. Another protein, gp78, has also been
shown to be required for Ube2g2-mediated chain pre-assembly, and it is thought that
gp78 may act to mediate Ube2g2 dimerization.
Not all E2s can facilitate the conjugation of a charged Ub directly to an
unmodified substrate; in some cases, the E2 requires a pre-ubiquitinated protein as its
substrate, as is the case for Ubc13-Mms and Ube2k in the ubiquitination of BRCA1 [81].
Regulation of E2 Activity
Like many components of the UPS, E2 abundance is also regulated by
ubiquitination. A study on the yeast E2 Ubc7 showed that, in response to a decrease in
the level of its binding partner, Ubc7 was ubiquitinated and targeted for proteasomal
degradation by UFD4 [82]. Notably, the site of ubiquitination was the catalytic Cys
residue of Ubc7, rather than a Lys residue.
Some E2 enzymes also function as oligomers: for example, the homodimerization
of Rad6 in DNA repair [83], and the heterodimerization of Ubc13 and Uev1A in IKK
activation [10].
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Figure 1.7. A proposed model of polyUb chain pre-assembly by E2 enzymes.
E2 enzymes working in concert are thought to be involved in the pre-assembly of polyUb
chains. Two molecules of Ube2g2 associate with each other, and this interaction is
thought to be mediated by gp78. (1) An activated Ub molecule from one E2 is conjugated
to the other. (2) The donor E2 is charged again, and (3) the process continues.
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E3 UBIQUITIN LIGASE ENZYMES
The E3 ligases can be divided into two main subclasses based on the mechanism
of Ub transfer to the substrate proteins. The RING (Really Interesting New Gene)
subclass of E3 ligases facilitate the direct transfer of Ub to the substrate protein, whereas
for the HECT (Homologous to the E6-AP Carboxy-Terminus) ligases, the E2 enzyme
transfers Ub to the HECT ligase, which is then transferred to the substrate protein (Fig.
1.8).
RING Subclass of E3 Ubiquitin Ligases
Members of the RING subclass of E3 ligases are characterized by the RING
domain, which comprises Cys and His residues in a C3/H2/C3 arrangement that chelates
two Zinc ions. In some types of E3 enzymes, the RING-BOX (RBX) domain is contained
within a single E3 polypeptide, whereas in some ligases—such as in the SCF complex
and APC/C—the RING domain resides in a separate subunit. The RING domain
facilitates the activation of the RING ligase by the small Ub-like protein (Ubl) NEDD8
(Neuronal Precursor Cell Expressed, Developmentally Down-regulated 8) [84], also
known as RUB1 (Related to Ubiquitin) in yeast and plants. RING domains are also
involved in facilitating other protein–protein interactions. For instance, MdmX (mouse
double mutant X) and Mdm2 interact through their RING domains, as a way for MdmX
to regulate Mdm2 activity [85].
There are two commonly known E3s belonging to the RING E3 class: the SCF
ligases, and the anaphase-promoting complex/cyclosome (APC/C).
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Figure 1.8. Mechanism of transfer of activated ubiquitin to HECT and RING ligases.
(A) (1) The occupied E2 Ub-conjugating enzyme binds the HECT ligase. (2) A
transthiolation event occurs between the HECT Cys thiol group and the E2-bound Ub,
and a HECT–Ub thiol intermediate is formed. (3) The activated Ub is then transferred to
the HECT ligase-bound substrate. (B) The occupied E2 Ub-conjugating enzyme binds the
RING ligase and the activated Ub is directly transferred to the substrate, without an
intervening E2–Ub intermediate.
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SCF Subclass of RING Ligases
SCF ligases are multi-subunit enzyme complexes minimally composed of four
protein subunits: (i) a CULLIN1 (CUL1) backbone, which acts as a scaffold; (ii) an
RBX1 protein, which binds the CUL1 C-terminus; (iii) a SKP1 (S-phase kinaseassociated protein 1) adapter protein, which binds the CUL1 N-terminus, and links the
(iv) variable F-box protein to the complex, which imparts substrate-specificity to the SCF
ligase (reviewed in [86]; Fig. 1.9). Thus far, functional SCF complexes are thought to be
composed of one of each subunit; however, this understanding has been challenged by
the finding that the at least one SCF complex requires the oligomerization of its F-box
protein for full functionality [87]. Further analysis is required to determine whether this is
the case for other SCF complexes. The SCF complex and its components will be
described in further detail later in this chapter.
Other Cullin-RING Ligases
While SCF ligases are the most commonly described class of the Cul-RING
ligases, other Cul proteins participate in the formation of non-SCF ligases and play
important roles in cell cycle and signaling. For example, a Cul3-based ligase is involved
in the ubiquitination of cyclin E [88]. A Cul7-based SCF-complex was found to contain
Skp1 and Fbx29 [89], suggesting that Skp1 association is not limited to Cul1.
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(A) The SCF ligase is minimally composed of four protein subunits. The CUL1 scaffold
(grey) binds the RBX1 protein (green) at its C-terminus, and the SKP1 protein (purple) at
its N-terminus. The SKP1 C-terminus binds the N-terminal F-box motif of the F-box
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The Anaphase-Promoting Complex/Cyclosome
The APC/C, like the SCF complex, is a multi-subunit complex that contains a
RING domain for facilitating ubiquitination activity. More than a dozen subunits
assemble to form the APC/C, and a number of the subunits play roles homologous to that
of SCF components in the ligase. For instance, APC2 contains a Cullin homology motif,
and APC11 contains the RING finger (reviewed in [90]). Analogous to the F-box proteins
for substrate specificity, APC/C target specificity is facilitated by co-activators such as
CDC20 and CDH1 [91], which contain mainly WD40 repeats for protein–protein
interaction. The APC/C, like SCF complexes, is involved in regulating the abundance of
many cell cycle regulators including securin and B-type cyclins [92], as well as F-box
proteins such as Skp2 [93].
HECT Subclass of E3 Ubiquitin Ligases
HECT ligases functionally differ from RING ligases in that HECT ligases form an
intermediate with the activated Ub before transferring Ub to the substrate, as opposed to
RING ligases that transfer Ub from the E2 directly onto the substrate. The formation of
this Ub-thioester intermediate is facilitated by the transfer of charged Ub from the E2 to a
Cys residue within the C-terminus of the HECT ligase (reviewed in [94]).
Substrate specificity of HECT ligases is similarly mediated by protein–protein
interaction domains, and is characterized by their constitutive domains. HECT ligases can
contain RCC1-like domains (RLDs), tryptophan (Trp)-Trp domains (WW), or neither of
the two, and are known as HERC E3s, C2-WW-HECT E3s, or SI(ngle)-HECT E3s,
respectively (reviewed in [95]).
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Notable substrates of HECT ligases include Smad4, a tumour suppressor modified
by a C2-WW-HECT ligase [96], and PTEN (phosphatase and tensin homolog) that is
modified by NEDD4-1 [97]. HECT ligases have been shown to promote the formation of
both K29- and K48-linked chains [98].
E3 Ligases as Cancer Targets
The aberrant functioning of E3 ligases has been implicated in a variety of diseases
including cancer, making these components of the UPS desirable drug targets. For
example, dysregulation of Mdm2 is implicated in oncogenesis. In this context,
upregulation of Mdm2 activity causes a concomitant decrease in p53 abundance, thus
leading to the dysregulation of downstream genes (reviewed in [99]).
The activity of small molecule inhibitors against Mdm2 was tested for their ability
to mitigate the increased activity of Mdm2. Nutley inhibitors, or nutlins, were screened,
and a number of these nutlins with the ability to inhibit Mdm2–p53 interaction were
identified [100]. Effective inhibitors were found to mimic p53 peptides that interact with
Mdm2. Hence, much effort has been placed in the development of small molecules that
inhibit E3–substrate interactions in pathologies that involve the over-activity of E3
ligases.
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THE SCF LIGASE
Initial studies of the SCF ligase and its components were performed in yeast, and
have implicated SCF components in cell cycle and cell division control. Many cell cycle
regulatory proteins are under the regulation of targeted proteolysis mediated by the SCF
complex. Notable substrates include the cyclin-dependent kinase (CDK) inhibitor, p27Kip1
[101], cyclins D1 and E [102, 103], and β-catenin [104]. Interestingly, control of the cell
cycle is also regulated through an interplay between the SCF and APC/C ligases. For
instance, activators of APC/C are ubiquitinated by SCF ligases at certain stages of the
cell cycle, and F-box proteins are alternatively ubiquitinated by APC/C (reviewed in
[105, 106]). The following sections discuss the components of SCF ligases, namely Skp1,
Cul1, Rbx1, and F-box proteins.
The Skp1 Adapter Protein
Skp1 also plays roles independent of SCF function. The S-phase kinase cyclin
A/CDK2 was found to associate with two other proteins: p19 (later known as the S-phase
kinase-associated protein 1—Skp1) and p45 (Skp2, an F-box protein) [107]. In this
function, Skp1 participation in the complex was essential for S-phase kinase function,
although Skp1 did not act in the context of an E3 ligase.
Studies have shown that Skp1 plays ubiquitin-dependent and -independent roles
in centrosome duplication. Immunofluoresence studies localized Skp1 to the centrosome
[108], and studies suggest that Skp1 plays a role in centrosome organization [109]. In
addition, other components of the SCF complex, such as neddylated CUL1 and F-box
proteins, have been found to localize to centrosomes, suggesting that Ub ligase activity is
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necessary for the targeted degradation of components involved in the centrosome cycle
[109].
Skp1 is also a component of the RAVE complex in conjugation with Rav1 and
Rav2, which regulates vacuolar (V)-ATPases [110]. Abrogation of this function of Skp1
in this context has been hypothesized to be involved in the development of Sjögren’s
syndrome [111], which is characterized by fatigue and other symptoms such as dry eyes,
dry mouth, and rheumatoid arthritis [112].
Function of the SCF complex is commonly known to be regulated at the level of
CUL1 modification by Nedd8/RUB1, and the antagonizing interaction with CAND1
[113] (described later). Current studies into Skp1 post-translational modification are
beginning to suggest this may play a role in the regulation of SCF ligases. Recent work in
our lab has shown that human Skp1 is phosphorylated, and that this phosphorylation
event can modulate the specificity of Skp1 interaction with certain F-box proteins (Jalili,
et al.; unpublished).
Other post-translational modifications, such as glycosylation, are also involved in
regulating the function of Skp1. For example in Dictyostelium, O-linked glycosylation of
a Skp1 hydroxyproline residue directs its nuclear localization [114].
The ARABIDOPSIS SKP1-LIKE Family
The complement of genes that are known or predicted to encode subunits of the
SCF ligase is highly expanded in Arabidopsis, and indeed, plants in general. The
Arabidopsis genome encodes 21 ARABIDOPSIS SKP1-LIKE (ASK) proteins [115] and
over 700 known or predicted F-box proteins [116], in contrast to the human and yeast
genomes, which encode a single SKP1 protein together with 69 and 11 F-box proteins,
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respectively [117]. SCF components in Arabidopsis enjoy the potential to form a large
number of distinct SCF complexes, but the combinatorial diversity is increased even
more when taking into account that the stoichiometry of association of each of the
subunits is more than 1:1:1:1. For instance, our group has shown that efficient activity of
the SCFTIR1 complex is dependent on the oligomerization of the F-box protein TIR1 [87],
suggesting that some SCF complexes may assemble with more than one of each
component.
Interaction studies have shown that ASK1 and ASK2 interact with most of the Fbox proteins submitted to a bimolecular fluorescence complementation study, and that
expression of the ASK genes is temporally and spatially different [118].
ASK1 and ASK2 are both important for early development in Arabidopsis,
including embryogenesis and seedling development [119]. An ASK1/ASK2 double mutant
line was generated (ask1-1/ask1-1 ask2-1/ask2-1) but was found to be male sterile,
although ask1-1 could be maintained as a heterozygous plant [120]. An ASK1/ask1-1
ask2/ask2 plant was identified and used for further studies, and was found to exhibit
defects in a variety of processes, including embryonic and post-embryonic development,
cell division, and the mis-expression of the key regulator gene, BREVIPEDICELLUS
(BP/KNAT1), important in meristem establishment and maintenance [121].
In conjunction with ASK–F-box interaction experiments, these results suggest
that while ASK1 and ASK2 are the major SCF adapters that link many of the currentlyknown characterized F-box proteins, these two ASK proteins share redundant and
overlapping roles, as well as roles distinct from each other. Further, given that plants
harbouring a cul1 null allele experience phenotypes more severe than that of ASK1/ask137

1 ask2/ask2, other ASK proteins may well contribute to regulation of early embryonic
development [119].
The CUL1 Scaffold
CUL1 was originally discovered in yeast as Cell Division Control protein 53
(Cdc53), which is required for the ubiquitination-dependent degradation of Cln2, and
associates with the E2 Cdc34 [122]. Cdc53 was later characterized as a scaffold for
binding Skp1/F-box proteins and Cdc34 [123].
In yeast two-hybrid experiments using a human cDNA library, the human Cdc53
homologue Cul1, was found to interact with SKP1 [124]. This study also showed that
Cul1 could complement a yeast cdc53ts mutant, and that Cul1 could associate as part of a
human SCF ligase.
In Arabidopsis, the axr6 (auxin resistant 6) mutant was found to be impaired in
auxin signaling [125]. This mutant was found to encode an allele of CUL1, which
correctly suggested that SCF function was involved in auxin signaling [126].
CUL1 binds the RBX protein at its C-terminus, and the SKP1–F-box protein
dimer at its N-terminus. As a scaffold, CUL1 serves to bring the substrate protein in close
proximity to the E2 enzyme bearing the activated Ub moiety to be transferred to the
substrate [127]. A crystal structure of the human SCFSkp2–E2 complex revealed that the
distance between the F-box protein and E2 catalytic Cys residue is ~50 Å, which signifies
a large gap between the substrate and the Ub-donating E2; this suggests that there is
flexibility within the CUL1 backbone to allow for the proximal positioning of substrate
with E2 [127]. Regulation of SCF ligases through the CUL1 subunit is discussed later in
this section.
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The RBX Protein
The RING finger protein ROC1 (Regulator Of Cullins) was identified in a yeast
two-hybrid survey using mouse Cul4a as bait against a HeLa pGAD-cDNA library, and
was also found to interact with Cul1 (at its C-terminus), Cul2 and Cul5 [128]. ROC1 was
found to co-enrich with complexes immunoprecipitated with anti-SKP1 antibody; the
same was true for enrichment using anti-ROC1 antibody, which was able to coprecipitate SKP1.
Functionally, ROC1-containing complexes were found to promote substrateindependent protein ubiquitination in an E1- and E2-dependent manner [129], suggesting
its role in E3 function. Further, mutations of conserved residues in ROC1 abolished
ROC1–Cul1 ubiquitinating function, suggesting the essentiality of ROC1 in Cul–RING
ligase function [128].
The function of ROC1 (also known as the RBX (RING-BOX) protein) and Hrt1
was found to be involved in E2–E3 interaction. The E2 conjugating enzyme binds the E3
through the RING domain, causing a conformational change and the transfer of Ub from
the E2 to the substrate (reviewed in [130]). Further, RBX1 was found to be essential for
CUL1 Nedd8/RUBylation and thus Cul–RING activation [131]. In this context, RBX1
functions as a Nedd8/RUB E3 by facilitating the transfer of the activated Ubl from the
cognate E2 to a Lys residue within CUL1 [132].
ROC1 shares 51% sequence identity with ROC2, and 38% sequence identity with
the APC/C RING protein, APC11. In addition to the RING domain, these proteins are
rich in Trp residues; of the six highly conserved Trp residues, three are followed by
acidic residues, similar to WD repeats. Unlike ROC1, which interacts with all of the
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aforementioned Cul proteins, APC11 was found to only interact with Cul5; and while the
five aforementioned Cul proteins co-enriched in complexes captured with antibody
against ROC2, ROC2 was found to co-enrich only with Cul2, 3, and 4.

The A. thaliana genome encodes for two RBX-like genes—RBX1a and RBX1b—
that are 83% identical to each other, and share 75% and ~50% sequence identity to
human RBX1 and yeast Hrt1, respectively [133]. Studies were focussed on RBX1a as it
was found to be expressed throughout the plant (but not RBX1b); these studies revealed
that RBX1a is involved in SCF activity.
F-box Proteins
F-box proteins are characterized by an N-terminal, approximately 40-residue
motif first identified in cyclin F, which is important for binding to Skp1/ASK1 [134].
Cyclin F was identified as a suppressor of the cdc4-1 allele in yeast and, used as bait in
Y2H experiments, cyclin F was found to associate with the human homologue of Skp1
[134]. F-box proteins are subdivided into three categories based on their protein–protein
interaction motifs. FBLs are leucine-rich repeat (LRR)-containing F-box proteins (e.g.,
Skp2); FBWs contain WD-40 repeats (e.g., β-TrCP); and FBOs contain interaction motifs
other than those described by the first two groups (reviewed in [117]). Kelch repeatcontaining F-box proteins have been found in Arabidopsis [135] and in some cases, have
been classified into their own category known as the FBKs [136].
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Regulation of SCF Ligases by Nedd8/RUB1 and CAND1
Regulation of SCF ligase assembly and activity have thus far been described at
the level of CUL1 by the opposing inhibitory binding of CAND1 to CUL1–RBX1, and
the activating conjugation of Nedd8/RUB1 to a Lys residue within CUL1 (Lys720 in
human Cul1) [113, 137]. Conjugation of Nedd8/RUB1 to CUL1 has been shown to
inhibit the binding of TIP120A, later known as CULLIN-ASSOCIATED NEDD8DISSOCIATED 1 (CAND1) [138]. Binding of CAND1 to CUL1–RBX1 was also shown
to inhibit SCF substrate-dependent ubiquitination by preventing the binding of the SKP1–
F-box protein pair to CUL1.
CUL neddylation has also been found to regulate the abundance of CUL1 and
CUL3, as forms of the two CUL proteins resistant to neddylation were found to be stable,
and the level of these two proteins were low in cells deficient in COP9 SIGNALOSOME
(CSN) activity [139]. (CSN is responsible for deneddylation of modified CUL.)
MLN4924 was identified in a screen for small molecules that inhibit the activity
of Nedd8-activating enzymes (NAEs). The drug was found to form an adduct with Nedd8
that essentially competes with the binding site of the natural NAE ligand Nedd8–AMP
within the NAE [140]. A study in plants has shown that the drug is also effective at
inhibiting RUBylation of CUL1, and can interfere with activity of CUL4-containing E3
ligases [141].
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E4 UBIQUITIN LIGASE ENZYMES
A lesser known family of enzymes involved in the ubiquitination cascade are the
E4 ligases. Initially studied in yeast, E4 ligases were shown to be involved in promoting
the formation of polyUb chains on single Ub-conjugated substrates [142]. In experiments
using purified E1, E2, E3, and E4 enzymes, using Protein A as a substrate, Koegl, et al.
showed that efficient polyubiquitination of the substrate required all four enzymes. The
abundance of resulting higher MW species corresponding to substrate modified with
longer polyUb chains was proportional to the amount of E4 added to the in vitro reaction.
This suggests that the E4 enzyme is necessary for the efficient polyubiquitination of, at
least, some proteins (Fig. 1.10).
U-box-containing E4 Enzymes
Many proteins identified as possessing E4 ligase activity have been found to
contain a U-box. The U-box has been described as a modified RING domain, and UFD2
from yeast was the first enzyme identified as possessing the novel E4 (i.e., polyUb chainextending) activity [143]. Although both the U-box and RING finger share conserved
interaction surfaces, the hydrogen-bonding networks serve to stabilize the cross-brace
arrangement in the former, instead of zinc-binding sites in the latter [144].
E4 ligases have been shown to play important roles in different organisms. For
example, the Dictyostelium UFD2 homologue NOSA has been shown to be required for
cellular differentiation. Mammalian UFD2 has been shown to promote the degradation of
pathological forms of ataxin-3, which is important in preventing the development of
Machado-Joseph disease [145].
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Figure 1.10. Proposed models of polyubiquitination.
(1) The substrate is ubiquitinated in an E2–E3-dependent manner. (2A)
Polyubiquitination can occur in a sequential manner, whereby a newly-charged E2
associates with the E3-bound monoubiquitinated substrate, and (3A) subsequent Ub
moieties are be added to the growing polyUb chain. (2B) After monoubiquitination, an
E4 ligase associates and (3B) carries out extension of the polyUb chain. (2C) After
monoubiquitination, E3s can homo- or heterodimerization, or an E3 can associate with an
E4, to (3C) promote polyUb chain extension.
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Non-U-box-containing E4 Enzymes
While most described E4 enzymes possess a U-box, some non-U-box-containing
E4 enzymes have been described, namely p300 and the BUL1 (BINDS UBIQUITIN
LIGASE 1)–BUL2 complex. p300 has been shown to promote the addition of Ub
moieties on monoubiquitinated p53, but only in conjunction with the E3 ligase Mdm2
[146, 147]. BUL1–BUL2 acts to extend the Ub chain on GAP1, using the
monoubiquitination event catalyzed by the E3 ligase RSP5 as a starting point [148].
E3–E4 Complex-dependent Polyubiquitination
There are some instances where enzymes that possess apparent E3 activity appear
to possess E4 chain-elongating activity after forming a complex. A notable example of
this are the C. elegans proteins UFD2 and CHN-1 (C-terminus of Hsp70-interacting
protein) [149]. Individually, these two proteins act in concert with E1 and E2 enzymes to
catalyze short Ub chains (one to three Ub moieties) on its substrate UNC-45. However, in
complex with each other, UFD2 and CHN-1 act as an E4 ligase to promote the formation
of longer polyUb chains.
E4 Ligases in Plants
E4 ligases have been shown to be important in regulating aspects of the plant
immune response. For instance, the E4 ligase MUSE3 (Mutant, snc1-enhancing 3) in
coordination with the F-box protein CPR1 (CONSTITUITIVE EXPRESSOR OF PR
GENES 1) has been shown to be required for the efficient ubiquitination and degradation
of nucleotide binding and leucine-rich repeat domain (NLR)-containing immune
receptors, namely SNC1 and RPS2 [150].
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RECOGNITION OF UBIQUITINATED PROTEINS
It has been assumed for some time that in order for ubiquitinated proteins to be
recognized by the 26S proteasome, they must be modified with a chain composed of four
or more Ub molecules linked through the Ub K48 residue [151, 152]. However, recent
reports have suggested that this does not necessarily hold true since even
monoubiquitinated proteins can be recognized by the proteasome (reviewed in [153]).
Further, there is mounting evidence that proteasomal degradation does not always require
that the substrate be ubiquitinated. The first and most notable example is ornithine
decarboxylase (ODC), which has been shown to be degraded by the 26S proteasome in a
ubiquitination-independent manner [154]. The p21 protein has also been shown to be
degraded in a Ub-independent manner [155]; however, p21 can be ubiquitinated at its Nterminus for targeting to the 26S proteasome [156].
Ubiquitin Chains Imbue Diverse Signals
Until recently, studies into targeted protein degradation showed that K48-linked
polyUb chains were the primary signal for 26S proteasome-mediated degradation, albeit
not exclusively. PolyUb chains formed through other lysine residues (e.g., K11 and K29
[157]) were also shown to signal proteins for proteasomal degradation, while K63-linked
polyUb chains and monoubiquitination were shown to serve non-proteasomal functions.
However, previously held notions are continually being dismantled and revised by recent
and current studies.
For example, a substrate of the yeast HECT ligase Rsp5, Mga2-p120, has been
shown to be modified with a K63-linked chain, promoting its degradation by the 26S
proteasome [158]. Furthermore, while studies have suggested that proteasome-destined
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ubiquitinated proteins need to be modified with Ub chains comprising four or more Ub
moieties, a recent study has shown that multi-monoubiquitination is sufficient to promote
the monoubiquitinated protein’s proteasomal degradation. This latter study showed 82
and 220 proteins were degraded in this manner in yeast and mammalian cells,
respectively [159]. How these chains are recognized as signals for proteasomal
degradation will be discussed in the section regarding the 26S proteasome.
To further deviate from the generalization that all non-K63-linked Ub chains
target proteins for proteasomal degradation, the apoptosis signal-regulating kinase 1
protein (ASK1; not to be confused with the Skp1 homologue in Arabidopsis), involved in
antiviral innate response, was found to be modified with a K29-linked chain by
SCFFbxo21, and this ubiquitination event was implicated in ASK1 activation, but not
degradation [160].
Ubiquitin-binding Domains (UBDs) Recognize Ubiquitinated Proteins
The interpretation of the Ub tag is facilitated in part by ubiquitin-binding domain
(UBD)-containing proteins. The differentiation between chain-types is made possible
through the different topologies exhibited by the different chains. For instance, K48, K11,
and K6-linked chains adopt a closed or “compact” conformation. Through their Ub I44
and I36 hydrophobic patches, Ub moieties within a chain can interact with each other to
form these compact conformations. Alternatively, K63-linked chains and, presumably,
M1-linked chains adopt an “open” conformation (reviewed in [1]).
The conserved I44 residue was believed to be facilitate the binding of Ub to
UBDs [161], however, binding of UBDs contained within the translesion synthesis (TLS)
polymerase subunit polι were capable of binding a UbI44A variant [162].
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Monoubiquitination
Some proteins that contain ubiquitin-binding domains (UBDs) are
monoubiquitinated as a means of regulation. For example, when the UBD-containing
protein is monoubiquitinated, its UBD interacts with the Ub modification and the UBD is
sequestered from binding its substrates. This is a mode of regulation of UCH-L1, a DUB
implicated in Parkinson’s disease, wherein the UCH-L1 is monoubiquitinated on a Lys
residue proximal to the active site [163].
Monoubiquitination of transmembrane receptors such as α-factor receptors,
permeases and transporters has been shown in yeast to be sufficient in the Ub-dependent
initial steps of cargo internalization and vacuole-targeting of said cargo [164, 165].
Nonetheless, K63-linked polyubiquitination of the substrates involved was shown to
enhance the rate of internalization [166]. In mammalian cells, the process additionally
requires the ubiquitination of endocytic adaptors (reviewed in [167]).
The number of monoUb modifications is also important. Multimonoubiquitination—the addition of single Ub tags at multiple sites—is required for the
internalization and degradation of the epidermal growth factor (EGF) receptor [168], and
is implicated in the regulation of other RTKs including PDGFR (platelet-derived growth
factor) [169], Met/HGFR (hepatocyte growth factor receptor) [170] and TrkA [171].
Non-canonical Ubiquitination
Most known ubiquitination events occur on internal lysine residues within the
substrate protein, and in a small number of cases, the amino terminus of the protein. As
our knowledge of ubiquitination and ubiquitinated proteins increases, we are beginning to
learn more about non-canonical forms of ubiquitination. Further evidence suggests that
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proteins can also be ubiquitinated at Thr, Ser, and Cys residues (reviewed in [172]). A
study looking at the proteasome-mediated degradation of the auxin response co-repressor
IAA1 has shown that a Lys-less variant of the protein was still ubiquitinated and
degraded by the proteasome, suggesting that IAA1 is ubiquitinated in an oxyesterdependent manner [173]. In yeast, a Lys-less variant of the inner nuclear membrane
protein Asi2 was shown to be efficiently ubiquitinated in a manner dependent on the
Doa10 ligase in conjunction with Ubc6 and Ubc7 [174]. To determine the residue type(s)
modified in this Lys-less mutant, the group tested sensitivity of the Ub conjugates to high
pH (which is expected to remove Ub conjugated to Ser/Thr residues [175, 176]). The
Lys-less mutant was found to be unmodified at high pH, whereas wildtype Asi2 retained
its ubiquitination status, suggesting that the Lys-less mutant is modified at residues
distinct from that of wildtype.
This last example suggests a potential issue with the use of Lys-less mutants in
that it is possible that in the absence of Lys residues E3 ligases are capable of
ubiquitinating other residues. Indeed, the E3 ligase KSHV-K3, whose major target is the
major histocompatibility complex-I (MHC-I), is capable of ubiquitinating both wildtype
MHC-I at Lys residues, as well as Lys-less MHC-I on Cys or Ser residues [177].
Alternatively, MHC-I is preferentially ubiquitinated on Ser/Thr residues by the mouse γherpesvirus K3 even in the presence of MHC-I Lys residues [178].
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THE 26S PROTEASOME
The 26S proteasome is the major site of controlled proteolysis in the eukaryotic
cell. The proteasome itself enjoys combinatorial diversity afforded by interchangeable
subunits. The 26S proteasome is composed of the 20S core particle (CP), and a 19S
regulatory particle (RP) at each end of the barrel-shaped CP. These RPs act to regulate
entry of proteins into the lumen of the CP.
20S Core Particle
The CP is the main site of proteolysis within the proteasome. Proteasomes have
been found to exist in all three branches of life. Despite the fact that UPS does not exist
in bacteria, proteasomes have been isolated from Thermoplasma acidophilium and are
dispensable for viability (reviewed in [179]). In archaebacterium, a 20S-proteasome-like
structure that possesses chymotryptic activity has been isolated and partially
characterized [180].
The subunit composition differs between eukaryotic and prokaryotic proteasomes.
Whereas there are two copies each of seven distinct α and seven distinct β subunits in
higher eukaryotes, prokaryotic subunits comprise 14 copies each of distinct α and β
subunit. All proteasomes possess a barrel shape formed by four stacked heptameric rings;
in eukaryotes, the subunits adopt an α1-7β1-7β1-7α1-7 arrangement (reviewed in [179, 181]).
Three types of β subunits possess proteolytic activity, namely β1, β2, and β5, which
exhibit caspase-like, trypsin-like, and chymotrypsin-like activity, respectively. The
expression of some subunits can be differentially regulated; for example, γ-interferon can
promote the expression of induced β-subunits (βi) that associate with the other
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proteasome subunits to form immunoproteasomes, which specialize in the processing of
antigens for presentation by MHC-I molecules [182].
Some of the β subunits have N-terminal propeptides consisting of eight residues.
In terms of assembly, seven α subunits and seven β subunits form heptameric rings,
forming half of the holoproteasome, with propeptides still attached to the β subunits
[183]. In yeast, it has been shown that though the propeptide of β5 is necessary for
viability, the β1 and β2 peptides are dispensable for cell viability and assembly of the
proteasome [184]. When two half holoproteasomes associate, the N-terminal propetides
are cleaved and the holo(20S)proteasome is formed.
Most in vitro studies have shown that proteins are unable to translocate through
the lumen of the CP, given that N-terminal tails of the α subunits effectively block
protein entry into the lumen [185]. As such, a gate that mediates the entry of proteins is
required.
19S Regulatory Particle
The RP is positioned at either end of the 20S CP to regulate the entry of proteins
into the core lumen; in this form, the two 19S RPs (also known as PA700) and the 20S
CP form the canonical 26S proteasome. The RP is composed of 18 subunits that form a
base and lid, which are connected by a protein acting as a hinge. The proteins that form
the RP are known as Rpn (regulatory particle non-ATPase) or Rpt (regulatory particle
ATPases Associated with diverse cellular Activities) proteins. In the base, there are six
Rpt proteins (Rpt1–6) and three Rpn proteins, while the lid comprises nine Rpn proteins
(reviewed in [186]). Rpn10 also acts as a hinge between the base and lid structures [187].
These subunits function to unfold the client protein to allow for entry of a linearized
50

polypeptide through the lumen. Further, as mentioned previously, the N-terminal tails of
the α subunits are arranged in such a way that without the RP the lumen is essentially
blocked for entry of substrate proteins. N-terminal extensions of subunits within the RP
base have been shown to enter the CP and physically displace these tails blocking the
entrance to the CP, allowing for proteins to enter the core lumen (reviewed in [188]).
Additionally, the Rpn10 and Rpn13 subunits act as Ub-recognition components in the RP
[189, 190]. The RP also contains DUBs which function in the removal and recycling of
the Ub tag, allowing for the reptation of client proteins through the core lumen (reviewed
in [188]).
The assembly of the 19S RP was studied using labelling experiments, which
suggested that formation of the 19S RP occurs on already-formed 20S CPs, and that
formation of the 19S lid occurs prior to formation of the base [191]. In this proposed
pathway of 19S assembly, a complex composed of Rpn2, Rpn10, Rpn11, Rpn13, and
Txnl1 (proteasome-associated thioredoxin) form on the 20S CP; this is followed by the
association of an Rpt3–Rpt6 dimer with the Rpt1–Rpt2–Rpn1 trimer. Formation of the
base is completed by the addition of an Rpt4–Rpt5 dimer.
Formation of the 19S lid portion was studied in S. cerevisiae. By using lid-subunit
mutants, it was found that two preassembled portions—namely, Rpn5–Rpn6–Rpn8–
Rpn9–Rpn11 and Rpn3–Rpn7–Sem1—associate with each other, followed by the
incorporation of Rpn12 [192]. The 19S lid and base associate with each other through
Rpn10 acting as a hinge [187], and Rpn6 has been shown to stabilize the interaction
between the CP and RP [193].

51

Recognition of Substrates by the 26S Proteasome
In general, it has been shown that ubiquitinated proteins are recognized by UBDcontaining proteins in the 19S RP, deubiquitinated by DUBs and subsequently unfolded
by the ATPases. Denatured proteins are then allowed to enter the 20S CP for proteolysis
(reviewed in [194]). The 19S RP also has the ability to recognize misfolded proteins, and
acts to maintain the soluble-state of these proteins until they are refolded or degraded
[195].
Limited Proteolysis by the Proteasome
The proteasome has been shown to efficiently trap proteins until they are reduced
to peptides of no longer than 25 residues long; the distance between protease active sites
within the lumen is thought to act as a “molecular ruler” to dictate the length of the
processed peptides [196]. However, some proteins are post-translationally modified by
the proteasome through limited proteolysis to regulate their activity. For instance, the
p100 and p105 proteins involved in NF-κB signalling are cleaved into their mature forms,
p52 and p50, respectively (reviewed in [197]). Targeting to the proteasome is
accomplished via phosphorylation and ubiquitination of the precursor [198-200].
Proteasome Inhibition
Peptidomimetics are a common class of inhibitors used against the proteasome,
targeting one or more of the proteolytic enzymes within the CP; these include MG115,
MG132, and lactacystin, which share a common structural backbone with the actual
peptide targets of the proteases (reviewed in [201]).
The proteasome is a common target for drugs in the treatment of many diseases,
including cancer. In rapidly-dividing cells, one characteristic is the accumulation of
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misfolded proteins and the increased need for proteasome activity to allow the malignant
cell to proliferate, thus proteasomal inhibition can rein in uncontrolled proliferation
(reviewed in [202]). Bortezomib is one of the earliest proteasome inhibitor drugs
discovered, and is a boron-containing dipeptide that selectively inhibits the
chymotrypsin-like activity of the proteasome (reviewed in [203]).

53

THE N-END RULE PATHWAY
Most of the discussion thus far has explored E3s and their role in recruiting
substrates for ubiquitination and, in most instances, targeting them for controlled
degradation. What has not yet been discussed is what determines the protein half-life. For
some proteins, temporal control is dependent on certain cell-cycle phases, or as we will
see in later sections, particularly in plants, targeted degradation is dependent on certain
hormone and other external signals. One other factor dictating protein half-life is the Nend rule, which states that the identity of the first N-terminal residue (after Met1) dictates
the relative stability of the protein. Designated as stabilizing and destabilizing residues,
these amino acids differ between different organisms. For instance, in E. coli, His, Ile,
Asp, and Glu residues play a stabilizing role, whereas these same residues act as
destabilizing residues in yeast (reviewed in [204]). These residues, in addition to an
internal Lys residue, comprise the “N-degron,” which is characteristic of most N-end rule
substrates.
These residues are first exposed through the action of Met aminopeptidases
(MetAPs), generating a new N-terminus. In addition, some of these new N-terminal
residues are further subjected to modification by aminotransferases; thus, residues are
further classified as primary or secondary stabilizing or destabilizing residues.
Specific E2 enzymes and E3 ligases have been implicated in the ubiquitination of
N-end rule substrates. In yeast, UBC2 (RAD6) has been shown to be involved in the
degradation of a few N-end substrates [205].
In Arabidopsis, The N-end rule pathway is involved in regulating response to
hypoxia and oxygen sensing [206, 207]. The two-RING domain-containing E3 ligase
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PRT1 is an E3 involved in the N-end rule pathway, whose substrates specifically contain
aromatic residues at their N-termini [208].
ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION
In addition to the controlled degradation of normal proteins, protein ubiquitination
is also involved in housekeeping functions, such as in the removal of misfolded proteins
emerging from the endoplasmic reticulum, where this pathway of regulation is known as
endoplasmic reticulum-associated degradation (ERAD; reviewed in [209]) and has been
shown to involve specific E3 ligases for its regulation. N-glycans have been implicated in
the process of recognizing misfolded proteins. Misfolded proteins have been shown to be
N-glycosylated, and these modified proteins were found to interact with the F-box
proteins Fbs1 and Fbs2. It is believed that the N-glycans are removed prior to
proteasome-mediated degradation by a proteasome-associated N-glycanase (reviewed in
[209, 210]).
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PROTEIN UBIQUITINATION IN PLANT PATTERNING AND DEVELOPMENT
Unbiased genetic surveys leading to the identification of mutants impaired in
plant patterning and development in A. thaliana have frequently identified mutant alleles
of components of the Ub ligase machinery (reviewed in [211]). Given the genetic
complexity of the F-box gene family in Arabidopsis, it is no surprise that many of these
mutant alleles are those of the F-box genes. In this section, I describe several F-box
proteins, their discovery, and their roles in plant patterning and development. Several of
these F-box proteins are involved in integrating response to hormones and external
environmental cues. Because of the central role of auxin and its regulators in almost all
aspects of plant biology, I have reserved a separate section for its description, and is thus
not included here.
Abscisic Acid Response
Abscisic acid (ABA) is a plant hormone that is involved in the regulation of seed
dormancy and germination, as well as seedling growth, among other processes [212].
ABSCISIC ACID-INSENSITIVE5 (ABI5) is a basic domain/leucine zipper (bZIP;
[213]), that plays a crucial role in post-germinative growth arrest [214]. The E3 ligase
KEG (KEEP ON GOING) has been shown to down-regulate levels of ABI5 in the
absence of ABA, thus inhibiting growth arrest [215]. The regulation of KEG levels was
found to be mediated by ABA-induced phosphorylation either by KEG itself (which
contains a kinase domain) or by an entirely different kinase which regulates KEG
autoubiquitination [216].
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Light Response
The CUL4-based E3 ligase CUL4-RBX1-CDD was found to be important in the
repression of photomorphogenesis [217].
Phytochromes are light receptors that undergo conformational changes upon
absorbing light. Phytochromes are expressed in the Pr form, which absorb red light. Upon
absorption, they are converted to the Pfr form, which absorb far-red light. Studies suggest
that this transition mediates the ubiquitination of phytochromes in the Pfr form [218, 219].
The phytochrome PHYA has been shown to be ubiquitinated and targeted for degradation
in vitro by the E3 ligase COP1 (CONSTITUITIVE PHOTOMORPHOGENESIS1;
[220]). CRYPTOCHROME 2 (CRY2) has also been shown to be ubiquitinated by COP1
[221]. Other substrates of COP1 include the transcription factor HFR1 [222], and
CONSTANS [223]. It has also been shown that COP1 plays a role in regulating the
abundance of p53 and c-Jun in mammals, suggesting that COP1 may be implicated in
tumorigenesis [224].
Drought Response
The expression of the homologous U-box-containing E3 ligases PUB22 and
PUB23 was found to rapidly increase in the presence of abiotic stresses. pub22 and
pub23 loss-of-function alleles were found to contribute to drought-tolerance, suggesting
that PUB22 and PUB23 act in drought response [225]. In addition, these two proteins
were found to associate with RPN12a of the 19S regulatory particle.
Herbivory and Shade-Avoidance Response
As sessile organisms, plants are compelled to turn to other methods to mitigate
damage by organisms in their habitat, as well as to compete with other plants for
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resources such as light. Jasmonates are a class of phytohormones that are involved in
integrating responses to the aforementioned environmental challenges with the UPS
[226]. Similar to the role of TIR1 as an auxin receptor, the F-box protein CORONATINE
INSENSITIVE 1 (COI1) is the receptor for jasmonate in plants, specifically, the active
form of jasmonate (3R,7S)-jasmonoyl-L-isoleucine (JA-Ile). Unlike TIR1, binding of JAIle to COI1 requires COI1 interaction with its substrates, the JAZ (JASMONATE-ZIM
DOMAIN) proteins [227]. Radioligand studies showed that JA-Ile exhibits very low
binding to COI1 alone, and no binding to JAZ proteins, suggesting that COI1 and the
JAZ protein must form a co-receptor complex for binding JA-Ile.
Light plays an important role in plant patterning and development and other plantspecific processes. It is important to note that it is not only the quantity of light that is
important, but also the quality of light, in terms of the wavelength of light reaching the
plant. For instance, plants that are shaded below other plants receive light that is enriched
for less-desired far red (FR) light over red (R) light. Sensing this low R/FR ratio causes a
plant to elicit the shade-avoidance response, whereby vertical growth is suppressed in
favour of lateral growth of photosynthetic tissues (i.e., leaves), so that they may avoid the
shade produced by plants higher up in the environment. It has been shown that plants
with impaired JA biosynthetic pathways are unable to respond efficiently to a low R/FR
ratio, and also that a low R/FR ratio induces expression of COI1 [228], connecting
jasmonate signalling and light response.
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TRANSPORT INHIBITED RESPONSE 1 (TIR1) is an F-box Protein and Auxin
Receptor
Auxins are a class of phytohormones, indole-3-acetic acid (IAA) being the
common active form of the compound. Herein, all references to auxin pertain to IAA.
The essentiality of auxin in plant processes was known well before its actual mechanism
of action was elucidated. A review by Sakis Theologis, a pioneer in the field of auxin
biology, written in 1986, describes in detail the role of auxin in transcriptional regulation,
but no known mechanism of action [229].
Many components of the SCF subclass of E3 ligases in Arabidopsis were
discovered through screens of auxin-insensitive mutants. As it became apparent that
degradation of Aux/IAA co-repressor was responsible for auxin response, the focus had
shifted onto connecting Aux/IAA with its cognate E3 ligase. A study by Gray, et al., in
2001 showed that TIR1 interacts with Aux/IAA through its domain II, and promotes
Aux/IAA degradation through SCFTIR1 [230]. The interaction between TIR1 and its
substrates is mediated by direct binding of auxin to TIR1, which has led to the
designation of TIR1 as an auxin receptor [231], and TIR1–Aux/IAA binding is not
dependent on post-translational modification of the latter (in contrast to some F-box–
substrate pairs, such as Skp2 and p27, where p27 must first be phosphorylated for Skp2
recognition and binding [232]).
Although TIR1 can be considered a paradigm in our understanding of ubiquitinmediated gene expression, there still exists a knowledge gap. For instance, TIR1 belongs
to a group of other auxin F-box proteins, or AFBs. A study by Mark Estelle’s group
assessed auxin response in tir1/afb loss-of-function mutants where pyramiding of
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multiple mutants resulted in additive effects, suggesting that while there is some
redundancy and overlap between the function of TIR1 and other members of the AFB
gene family, each of these AFBs likely have their own unique roles in auxin response
[233].
Further, we have shown that efficient degradation of TIR1 substrates is dependent
on the homo-ologiomerization of TIR1 [87]. In this study, the degradation of known
SCFTIR1 substrates was significantly reduced when co-expressed with oligomerizationdeficient tir1 alleles, both in the Nicotiana transient expression system, and a
heterologous yeast system.
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EXPANDING OUR CATALOGUE OF UBIQUITINATED PROTEINS
It is clear that ubiquitination is an important aspect of gene product regulation in
all eukaryotes, and genetic and functional evidence suggest that this is equally true for
plants. In order to better understand why plants, specifically A. thaliana, have expanded
their complement of proteins involved in the UPS, we must gain a better understanding of
the full complement of proteins that are subjected to ubiquitination.
It is the aim of my study to expand upon the current catalogue of ubiquitinated
proteins in hopes that uncovering the breadth of substrates can inform and guide further
studies into the significance of the UPS in plants.
To that end, I describe my work towards the adaptation and implementation of a
proteome-wide approach for the identification of candidate ubiquitinated proteins in
Arabidopsis. Further, I assess the amenability of a proximity-based labelling approach for
the identification of interacting proteins that may one day be used to identify E3–
substrate pairings in plants.
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CHAPTER 2
LARGE-SCALE UBIQUITIN PROFILING USING THE
DIGLYCINE-SCANNING APPROACH1

1

The work described in this chapter is the product of joint work.
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INTRODUCTION
Genetic and genomic data suggests that ubiquitination plays an important part in
gene regulation
Roughly 5% of the Arabidopsis thaliana genome is known or predicted to encode
for components of the ubiquitin-proteasome system (UPS) [1], and while a plethora of
genetic and genomic evidence exists to suggest that the UPS plays important roles in
plant patterning and development, little is known about the number or identity of proteins
that are actually subjected to ubiquitination. Knowledge of the actual proteins that are
subjected to Ub post-translational modification would provide important insight into the
scope and importance of protein ubiquitination as a significant aspect of gene regulation
in Arabidopsis. The importance of Ub post-translational modification to the success of
the plant evolutionary paradigm is hinted by the finding that unbiased genetic surveys
assessing mutants with aberrant patterning and development have often identified mutant
alleles of proteins involved in the UPS (reviewed in [2]).
The large-scale identification of ubiquitinated proteins is complicated by many
factors, first of which is the generally low abundance of ubiquitinated proteins in the cell
[3]. This issue is further exacerbated by the mostly transient nature of the modification, in
that most proteins modified by K48-, K63-, and K11-linked polyUb chains—the topthree most common forms of Ub modification—exhibit a short half-life prior to
degradation via the 26S proteasome (K48- or K11-modified chains) [4], or are
alternatively sent to the lysosome for degradation as in the case of some K63-linked
chains [5].
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The lack of a canonical ubiquitination motif complicates ubiquitination site
prediction
Unlike other post-translational modifications such as phosphorylation or
prenylation that are mostly directed to specific motifs, there have not yet been widelydetermined motifs that apply to a broad array of ubiquitinated proteins. That being said,
currently-known substrates of the E3 ligase SCFβ-TrCP possess a so-called phosphodegron
motif that, as the name implies, must first be phosphorylated for substrate binding to βTrCP [6]. The motif is characterized by two phosphorylated Ser residues in the sequence
context of DpSGϕXpS (where ϕ = hydrophobic amino acid, X = any amino acid).
However, the presence of a phosphodegron motif only suggests that the protein is
ubiquitinated by SCFβ-TrCP and does not dictate any specific site of ubiquitination, except
that the ubiquitinated Lys residue is generally 9–13 residues N-terminal of the
phosphodegron motif [7].
The requirement that substrates be modified prior to ubiquitination does not hold
true for all substrates. For instance, literature published decades ago indicate that
substrates of the SCF complex are first phosphorylated in order for their recognition by
F-box proteins, such as Skp2 [8]. While this is true in many cases, there are many F-box
proteins that do not require the phosphorylation of their substrates for recognition and
modification, most notably TIR1 in plants [9].
The lack of a canonical motif has been the impetus for the development of
predictive software to aid in the discovery of ubiqutinated proteins. Many of these
applications, such as UbPred and Ubipredictor [10, 11], employ machine learning
algorithms using data generated from high-throughput ubiquitination screens discussed in
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the next section. The concerns associated with this approach will be brought to light in
the discussion section to follow.
Contemporary approaches to ubiquitome profiling
Many approaches have employed anti-ubiquitin antibodies to immune-enrich
ubiquitinated proteins from cell lysates, followed by western blotting or mass
spectrometry (MS) analysis. One issue with these approaches, and inherent to
immunoprecipitation-based protocols in general, is the non-specific enrichment of
interactors of the target (ubiquitinated) proteins (reviewed in [12]). To mitigate this issue,
some groups have generated cell/plant lines expressing His6-tagged Ub to allow for the
use of immobilized metal affinity chromatography (IMAC) that serves to reduce nonspecific enrichment. This approach was improved upon by Kim, et al., by employing a
two-step enrichment process, wherein the first step involved enrichment using Ubbinding domains immobilized on columns, followed by further enrichment using Ni2+NTA columns [13]. Nevertheless, the study identified only approximately 950 candidate
proteins in Arabidopsis.
Experiments similar to the immune-enrichment protocols have employed tandem
Ub-binding entities (TUBEs) that bind to the Ub tags and allow for enrichment of the
ubiquitinated proteins. These TUBEs have also been suggested to provide protection of
the Ub–substrate from DUBs, thus increasing their abundance [14].
The low abundance of ubiquitinated proteins identified in any screen can be
attributed to the decreased half-life of many of the modified proteins, as well as the
activity of deubiquitinases (DUBs) that act to remove Ub from target proteins. To
increase the half-life of the ubiquitinated proteins, many have turned to proteasome
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inhibitors such as MG132 or lactacystin to prevent degradation of the ubiquitinated
proteins (reviewed in [15]). DUBs can similarly be inhibited through the use of Nethylmalemide (NEM), chloroacetamide, and other specific DUB inhibitors, or Cysprotease inhibitors in general (reviewed in [16]).
One question that arises with the use of such inhibitors concerns the dependence
of the UPS on the full functionality of the proteasome and DUBs. For example, the
activity of certain proteins requires processing by the 26S proteasome, such as in the case
of the limited proteolysis of the p105 polypeptide into the active p50 subunit of NF-κB
[17]. It is conceivable that the activity of a protein involved in ubiquitinating another
protein (i.e., a component of an E3 Ub-ligase) is dependent on the full or partial
degradation of an upstream protein, hence, the inhibition of the proteasome may interfere
with its function and thus affect the ubiquitome. This is not as important a concern with
the use of DUB inhibitors, since these inhibitors are generally added during lysis (where
all activity is or should already be halted). On the other hand, the use of proteasome
inhibitors requires that cells/tissues be treated for some extended time before lysis during
which the ubiquitination process is still ongoing (i.e., 4–16 hours pre-lysis). There are
instances, nonetheless, when DUB treatment is preferentially performed prior to lysis.
A more-recent interaction-based ubiquitome screening approach employs fusing a
Ub-associated (UBA) domain to an E3 ligase of interest, known as “ligase trapping” [18].
When the substrate protein is recruited to the ligase of interest, the conjugated polyUb
chain also interacts with the ligase-fused UBA domain, stabilizing the interaction. To
allow for more stringent washes, cell lines expressing His6-tagged Ub for downstream
metal affinity chromatography were utilized in the study.
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The UBAIT (Ub-activated interaction traps) system is another method developed
for the identification of ubiquitinated proteins and their cognate E3s, similar to previous
ligase-trapping approaches. In this approach, the UBAIT comprises the E3 ligase
substrate-interacting component, covalently linked to Ub [19]. The UBAIT Ub is
activated in an E1- and E2-dependent manner, and can be incorporated into the nascent
Ub chain forming on the substrate of the specific UBAIT. The result is the E3 substraterecognition subunit covalently-bound to its substrate, which can then be affinity purified
and submitted to MS analysis. One disadvantage to these approaches is the targeted
nature of the screen, which may not be easily applied to a larger-scale unbiased search for
ubiquitinated proteins. Nonetheless, this approach can be very useful for validation
studies, or studies directed at characterizing the interactions between specific ligases and
their substrates.
Other trap approaches have been used to capture ubiquitinated proteins in a chainspecific manner. K63-linked polyUb chain-modified proteins have been identified using
“sensor-based proteomics” [20], which employs the sensor V´3K0 that specifically binds
K63-linked Ub chains [21]. The sensors can then be immobilized, and proteins modified
with K63-linked Ub chains can be captured and submitted to proteomic analysis.
Protein microarray-based approaches employ the incubation of whole-cell extracts
or purified UPS components with protein microarrays printed with a large number of
proteins from the system being assessed. Proteins ubiquitinated on the microarray as a
result of incubation with ubiquitination-competent extracts can be subsequently detected
using anti-Ub antibodies. This technique was employed in the identification of substrates
of Rsp4p in yeast [22], wherein Ub, E1, E2, and the human E3 ligases NEDD4 and
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NEDD4-1 were added to human protein microarrays [23]. While the utility of this
approach has been demonstrated, it does present some drawbacks. For instance, the
HECT ligases employed in these studies were single-subunit E3s; attempting to perform
this type of study using an SCF-class E3 would require the expression and purification of
(at least) four separate subunits. Secondly, one would need to know the associated E2
enzyme that cooperates with the E3 in question. While the number of E2s is small in
yeast and mammalian systems, the number of E2 proteins in Arabidopsis is significantly
larger [1].
A previous study employed protein microarrays for the identification of proteins
differentially ubiquitinated at select stages of the cell cycle in human cells [24]. To that
end, whole-cell extracts treated with specific cell cycle inhibitors to block the cells in
certain cell cycle phases were employed. The extracts thus obtained were incubated with
human protein-populated microarrays and supplemented with UbcH10 (an E2). While
this approach was not necessarily directed to the identification of substrates of a specific
E3, the use of UbcH10 to some extent may have biased identification towards certain
ubiquitinated targets. A truly unbiased survey would employ whole-cell extracts that
were not supplemented with selected E3s.
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The diglycine-remnant
Ub is conjugated to proteins via the C-terminal Gly of Ub and, generally, an
internal lysine residue within the target protein. In rare cases the N-terminal primary
amines serve as ubiquitination sites such as with MyoD, the transcriptional activator
crucial in muscle development [25]. The Ub carboxyl end terminates in Arg-Gly-Gly
(RGG). When ubiquitinated proteins are subjected to trypsinolysis, the nature of the Ub
C-terminal end results in a Gly-Gly or ‘digly’ (GG) remnant remaining conjugated to the
Lys residue within the modified protein. This digly remnant is also expected to render the
modified Lys residue resistant to trypsin cleavage; hence, the resulting peptide possesses
a missed cleavage and a mass shift of +114 Da arising from the digly remnant [26].
Similar to phospho-proteomic approaches, these digly footprints allow for the elucidation
of specific modified Lys residues and indicate where the protein is ubiquitinated, which
can provide valuable insight into the function of the modification.
Recent studies have taken advantage of these digly-modified peptides for the
high-throughput identification of ubiquitinated proteins [27]. However, a limitation of
this approach is that samples submitted to MS analysis contain both digly-modified and
unmodified peptides, the latter of which are expected to greatly outnumber the desired
modified peptides and thus may compromise detection of lower-abundance peptides.
The development of a diglycyl-lysyl antibody specific for the digly-modified Lys
residue, has allowed for the enrichment of these digly-modified peptides, thus reducing
the abundance of unmodified peptides before submission to MS analysis [26]. The
enrichment of digly-modified peptides also circumvents a potential source of falsepositives arising from modifications isobaric to the digly adduct [28]. One such example
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is the commonly-used alkylating agent iodoacetamide which can result in the conjugation
of a 114-Da moiety to Cys residues, which can be conflated with a digly-modified
peptide. (It should be noted that a report suggests this modification is extremely rare
when proteins are treated with concentrations of iodoacetamide at or below 50 mM [29].)
Since identification of candidate proteins in the digly enrichment approach is incumbent
on both enrichment and the mass shift, peptides that are modified only with non-digly
isobaric groups should not be identified.
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Expanding the catalogue of known or candidate ubiquitinated proteins in
Arabidopsis
Available genetic and functional evidence strongly suggest that protein
ubiquitination plays a disproportionately large role in the regulation of plant patterning
and development, as well as other roles in the day-to-day survival of plants. However, in
aggregate, large-scale unbiased surveys and smaller directed studies have thus far
identified less than two thousand candidate ubiquitinated proteins, and among these only
a small number have been validated as bona fide ubiquitinated proteins. In order to
preview the scope and the functional significance of the large number of components of
the UPS in Arabidopsis, it is important to determine the extent to which proteins in this
organism are actually subjected to protein ubiquitination. For example, a key aspect of
plant patterning, development, and environmental response involves the integration of
hormone response where, at the molecular level, these responses are largely regulated by
the action of the UPS machinery—specifically by the action of SCF complexes [30].
Indeed, the master regulator of plant patterning and development, auxin, exerts its effects
principally through activation of the SCFTIR1 complex [31, 32], suggesting that protein
ubiquitination is central to the regulation of diverse plant-specific processes. By
understanding what proteins are subjected to this post-translational modification, we will
be able to address the broader question as to why the UPS is much elaborated in plants
and how this complexity contributes to the success of the plant evolutionary paradigm.
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CHAPTER OVERVIEW
In this chapter, I describe work directed towards the goal of expanding the
catalogue of ubiquitinated proteins in A. thaliana seedlings. The availability of an antidiglycine remnant antibody allows for the enrichment of digly-modified peptides derived
from ubiquitinated proteins, with the enriched proteins then submitted to MS analysis.
This approach has been employed in other systems, but to my knowledge, this study is
the first to employ the diglycine-scanning approach in combination with specific
workflow protocols for the preparation of peptides for enrichment (notably RuBisCO
depletion using protamine sulfate) followed by filter-aided sample preparation (FASP).
This study revealed a list of heretofore unreported candidate ubiquitinated
proteins, and with further development, can be used for quantitative studies.
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MATERIALS & METHODS
Plant material
Wild-type Arabidopsis thaliana seedlings, ecotype Col-0 (ABRC Stock No.
CS7000) were surface sterilized in 70% ethanol for 2 min, followed by washing with
50% bleach/0.1% Triton X-100 for 10 min. Seeds were then rinsed with sterilized water
four times.
For seeds grown on solid media, seeds were placed on 0.5´ MS (Murashige and
Skoog) agar [2.165 g/L MS salts; 1% sucrose; 0.8% agar pH 5.7], to which a 5-mL
overlay of 0.5% agarose was added. Petri dishes were sealed with parafilm and stratified
at 4˚C in the dark for 2 days before transfer to a Conviron chamber set to 16 h daylight/8
h night.
For seeds grown in liquid media, washed seeds were stratified for 2 days and
transferred to flasks containing 100 mL liquid 0.5´ MS media. Flasks were incubated as
per the above conditions. For MG132 treatments, media from 14-day-old seedlings was
aspirated and exchanged with media containing 10 µM MG132 (Sigma, cat. no. C2211)
for 16 h.
Wild-type Nicotiana benthamiana seeds were sown on soil for 2 weeks, and postemergent seedlings transferred to individual pots.
Whole cell lysate preparations and trypsin digests
A variety of lysis buffers were tested for the preparation of whole cell lysates in
preparation for mass spectrometry analysis. Unless otherwise indicated, 14-day-old
Arabidopsis seedlings were flash frozen and ground in liquid nitrogen, and the powder
was resuspended in one of the lysis buffers described below.
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Lysis buffer used in mammalian diglycine-scanning experiment (Udeshi, et al. [33])
1 mL of lysis buffer [8 M urea, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1 Complete mini protease inhibitor (Roche, 4693124001), 1 mM PMSF, and 1
mM chloroacetamide] was added per gram of plant tissue. Suspensions were cleared by
centrifugation at 14,000 g for 10 min, repeated twice, at 4˚C. Lysates were incubated with
5 mM DTT for 45 min at room temperature, followed by incubation with 50 mM
iodoacetamide for 30 min in the dark at room temperature. Proteins were precipitated
with 12.5% TCA and incubated at 4˚C for 2 h. Precipitated proteins were collected by
centrifugation at 14,000 g for 10 min at 4˚C, and washed with ice-cold acetone, three
times. The pellet thus obtained was resuspended in 50 mM ammonium bicarbonate, to
which sequencing-grade trypsin (Promega, cat. no. V5117) was added in a 1:100 ratio,
and incubated at 37˚C for 16 h. Digests were stopped by the addition of formic acid to
20%.
Lysis buffer used in rice diglycine-scanning approach (Xie, et al. [27])
1 mL of lysis buffer [20 mM HEPES, pH 8.0; 8 M urea; 1 mM sodium
orthovanadate; 1 mM sodium β-glycerophosphate; 2.5 mM sodium pyrophosphate] was
added per gram of plant tissue, and the suspended powder was sonicated at a power level
of 5 for 10 s, followed by a 1-min rest on ice, repeated for a total of two bursts. Lysates
were cleared by centrifugation at 14,000 g for 10 min, twice at 4˚C.
Waters® protocol for peptide preparation in Arabidopsis
The protocol described in a Waters® poster for proteome analysis in Arabidopsis
[Ritchie, M., Langridge, J., McKenna, T., Amme, S., and Mock, H.-P. “Proteome
analysis of cold stress response in Arabidopsis thaliana: a label-free quantitative
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proteomic study.” 2005]. The ground plant powder was resuspended in 10% TCA/0.07%
β-mercaptoethanol in acetone [34], and precipitated proteins were washed in acetone. The
pellet was resuspended in 8 M urea, 2% CHAPS, 30 mM Tris-HCl, pH 8.5 [35]. Extracts
were then diluted in water, 1:10, and digested with sequencing-grade trypsin (Promega,
cat. no. V5117) at a 1:100 trypsin:protein ratio.
RuBisCO depletion by protamine sulfate
14-day-old Arabidopsis seedlings were flash-frozen in liquid nitrogen and ground
to a fine powder. Each gram of powder was resuspended in 10 mL of lysis buffer
consisting of 500 mM Tris-HCl (pH 8.3), 2% v/v IgepalTM, and 20 mM w/v MgCl2. The
suspended powder was centrifuged at 12,000 g for 10 min at 4˚C and the supernatant was
further cleared by passing through a cell strainer. A 1% w/v stock solution of protamine
sulfate (Sigma, cat. no. P4020) was prepared and added to the clarified lysate to a final
concentration of 0.12%, followed by incubation on ice for 30 min after vortexing. The
lysate was centrifuged at 12,000 g for 10 min at 4˚C. Four volumes of 12.5% TCA in
acetone was added to the supernatant, and incubated at -20˚C for 1 h. Precipitated
proteins were collected by centrifugation, washed with 80% acetone four times and
subsequently air-dried.
Filter-aided sample preparation (FASP)-mediated protein digestion
Precipitated proteins were resuspended in UA buffer [8 M urea, 0.1 M Tris-HCl
pH 8.5], filtered through a 0.20-µm syringe filter (Sarstedt, 83.1826.001) and the
concentration was measured. 5 mg of protein was diluted in UA buffer to a final volume
of 10 mL with 5 mM DTT and incubated at room temperature for 45 mins. The protein
was loaded onto an Amicon Ultra-15 Centrifugal Filter Device (Millipore, 30K,
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UFC903008). The Amicon filter was centrifuged at 5,000 g in a fixed-rotor centrifuge
until the total sample was filtered and concentrated 10-fold (approximately 20-25 min).
The filters were washed twice by adding 10 mL of UA buffer followed by centrifugation
at 5,000 g. Proteins were alkylated on-column by adding 2 mL of 50 mM iodoacetamide
(Sigma, cat. no. I6125) prepared in UA buffer and incubated at room temperature for 30
min in darkness. The filter was centrifuged and washed three times with 10 mL UA
buffer and further washed twice with 10 mL of 50 mM ammonium bicarbonate (Sigma,
cat. no. A6141). Sequencing-grade trypsin (Promega, cat. no. V5117) in 1 mL of 50 mM
ammonium bicarbonate was added to the filter at a trypsin:protein ratio of ~1:100, and
the filter was gently mixed and incubated at 37˚C for 1 hour. An additional 1:100
quantity of trypsin was then added, and the filter was re-incubated at 37˚C for 16 h.
Following digest, peptides were collected by centrifuging the filters at 4,000 g for
15 min, followed by two washes with 500 µL of 50 mM ammonium bicarbonate, and
pooling together of eluates.
Desalting peptides
Peptides were desalted using Waters® Oasis HLB 1cc (10 mg) columns (cat. no.
127A34234A). Columns were activated using 400 µL 0.1% TFA in acetonitrile (ACN),
and washed with 400 µL of 0.1% TFA in H2O. Peptides to be desalted were added to the
column, which was then washed again with 0.1% TFA/H2O. Peptides were eluted using
400 µL 65% ACN/35% H2O, and dried completely using a SpeedVac™.
Enrichment of digly-modified peptides using the Lucerna anti-diglycyl-lysyl
antibody
Lyophylized peptides were resuspended in ice-cold IAP buffer [50 mM 3-(Nmorpholino) propanesulfonic acid (MOPS), 10 mM sodium phosphate, 50 mM NaCl] and
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its concentration was measured. 600 µg of peptides were diluted to 1 mL in IAP buffer, 5
µg of anti-diglycyl-lysyl antibody (Lucerna, GX41) was added and the mixture incubated
on a rocker at 4˚C for 4 hours. Immune complexes were precipitated by adding 20 µL of
50% protein G resin (GenScript, L00209) for 2 hours at 4˚C. Beads were collected by
centrifugation at 2,000 g for 5 min and washed three times in 1 mL of ice-cold PBS-T for
5 min, followed by washing twice in PBS. Peptides were eluted by adding 100 µL of
0.15% trifluoroacetic acid (TFA; Sigma, cat. no. T6508-1) and incubated rotating at room
temperature for 15 min, followed by centrifugation. This step was repeated and eluates
were pooled together and desalted as described above.
Enrichment of digly-modified peptides using the PTMScan® diglycyl-lysyl kit
Dried peptides were mechanically resuspended in 1.4-mL ice-cold IAP buffer.
The resuspension was cleared by centrifugation at 10,000 g for 10 min at 4˚C. The
soluble fraction was added to pre-washed antibody-bead slurry and incubated at 4˚C for 3
h. Beads were centrifuged at 2,000 g for 30 s, and washed three times with IAP buffer,
followed by three washes with ultra-pure H2O. Peptides were eluted by the addition of 55
µL of 0.15% TFA for 10 min. Eluates were collected after centrifugation at 2,000 g for
30 s, followed by addition of a further 50 µL of 0.15% TFA. Eluates were pooled and
desalted and prepared for mass spectrometry analysis.
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Mass spectrometry (MS) analysis
MALDI-TOF-MS
Peptides were spotted on a MALDI target plate (Applied Biosciences) and
allowed to crystalize with matrix [10 mg/mL α-cyano-4-hydroxycinnamic acid, 65%
acetonitrile, 35% H2O, and 0.1% trifluoroacetic acid] (1:1). Matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) analysis was
performed on a Voyager-DE pro TOF-MS (Applied Biosystems). To obtain spectra of
parent ions, the machine was operated in the linear positive mode. Post-source decay
(PSD) was performed on selected parent ions by operating the instrument in the
reflectron mode. PSD spectra were captured by stitching together 8–10 segments of
various mirror ratios using the Data Explorer software.
MSE
Liquid chromatography MS (LC-MS) analysis was performed on a Waters®
Synapt G2 mass spectrometer.
Data processing was performed using Progenesis software (Nonlinear Dynamics),
or ProteinLynx Global SERVER (PLGS) software (Waters®), v.3.0.3.
The TAIR10 protein list (updated 2011-08-23) was used for data analysis
(http://www.arabidopsis.org/).
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In planta validation of protein ubiquitination
The Nicotiana benthamiana heterologous expression system was used for
transient expression of candidate constructs using the previously-described
Agroinfiltration system [36].
For transient expression in Arabidopsis seedlings, the AGROBEST protocol was
employed [37]. Agrobacterium tumefaciens (GV3101 strain) cells harbouring the desired
constructs (Table 2.1) were streaked onto LB agar containing the appropriate antibiotics
for 3 days at 28˚C. Individual colonies were selected and grown in LB broth with
antibiotics for 2 days at 28˚C. Cells were harvested by centrifugation and resuspended in
activation buffer comprised of 0.25X MS and AB salts, and 200 µM acetosyringone
(BioBasic, cat. no. AB1111), to an OD600 of 0.2, for 12–16 hours. Bacteria were then
harvested and resuspended to OD600 of 0.02 in activation buffer and subsequently
exposed to seedlings.
Sterile Arabidopsis seedlings (wildtype CS7000, or other mutant lines) were
incubated at 4˚C in the dark for 3 days, then ~10 seedlings were transferred to each well
of a 6-well plate containing 1 mL of 0.5´ MS broth. Seedlings were incubated at 22˚C in
a Conviron growth chamber set to 16 h/8 h light/dark, for 4 days prior to exposure to
activated Agrobacterium suspensions.
After two days of co-cultivation, the bacterial suspension was removed, and
seedlings were rinsed with PBS or 0.5´ MS broth. 1 mL of fresh 0.5´ MS was added,
supplemented with 100 µM Timentin (GoldBio, cat. no. T-104-2), and the seedlings
further incubated for 3 days.

95

Table 2.1. Plasmids generated and used in this study.
Destination Vectors
Tag
pSK102
N-terminal HA3
ENTRY Vectors
ATG Number
pENTR223:PATL1
AT1G72150
pENTR223:PATL2
AT1G22530
pENTR223:RIBOSOMAL PROTEIN S3 AT2G31610
pENTR223:PGDH1
AT4G34200
Expression Vectors
Product
pSK102:PATL1
HA3:PATL1
pSK102:PATL2
HA3:PATL2
pSK102:S3
HA3:S3
pSK102:PDGH1
HA3:PDGH1
ABRC: Arabidopsis Biological Resource Center, Ohio
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Source
[38]
Source
ABRC
ABRC
ABRC
ABRC
Source
This study
This study
This study
This study

Boiling plant lysis
Whole seedlings (7–14-day-old) were placed in 1.5-mL microcentrifuge tubes, to
which lysis buffer [39] was added [0.1 M EDTA, pH 8.0; 0.12 M Tris-HCl, pH 6.8; 4%
w/v SDS; 10% v/v β-mercaptoethanol; 5% v/v glycerol; 0.005% w/v bromophenol blue]
at a volume of 100 µL/3 seedlings. The tissue was briefly ground using a plastic pestle
and boiled at 95˚C for 10 min. Lysates were centrifuged at room temperature to remove
debris, and samples were loaded directly onto SDS-PAGE for gel or western blotting
analysis.
In vitro degradation assays
7-day-old Arabidopsis seedlings were flash-frozen in liquid nitrogen and lysed in
100 mM Tris-Cl (pH 7.5), 10 mM NaCl, 10 mM MgCl2, 4 mM PMSF, 5 mM DTT, 10
mM ATP [40]. About 100 ng of purified GST-fusion protein (substrate) was added per
100 µL of reaction, and the reaction was allowed to proceed at 25˚C for 1 h. Aliquots
were collected at the indicated time points and quenched by boiling with 4´ Laemmli
sample buffer (BioRad, cat. no. 161-0737) containing β-mercaptoethanol. Reactions were
subjected to 12% SDS-PAGE and western blotting. Blots were probed with rabbit antiGST antibody (Santa Cruz, Z-5) and goat-anti rabbit secondary (Sigma, cat. no. A0545).
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RESULTS
Assessing the amenability of the diglycine scanning approach in Arabidopsis thaliana
To date, all studies employing the anti-diglycyl-lysyl antibody (herein referred to
as the “digly antibody”) have been in mammalian cells and tissues. To confirm that the
Lucerna GX41 digly antibody can enrich for digly-modified peptides in Arabidopsis
lysates, and to optimize peptide preparation conditions, we conducted a series of
reconstitution experiments (Fig. 2.1).
For optimization of trypsinolysis, we prepared lysates from 14-day-old
Arabidopsis seedlings and supplemented the extract with synthetic recombinant human
K48- or K63-linked Ub chains. One set of extracts was supplemented with the
recombinant Ub chains prior to trypsinolysis (Fig. 2.1, “SB”), while another set was
supplemented with pre-trypsinolyzed synthetic Ub chains after trypsinolysis (“SA”).
Peptides were then subjected to enrichment with the digly antibody.
We first performed the reconstitution experiments using synthetic K48-linked
poly-Ub chains mixed with Arabidopsis extracts as in the previously described schema.
Peptides were subsequently subjected to MALDI-TOF-MS before and after enrichment
with the digly antibody (Fig. 2.2). We were able to detect a peak at m/z 1460—which
corresponds to a K48 digly-bearing peptide in peptide preparations supplemented with
the synthetic chains. For samples where the Arabidopsis extract and synthetic chains
were co-trypsinolyzed, the m/z 1460 peak could only be detected after digly enrichment
(Fig. 2.2, B, E).
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Figure 2.1. Schematic diagram for optimization of trypsinolysis and digly-enrichment.
Arabidopsis plants were flash-frozen and ground in liquid nitrogen, and resuspended in
lysis buffer. One fraction of clarified extracts was supplemented with synthetic human
recombinant Ub chains (K48- or K63-linked) prior to trypsinolysis (“SB”). Both the SB
and unsupplemented fraction (“EO”) were reductively alkylated, followed by
trypsinolysis. The EO fraction was further divided and supplemented with pretrypsinolyzed synthetic Ub chains (“SA”). Peptide mixes were then subjected to immuneenrichment with the digly antibody, followed by MS analysis.

99

PRE-ENRICHMENT

ELUTED
D

K48 chain
(digested)
K48-T

A

GG
|
LIFAGK48QLEDGR

ELUTED
G

E

H

F

antibody
antibody

A.t.-T+P/T-K48
SA

C

EO
A.t.-T

(A.t.+K48)-T
SB

B

Figure 2.2. Reconstitution experiments using synthetic K48-linked polyubiquitin chains.
Legend continued on next page
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Figure 2.2. Reconstitution experiments using synthetic K48-linked polyubiquitin chains.
(A-C) Various preparations of trypsinolyzed Arabidopsis extracts and K48-linked Ub
chains were submitted to MALDI-TOF-MS analysis. (A) trypsinolyzed synthetic K48
chains; (B) Arabidopsis extract mixed with synthetic K48-linked chains, then
trypsinolyzed; (C) trypsinolyzed Arabidopsis extract mixed with pre-trypsinolyzed K48linked chains.
(D-H) The peptides were subjected to immune-enrichment using the anti-digly antibody,
and immune complexes were captured on protein G sepharose. Peptides were eluted with
0.15% TFA, concentrated and submitted to MS analysis: (D) trypsinolyzed synthetic
K48-linked chains; (E) Arabidopsis extract mixed with synthetic K48-linked chains, then
trypsinolyzed; (F) trypsinolyzed Arabidopsis extract mixed with pre-trypsinolyzed K48
chains; (G) trypsinolyzed Arabidopsis proteins; (H) antibody only. Arrows indicate the
peak at m/z 1460 corresponding to the K48(-GG)-containing peptide.

Labels are described in Fig. 2.1.
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Since we were unable to detect peptides derived from endogenous K48-linked
polyUb chains, we increased the trypsin:protein ratio and subjected the peptides to
enrichment with the digly antibody, followed by MALDI-TOF-MS analysis (Fig. 2.3A).
We detected a peptide peak at m/z 1460, which corresponded to the K48 digly-bearing
peptide. To confirm the identity of this peak, we performed post-source decay on the
peptide and found a number of y ions (y1 through y6) and b8 and b9 ions that corresponded
to the expected fragmentation pattern of the peptide (Fig. 2.3B).
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Figure 2.3. Detection of digly-modified peptides derived from endogenous K48- and
K63-linked polyubiquitin chains.
(A) Arabidopsis extracts were subjected to trypsinolysis with a 1:25 trypsin:protein ratio.
Peptides were subjected to enrichment with anti-digly antibody and subjected to MALDITOF-MS analysis.
(B) Post-source decay was performed on the m/z 1460 peak to ascertain the sequence.
The annotated sequence is provided in the inset.

103

Mid-scale diglycine-enrichment
Following satisfactory results from the reconstitution experiments, scaled-up
experiments were performed. To that end, 13-day-old plants were treated with 10 µM
MG132 in 0.5´MS broth for 16 h pre-harvest. Plants were harvested, flash-frozen and
ground, and approximately 1 mg of Arabidopsis proteins were subjected to trypsinolysis
(as per [33]) and digly-modified peptides were enriched using the Lucerna (GX41) digly
antibody and subsequently submitted to MS analysis.
In this experiment, only six digly-modified peptides were identified, four of
which were derived from polyUb chains; the remaining two were derived from
phosphoenolpyruvate carboxylase 1 and an S8 ribosomal protein (Table 2.2). There was,
however, a large number of non-digly-modified peptides that were identified in this
screen. To investigate further this result, the efficiency of the trypsinolysis protocol was
assessed, leading to testing of other protocols.
Mass spectrometry analysis of unenriched peptides
One potential reason for the low abundance of enriched peptides could be the
inefficient trypsinolysis of proteins arising from suboptimal protein preparation. To
assess this possibility, sample preparation protocols described in two different studies
were employed, and unenriched samples were submitted to MS analysis. Xie, et al.,
sought to identify digly-modified peptides in rice using the Cell Signal Technologies
(CST) PTMScan® ubiquitin remnant motif kit [27], and a technical poster by Waters®
Corporation detailed a preparation protocol for proteomics analysis of Arabidopsis plants.
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Table 2.2. Candidate digly-modified peptides identified in the mid-scale diglycineenrichment experiment.
ATG No.
AT1G53310.3
AT5G59850.1
AT5G03240.3
AT5G03240.3
AT5G03240.3
AT5G03240.3

Protein Description
Phosphoenolpyruvate carboxylase 1
Ribosomal protein S8 family protein
polyubiquitin 3
polyubiquitin 3
polyubiquitin 3
polyubiquitin 3

Peptide Modification
GlyGly(5)
GlyGly(6)
GlyGly(6)
GlyGly(6)
GlyGly(9)
GlyGly(5)

Number in parentheses indicates location of assigned modified residue.
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Peptide Sequence
EYGVKLTMFHGR
KNVGGKVLGFFY
LIFAGKQLEDGR
MQIFVKTLTGK
TLADYNIQKESTLHLVLR
TLTGKTITLEVESSDTIDNVK

I employed the protein extraction and trypsinolysis protocols described, here
referred to as the rice and Waters® protocols, respectively. Whole-cell (unenriched)
peptide samples were directly submitted to MS analysis. From a single run, 2922/657 and
1701/606 unique peptides/proteins were identified from the samples prepared using the
rice and Waters® protocols, respectively; of those, 832 of the peptides were mutually
identified (Fig. 2.4A). Between both runs, 182 candidate digly-modified peptides were
identified from 144 proteins (Tables A.1 & A.2, Fig. 2.4B). Sequence logos were
generated using the seq2logo tool and the data collected from the MS analyses to
determine whether any ubiquitination motifs might exist (Fig. 2.4C,D). The three
residues flanking both ends of the putative modified-Lys residues failed to show any
convincing conservation; the logos are also different between the digly-modified peptides
identified in each of the two screens. The majority of candidate proteins were assigned a
single digly-modified peptide, with very few proteins assigned more than three peptides
(Fig. 2.4E). Gene ontology characterization using the Panther Classification System
showed proportionately similar distributions of candidate ubiquitinated proteins across
molecular functions, biological processes, and cellular components (Fig. 2.4F,G).
It was also noted that both digly-modified and unmodified peptides derived from
ribulose 1,5-bisphosphate carboxylase/oxygenase (RuBisCO) were found in high
abundance in both sample preparations, as expected given its role in the initial steps of
carbon fixation. It was proposed that the high abundance of these peptides may be
obstructing the detection of the lower-abundance peptides of interest, and thus needed to
be depleted from the sample. To that end, I sought to prepare peptide preparations
depleted for RuBisCO content.
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Figure 2.4. Summary of candidate peptide identifications using the Waters® and rice
protocols.
Venn diagrams representing (A) all peptides and (B) only digly-modified peptides
identified in MS analysis of samples prepared according to the Waters® and rice
protocols. Venn diagrams were generated using Venny 2.1.0 (Oliveros, J.C. (2007-2015)
Venny. An interactive tool for comparing lists with Venn’s diagrams.
bioinfogp.cnb.csic.es/tools/venny/). Sequence logos were generated using the seq2logo
tool [41] for ±3 residues surrounding candidate digly-modified Lys residues for peptides
identified using the (C) Waters® and (D) rice protocols. Amino acid residues along the xaxis represent consensus residues.
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(E) Number of candidate digly-modified peptides identified per candidate protein per
screen. Gene ontology characterizations for candidate proteins identified through the (F)
Waters® and (G) rice protocols distributed by molecular function, molecular process, and
cellular component. Data was generated using the Panther Classification System
(http://www.pantherdb.org/).
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Selective depletion of RuBisCO by protamine sulfate
RuBisCO has been reported to constitute 30–60% of leaf proteins and its
abundance has been problematic for other plant proteomic studies [42, 43]. In our initial
approaches, where RuBisCO was not first depleted, digly-modified peptides derived from
RuBisCO were consistently identified in high abundance which raised the possibility that
these may impede the detection of less-abundant proteins. To remedy this issue, we
sought methods to selectively deplete RuBisCO from our lysates. Various methods have
been described involving the use of various concentrations of polyethylene glycol (PEG)
or anti-RuBisCO IgY antibodies to immunodeplete the protein (discussed in [44]). While
the PEG-based procedure was effective at depleting approximately 85% of RuBisCO, the
protocol required a short incubation at high temperatures which raised concerns for
protein stability [42]. The latter method requires the use of costly antibodies or columns,
and has only been shown to deplete about 10% of the total RuBisCO content in the lysate
[45, 46]. A more recent study showed the use of protamine sulfate (PS) to be an effective
reagent for the selective precipitation of RuBisCO from leaf tissue, as well as highly
abundant seed storage proteins in seeds of legume plants [46].
I employed PS for the depletion of RuBisCO as the first step in the diglyenrichment protocol. Lysates derived from wildtype Arabidopsis seedlings were treated
with 0.12% PS and RuBisCO-depleted lysates were collected for downstream
applications. SDS-PAGE analysis (Fig. 2.5) of the insoluble fraction and supernatant
after PS treatment suggest that a large amount of RuBisCO has been depleted from the
lysate, and that the majority of proteins in the insoluble fraction are comprised of
RuBisCO large and small chains.
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Figure 2.5. RuBisCO depletion by protamine sulfate precipitation.
Lysates prepared from 14-day-old Arabidopsis seedlings were treated with 0.12%
protamine sulfate (PS) and kept on ice for 30 min. Lysates were clarified by
centrifugation and proteins in the supernatant were precipitated in 12.5% TCA/acetone.
The protamine sulfate pellet was resuspended in lysis buffer and proteins were likewise
precipitated. The TCA/acetone pellets obtained were boiled in sample buffer and
subjected to SDS-PAGE before staining with Coomassie blue dye.

-PS: no protamine sulfate added to lysate; +PS: lysate after PS depletion; PS pellet:
insoluble fraction obtained after PS treatment and resuspended.
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FASP-facilitated trypsin digestion and enrichment of digly remnant-bearing
peptides
A major concern for plant proteomics studies is the presence of metabolites and
other compounds in plant cells that can interfere with the efficient trypsinolysis of plant
proteins. To deplete lysates of potentially interfering compounds, the FASP protocol was
employed. RuBisCO-depleted lysates were loaded onto Amicon Ultra-15 filter cartridges
for FASP-mediated trypsin digestion as described [47]. Bound proteins were washed with
8 M urea/0.1 M Tris-HCl, followed by several washes with ammonium bicarbonate.
Trypsin digestion was achieved in-filter by incubation at 37˚C for 16 h. Peptides were
eluted from the column by virtue of their smaller molecular weight and ability to
permeate through the filter, thus leaving behind undigested proteins and trypsin in the
filter. The eluted peptides were subsequently desalted prior to enrichment of digly
remnant-bearing peptides.
Peptides were incubated with digly antibody for 4 h and immune complexes were
captured by incubation with protein G resin. The resin was washed three times in PBS-T
and three times in PBS, and peptides were eluted in 0.15% TFA, followed by desalting.
Peptides were submitted to UPLC (ultra-performance liquid chromatography)-MS
analysis using 2- and 4-µL injection volumes (Table A.3).
Again, only a small proportion of candidate peptides were found to be diglymodified—roughly 9% in both the 2- and 4-µL injections. Notably, there was very little
overlap in the candidate peptides identified between the 2- and 4-µL injections; only 6
digly-modified peptides were found in common between the two injection volumes (Fig.
2.6A,B).
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Figure 2.6. Candidate peptides identified using the RuBisCO-depletion/FASP/diglycineenrichment protocol.
Venn diagram comparing (A) all unique peptides and (B) unique digly-modified peptides
identified in the 2- and 4-µL sample injection volumes. Diagrams were generated using
the Venny tool v2.1.0 (http://www. http://bioinfogp.cnb.csic.es/tools/venny/).
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Upon analyzing the candidate protein assignments based on digly-modified
peptides, there was more significant overlap between protein identifications between the
two injection volumes, roughly 27% (Fig. 2.7A). Most candidate proteins were assigned
a single digly-modified peptide (112 and 102 peptides in the 2- and 4-µL injections,
respectively), and a smaller proportion of proteins were assigned more than one diglymodified peptide (Fig. 2.7B).
Taken together, these results raise multiple concerns. Firstly, the lack of
significant overlap between peptides identified in each of the technical replicate
injections was disconcerting; whether this is a result of the injections themselves or the
data processing must be resolved. Secondly, there is still a relatively small proportion of
candidate digly-modified peptides identified in contrast to non-digly-modified peptides.
While a previous study has shown that the Lucerna GX41 antibody does non-specifically
enrich for non-digly-modified peptides, that study showed that 35% of the peptides
captured were digly-modified [48], in contrast to our 9%, suggesting that our enrichment
protocol required further optimization.
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Figure 2.7. Candidate proteins identified using the RuBisCO-depletion/FASP/diglycineenrichment protocol.
(A) Venn diagram comparing the number of candidate proteins identified by diglymodified peptides, generated using the Venny 2.1.0 tool (http://www.http://bioinfogp.
cnb.csic.es/tools/venny/). (B) Number of candidate digly-modified peptides assigned per
protein.
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Pre-enrichment peptide fractionation by strong anion exchange chromatography
A previous study showed that fractionating tryptic peptides prior to diglyenrichment resulted in the identification of a larger number of digly-modified peptides,
owing to the decreased complexity of the peptide sample [33]. I also expect this step to
reduce possible saturation of the digly-antibody with polyUb chain-derived peptides. To
test if pre-fractionation would improve identification, we proceeded with punctuating the
current diglycine-enrichment protocol with a strong anion exchange (SAX)
chromatography fractionation step between the FASP step and immunoprecipitation.
Ten fractions were collected, and non-adjacent fractions were pooled to generate
five samples (i.e., fraction 1 was combined with fraction 6, fraction 2 with 7, and so on)
and each individually subjected to digly-enrichment following the same protocol as
before. Interestingly, digly-modified peptides were only identified in sample 1
(comprising fractions 1 and 6; Table A.4), and very little in the way of other unmodified
peptides in the four other samples. 101 candidate peptides were identified, assigned to 68
proteins. Similar to the previous screens, no convincing consensus sequence could be
determined (Fig. 2.8A), and the consensus that was generated did not match those from
previous screens (cf. Fig. 2.4C,D). 45 candidate proteins were assigned a single diglymodified peptide, and 15, 4, and 2 proteins were assigned two, three, and four diglymodified peptides, respectively (Fig. 2.8B). Gene ontology classifications (Fig. 2.8C)
suggest a distribution of molecular process, biological function, and cellular component,
similar to our previous screens.
Given the continued relatively small number of unique digly-modified peptides
identified using the protocol described, we proceeded to modify the protocol further.
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Figure 2.8. Summary of candidate protein identifications from diglycine-enrichment
incorporating SAX pre-fractionation.
(A) Sequence logos generated using the seq2logo tool [41] for ±3 residues surrounding
candidate digly-modified Lys residues for digly-modified peptides identified using the
SAX pre-fractionation protocol coupled with digly-enrichment. (B) Graphical
representation of the number of digly-modified peptides assigned per candidate protein.
(C) Gene ontology characterizations distributed based on molecular function, biological
process, and cellular component. Data was generated using the Panther Classification
System (http://www.pantherdb.org/).
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Testing the CST PTMScan® Ubiquitin Remnant Motif kit
A previous study employed both the Lucerna GX41 antibody and the CST
PTMScan® Ub motif kit and found that, while there were mutually-enriched diglymodified peptides, the two antibodies showed some preference towards different peptides
[48]. To test whether the CST antibody would improve identification, we employed the
commercial CST kit for peptide enrichment.
The workflow was kept consistent with that of previous experiments (i.e., MG132
treatment, PS-mediated RuBisCO depletion, FASP), with the exception that the
enrichment protocol accompanying the kit was followed. Two iterations of the diglycinescanning protocol were performed (herein known as “CST1” and “CST2;” Tables A.5 &
A.6, respectively), but failed to provide significant improvement in the number of
candidate digly-modified peptides; however, peptides distinct from those identified in our
previous screens were being identified. As expected, digly-modified peptides derived
from K6-, K11-, K48-, and K63-linked polyUb chains were all identified.
Similar to the other enrichment protocols, most candidate digly-modified peptides
map to a single protein (31 and 63 in the CST1 and CST2 enrichments, respectively), and
roughly a third of the proteins assigned two digly-modified peptides (Fig. 2.9).
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Figure 2.9. Summary of CST1 and CST2 diglycine-enrichment results.
Candidate (A) digly-modified peptides and (B) proteins identified in the CST1 and CST2
diglycine-enrichment experiments were analyzed by Venny 2.1.0 (http://bioinfogp.
cnb.csic.es/tools/venny/).
(C) Number of digly-modified peptides assigned per candidate protein identified in the
CST1 (black) and CST2 (grey) diglycine-enrichments. Cumulative results are indicated
in white.
(D) Analysis of ±3 residues surrounding the digly-modified Lys residue by the seq2logo
tool [41].
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Sequential diglycine-enrichment increases identification
A previous study compared the nature of the peptides identified using the Lucerna
and CST antibodies, and found evidence of some bias with respect to the peptides
enriched using each of the antibodies [48]. In this study, Wagner, et al., found that the
Lucerna GX41 antibody preferentially enriched digly-modified peptides with adjacent
non-polar and basic residues, whereas the CST kit enriched mostly those peptides with
acidic residues surrounding the digly-modified Lys. We speculated that there was the
possibility that some peptides would not be captured by using only one of the two
antibodies. Further, we were enriching a large number of peptides derived from
housekeeping proteins (i.e., RuBisCO, heat-shock proteins, and the like), as well as Ubderived peptides.
We wanted to test whether the use of both antibodies sequentially would assist in
increasing the identification of digly-modified peptides based on two ideas: firstly, that
the first enrichment step would decrease the complexity of the sample and essentially
deplete the sample of higher-abundance peptides; and secondly, that the successive
enrichment step would capture any peptides that remain unbound either because they
were outcompeted for binding to the first antibody by higher-abundance proteins, or
simply because of antibody bias. In the first step, the CST kit was used in the “first-pass”
enrichment; the flow-thru was then subjected to a “second-pass” enrichment, wherein the
Lucerna GX41 antibody was used. Samples were submitted separately to MS analyses.
Collated results from two technical replicates of the first-pass enrichment (Table A.7)
and three technical replicates of the second-pass enrichment (Table A.8) were filtered for
digly-modified peptides only, and duplicate identifications were removed.
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Similar to previous enrichments, the majority of candidate proteins identified in
the first-pass enrichment were assigned a single digly-modified peptide, with a fewer
number assigned two digly-modified peptides (Fig. 2.10A). Most candidate ubiquitinated
proteins identified in the second-pass enrichment were assigned a single digly-modified
peptide, and very few with two or three peptides (Fig. 2.10B). 273 of the candidate
ubiquitinated proteins (as compiled between the first- and second-pass enrichments) were
assigned a single digly-modified peptide, with 100 and 35 of the proteins assigned two
and three digly-modified peptides, respectively (Fig. 2.10C). Three proteins were
assigned seven digly-modified peptides across both enrichments (Table 2.3). Between
the first- and second-pass enrichment experiments, 10 candidate digly-modified peptides
were mutually identified (Fig. 2.10D); 50 candidate ubiquitinated proteins were mutually
identified, and 274 and 99 proteins were uniquely identified in the first and second pass,
respectively (Fig. 2.10E).
Sequence analysis using the seq2logo tool again failed to reveal any consensus
sequences consistent with sequence logos generated in the other screens (Fig. 2.10F,G).
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Figure 2.10. Summary of results from the sequential diglycine-enrichment experiment.
Number of candidate peptides identified in the (A) first-pass and (B) second-pass
enrichment screen assigned per protein. (C) Total number of candidate ubiquitinated
proteins identified between the first- and second-pass enrichments.
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Figure 2.10 (cont’d) Summary of sequential diglycine-enrichment experiment
Candidate (D) digly-modified peptides and (E) proteins identified in the first- and
second- pass enrichments were analyzed using Venny v2.1.0 (bioinfogp.cnb.
csic.es/tools/venny/). Sequence logos for candidate digly-modified peptides obtained in
the (F) first pass and (G) second pass enrichments were generated using the seq2logo tool
[41] for the ±3 residues surrounding the modified Lys residue.
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Table 2.3. Candidate ubiquitinated proteins assigned five or more digly-modified
peptides in the sequential-enrichment experiment.
ATG No.
Protein Description
5 digly-modified peptides

AT2G18960.1

ATPase 1_ plasma
membrane-type

Peptide Modification(s)

Peptide Sequence

GlyGly(3)
DGKWSEQEAAILVPGDIVSIK
carb+C(9);carb+C(11);GlyGly(31) VLTSIGNFCICSIAIGIAIEIVVMYPIQHRK
DGIDNLLVLLIGGIPIAMPTVLSVTMAIGSHRLSQ
GlyGly(41)
QGAITKR
carb+C(7);GlyGly(8)
NLVEVFCKGVEK
GlyGly(31)
DQVLLFAAMASRVENQDAIDAAMVGMLADPK

6 digly-modified peptides

AT2G30110.1

Ubiquitin-activating
enzyme E1 1

GlyGly(9)
GlyGly(*)
GlyGly(23)
GlyGly(*)
GlyGly(9)
carb+C(16);GlyGly(20)

NYSIPEVDKLKAK
AETFGIPIPEWTKNPKEAAEAVDR
QLIYTFPEDAATSTGAPFWSAPKR
ASEANDKNDNTIIGSDLASSKK
EVLQWLEDK
LEDAKVFTVGSGALGCEFLK

7 digly-modified peptides
GlyGly(20)
GlyGly(13)
GlyGly(18)
Glycine--tRNA ligase 1_ GlyGly(14)
AT1G29880.1
mitochondrial
GlyGly(10);ox+M(4)
GlyGly(23)
carb+C(14);carb+C(16);GlyGly
(38)
GlyGly(10)
carb+C(14);GlyGly(22)
GlyGly(1)
Formate--tetrahydrofolate
AT1G50480.1
GlyGly(12);ox+M(6)
ligase
GlyGly(11)
carb+C(2);GlyGly(9)
GlyGly(15)
GlyGly(2)
GlyGly(20)
GlyGly(13)
Phosphoethanolamine NAT3G18000.1
GlyGly(18)
methyltransferase 1
GlyGly(14)
GlyGly(10);ox +M(4)
GlyGly(23)

AHSDKSGTPLVAEEKFAEPK
EAASVVSSVSEGK
LEFLMFPREEQMSGQSAK
ASGHVDKFTDLMVK
EEQMSGQSAK
QGLLRVREFTLAEIEHFVDPENK
QHFILEENMLEVDCPCVTPEVVLKASGHVDKFTD
LMVK
IFHETSQSDKALFNR
KFSMDAGAFDAVVCSHHAHSGK
KGAPSGFVLPIR
ERLGKMVIGNSK
QPSQGPTFGIK
LCPPNKEGK
SYGASGVEYSDQAEK
RKSNPTHYR
AHSDKSGTPLVAEEKFAEPK
EAASVVSSVSEGK
LEFLMFPREEQMSGQSAK
ASGHVDKFTDLMVK
EEQMSGQSAK
QGLLRVREFTLAEIEHFVDPENK

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.
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An unenriched fraction was also submitted to MS analysis—that is, the fullyprocessed sample (i.e., PS treatment and FASP; Table A.9). Similar to the enrichment
studies, the majority of candidate ubiquitinated proteins were identified by a single diglymodified peptide, and a large portion by two digly-peptides (Fig. 2.11A). A comparison
of the digly-modified peptides identified in this experiment and those obtained from the
sequential-enrichment experiment revealed a very small overlap (Fig. 2.11B), suggesting
mostly all digly-modified peptides identified in each experiment are unique. Comparative
analysis suggested greater overlap at the protein level (Fig. 2.11C), indicating that the
distinct digly-modified peptides were being identified from a similar pool of proteins.
Again, a profile containing low consensus scores for the residues surrounding the
modified Lys residue was obtained (Fig. 2.11D), and proteins were distributed similarly
to those identified previously with respect to gene ontology classifications (Fig. 2.11E).
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Figure 2.11. Summary of diglycine-scanning in unenriched peptide preparations.
(A) Number of digly-modified peptides assigned per candidate protein. Overlap between
(B) digly modified peptides and (C) candidate ubiquitinated proteins based on the
identification of digly-modified peptides in the sequential diglycine-enrichment (“Seq.
Enrichment”) experiment and unenriched peptide preparation. Analysis was performed
using the Venny v2.1.0 (bioinfogp.cnb. csic.es/tools/venny/).
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Figure 2.11. (cont’d) Unenriched summary
(D) Sequence logo was generated using the seq2logo tool [41] for ±3 residues
surrounding the modified Lys residue. (E) Distribution of candidate ubiquitinated
proteins by gene ontology classifications based on molecular function, biological process,
and cellular component. Data was generated using the Panther Classification System
(http://www.pantherdb.org/).
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LRGG-modified peptides are detectable in diglycine-enriched fractions
It has been reported that the trypsinolysis of some ubiquitinated proteins results in
peptides bearing a Ub footprint containing a missed-cleavage between Arg74 and Gly75:
Leu-Arg-Gly-Gly (LRGG) instead of a digly-remant [49]. To determine whether these
LRGG-modified peptides could be captured by the anti-digly-antibodies being used, MS
data was analyzed searching for the specific modification which results in an m/z shift of
+343.2. A small list of LRGG-modified peptides was generated, suggesting that
enrichment with the digly-antibody does not necessarily exclude LRGG-modified
peptides (Table A.10 & A.11). The list of LRGG- and digly-modified peptides were
compared to assess overlap between LRGG- and digly-modified peptides (Fig. 2.12).
While a small number of candidate proteins were identified based on LRGG-modified
peptides only, most proteins that were assigned LRGG-modified peptides were also
assigned digly-modified peptides at other Lys residues. All but one of the 27 candidate
proteins were assigned a single LRGG-modified peptide; the remaining protein was
assigned two LRGG-modified peptides.
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Figure 2.12. LRGG-modified peptides.
The number digly-modified peptides and LRGG-modified peptides identified in the firstpass (A) and second-pass (C) enrichments were compared. The number of proteins
identified based on these identifications were also compared for the (B) first- and (D)
second-pass enrichments. Analyses were performed using the Venny v2.1.0 tool
(bioinfogp.cnb. csic.es/tools/venny/).
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Cumulative results
All of the candidate ubiquitinated proteins identified through the large-scale
approaches undertaken in this study were pooled together, including the data from the
unenriched sample preparations. Commonly-identified candidate proteins—that is, those
proteins with digly-modified peptides identified in at least three of the screens—suggest
that many housekeeping proteins are subjected to ubiquitination (Table 2.4). As
expected, digly-modified peptides derived from polyUb chains were identified in all
screens, namely those derived from K6-, K11-, K48-, and K63-linked chains, with diglymodified peptides derived from the latter two being most prominently identified.
Distribution of the proteins by gene ontology classification suggest that a large
proportion of the proteins possess catalytic activity and are involved in metabolic
processes, with roughly a quarter of these candidate ubiquitinated proteins localizing to
an organelle (Fig. 2.13A). A diverse panel of protein classes were indicated, with those of
oxidase reductase and nucleotide binding classes being the most prominent (Fig. 2.13B).
Interestingly, and as expected, proteins involved in the UPS comprise a noticeable
portion of the candidate proteins identified (Fig. 2.13C, Table B.1).
The cumulative results of the screens described in this study were compared to the
existing list of candidate ubiquitinated proteins generated by others [13, 50]. 280
candidate proteins—or 15%—were mutually identified between our screens and those
from other studies (Fig. 2.13D).
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Table 2.4. Commonly-identified in diglycine-scanning experiments.
Protein Description
1-aminocyclopropane-1-carboxylate oxidase 4
2-Cys peroxiredoxin BAS1-like_ chloroplastic
5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 2
ADP_ATP carrier protein 1_ mitochondrial
ADP_ATP carrier protein 2_ mitochondrial
ATP-citrate synthase beta chain protein 2
ATPase 1_ plasma membrane-type
Biotin carboxylase_ chloroplastic
Calreticulin-2
Catalase-3
Chaperone protein htpG family protein
Chaperonin 60 subunit beta 3_ chloroplastic
Chlorophyll a-b binding protein CP26_
chloroplastic
Chloroplast stem-loop binding protein of 41 kDa
a_ chloroplastic
Cytochrome f
Cytosolic isocitrate dehydrogenase
Eukaryotic aspartyl protease family protein
Ferredoxin--NADP reductase_ leaf isozyme 1_
chloroplastic
Glucose-1-phosphate adenylyltransferase small
subunit_ chloroplastic

Protein Description
Glyceraldehyde-3-phosphate dehydrogenase
GAPB_ chloroplastic
Heat shock 70 kDa protein 6_ chloroplastic
HEAT SHOCK PROTEIN 89.1
Heat shock protein 90-2
heat shock protein 90.1
Leucine aminopeptidase 1
Nitrile-specifier protein 1
Oxygen-evolving enhancer protein 2-1_
chloroplastic
Pectinesterase/pectinesterase inhibitor 3
Phosphoglycerate kinase 1_ chloroplastic
Photosystem II CP47 reaction center protein
Polyketide cyclase/dehydrase and lipid transport
superfamily protein
Polyubiquitin 8
Probable fructose-bisphosphate aldolase 2_
chloroplastic
Probable fructose-bisphosphate aldolase 3_
chloroplastic
Probable mediator of RNA polymerase II
transcription subunit 37c
Ribulose bisphosphate carboxylase large chain
Transketolase-2_ chloroplastic
UTP--glucose-1-phosphate uridylyltransferase 1

Peptide Sequence
MQIFVK*TLTGK
TLTGK*TITLEVESSDTIDNVK
Ubiquitin
LIFAGK*QLEDGR
TLADYNIQK*ESTLHLVLR
Asterisks (*) indicate digly-modified residue.
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Chain Type
K6
K11
K48
K63

A

B

Figure 2.13. Summary of all diglycine-scanning experiments.
All candidate proteins identified in the major screens in this project were submitted to
Panther (pantherdb.org/) for gene ontology distribution analysis by (A) molecular
function, biological process, cellular component, and (B) protein class.
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Figure 2.13. (cont’d) Summary of all diglycine-scanning experiments.
(C) Distribution of candidate ubiquitinated proteins by protein class. A detailed legend
can be found in Table B.1. (D) Comparison of candidate proteins identified in the
Vierstra group’s high-throughput screens ([13, 50]), and all candidate proteins identified
in the large-scale screens identified in this study. Venn diagram generated by the Venny
2.1.0 tool (bioinogp.cnb.csic.es/). (E) Analysis of ±3 residues surrounding the diglymodified Lys residue by the seq2logo tool [41].
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Validation of candidate ubiquitinated proteins
To confirm the modified nature of candidate proteins identified through the
screen, we selected a number of proteins for further analysis. For our initial validation
studies, we selected four candidate proteins (Table 2.5), namely, PATELLIN-1 (PATL1),
PATL2, RIBOSOMAL PROTEIN S3 (herein referred to as S3), and
PHOSPHOGLYCERATE DEHYDROGENASE1 (PGDH1). Ubiquitin footprints have
only been described for PATL1 and S3, and of these proteins only S3 was identified in
our study as being modified on a lysine residue consistent with previous reports [51].
Digly-modified peptides derived from PATL1 were identified in our study with modified
lysine residues distinct from those previously reported.
cDNAs for the four aforementioned proteins were obtained from the Arabidopsis
Biological Resource Centre (ABRC), and subcloned into Gateway®-compatible plant
vectors for expression as N-terminal HA-tag fusions [38]. The proteins were ectopically
expressed in the heterologous Nicotiana benthamiana transient expression system to
confirm proper construction of the plasmids. Western blots revealed bands migrating at
the corresponding expected molecular weights of each of the expression constructs (Fig.
2.14A).
N. benthamiana is widely used in plant biology for protein expression studies, and
it is known that ubiquitination processes in Arabidopsis can be recapitulated in Nicotiana
[36, 52]. Nevertheless, we sought to perform the validation studies in Arabidopsis to
address any issues arising from using a heterologous system.
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Table 2.5. Candidate proteins selected for further analysis.
ATG No.
AT2G31610

Protein
Description
40S ribosomal
protein S3-1

Peptide Sequence
FKDGYMVSSGQPTK*

Screen
2 µL

AGEWKRNK*
W
NVAQADASVK*
W
EPPAK*DSKLVQHER
S
AT4G34200
FASSLSESGEVK*
2 µL
DSK*LVQHER
CST2
EAPAAEAEK*
2 µL
ALEEFK*ELVR
2 µL
AEVTTEK*ASSAEEDGTK
4 µL
EGHVVIYSSYGEFQNK*
W
AT1G72150 Patellin-1
MVFAHGVDKEGHVVIYSSYGEFQNK*
W
CST1
VLGADVSYGAQFEPTTEGSYAVIVSK*TR
CST1
SADVAAAPVVKEKPITDK
CST1
AVKQFEDNYPEFAAK
IQFQEK*CVRSLDFSPEAK
4 µL
AVAAPAPEATEEK*
4 µL
AAPGETK*
W
NALAELKELVREALNK*
W
AT1G22530 Patellin-2
ASEAGKVVITIDNQTFKK#
CST1
CST2
YVAPEVVPVKYGGLSK*DSPFTVEDGVTEAVVK*
CST2
EILQSESFKEEGYLASELQEAEK*
Asterisks (*) indicate digly-modified residue. # indicates ambiguous assignment of digly-modification.
D-3phosphoglycerate
dehydrogenase 1
(chloroplastic)

Screen/enrichment protocol in which the peptide(s) was detected. 2 µL: first large-scale study, 2 µL
injection; 4 µL: first large-scale study, 4 µL injection; W: Waters® protocol; S: large-scale study with
SAX pre-enrichment step.
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Conventional expression studies in Arabidopsis require the generation of stable
transgenic plants, which take several months to generate and mature. To facilitate rapid
protein expression studies in Arabidopsis, the Agrobacterium-mediated transient
expression in Arabidopsis protocol (“AGROBEST”) was employed [37]. In this
Arabidopsis transient expression system, seedlings are co-cultivated with Agrobacterium
cells harbouring the expression constructs of interest.
The AGROBEST protocol was performed to express the four candidate proteins.
Infected seedlings were directly boiled in lysis/sample buffer and proteins were subjected
to western blotting (Fig. 2.14B). Bands corresponding to PGDH1 and S3 were visible on
the western blot, however, PATL1 and PATL2 appeared to be absent.
Given that the AGROBEST system was not amenable to the detectable expression
of PATL1 and PATL2, the Nicotiana transient expression system was used for
subsequent experiments. The four candidate proteins were expressed in the Nicotiana
system, and subjected to immunoprecipitation in order to assess their ubiquitination status
(Fig. 2.15). Western blotting of enriched proteins reveals upwards smears originating
from the expected molecular weight of the protein suggesting that the proteins are
ubiquitinated; however, we were unable to validate their ubiquitination status using both
pan- and chain-specific Ub antibodies.
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PATL2
PDGH1

PATL1
S3

IB: HA

HA3:PGDH1

HA3:S3

HA3:PATL2

HA3:PATL1
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IB: HA

Figure 2.14. Expression of candidate proteins in the Nicotiana and Arabidopsis
(AGROBEST) transient expression systems.
(A) Candidate proteins were expressed as fusions with N-terminal HA-tags in the
Nicotiana transient expression system. Extracts collected 3-dpi were subjected to western
blotting and probed with anti-HA antibody. (B) Arabidopsis seedlings were co-cultivated
with Agrobacterium cells harbouring expression constructs for the indicated candidate
proteins. Plants were lysed in boiling lysis buffer and subjected to western blotting and
probed with anti-HA antibody.
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PATL1
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PGDH1
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kDa
-150
-100
-75
*-50
-37
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Figure 2.15. Validation of protein ubiquitination by immunoprecipitation and western
blotting.
Proteins expressed in the Nicotiana transient expression system were enriched using antiHA antibody, subjected to western blotting and probed with anti-HA antibody. Asterisks
(*) indicate non-specific bands.

In: input; IP: immunoprecipitates
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DISCUSSION
To my knowledge this study is the first that not only employs the anti-diglycine
antibody for the enrichment of digly-modified peptides in Arabidopsis, but utilizes a
workflow that first involves the depletion of RuBisCO followed by FASP-facilitated
generation of peptides. Through reconstitution experiments (Fig. 2.1–2.3, Appendix C),
we displayed the utility of the antibody in Arabidopsis, and expanded its use to largescale screens, resulting in the identification of several hundred previously-unreported
candidate ubiquitinated proteins. Further, while a previous study had compared the use of
the two different digly-antibodies described in this study, this study is the first to use
these antibodies in a sequential manner in order to reduce sample complexity and
increase the yield of identifiable and unique digly-modified peptides. Additionally, these
findings support previous studies with respect to candidate ubiquitinated proteins
identified, while expanding on that knowledge by providing the location of specific
putative Ub footprints.
Adapting the protocol for use in plants required significant bottom-up
troubleshooting
A significant effort was placed in optimizing the trypsinolysis protocol. A
diglycine-enrichment approach using a published protocol [33] failed to reveal diglymodified peptides other than those derived from polyUb chains and two proteins (Table
2.2). This led to a program of protocol optimization in order to ensure that insufficient
trypsinolysis was not the reason for the lack of identification. Protocols specific for plant
tissues were employed, namely one described in a technical poster by Waters®
corporation, and one described for diglycine-enrichment in rice [27]. Unenriched peptide
preparations were submitted to MS analysis, and while they did show a larger yield of
140

peptides on whole, we expected to see a much more diverse set of peptides identified.
Nonetheless, 144 candidate ubiquitinated proteins were identified using both protocols
from 182 candidate digly-modified peptides (Table A.1 & A.2, Fig. 2.4).
Given that RuBisCO is the dominant protein in all photosynthetic plant cells, it
was no surprise that the majority of peptides identified in any screen—digly-modified or
non-modified—were derived from RuBisCO. In order to reduce the sample complexity, I
used PS to deplete RuBisCO in plant lysates ([46], Fig. 2.5), and the resulting depleted
lysates were then submitted for further processing.
Another peptide preparation protocol, FASP, was employed in conjunction with
the PS depletion step. I anticipated that use of a filter in the FASP method would serve to
reduce the concentration of plant metabolites and other compounds that might interfere
with trypsinolysis. Further, because of the 30-kDa molecular weight cut-off of the filters
employed, free polyUb chains should also be excluded from trypsinolysis. This was seen
as an advantage as a high abundance of polyUb chain-derived peptides could otherwise
saturate the digly-antibodies.
The PS+FASP protocol was employed using Arabidopsis seedlings treated with
MG132 in an attempt to block the degradation and enhance the recovery of ubiquitinated
proteins, and 68 mutually-identified candidate proteins were identified across two
iterations of the experiment (Fig. 2.6 & 2.7, Table A.3). A similar approach, but
employing a pre-fractionation step using SAX in an attempt to increase the number of
identified candidate ubiquitinated proteins failed to significantly increase the number of
identifications (Table A.4), since most proteins were identified by a single diglymodified peptide (Fig. 2.8B).
141

In the event that poor enrichment was a consequence of the antibody itself, the
CST Ub PTMScan® kit was used, but failed to provide a significant improvement over
the number of identified candidate proteins (Table A.5 & A.6; Fig. 2.9).
A previous study had shown the Lucerna GX41 antibody and that in the CST kit
showed a differential preference towards residues surrounding the modified Lys residue
[48]. Qualitatively, residues surrounding the modified Lys residue in peptides enriched
using the Lucerna (Fig. 2.8A) and CST antibodies (Fig. 2.9D) suggest that the antibodies
do not significantly preferentially enrich for a discernable pattern.
Given that a large number of digly-modified peptides were derived from common
housekeeping proteins in all screens, we reasoned that successive enrichments with the
digly-antibodies may serve to further reduce sample complexity, and allow for the
identification of lower-abundance proteins. To that end, sequential diglycine-enrichment
experiments were performed, wherein the first-pass enrichment employed the CST
antibody (Table A.7), followed by second-pass enrichment of the flow-thru using the
Lucerna antibody (Table A.8). This protocol increased the total number of identified
candidate proteins, and revealed a small overlap between peptides identified in the firstand second-pass enrichments (Fig. 2.10D,E), suggesting that unique peptides were
captured in the subsequent enrichment step that were not initially enriched. Very little
could be determined in terms of consensus sequence in the residues surrounding the
candidate modified Lys residue (Fig. 2.10F,G), again suggesting that there was no
preferential enrichment of specific peptides. The sequential enrichment also allowed for
the identification of candidate proteins by multiple peptides containing digly-footprints,
with three proteins assigned 7 digly-modified peptides each (Fig. 2.10A–C, Table 2.3).
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Comparison MS analysis of enriched versus unenriched fractions was carried out
(Table A.9, Fig. 2.11A) in order to determine the efficiency of the enrichment, and the
results suggest that there are still a number of digly-modified peptides that are not being
captured by either antibody (Fig. 2.11B), though the number of candidate ubiquitinated
proteins in the sequential enrichment experiment was found to be greater (Fig. 2.11C).
Analysis of residues surrounding the modified Lys residue again failed to show a
convincing consensus sequence (Fig. 2.11D), and the distribution of proteins based on
gene ontology terms is comparable to those from the other screens employed in this study
(Fig. 2.11E) suggesting that no particular approach is enriching or detecting one
subpopulation of protein over others.
Taken together, these results suggest that the diglycine-enrichment approach is
usable in Arabidopsis, though some further refinement might be required on all fronts,
including antibody specificity and affinity, sample preparation, MS analysis, and data
processing. The Lucerna (GX41) digly-antibody was generated against digly-modified
peptides derived from chemically-prepared modified histones [26]. Increased specificity
and affinity towards plant-derived digly-peptides may benefit from generating
recombinant antibodies using phage display libraries—an approach successfully used for
the generation of chain-specific anti-polyUb antibodies [53]—specifically designed
against plant digly-peptides. On the MS front, increased technical and biological
replicates, as well as the inclusion of internal standards and further optimization of
acquisition parameters may improve the accurate identification of candidate proteins.
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Many candidate ubiquitinated proteins are housekeeping proteins
As expected, the identified candidate proteins included a large number of
housekeeping proteins with RuBisCO being dominant despite depletion with PS (Fig.
2.4). Other candidate proteins included heat-shock proteins, ribosomal proteins, and
myrosinase. Interestingly, the identification of candidate digly-modified peptides derived
from RuBisCO itself is a unique finding. RuBisCO is often immediately discarded as a
contaminant in many high-throughput assays, as was the case in a previous study [13].
However, other studies have shown that RuBisCO was degraded in a Ub-dependent
manner [54], and an anti-Ub-reactive band co-migrating at the expected molecular weight
of a Ub–RuBisCO conjugate was detected [55]. To my knowledge, mine is the first study
directly suggesting that RuBisCO is ubiquitinated at specific sites as reported here.
Expanding the ubiquitome
This study adds a significant number of candidate proteins to the expanding
catalogue of reported ubiquitinated proteins. 280 candidate proteins identified in this
study overlap with the lists generated by two large-scale studies performed by the
Vierstra group, and extends the list with 648 additional candidate proteins that were not
identified in previous studies (Fig. 2.13D).
As expected, the results shown here found that proteins involved in the UPS are
ubiquitinated; 2.8% of the candidate digly-modified peptides were found to be derived
from F-box proteins, E3 ligases, UBD-containing proteins, and DUBs—among other
proteins—across all of the screens and protocols employed (Fig. 2.13C). Given that more
than 5% of the Arabidopsis genome encodes for known or predicted components of the
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UPS, these results strongly suggest that a large number of these proteins are themselves
subjected to UPS regulation.
The consistent identification of digly-modified peptides derived from K48- and
K63-linked polyUb chains (Table 2.4) in all screens was used as a control for the
diglycine-enrichment experiments. Further, K6- and K11-linked chains were identified in
the majority of screens, suggesting that K6- and K11-linked chains are common in the
ubiquitome expressed in Arabidopsis seedlings. This finding is consistent with a previous
proteomic screen that found that polyUb chains were found in Arabidopsis in the relative
abundance of K48>K63>K11>>>K33/K27/K6 [13].
While there is little overlap between the footprints identified in this study and
those from previous studies, there are a number of candidate digly-modified peptides that
are derived from previously-reported ubiquitinated proteins. For example, in the SAX
pre-fractionation experiment, a digly-peptide derived from CONSTANS (CO) was
identified (Table A.3). CO was reported to be ubiquitinated by the E3 ligase COP1, and
degraded by the proteasome, although the ubiquitination site was not reported and it was
only shown that its ubiquitination did not occur at the C-terminus [56]. Indeed, our study
supports this finding and suggests that a ubiquitination event occurs on Lys125, which
resides within the N-terminal half of CO.
Other examples of candidate proteins that are of interest include the PATL
proteins PATL1 and 2 (Table 2.5), which have been directly and indirectly reported to be
ubiquitinated. Validation experiments were planned to be undertaken in the Arabidopsis
‘AGROBEST’ transient expression system, but the system was found not to be amenable
to the detectable expression of PATL1 and PATL2 (Fig. 2.14). These validation
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experiments were performed in the Nicotiana transient expression system instead, where
immunoprecipitation of the expressed proteins submitted for validation experiments
exhibited characteristic smears consistent with the suggestion that they are ubiquitinated
(Fig. 2.15).
A large proportion of identified peptides are not digly-modified
A previous study employing the Lucerna GX41 digly antibody reported that
64.65% of peptides identified in the screen did not contain any digly-modified Lys
residues in samples prepared from murine tissues [48], although an equivalent value has
yet to be reported for the CST PTMScan® Kit.
The majority—roughly 10%—of peptides identified in this screen (using both the
Lucerna antibody and the CST kit) were unmodified. Control enrichments using
sepharose beads only failed to identify a large number of peptides, suggesting that the
non-specific enrichment of unmodified peptides is attributable to the digly antibody itself,
and not the beads used for immobilization of the antigen:antibody complex. In bead-only
control experiments, no candidate digly-modified peptides were identified and very few
peptides were identified at all (Table A.12). It should be noted that the CST kit included
antibody pre-conjugated to the beads, thus the corresponding bead-only control
enrichment for the CST kit could not be performed.
A qualitative assessment of non-digly-modified peptides that were enriched and
identified in this study suggests that roughly half of these peptides contain Gly-Gly
within their primary sequence. Whether this finding is a contributing factor in their nonspecific enrichment remains to be determined. Alternatively, qualitative assessment of
enriched digly-modified peptides failed to identify primary Gly-Gly sequences within
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candidate digly-modified peptides, suggesting that these peptides are not being enriched
because of internal Gly-Gly sequences as one possible cause of non-specific binding.
The efficacy of the digly-antibody has not yet been reported in Arabidopsis, and
thus its specificity has not yet been reported. It is not inconceivable that the antibody
functions less than optimally in this system, as it has only been used primarily in
mammalian systems. It is also true that antibodies that are commonly used for detection
of mammalian proteins fail to effectively detect the corresponding proteins in plants, or
do so with a high incidence of non-specific cross-reactivity. Many commonly-used
antibodies in other systems designed against epitope tags often fail to detect these tags in
plant lysates (i.e., FLAG- and HA-tags), which is possibly due to contaminating and
competing factors in plant extracts or even post-translational modifications that alter
epitopes.
Further refinement of the enrichment protocol may require further optimization of
the antibody itself. Nonetheless, through both the reconstitution experiments and largescale digly-enrichment assays undertaken in this study, I have demonstrated that the
digly-antibody can be used for the identification of ubiquitinated proteins in Arabidopsis.
Ubiquitinated lysine residues are not always resistant to trypsin cleavage
A hallmark of trypsin cleavage is its inability to cleave post-translationallymodified Lys and Arg residues, which is exploited in the diglycine-scanning approach.
Lys residues that are ubiquitinated are expected to be resistant to C-terminal trypsin
cleavage. Hence, for all proteins whose ubiquitination sites reside within an internal Lys
residue (i.e., Lys residues that do not reside at the very C-terminus of the protein) it is
expected that the corresponding digly-modified peptide should not contain a C-terminal
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digly-modified Lys. Nonetheless, this and previous studies [13] have identified diglymodified peptides from known ubiquitinated proteins that possess C-terminal digly-Lys
residues. Some of these C-terminal digly-Lys residues also correspond to previouslyidentified ubiquitination sites, further supporting the verity of the identification. A study
by Denis, et al. [49], showed that trypsinolysis of Ub chain standards resulted in the
formation of peptides bearing C-terminal digly-modified Lys residues, again supporting
the notion that Lys modification does not necessarily result in resistance to trypsin
proteolysis. This is an important finding given that some high-throughput screens have
intentionally excluded identifications of peptides containing C-terminal digly-modified
Lys residues, most notably the screen performed by Kim, et al. [13]. Excluded peptides
from their study include peptides derived from bona fide ubiquitinated proteins with
those digly-modified C-terminal Lys residues previously reported as the site of
ubiquitination. This highlights the importance of careful analysis of data obtained in large
screens, and that any en masse filtering process must be carefully optimized to ensure
that false positives are, indeed, false positives.
More interestingly, the same study by Denis, et al., showed that trypsinolysis of
ubiquitinated proteins can result in peptides bearing a footprint that itself contains a
missed cleavage (LRGG) instead of the canonical digly motif (-GG). It was hypothesized
that sterically, the residues surrounding Arg74 and Gly75 of Ub may not be accessible to
trypsin, thus resulting in the missed cleavage [49]. This finding has potential implications
for discovery studies of ubiquitinated proteins involving searches for the digly remnant;
that is, modification searches may need to include the +383.2 m/z modification.
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Until now, it has not been reported whether the digly antibody was capable of
enriching for LRGG-modified peptides. The study presented here suggests that LRGGmodified peptides can be identified in screens using either the CST kit or the Lucerna
GX41 antibody (Table A.10 & A.11), and that many of these candidate LRGG-modified
peptides are derived from proteins that also contain digly-modified peptides (Fig. 2.12).
Nonetheless, further study is required to confirm that the LRGG modification identified
in this study is a consequence of the proposed steric hindrance preventing complete
proteolysis between Arg74 and Gly75, and not simply due to insufficient addition of
trypsin to the reaction. Further, given the enrichment of a large number of non-diglymodified peptides, it is possible that the LRGG-modified peptides are simply included in
this list non-specifically. In any case, the presence of putative LRGG-modified peptides
suggests that this modification does not entirely preclude these peptides from enrichment
with the digly antibodies used in this experiment. Thus, the diglycine-enrichment
protocol may be a useful tool for identifying other types of digly-based Ub footprints that
may otherwise be excluded from other screens.
Advantages of the diglycine-scanning approach
The successful identification of ubiquitinated proteins has been plagued by a
variety of factors including the low stoichiometry of ubiquinated proteins and the rapid
turnover of proteins marked for degradation by the Ub tag. This may be equally true for
both large-scale discovery studies, as well as for small- or individual-scale experiments.
The diglycine-scanning approach alleviates some of these issues in that protein
fractionations are no longer constrained by mild conditions for immunoprecipitation,
which in many cases leave the crude extract active in terms of DUB and other
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protease/proteasome activity. Some of these issues have been circumvented through the
use of transgenic cells/plants expressing His6-tagged Ub [51], allowing for immobilized
metal affinity chromatography (IMAC) enrichment under denaturing conditions.
A Ub combined fractional diagonal chromatography (COFRADIC) approach was
undertaken by Walton, et al., to map the Arabidopsis ubiquitome [57]. Primary amines on
all proteins are first protected through N-acetylation followed by deubiquitination of the
modified proteins with USP2cc, the promiscuous catalytic core of the human DUB USP2.
The newly-exposed primary amine sites—previously occupied by the Ub tag—were then
modified with Gly-BOC (butyloxycarbonyl) and proteins subjected to RP-HPLC
(reverse-phase high-performance liquid chromatography). The BOC group was then
removed from the peptides by acid treatment leaving behind the Gly residue and the
peptides were subjected to MS analysis.
The preliminary COFRADIC experiment resulted in the identification of 3009
unique peptides after two replicates, mapping sites to 1607 proteins. Interestingly, the
only peptides identified derived from polyUb chains were those resulting from
trypsinolysis of K48-linked polyUb chains. They argue that the low stoichiometry of the
other linkages may be a factor in the inability of COFRADIC to detect the other
modifications. In my data presented here, peptides derived from K63-linked chains in
addition to K48-linked chains have always been abundant to the extent that diglymodified K63 peptides were detectable even through lower-sensitivity MALDI-TOF-MS
analyses of both enriched samples (using digly-antibody) and non-enriched whole-cell
preparations (Fig. 2.3). An additional feature of the approach is that the protocol
employed ArgC for proteolysis, which resulted in averagely larger peptides than trypsin,
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making the identification of peptides more difficult. That being said, trypsinolysis and
ArgC degradation will result in the same K63 digly-modified peptide (m/z 2228 in
Arabidopsis) given that the most proximal ArgC cleavage sites flanking K63 are
degenerate with that of trypsin (both are Arg sites), so that ArgC and trypsin proteolysis
both result in a peptide that is identical. Nonetheless, an advantage of the COFRADIC
system is its potential to identify non-canonical (i.e., non-Lys) ubiquitination sites, such
as N-terminal ubiquitination, which would not be captured using digly antibodies.
A further advantage of our study is the direct identification of candidate
ubiquitinated proteins based on the digly-remnant, rather than relying on both modified
or unmodified peptides for protein identification. For instance, many candidate proteins
identified in Ub-affinity chromatography-based experiments were identified through the
enrichment of unmodified peptides. Thus, what is produced is a list of proteins with no
Ub footprint, and no evidence that they are ubiquitinated besides the fact that they are
captured by the affinity column.
Ubiquitination sites display no conserved ubiquitination motif
This study has employed a number of different approaches towards the goal of
identifying novel candidate ubiquitinated proteins in Arabidopsis. Qualitative assessment
of all candidate digly-modified peptides identified in this study reveals that there is no
conserved motif surrounding the modified Lys residues in these digly-remnant-containing
peptide data sets (summarized in Fig. 2.13E), which makes the generation of predictive
tools much more difficult. The closest equivalent of a “ubiquitination motif” are
“degrons” or “phosphodegrons” contained in some proteins—sequences that are known
to bind cognate E3 ligases to promote the protein’s ubiquitination (reviewed in [58]). For
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example, substrates of SCFβ-TrCP possess a conserved phosphodegron—a sequence which
contains single or multiple Ser/Thr residues that must be phosphorylated in order for βTrCP binding [59], although motifs surrounding the modified Lys residues have not been
described.
Current software designed for ubiquitination site determination such as UbPred
[11] employ machine learning approaches and train such software against current
empirically-determined datasets. While combing through current datasets is useful, a
limitation to this approach is that these software would be limited to being able to predict
ubiquitination sites that occur within the same context as those substrates from which the
software was trained. For example, development of prediction software by Walsh, et al.,
[60] utilized the list of ubiquitination sites determined by Wagner, et al., who used the
Lucerna GX41 antibody for digly-enrichment [48]. While the approach undertaken in this
thesis shares a similar limitation, there is no doubt that the dataset arising from the
Wagner study is biased; indeed, the Wagner study showed that a significant number of
digly-modified peptides were not enriched based on the antibody in use. Thus, any bias in
the dataset would be expected to manifest itself in any software using such datasets for
training. This highlights the importance of empirically generating a list of ubiquitinated
proteins to as large an extent as possible, in order to more effectively train software for
predicting ubiquitination sites.
The future of the diglycine-scanning approach in Arabidopsis
Multiple iterations of the diglycine-scanning approach have revealed unique
difficulties arising from the plasticity and dynamic nature of plants. Plants owe their
evolutionary success to their ability to cope with biotic and abiotic factors as complex
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sessile organisms that are transparent to environmental challenges. Plants exhibit
tremendous plasticity in their response to changes in their environment at the
transcriptomic, metabolomic, and undoubtedly, proteomic levels. While external
experimental variables (e.g., growth conditions) are kept as constant as possible, it is
nevertheless true that small discrepancies in the preparation procedure can be expected to
manifest themselves as changes at the molecular level. Thus, multiple repeats of each
experiment are important in the development of an approach that best captures the plant
ubiquitome.
One of the main objectives of this project was to develop an approach that would
allow for the identification of differentially ubiquitinated proteins in different genetic
backgrounds so as to associate the ubiquitination of proteins with certain components of
the ubiquitination machinery. As this project has progressed, this goal has proven to be a
tall order. Firstly, the lack of the identification of identical ubiquitination sites within and
across different preparations suggests that ubiquitination sites within some proteins are
dynamic. That is, it is possible that under different conditions and times, different Lys
residues are used for modification; thus, using high throughput approaches to determining
whether the preference towards certain sites carries biological significance would be
difficult, and requires more directed studies on individual candidates on an individual
protein basis. Secondly, the catalogue of ubiquitinated proteins in the wild-type
background must be as complete as possible using this approach in order to have a
sufficient list in which to juxtapose the mutant catalogue. If peptides are missing from
one list due to technical issues, then this will lead to the misidentification of differentially
ubiquitinated proteins.
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Biologically, there is a question of compensatory mechanisms and redundancies
that may exist within the system on multiple levels. For instance, by impairing CULRING ligase activity by using the Neddylation inhibitor MLN4924 or the thermosensitive
cul1-7 mutant line [61], there may be other E3 ligases that can facilitate the
ubiquitination of the CUL-RING ligase substrates—or in the case of the latter, other CUL
subunits—thus resulting in little to no observed difference the digly peptides derived
from those proteins between the two backgrounds. Further, it is also difficult to interpret
differential modified Lys residue identifications if they are proving to be inconsistent
even within the same genetic background.
Ideally, stable isotope labelling-based approaches can be used for comparing
peptides derived from plants of different genetic backgrounds. This would allow for the
growth of plants and preparation of materials under identical or near-identical conditions,
thus minimizing as much as possible variation between samples. This type of approach,
in conjunction with the diglycine-enrichment protocol developed here may provide the
best comparative quantitative approach to address ubiquitome-level changes.
Further, the diglycine-scanning protocol need not be employed on its own. Other
studies employing an affinity chromatography step, or even an approach like BioID
(discussed in Chapter 4), can be coupled to this procedure.
No single approach exists to capture the entire ubiquitome
There have been a number of large-scale approaches performed to date and,
including this one, it is apparent that there is no one-size-fits-all approach to the
identification of ubiquitinated proteins in Arabidopsis. In order to truly paint a broad
picture of the ubiquitome, multiple approaches must be combined, including those that
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have already been employed such as the approach used in this study, as well as tandem
purification/MS analyses, ligase trapping, and the like, as well as future tools that may
currently be in development.
Through this study, a workflow has been developed for the large-scale
identification in Arabidopsis of not only candidate ubiquitinated proteins, but also their
corresponding ubiquitination sites This study also supports the finding that diglyfootprints do not necessarily render modified Lys residues resistant to trypsin cleavage,
and that analyses should include searches for LRGG-modified peptides which may reveal
more candidate ubiquitinated proteins.
With further refinement and development, the approach described here can prove to
be invaluable to the field of plant ubiquitin biology and will greatly improve our
understanding of the role of ubiquitination in plant form and function.
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CONCLUSION
To my knowledge, this work is the first of its kind to undertake the large-scale
identification of ubiquitinated proteins in Arabidopsis, combining a RuBisCO-depletion
step, FASP and diglycine-scanning approaches. The relatively low yield in contrast to
expectations highlights the difficulty in identifying ubiquitinated proteins on a large
scale. These challenges are further compounded by the fact that plants are extremely
plastic to their environment where we expect their proteomes—including the component
ubiquitome—to exhibit dynamic change across developmental time and space.
This work presents only a limited snapshot of the Arabidopsis ubiquitome, but
can be expanded to study changes in the ubiquitome throughout development. In
conjunction with the use of quantitative MS tools, comparative analyses can be
performed between different Arabidopsis lines harboring loss-of-function alleles of
different components of the UPS. Further refinement of this approach will provide an
invaluable tool to the plant Ub community.
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CHAPTER 3
ASSESSING THE UBIQUITINATION OF PATELLIN-11

1

The work described in this chapter is the product of joint work.
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INTRODUCTION
Validation of candidate proteins identified in the large-scale screen
High-throughput proteomic screens can be very powerful tools for the efficient
identification of proteins subjected to various types of post-translational modifications.
Indeed, the large-scale diglycine-scanning approach described in Chapter 2 generated a
large number of candidate ubiquitinated proteins, including putative ubiquitination sites.
Nonetheless, the utility of such surveys relies on validating the findings of these screens
and undertaking functional studies to better understand the context in which these
ubiquitination events occur. To that end, four candidate proteins were selected for rapid
validation studies, to ensure the verity of the findings from the diglycine-scanning
approach (described in Chapter 2). One candidate, in particular, was of interest given its
potential involvement in auxin signaling; this protein is PATELLIN-1 (PATL1).
Cell division in plants
Cell division in plants differs from cell division in metazoans in that plant cells
possess a cell wall—which restricts the spatial rearrangement of cells—and a new cell
wall must be formed between nascent daughter cells. The acquisition of cell fate is
largely dictated by the asymmetric division of the parent cell, and because of the
immotile nature of the plant cell, the spatial orientation of the plant cell and the direction
in which the asymmetric division occurs is central in the acquisition of specific fates by
the nascent daughter cells (reviewed in [1]). Hence, proper cell wall formation is
paramount for proper cell differentiation and the biogenesis of complex tissues and
organs. In this process, the required materials are delivered to the newly-forming cell
plate through membrane-trafficking events (reviewed in [2]).
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Membrane-trafficking events dictate when the partition between new sets of
daughter chromosomes begins [3]. Mitotic spindle remnants form the fenestrated
phragmoplast in late anaphase, which initiates cell-plate formation [4]. Vesicles add to
the periphery and thus result in the expansion of the cell plate, with microtubule
depolymerization and polymerization occurring in the centre and edges, respectively [5,
6]. The cell plate is guided to the parent cell membrane in an actomyosin-dependent
manner [7-9]. Fenestrae within the phragmoplast are filled in through the fusion of new
vesicles. Many proteins that are involved in cell-plate biogenesis are related to proteins
involved in membrane-trafficking in other eukaryotes, such as the kinesin-related
proteins involved in cytokinesis [3].
The PATL family proteins are Sec14-GOLD domain-containing proteins
PATL1 was identified as a novel cell-plate-associated protein, sharing sequence
similarity with proteins implicated in membrane-trafficking in other eukaryotes [10].
PATL1 belongs to the six-member family of PATL proteins (including PATL2 through
PATL6) all of which contain a Sec14 lipid-binding domain as well as a C-terminal Golgi
dynamics (GOLD) domain.
The Sec14 domain was first described in the Sec14p lipid-binding protein in S.
cerevisiae, where these domains were found to undergo conformational changes upon
lipid binding that are thought to effect changes in adjacent domains [11]. Sec14p is able
to bind both phosphatidyl inositol (PtdIns) and phosphatidyl choline (PtdCh) and is
responsible for the bidirectional transport of these molecules across membranes [12]. The
GOLD domain comprises 90–150 amino acid residues forming a jelly-roll barrel, and is
involved in mediating protein–protein interactions [13]. For instance, GPC60 is a Golgi
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membrane protein that interacts with the N-terminal cytoplasmic region of Giantin,
through the GPC60 GOLD domain [14]. Additionally, the GOLD domain contains a Lysrich motif resembling known PtdIns-4,5-P2-binding motifs [15]. In Sec14-GOLD
proteins, the Sec14 domain invariably appears N-terminal to the GOLD domain
(reviewed in [15]).
Functionally, PATL1 was found to bind unilamellar membrane vesicles composed
of PtdCh and PtdIns, at a ratio of 10% and 90%, respectively, but not to vesicles
composed of phosphatidylethanolamine (PtdEth) [10]. The group also tested PATL1
binding to PtdIns derivatives where PATL1 was found to bind to vesicles composed
predominantly of PtdIns(5)P, as well as PtdIns(4,5)P2 and PtdIns(3)P, and to a much
lesser extent, PtdIns(4) and PtdIns(3,5)P2. PATL1 has also been implicated in cell wall
activities. For instance, proteomic analysis of cell walls of cucumber (Cucumis sativus
L.) lines that were either resistant or highly sensitive to the powdery mildew-causing
microbe Sphaerotheca fuliginea revealed different levels of PATL1 in each line [16].
PATL1 localization and expression
PATL1 protein was detected in all Arabidopsis tissues examined including root,
leaf, buds, closed and open flowers, and siliques [10]. In Arabidopsis root cells
undergoing cell division, PATL1 was found to localize to the cell plate in rapidlydividing cortical cells following cytokinesis. Fractionation experiments suggest that
PATL1 is a peripheral membrane protein since the majority of the protein was found
within the microsomal membrane (P100) fraction, although some protein was found in
the soluble cytosolic (S100) fraction. This supports the hypothesis that PATL1
peripherally associates with intracellular membranes. These findings were also replicated
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in zucchini (Cucurbia pepo) where similar results were found [17]. In a separate study,
PATL1 was found to co-enrich with the plasma membrane-associated disease resistance
protein RPS2 [18].
Expression of PATL genes in Arabidopsis was found to be up-regulated in
response to phosphorus starvation [19]. Though the significance of this PATL upregulation was not explained specifically, the study showed that membrane lipids are
remodelled under phosphate-deficiency, with the suggestion that increased abundance of
PATL transcripts may be important in this context. Similarly, in soybean (Glycine max)
where seven PATL genes were identified, expression of these genes was also found to be
up-regulated in response to phosphorus starvation [20]. However, unlike the PATL
proteins in the aforementioned species which were found to be expressed in many
different tissues, expression of soybean PATL genes was limited to roots and stems.
Auxin gradients play a central role plant patterning and development, and are
established by the polar plasma membrane-localization of PIN-FORMED (PIN) proteins
[21]. These PIN proteins are auxin transporters and through their asymmetric localization
mediate the directional flow of auxin [22].
Microarray studies were performed in order to identify genes that may be
regulators of PIN polarity in Arabidopsis [23]. To that end, the expression profiles of
genes in wildtype Col-0 and axr3-1 mutant backgrounds in response to the synthetic
auxin NAA (1-napthaleneacetic acid) were assessed. Their study showed that 523 and
667 genes were differentially regulated in the wildtype and axr3-1 backgrounds,
respectively, with an overlap of 245 candidate genes under AXR3-dependent auxin
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regulation, including the PATL genes. Further, these studies show that PATL4 colocalizes
with PIN proteins as the principal auxin efflux carriers in plants.
PATL proteins were identified in the diglycine-scanning approach
PATL1 was one of several proteins identified in the diglycine-scanning approach
discussed in the previous chapter, and was selected for further studies for several reasons.
PATL1 has already been identified through a high-throughput screen for ubiquitinated
proteins bearing the modified Lys site (Lys285) as previously reported [24]. Interestingly,
the large-scale diglycine-scanning analysis described in Chapter 2 has identified eight
candidate Lys residues within PATL1 that may act as ubiquitination sites which are
distinct from the previously-reported residue. PATL1 has been shown to be modified
with a K63-linked polyUb chain in a separate, large-scale screen for proteins modified
with K63-linked polyUb chains [25]. PATL1 was also found to interact with the DUB
AMSH3, which predominantly acts on K63-linked polyUb chains [26]. This same study
also showed that PATL2 interacts with AMSH3, providing indirect evidence to suggest
that PATL2 is ubiquitinated in a K63-linked fashion. Further, PATL1 protein levels were
found to be lower in seedlings homozygous for the amsh3 mutant allele when compared
to wild-type [26].
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CHAPTER OVERVIEW
In this chapter, I describe work performed towards the goal of characterizing the
ubiquitination events on PATL1. Specifically, we sought to elucidate the significance of
the ubiquitination event on PATL1 and to determine whether ubiquitination might direct
PATL1 to the proteasome and/or vacuole (lysosome) for degradation. We also wanted to
confirm reports that PATL1 was modified with K63-linked polyUb chains and to
determine whether ubiquitination involving other chain-types might be formed. Further,
because of the implication of auxin signaling on PATL expression, and the known
association between a member of the PATL family and PIN proteins involved in auxin
efflux, we tested whether a potential relationship existed between PATL1 and TIR1, and
if SCF complexes might be involved in PATL1 ubiquitination.
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MATERIALS & METHODS
Plasmids, Cloning, and Agrobacterium
The Gateway®-compatible TMV-Gate binary plasmids were used for expression
of proteins in Arabidopsis thaliana and Nicotiana benthamiana (a kind gift from Dr.
Kevin Rozwadowski ([27], Table 3.1). cDNAs encoding the proteins of interest were
obtained from the Arabidopsis Biological Resource Centre (ABRC), and were provided
in the pENTR223 backbone. For Gateway® cloning, 50 ng of each pENTR223 and pSK
construct were combined with 0.25 µL of LR Clonase II enzyme (Invitrogen) and
incubated at 25°C for 16 h. Reaction volumes were brought up to 10 µL with RO H2O
and 1 µM of reaction was used for electroporation of competent E. coli. Bacteria were
plated on LB agar supplemented with 50 µg/L kanamycin (BioBasic) for 16 h. Individual
transformants were grown in 5 mL LB broth with kanamycin for 16 h, and plasmids were
isolated using a mini prep kit (BioBasic, BS614; or Frogga Bio, PDH100).
Agrobacterium tumefaciens strain GV3101 or AGL1 were transformed with 100 ng of
construct via electroporation.
For production of recombinant protein in the bacterial expression system, PATL1
was sub-cloned into the pDEST565 Gateway®-compatible bacterial expression vector,
encoding an N-terminal GST-His6 tag. As above, 50 ng of each pENTR223 and
pDEST565 plasmids were mixed with 0.25 µL of LR Clonase II enzyme and incubated
for 16 h at 25°C. Sequence-verified constructs were introduced into E. coli BL21
CodonPlus-RIL cells via electroporation.
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Table 3.1. Plasmids used and generated in this study.
Destination Vectors
Tag
pSK102
N-terminal HA3
pDEST565
N-terminal GST-His6
pBiFP2
N-terminal nYFP
pBiFP3
N-terminal cYFP
pEarleyGate104
N-terminal YFP
pEarleyGate202
N-terminal FLAG
pEarleyGate203
N-terminal Myc
ENTRY Vectors
ATG Number
pENTR223:PATL1
AT1G72150
Expression Vectors
Product
pSK102:PATL1
HA3:PATL1
pBiFP2/3:PATL1
n/cYFP:PATL1
pBiFP2/3:ASK1
n/cYFP:ASK1
pBiFP2/3:TIR1
n/cYFP:TIR1
pDEST565:PATL1
GST-His6:PATL1
pEarleygate202:PATL1
FLAG:PATL1
pEarleygate203:PATL1
Myc:PATL1
Vac-CK
γ-TIC:CFP
ABRC: Arabidopsis Biological Resource Center, Ohio
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Source
[27]
Addgene
[28]
[28]
[29]
[29]
[29]
Source
ABRC
Source
This study
This study
[30]
[30]
This study
This study
This study
[31]

Recombinant expression in E. coli
E. coli BL21 cells harbouring the desired constructs were grown on LB agar
supplemented with 100 µg/L ampicillin (Sigma). A single colony was selected and grown
in 5 mL LB broth with 100 µg/L ampicillin for 16 h at 37°C. The following morning, 500
mL of fresh LB broth was inoculated with the overnight culture, and allowed to grow at
37°C until OD600 reached approximately 0.4–0.6. Expression of the recombinant protein
was induced by the addition of 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG,
BioBasic) and allowed to incubate at 37°C for 4 h.
Cells were harvested by centrifugation at 4,000 g at 4°C for 10 min. Cells were
lysed in 20 mL lysis buffer [25 mM Tris-Cl, pH 7.5; 100 mM NaCl; 1 mM EDTA; 1 mM
PMSF; 1 ´ cOmplete Mini Proteasome Inhibitor] with mechanical disruption by
sonication. Lysates were cleared by centrifugation at 6,000 g for 10 min. Recombinant
GST-fusion proteins were purified by adding 500 µL of a 50% slurry of glutathione resin
(Genescript, cat. no. L00206), and incubated at 4°C overnight. Beads were washed three
times in lysis buffer, and proteins were eluted in lysis buffer supplemented with 50 mM
reduced glutathione (Sigma, cat. no. G4705).
In planta degradation assays
N. benthamiana leaves were infiltrated with Agrobacterium cultures harbouring
the pSK102 constructs of interest, as described previously [32]. Infiltrated leaves were
injected with 50 µM MG132 (Sigma, cat. no. C2211), 10–100 µM concanamycin A
(Sigma, cat. no. C9705) or 0.1% DMSO diluted in water using a blunt-end Tuberculin 1mL syringe (BD, cat. no. 309659). Leaf discs were punched using a single-hole puncher
at the indicated time points. Proteins were extracted via a chemical lysis method [33],
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wherein three discs were incubated in 100 µL of sample buffer [0.1 M EDTA, pH 8.0;
0.12 M Tris-Cl, pH 6.8; 4% w/v SDS; 10% v/v 2-mercaptoethanol; 5% v/v glycerol;
0.005% w/v bromophenol blue] for 7 min at 80°C.
In vitro degradation assay
Extracts were prepared from 7- or 14-day-old Arabidopsis seedlings, which were
flash-frozen and ground in liquid nitrogen prior to suspension in 1 mL of Wang’s [34]
lysis buffer [50 mM Tris-Cl, pH 7.5; 10 mM NaCl; 10 mM MgCl2; 4 mM PMSF; 5 mM
DTT; 10 mM ATP] per 1 g tissue. Lysates were cleared by centrifugation at 13,000 g for
10 min, twice.
Clarified lysates were supplemented with either 100 µM MG132 or DMSO, and
recombinant purified protein. Reactions were aliquoted into 20-50 µL samples, and
incubated at 22°C for the indicated durations. Samples were boiled in 4´ Lammeli buffer,
and subjected to western blotting and probed with anti-GST antibody (Santa Cruz, Z-5).
Immunoprecipitation
Agro-infiltrated Nicotiana leaves expressing the constructs of interest were flashfrozen and ground in liquid nitrogen and resuspended in RIPA buffer [150 mM NaCl;
0.5% sodium deoxycholate; 50 mM Tris-Cl, pH 8.0; 0.1% SDS; 1% Igepal; 1´ cOmplete
Mini Protease Inhibitor Cocktail (Roche); 5 mM iodoacetamide; 5 mM Nethylmaleimide; 1 mM PMSF]. 0.6% w/v of insoluble polyvinyl(poly)pyrrolidine (PVPP)
was added to the suspension, which was then vortexed. Lysates were cleared by
centrifugation at 13,000 g for 10 min at 4˚C, twice. Samples were pre-cleared by
incubation with a 50% slurry of protein G agarose for 2 h at 4˚C. Beads were removed by
centrifugation, and 1 mL of cleared lysates were incubated overnight with 5 µL of anti172

HA antibody (Roche, 3F10). Immune complexes were captured with protein G
Dynabeads® (Invitrogen, cat. no. 1003D) for 4 h at 4˚C. Samples were washed with wash
buffer [50 mM TRIS-HCl, pH 7.5; 0.1% Triton X-100; 150 mM NaCl; 0.1% SDS] three
times for 2 min. Enriched proteins were eluted by boiling with 50 µL 4´ Laemmli buffer.
Microscopy
Nicotiana leaves Agro-infiltrated with the appropriate constructs were submitted
to epifluoresence microscopy (Leica DMI6000) at 3 days post-injection (dpi). Leaf punch
discs were mounted on moistened microscope slides with the abaxial side facing up and
coverslipped. Fluorescent protein tags were visualized using the GFP and CFP filters for
YFP- and CFP-tagged proteins, respectively.
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RESULTS
PATL1 degradation is sensitive to the proteasome inhibitor MG132
Modification with K63-linked polyUb chains is generally known to serve 26S
proteasome-independent roles, both non-proteolytic and proteolytic. In yeast [35] and
mammals [36], K63-linked ubiquitination can serve to target the modified protein for
degradation via the vacuole/lysosome, although K63 chain-directed vacuolar degradation
in plants has yet to be described.
Results from our diglycine-scanning approach (Chapter 2, Table 2.5) revealed
candidate Ub-remnant footprints on PATL1 Lys residues distinct from the previouslyreported Lys285 residue. To see if ubiquitination on additional lysine residues served
different signaling roles, we wanted to test if PATL1 is subject to degradation by the 26S
proteasome. An in vitro cell-free degradation assay was performed by incubating
bacterially-expressed GST:PATL1 with active extracts derived from Arabidopsis
seedlings. Reactions were treated with the proteasome inhibitor MG132 or mock treated
with DMSO, quenched and boiled at the indicated time points with sample buffer.
With the mock DMSO treatment, levels of GST:PATL1 appeared to decrease
over time (Fig. 3.1), while the levels of GST:PATL1 appeared to be stable in extracts
treated with MG132, suggesting that degradation of PATL1 is to some extent,
proteasome-dependent.
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Figure 3.1. Degradation of PATL1 in a cell-free system.
(A,B) Purified recombinant GST:PATL1 was incubated in cell extracts prepared from 14day-old Arabidopsis seedlings. Reactions were supplemented with MG132 or DMSO
(control) and incubated at 22°C for the indicated times. Reactions were quenched by
boiling in sample buffer and subjected to western blotting before probing with anti-GST
antibody. (C) Quantification of fold-change in GST:PATL1 levels between 0 and 60
minutes in MG132- and DMSO-supplemented reactions of the experiment shown in (A).
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BiFC analysis suggests that TIR1 does not interact with PATL1
Because of the influence of auxin signaling on PATL1 expression, we proposed
that SCFTIR1 may be involved in PATL1 ubiquitination. To explore this hypothesis,
bimolecular fluorescence complementation (BiFC) analyses were performed in a jointeffort with an undergraduate honours student (Mr. Jacob Bender). PATL1 and TIR1 were
expressed in the Nicotiana transient expression system as fusions to either N- or Cterminal fragments of YFP (nYFP and cYFP, respectively) and leaves were analyzed
using epifluorescence microscopy. In case PATL1 is degraded in a 26S proteasomedependent manner, leaves were treated with 50 µM MG132 4 hours prior to imaging.
Split-YFP-tagged ASK1 and TIR1 were co-expressed to display a positive BiFC
interaction, as evidenced by the punctate fluorescence in the nucleus (Fig. 3.2, left panels,
white arrow). Co-expression of split-YFP-tagged TIR1 and IAA7—representing an Fbox–substrate interaction—also resulted in the expected fluorescence signal (Fig. 3.2,
centre panels). We failed to see a signal in the nYFP:PATL1 + cYFP:TIR1 combination,
as well as the reciprocal combination (Fig. 3.2, right panels). Based on these results, we
are unable to show that TIR1 interacts with PATL1.
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nYFP:TIR1
cYFP:ASK1

no injection
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cYFP:PATL1
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Figure 3.2. PATL1 interaction network generated by BiFC analysis.
The indicated BiFC constructs were co-expressed in the Nicotiana leaf transient
expression system. Leaves were treated with 50 µM MG132 4-h prior to imaging and the
leaf punches were submitted to epifluorescence microscopy. White arrow indicates
punctate fluorescence arising from a positive BiFC interaction within the nucleus. Scale
bar = 50 µm.
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PATL1 degradation is insensitive to vacuolar inhibition
Previous reports have suggested that PATL1 is modified with a K63-linked
polyUb chain and interacts with the K63-specific DUB AMSH3 [25, 26], although the
biological function of this ubiquitination modification has not yet been reported. K63linked polyubiquitination has been associated with non-proteasomal signaling;
alternatively, these chains can direct their substrates for lysosomal degradation (reviewed
in [37]).
To test whether PATL1 was being targeted for degradation by the lysosome, in
planta degradation assays were performed in the presence of concanamycin A, a VATPase inhibitor used to impair lysosome function [38]. In planta degradation assays
were performed similar to those that used MG132 for inhibition of proteasomal function.
In brief, PATL1 was expressed in the Nicotiana transient expression system and injected
with 10–100 µM concanamycin A (CMA) 3 dpi (days post-injection), for a total of 4
hours prior to harvesting proteins. Lysates were subjected to western blotting and probed
with anti-HA antibody (Fig. 3.3).
CMA treatment of leaves transiently expressing PATL1 did not result in an
appreciable stabilization of relative protein abundance, suggesting that K63-linked polyubiquitination does not target PATL1 for vacuolar degradation—at least not in leaf
tissues of N. benthamiana.
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Figure 3.3. In planta degradation of PATL1 is insensitive to lysosomal inhibition with
concanamycin A and sensitive to MG132.
PATL1 was expressed in the Nicotiana transient expression system with an N-terminal
3´HA-tag. Leaves were treated with 0.1 M concanamycin A (CMA) or 50 µM MG132 4
h prior to lysis. Leaf punches were collected, boiled, and lysates were subjected to
western blotting before probing with anti-HA antibody. RuBisCO was visualized by
Ponceau S staining and was used as the loading control.
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PATL1 does not localize to the vacuole in the Nicotiana transient expression system
To further investigate the finding that PATL1 is not targeted for vacuolar
degradation, we assessed the subcellular localization of PATL1. To that end, PATL1 was
expressed with an N-terminal YFP-tag and co-expressed in the Nicotiana transient
expression system with a known tonoplast (vacuole membrane) marker in plants, γTIP:CFP [31]. Leaf discs were analyzed by epifluorescence microscopy. Signals arising
from the YFP channel suggests that PATL1 localized to the cytosol, but did not colocalize with the tonoplast marker (Fig. 3.4, left panels).
It has been reported that fluorescence of auto-fluorescent proteins in the vacuole
is often obscured [39]. To inhibit potential degradation of the protein if it were to localize
within the vacuole, and to prevent the inhibition of auto-fluorescence within the vacuole,
leaves were treated with 100 µM CMA 4 hours pre-imaging. These results likewise
suggested that PATL1 did not localize within the vacuole or the tonoplast (Fig. 3.4,
centre panels). Given that MG132 has been shown to increase the relative abundance of
PATL1 in both in vitro and in planta degradation assays, the localization of YFP:PATL1
was also assessed in leaves treated with 50 µM MG132, 4 h pre-imaging (Fig. 3.4, right
panels). No localization distinct from those seen in CMA treatments was observed.
Taken together with the CMA in planta degradation assays, these results provide
further evidence that K63-linked polyubiquitination of PATL1 does not result in its
vacuolar degradation in the Nicotiana transient expression system. K63-linked polyUb
chains have been associated with non-proteolytic functions such as signaling endocytic
and endosomal sorting (reviewed in [40]). Our results suggest that K63-linked
modification of PATL1 may serve a non-proteolytic role.
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Figure 3.4. Subcellular localization of PATL1 in the Nicotiana transient expression
system.
The tonoplast marker γ-TIP:CFP and YFP:PATL1 were co-expressed in the Nicotiana
transient expression system. Leaves were treated with 100 µM CMA or DMSO, and
submitted to epifluorescence microscopy 4 hours post-treatment. Solid arrows indicate
location of small vacuoles. Scale bar = 50 µm.
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Determining ubiquitin chain topology and modification site on PATL1
Two previous reports have identified PATL1 as a ubiquitinated protein. In the
first report, Lys285 of PATL1 was found to be digly-modified suggesting that PATL1
was ubiquitinated [24]. In the second report that used a K63 chain-specific sensor,
PATL1 was identified as possessing a K63-linked chain [25]. Whether these two items of
data are independent of each other, or are describing the same event, is yet to be
determined. To address this question and, additionally, whether PATL1 is modified with
multiple chain types, PATL1 was expressed with an N-terminal 3´HA-tag in the
Nicotiana transient expression system and enriched with anti-HA antibody.
Immunoprecipitates were subjected to western blotting, and successful
enrichment was confirmed by probing with anti-HA antibody (Fig. 3.5A). A band
migrating at the expected molecular weight was observed, with a corresponding highmolecular weight smear. To confirm that this smear was indicative of ubiquitination, the
blot was probed with two different types of anti-Ub antibody, but neither blot was
reactive to the antibody (data not shown). It is possible that this lack of reactivity is due
to low-sensitivity of the antibody, or that the immune-enriched protein is not
ubiquitinated.
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Figure 3.5. Immune-enrichment and characterization of PATL1.
HA3:PATL1 was expressed in the Nicotiana transient expression system. Leaves were
injected with 50 µM MG132 4-h pre-lysis. Lysates were immunoenriched with anti-HA
antibody and immunoprecipitates were subjected to western blotting. Blots were probed
with anti-HA antibody.
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Given the availability of BiFC expression constructs for PATL1, we decided to
assess whether PATL1 was capable of forming a homo-ologimer. While most Sec14
proteins described are known to function as monomers, there has been one case reported
in which a yeast Sec14 protein, Sfh3 (Sec14 family homologue 3), was found to
homodimerize [41]. nYFP- and cYFP-N-terminal-tagged PATL1 were co-expresed in the
Nicotiana heterologous expression system and submitted to epifluorescence analysis (Fig.
3.6). Fluorescence was observed localizing to the periphery of the upper epidermal leaf
cells, suggesting cytoplasmic localization of a dimerization event, consistent with the
localization of the protein in the previous localization experiments (cf. Fig. 3.4). To
validate the BiFC results, Myc- and FLAG-tagged PATL1 were co-expressed in the
Nicotiana transient expression system and lysates were enriched using anti-Myc
antibody. Western blotting of immune-enriched samples revealed co-enrichment of
FLAG:PATL1 with Myc:PATL1 (Fig. 3.7), further lending credence to the BiFC results.

184

Figure 3.6. Homodimerization of PATL1 revealed by BiFC.
nYFP:PATL1 and cYFP:PATL1 were co-expressed in the Nicotiana transient expression
system. Leaves were treated with 50 µM MG132 4 hours prior to epifluorescence
microscopy. Fluorescence arising from an interaction can be observed at the periphery of
the cell.
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Figure 3.7. Confirming PATL1 dimerization by co-immunoprecipitation.
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Myc:PATL1 and FLAG:PATL1 were co-expressed in the Nicotiana transient expression
system. Leaves were treated with 50 µM MG132 4 hours prior to protein extraction in a
native lysis buffer. Lysates were submitted to immune-enrichment with anti-Myc
antibody. Immune-enriched proteins were submitted to western blotting and probed with
anti-FLAG antibody.
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DISCUSSION
Digly-modified peptides derived from PATL1 were identified in our large-scale
diglycine-enrichment screens (Chapter 2), with putative conjugation sites mapping to
novel Lys sites. PATL1 is described as a novel cell plate-associated protein, and has been
shown to be ubiquitinated in a K63-linked manner.
PATL1 degradation is dependent on the 26S proteasome
I wanted to test whether PATL1 might be degraded by the 26S proteasome; to that
end, an in vitro degradation assay was performed with recombinant PATL1 incubated in
cell-free Arabidopsis extracts. PATL1 protein levels were stable in reactions
supplemented with MG132 (Fig. 3.1), suggesting that degradation of PATL1 is
dependent on the 26S proteasome either directly (i.e., a substrate itself) or indirectly (i.e.,
its degradation is dependent on processing of other proteins by the proteasome).
Expression of the PATL genes was found to be regulated in an auxin-dependent manner,
and other PATL family members, namely PATL4, have been implicated in the vectorial
transport of auxin [23]. TIR1, and other auxin F-box proteins (AFBs) are principally
responsible for integrating auxin response through their activity as part of the SCF
complex [42]. To test whether the SCFTIR1 might be involved in the ubiquitination of
PATL1, we first performed BiFC analysis to assess if TIR1 interacted with PATL1 and
failed to detect an interaction (Fig. 3.2), suggesting that TIR1 is likely not directly
involved in PATL1 degradation.
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PATL1 is not degraded in nor targeted to the vacuole
Given the reported K63-linked polyUb modification of PATL1, I wanted to test
whether PATL1 was also being degraded in the vacuole. One consequence of K63-linked
polyUb modification is the degradation of the Ub-conjugate via the vacuole/lysosome,
although in plants no K63-modified proteins have yet been shown to be degraded in the
vacuole. To address the question, the V-ATPase inhibitor CMA was employed, which
acts to inhibit acidification of the vacuole [38]. In this manner, proteases within the
vacuole are not expected to be active, though transport of proteins in and out of the
compartment should not be affected. In planta degradation assays involving the transient
expression of PATL1 in the Nicotiana system and subsequent CMA treatment suggested
that PATL1 is not degraded in the vacuole, since no stabilization or increase in the
relative abundance of the protein was observed (Fig. 3.3). To further support this finding,
fluorescence co-localization experiments were performed. YFP:PATL1 failed to colocalize with the tonoplast (vacuole membrane) marker γ-TIP, suggesting that PATL1
was not targeted to the tonoplast, nor within the vacuole compartment itself (Fig. 3.4, left
panels). It has been noted that fluorescence from otherwise fluorescent proteins are
generally undetectable from within the vacuole because of the low pH; however, this
issue has been circumvented with CMA treatment [39]. PATL1 similarly displayed
cytoplasmic localization both in the absence and presence of CMA, further supporting the
suggestion that PATL1 is not targeted to the vacuole for degradation (Fig. 3.4, centre
panels). Leaves were also treated with MG132 to assess whether an abundance issue
might affect detection of its localization, but this was not the case (Fig. 3.4, right panels).
Taken together, these results suggested that PATL1 degradation was not mediated by the
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vacuole, at least in the Nicotiana system, and that its K63-linked ubiquitination must be
serving a role other than degradation—perhaps one in regulating PATL1 trafficking.
Indeed, the DUB AMSH3 was found to be essential in intracellular trafficking [26], and
may be regulating the activity of PATL1 by augmenting PATL1 localization in a Ubdependent manner. Further studies are required to further characterize the function of the
K63-linked modification.
The presence of multiple ubiquitination sites could not be confirmed
The large-scale diglcyine screen that forms part of this work suggested that
PATL1 was ubiquitinated at multiple Lys residues. To confirm this finding, we sought to
perform western blotting and MS analyses to determine the topology of ubiquitination
and the modification sites. To that end, transiently-expressed PATL1 was
immunoenriched (Fig. 3.5), however we were unable to detect ubiquitination using antiUb antibodies. Detecting ubiquitinated species can be a difficult task, especially in cases
where the Ub-conjugate is targeted for degradation. Even in the presence of a protease
inhibitor, ubiquitinated proteins are still subjected to DUB activity which prevents their
efficient detection. Leaves were treated with MG132 prior to protein extraction, and the
DUB inhibitors N-ethylmaleimide (NEM) and chloroacetamide were added to the lysates
during immunoprecipitation. A faint, but characteristic smear was visible when probing
with anti-HA antibody, which suggested enrichment of ubiquitinated species. Further
work is required on this front to characterize the high-molecular weight species, and
putative ubiquitination sites.
Though we were not able to directly show that PATL1 is modified with polyUb
chain-types other than K63-linked chains, the results described in this study, together
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with those from the two previous reports [24, 25], strongly suggest this to be the case.
The first study reported a digly-footprint on Lys285 of PATL1; additional and previously
unreported digly-modified Lys residues were identified in our approach (Chapter 2,
Table 2.5). In a sensor-based method, the second study reported that PATL1 was
modified with a K63-linked chain, though it was not known whether Lys285 was
modified with a K63-link or other chain-type. Given that our results suggested that
PATL1 was degraded by the 26S proteasome, it is likely that PATL1 is modified with
other non-K63-linked polyUb chains. If, however, PATL1 was exclusively ubiquitinated
in a K63-linked manner, then PATL1 would be one of a very few K63-modified proteins
that are targeted for proteasomal degradation.
Determining the biological relevance of each of the candidate ubiquitination sites
would be difficult. Firstly, conventional approaches would undertake to mutate the eight
Lys residues in question both singly, and in all possible combinations. To further
complicate matters, ubiquitination of some proteins does not necessarily dictate that
specific Lys residues be ubiquitinated. For instance, the Aux/IAA protein IAA1 was
shown to be ubiquitinated on non-Lys residues in a Lys-less IAA1 variant [43];
nonetheless, Lys residues were ubiquitinated when present, suggesting that some residues
are preferentially ubiquitinated. This calls into question the value of undertaking sitedirected mutagenesis studies involving all or a subset of the candidate Lys residues. That
is, there is the possibility that mutating the Lys residues may not necessarily abolish
PATL1 ubiquitination, and may not truly reveal the significance of the ubiquitination
event(s) that are known to occur in vivo.
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This study is also the first to show that PATL1 may engage in a novel
homodimerization event, through both BiFC (Fig. 3.6) and co-IP (Fig. 3.7) experiments.
Most Sec14 domain-containing proteins described in yeast function as monomers,
however, the related Sfh3 protein was found to function as a homodimer [41]. In this
context, it was shown that dimeric PATL1 is not bound to PtdIns, but upon addition of
PtdIns, the PATL1 dimer dissociates and is stabilized as PtdIns-bound monomers. How
this might affect the dynamics of PATL1 function would require further study, however,
PATL1 dimerization may similarly modulate PtdIns binding in plants.
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CONCLUSION
The results presented here support the findings arising from the large-scale
diglycine-enrichment screens that additional ubiquitination sites exist on PATL1.
Degradation of PATL1 was found to be sensitive to proteasomal inhibition and
insensitive to the inhibition of vacuole acidification. Co-localization experiments
suggested that PATL1 did not localize within the vacuole or the tonoplast. Taken
together, these results suggest that the K63-linked polyubiquitination of PATL1 serves a
role other than targeting the protein for vacuolar degradation, and that PATL1 is likely
modified with other chain types. This study also suggests that PATL1 may engage in a
novel homodimerization event.
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CHAPTER 4
PROXIMITY-BASED BIOTIN LABELLING FOR PROTEIN–PROTEIN
INTERACTIONS
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INTRODUCTION
Protein activity oftentimes relies on the interaction of proteins with one another.
Understanding protein function not only relies on its structure but a knowledge of the
interaction networks in which the protein participates; thus, large-scale studies for the
identification of interacting protein–protein partners can serve as an invaluable tool for
the high-throughput characterization of protein function. The diglycine-scanning survey
in Arabidopsis (described in Chapter 2) delivered a list of candidate ubiquitinated
proteins with their associated Ub-remnant footprints. In order to provide context to the
ubiquitination events occurring on these candidate proteins, approaches need to be
designed to generate interaction networks that specifically associate the candidate
ubiquitinated proteins with their cognate UPS components. Further, assessing the
interaction networks in which UPS components participate can shed light on the
combinatorial diversity enjoyed by, particularly, subunits of the SCF complex in
Arabidopsis. Indeed, previous studies by our group have explored interaction networks
formed by various ASK and F-box proteins, suggesting that the formation of different
SCF complexes is dependent on the differential spatial and temporal expression of these
components [1]. Moreover, oligomerization of the F-box protein TIR1 was shown to be
important for the efficient degradation of known Aux/IAA protein substrates, revealing a
novel aspect of auxin-mediated ubiquitination [2]. Studies undertaken to further
characterize TIR1 oligomerization-dependent ubiquitination would be best served by
high-throughput approaches that can assess changes in the interaction profiles between
wildtype and mutant tir1 isoforms.
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APPROACHES FOR STUDYING PROTEIN–PROTEIN INTERACTIONS
Many techniques have been developed and employed for assessing protein–
protein interactions. Classical techniques such as co-immunoprecipitation (co-IP) assays
have been used for decades, with its capabilities increased with the advent of mass
spectrometry, producing the go-to technique of affinity purification-mass spectrometry
(AP-MS). However, approaches such as AP-MS carry with it several limitations, owing
to the nature of the interaction. In many instances, the protein–protein interactions are
transient, and are not sufficiently stable enough to be captured through IP techniques. To
circumvent this issue, chemical cross-linkers, such as formaldehyde or BS3 (reviewed in
[3]), can be used to stabilize the interaction, allowing interacting proteins to be
immunoprecipitated in complex with each other.
Bimolecular fluorescence complementation (BiFC)
In many cases, it is desirable to observe the protein–protein interaction in situ, in
order to learn about the context in which these interactions occur. Further, the subcellular localization of the interactions under study can often provide added insight into
its biological function.
Tom Kerppola at Michigan State University developed an in situ, fluorescencebased interaction assay known as bimolecular fluorescence complementation (BiFC) [4].
In this approach, two candidate interacting proteins are expressed as fusions with split
halves of an autofluorescent protein, such as yellow fluorescent protein (YFP). The split
halves are not autofluorescent individually, but when they come into proximity to each
other—as would be the case when their fusion partners interact—the fluorescent protein
(FP) halves re-associate and reconstitute the fluorescent signal. Through the use of
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fluorescence microscopy, a signal can then be observed suggesting an interaction
between the candidate proteins. The sub-cellular localization of this interaction can also
be visualized. This approach provides many advantages over its counterpart approaches.
Proteins can be studied in situ and in planta ([2, 5]), allowing for live-cell imaging. This
approach has been used to study temporal-dependent interactions, such as those involving
cell cycle regulatory proteins (reviewed in [6]). Further, the re-association of the split-FP
halves exhibits, in most cases, enhanced stability, thereby rendering visible otherwise
transient interactions. While the use of the fusion of a somewhat large FP tag can present
drawbacks arising from the potential to hinder a given interaction, this this can be largely
mitigated by generating the binary fusions in the 8 different orientations (i.e., N- and Cterminal tags) and testing the combinations represented by four orientational, plus the
other four with reciprocal tags on the candidate proteins.
One drawback to the BiFC approach is the need to generate individual, pairwise
transfections of split-FP-fusion expression constructs, thus hindering the scalability of
BiFC for application in high-throughput, unbiased interactome screens. Nonetheless,
BiFC has been and continues to be a very useful tool in both mammalian and plant
research communities. Experiments described in earlier chapters exploit this approach for
the analysis of select protein–protein interactions involving components of the SCF
complex.
Yeast two-hybrid (Y2H)
The heterologous yeast two-hybrid (Y2H) screen was developed in 1989, and
since then has become a widely-adopted approach for studying protein–protein
interactions on a large scale [7]. In its original form, the assay involved the fusion of the
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GAL4 activating domain (AD) and DNA-binding domain (BD) to two proteins of
interest. The interaction of the two proteins results in the trans-reconstitution association
of the AD and BD to a single complex, resulting in the formation of an active GAL4
transcription factor, and expression of the LacZ gene or other reporter gene products
useful for the identification of yeast clones harbouring productive interactions.
The Y2H approach is amenable to high-throughput screens given that cDNA
libraries can be rapidly subcloned into plasmids encoding AD-fusions. In large-scale
“fishing” approaches, bait proteins are fused to the GAL4 BD, and co-expressed in yeast
with cDNAs from the desired libraries fused to the GAL4 AD. β-gal-positive colonies
can be sequenced to determine the identity of the captured bait protein. The Y2H assay is
also amenable to semi-automation, as demonstrated in the development of a protocol for
generating a C. elegans interaction map [8]. Further, the approach has shown its utility in
the identification and characterization of protein-interaction studies in plants, including
the model species A. thaliana [9].
Despite its utility, there are some concerns regarding the use of heterologous
expression systems such as that employed by the Y2H system. First, and foremost, select
protein–protein interactions may be dependent on post-translational modifications for the
interaction to occur that may not be conserved in yeast. Secondly, because proteins in the
screen are constitutively expressed in yeast in the same temporal and spatial space where
they may interact they may not be co-expressed in the originating organism in vivo.
Hence, a large-scale approach would preferably be one that addresses these
considerations.
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PROXIMITY-BASED BIOTIN IDENTIFICATION (BIOID)
The biotin ligase (BirA)
The biotin-streptavidin interaction (KD = 10-13–10-15) is the strongest non-covalent
interaction currently known [10, 11]. Only a handful of endogenous proteins are
biotinylated in nature under the action of biotin ligating proteins (BLPs; reviewed in
[12]). In E. coli, this BLP is encoded by the BirA locus whose gene product biotinylates
the only biotinylated protein in E. coli—a subunit of acetyl-CoA carboxylase [13]. It was
thought that because of its small number of natural substrates, and the strength of the
biotin-streptavidin interaction, an assay could be developed that would take advantage of
these properties.
The Biotin Acceptor Peptide (BAP)-tag approach
One targeted interaction assay that utilizes BirA involves the fusion of a biotin
acceptor peptide (BAP) tag to one candidate interacting protein, and a BirA-tag to the
other [14]. If the two proteins interact or come into proximity with each other, the BAP
tag is specifically biotinylated, and can thus be enriched using avidin- or streptavidinconjugated beads followed by identification and characterization. The disadvantage to
this approach is that, similar to some of the aforementioned approaches, it is not readily
amenable to large-scale discovery studies.
A system similar to the BAP tag approach was developed for plant studies. In this
system, proteins were tagged with an ‘HBD’ tag, comprised of the biotin carboxyl carrier
protein domain (BCCD), which can be biotinylated in Nicotiana [15]. Expression of a
bait protein bearing the HBD tag allowed for in vivo biotinylation, followed by
streptavidin affinity capture of the fusion protein and its interactors. This technique has
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been used to study the cross-talk between pathogen-triggered immunity (PTI) and
effector-triggered immunity (ETI) in Arabidopsis [16].
Studies into a segment of the loop involved in BirA-ligand (biotin or bio-5’-AMP)
binding identified a highly conserved sequence—115GRGRXG120—found in all known
biotin holoenzyme ligases [13]. Binding kinetics studies showed that variations within the
loop at positions 115, 118, and 119 resulted in significant energetic penalties [17],
suggesting that point mutations of these residues would affect BirA-ligand binding.
A modified approach to the BirA-based method employs the R118G BirA mutant,
commonly referred to as in the literature as BirA*. (For simplicity, “BirA” hereafter
refers to the BirAR118G mutant.) As a promiscuous form of the ligase, BirA is capable of
activating biotin molecules within a 50-nm radius, effectively forming a cloud of
“charged” biotin molecules that are capable of conjugating to free amines on proteins in
proximity to BirA [10].
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PROTEIN–PROTEIN INTERACTION STUDIES TO UNDERSTAND
UBIQUITINATION IN PLANTS
A complete view of the Arabidopsis ubiquitome requires an understanding of the
link between the ubiquitination machinery and substrates of ubiquitination. Large-scale
protein–protein analyses would allow us to associate different components of the UPS
with their substrates. Indeed, the BioID approach has been used to identify interacting
proteins and potential substrates of the SCFβ-TrCP1/2 ligase in mammalian cells [18].
TIR1 is the paradigmatic plant-specific F-box protein
Approximately 700 known or predicted proteins comprise the F-box protein
family in Arabidopsis. Of the plant-specific F-box proteins, TIR1 is one of the most wellcharacterized and plays an important role in auxin perception [19, 20]. Though much is
known about TIR1 and its regulation of the downstream auxin response, many key
regulatory questions remain. Recently, our lab discovered that the SCFTIR1 complex
functions most-efficiently as an oligomer, despite the fact that TIR1 lacks a canonical
dimerization domain [2]. Further, TIR1 belongs to a family of related auxin F-box
proteins (AFBs), most of which are known to function in the auxin response. One study
has shown that the pyramiding of tir1 and afb mutant alleles results in a progressively
more severe auxin response phenotype, suggesting that TIR1 and AFBs play unique as
well as redundant roles in the auxin response [21].
A comprehensive understanding of TIR1 requires a complete catalogue of
substrates
It is clear that the while TIR1 serves as the paradigm for plant F-box proteins,
there is still much work to be done among the less-well characterized F-box proteins that
participate in regulating the auxin response. Identifying the substrates of TIR1 would
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allow us to expand our understanding of the molecular basis of auxin perception. As the
‘master regulator’ of plant patterning, auxin is involved in many aspects of plant
development. Most substrates of the SCFTIR1 complex that have been identified to date
have been restricted to the Aux/IAA family of proteins, which act as transcriptional corepressors that inhibit expression of auxin-responsive genes [20]. Interestingly, no studies
have actually identified endogenous Aux/IAA proteins as being ubiquitinated—possibly
because of their rapid turnover by the proteasome. Further, recent data from our lab has
shown that the oligomerization of TIR1 is required for the efficient degradation of a
number of known Aux/IAA protein substrates [2].
The BioID approach may offer a feasible approach for the identification of TIR1
substrates by screening for TIR1 interacting proteins and assessing their ubiquitination
status using both in vitro and in planta approaches.
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CHAPTER OVERVIEW
Here I describe attempts at adapting the BioID system for use in the plant system,
directed to the development of a high-throughput assay for the association of E3 ligase
components and their cognate substrates. The thrust of this project is two-fold; firstly, I
wanted to adapt the BioID approach in Arabidopsis as a means for the large-scale and
efficient validation of findings from the diglycine-scanning approach. Secondly, this tool
could prove valuable for the further characterization of TIR1 by generating a more
complete profile of SCFTIR1 substrates.
To that end, Gateway®-compatible binary plant expression vectors were
generated, and the expression of the BirA construct as well as its ability to autobiotinylate
in planta was tested. As a proof-of-principle experiment, BirA:TIR1 was co-expressed
with ASK1 in the Nicotiana transient expression system, to confirm that plants are
amenable to the BioID approach.
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MATERIALS & METHODS
Generating BioID plasmids for plant expression
The BirA-FLAG coding sequence was PCR amplified from the
pDEST_pcDNA5_BirA_FLAG-Nterm construct (a kind gift from the Raught Lab,
University of Toronto [22]) using primers containing restriction sites for XhoI (forward
5′-TTGGAGAGGACACGCTCGA GATGGACTACAAAGACGATGACGATAAAGC3′ and reverse 5′-TTGTACAAACTTGTGATCTCGAGCTTCTCGGCGCTCCGCAG3′). The resulting PCR amplicon and the binary plant expression plasmid pEarleyGate100
were digested with XhoI, and ligated using the Quick LigationTM Kit (NEB; cat. no.:
M2200) as per manufacturer’s instructions. Reactions were transformed into
electrocompetent TOP10 E. coli cells and selected on LB agar supplemented with 50
mg/L kanamycin. Transformants were grown in LB broth supplemented with 50 mg/L
kanamycin and plasmids were extracted using an EZ-10 Spin Column Plasmid DNA
Miniprep Kit per the manufacturer’s instructions (BioBasic; cat. no.: BS413).
A full list of constructs employed in this study can be found in Table 4.1.
Gateway® recombination
The procedure for Gateway®-mediated site-specific recombination is outlined in
Chapter 2.
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Table 4.1. Plasmids generated and used in this study.
Destination Vectors
Tag
pEarleyGate100
None
pEarleyGate201
N-terminal HA
pEarleyGateBirA
N-terminal BirA-FLAG
ENTRY Vectors
pENTR223:TIR1
pENTR223:IBR5

Source
[23]
[23]
This study
Source
ABRC
ABRC

Expression Vectors

Product

Source

pEarleyGate201:ASK1
pEarleyGate201:IAA7

HA:PATL1
HA:IAA7

[2]
[2]

pEarleyGateBirA:TIR1
pEarleyGateBirA:IBR5

BirA-FLAG:TIR1
BirA-FLAG:IBR5

This study
This study

ABRC: Arabidopsis Biological Resource Center, Ohio
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BioID pilot experiments in Nicotiana benthamiana
N-terminal BirA-fusions were co-expressed with N-terminal HA-tag fusions to
known interactors of the BirA-tagged proteins of interest in the N. benthamiana transient
expression system. Leaves were infiltrated with 50 µM biotin (BioBasic) 24 hours prior
to protein extraction. Leaves were flash-frozen and ground to a fine powder in liquid
nitrogen, and resuspended in grinding buffer [15] [50 mM HEPES, pH 7.5; 10 mM
EDTA; 330 mM sucrose; 0.6% polyvinylpyrrolidine; 1 mM DTT; 1 mM PMSF; 1X
Complete Protease Inhibitors (Roche)] at a ratio of 5 mL buffer per 1 g of tissue. Lysates
were twice cleared by centrifugation at 13,000 g for 10 min.
Biotinylated proteins were affinity-captured using streptavidin-conjugated beads
(Invitrogen, Dynabeads® MyOne Streptavidin C1). 10 uL of beads were added to each
lysate and incubated overnight at 4°C. Beads were washed three times in IP buffer
[50mM TRIS-HCl, pH 7.5; 0.1% Triton-X 100; 150 mM NaCl; 0.1% SDS].
Beads were incubated in 4´ Laemmli sample buffer (BioRad, cat. no. 1610747),
supplemented with 10% v/v 2-mercaptoethanol and 50 µM biotin, at 80°C for 7 min.
Samples were subjected to western blotting, and probed with rat anti-HA antibody
(Roche, 3F10).
Generation of transgenic plants
Agrobacterium harbouring the construct of interest were streaked onto LB agar
containing the appropriate antibiotics. A single colony was selected and grown in 5 mL
of LB broth supplemented with antibiotics for 48 h at 28˚C. The cultures were then used
to inoculate 500 mL of LB broth with antibiotics, and allowed to grow for 24 h at 28˚C.
Cells were harvested by centrifugation at 5,000 g for 10 min at room temperature and
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resuspended in 500 mL of 5% sucrose. Suspensions were mixed gently using a stir bar
and Silwet-77 was added to the suspension at 50 µL/500 mL. Aerial tissues including
floral buds of 8–12-week-old Arabidopsis plants were dipped in the solution with gentle
agitation for 10 s. Plants were then wrapped in plastic wrap, laid sideways, and incubated
in a dark drawer for 24 h. Plants were then removed and replaced in a Conviron chamber
until the emergence and subsequent recovery of seeds from siliques.
Selection of transgenic plants
Seedlings obtained from F1 progeny of the dipped plants were sown on 0.5X MS
agar as per standard procedures. Plants transformed with plasmids harbouring the bar
resistance gene were plated onto Basta®-containing 0.5´ MS agar (Bayer Crop Corp.; 25
µM), and stratified at 4˚C for 3 days in darkness. Following stratification, plates were
placed in light at 22˚C for 6 hours followed by 2 days of incubation at 22˚C in the dark.
Following dark treatment, plates were returned to light, after which plants exhibiting dark
green cotyledons and roots penetrating deep into the agar were recovered from the
Basta®-supplemented plates and transferred to fresh 0.5´ MS agar. Seedlings were
subsequently transferred to soil after about 2 weeks, and seeds were collected 8–10 weeks
later. The procedure for transgenic selection was repeated until a homozygous population
was obtained, usually at the 3rd transgenic generation (T3).

209

RESULTS
Generating Gateway®-compatible BioID plant expression vector
In order to perform the BioID experiments in plants, BioID plasmids first needed
to be generated for expression of the fusion constructs in plants. The majority of fulllength cDNAs encoded by the approximate 34,000 genes comprising the Arabidopsis
genome are available through the Arabidopsis Biological Resource Centre and cloned
into Gateway®-compatible vectors, thus facilitating cloning into custom expression
vectors. Thus, it was most appropriate to design the BioID plasmid to be Gateway®compatible.
Before starting construction of the plant BioID vector, I first assessed whether the
humanized form of BirA used in the mammalian BioID plasmids [24] could be expressed
in plants, noting the difference in codon selection bias the two living Kingdoms. To that
end, the BirA coding sequence was PCR-amplified from the pDEST_pcDNA5_BirAFLAG_Nterm plasmid using attB-containing primers for recombination into the
pENTR221 vector, followed by recombination into the plant expression vector,
pEarleyGate201, encoding an N-terminal HA-tag fusion [23]. The construct was
transformed into Agrobacterium strain AGL-1 and expressed in the Nicotiana transient
expression system. Western blotting of lysates from the agroinfiltrated leaves showed
strong expression of the HA:BirA fusion protein (Fig. 4.1), suggesting that the coding
sequence for the BirA-tag did not require further editing for plant expression.
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Figure 4.1. Expression of humanized BirA in Nicotiana.
The coding sequence of humanized BirA (mBirA*) was subcloned into a plant expression
vector and ectopically expressed as an N-terminal HA fusion in the Nicotiana transient
expression system. Tissues were flash-frozen and ground, and lysates were subjected to
western blotting, and probed with anti-HA antibody. Arrow indicates band migrating at
expected molecular weight of the construct.
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Given the successful expression of the BirA coding sequence in plants, I
proceeded with generating a Gateway®-compatible BioID plant expression vector using
the pEarleyGate100 [23] destination vector as the backbone. The BirA-FLAG coding
sequence was PCR-amplified from the pDEST_pcDNA5_BirA-FLAG_Nterm plasmid and
ligated into the pEarleyGate100 plasmid, N-terminal to the Gateway® cassette (Fig. 4.2).
Expression of this plasmid was anticipated to result in a construct composed of the BirAFLAG fused to the N-terminus of the protein-of-interest.
BioID fusion proteins are expressed and autobiotinylate in Nicotiana
To test the expression of the plant BioID plasmid, herein referred to as
pEarleyGateBirA, the coding sequences of TIR1 and IBR5 were subcloned into the
plasmid via Gateway® cloning into pEarleyGateBirA. IBR5 (INDOLE-3-BUTYRIC
ACID REPSONSE 5) is a dual-specificity phosphatase, identified through a screen for
EMS-mutagenized Arabidopsis lines resistant to indole-3-butyric acid [25]. Y2H and
BiFC analyses previously conducted in our lab suggest that IBR5 interacts with the SCF
ligase subunit ASK1. IBR5 was included in this proof-of-principle study to validate this
finding, and to further investigate its potential association with other components of the
SCF ligase.
Expression constructs were transformed into Agrobacterium strains GV3101 or
AGL-1 and used for agroinfiltration of Nicotiana leaves. Proteins were extracted from the
leaves 3 days post-infiltrated (dpi), and subjected to western blotting (Fig. 4.3). Probing
with anti-FLAG antibody revealed successful expression of BirA, BirA:TIR1, and
BirA:IBR5.
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35S

BirA
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attR1

GatewayTM site

attR2

Figure 4.2. Schematic diagram for pEarleyGateBirA.
The BirA coding sequence was subcloned from the human pDEST_pcDNA5_
BirA_FLAG plasmid into the pEarleyGate100 binary plant expression vector to generate
a Gateway®-compatible BioID plasmid for plant expression. The pEarleyGateBirA
plasmid incorporated the BirA-FLAG-tag N-terminal to the Gateway®-recombination
site and under the control of a constitutive 35S promoter.
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Figure 4.3. Expression of BioID constructs in Nicotiana.
BirA, BirA:TIR1, and BirA:IBR5 were expressed in the Nicotiana transient expression
system. Leaves were flash-frozen and ground, and lysates were submitted for western
blotting analysis, and probed with anti-FLAG antibody.
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To test the functionality of the BirA tag in terms of its capacity to biotinylate in
plants, the autobiotinylation of the fusion proteins was assessed. To that end, leaves
infiltrated with Agrobacterium harbouring the constructs of interest were injected with 50
µM biotin 2 dpi (24 hours prior to protein extraction). Tissues were lysed in grinding
buffer and subjected to western blotting, and probed with HRP-conjugated streptavidin
(Fig. 4.4). Bands migrating at the expected molecular weights of the fusion proteins were
observed.
Known interactors of BirA fusions are biotinylated
To assess whether known interacting partners of proteins fused to BirA were
being biotinylated in this system, pilot experiments were undertaken in the Nicotiana
transient expression system. In the first study, BirA:TIR1 and BirA:IBR5 were coexpressed with HA3:ASK1 as prey (herein simply referred to as HA:ASK1). Lysates
from these leaves were enriched with streptavidin-conjugated beads, subjected to western
blotting and probed with anti-HA antibody (Fig. 4.5A). A protein was detected in both
the BirA:TIR1+HA:ASK1 and BirA:IBR5+HA:ASK1 lysates that was not detected in the
BirA+HA:ASK1 lysate.
A similar experiment was performed to assess whether an interaction with a TIR1
substrate could be detected. BirA:TIR1 was co-expressed with HA:IAA7, and
biotinylated proteins were enriched using streptavidin-conjugated beads. Western blotting
of enriched proteins failed to detect to HA:IAA7 co-enriching with the streptavidinconjugated beads (Fig. 4.5B).
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Figure 4.4. Autobiotinylation of BioID constructs in Nicotiana.
(A) BirA:TIR1 and (B) BirA:IBR5 were expressed in the Nicotiana transient expression
system. Leaves were injected with 50 µM biotin 24 hours pre-extraction. Lysates were
subjected to western blotting and probed with with anti-FLAG antibody or HRPconjugated streptavidin. Arrows indicate bands migrating at the expected molecular
weights of the constructs.
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Figure 4.5. Assessing biotinylation of BirA-fusion interacting partners.
(A) HA:ASK1 and (B) HA:IAA7 were co-expressed with either BirA, BirA:TIR1, or
BirA:IBR5 in the Nicotiana transient expression system. Leaves were injected with 50
µM biotin 24 hours pre-extraction, and lysates were subjected to enrichment with
streptavidin-conjugated Dynabeads®. Precipitates were subjected to western blotting, and
probed with anti-HA antibody. Asterisks(*) indicate non-specific binding.
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Generating stable transgenic Arabidopsis lines
Given the success of expression and biotinylation capacity of the BirA constructs
in the Nicotiana transient expression system, I undertook to generate stable Arabidopsis
transgenic lines for large-scale studies. To that end, ~8–10 week old tir1-1 Arabidopsis
plants [20] were submitted to floral dip transformation [26] involving constructs
encoding BirA, BirA:TIR1, and a BirA fusion to a tir1 oligomerization-deficient isoform,
tirC140A [2]. The iterative selection process for transgenic lines proceeded as expected
through the T2 generation (Fig. 4.6). However, BirA:TIR1 plants in the T3 generation
exhibited markedly reduced viability to the point that recovery of progeny seed was not
possible, suggesting that the constitutive expression of these constructs has deleterious
effects on the growth of these plants even though transgenic lines expressing the
BirA:tir1C140A allele grew normally and were phenotypically healthily. Given these
results, it seemed reasonable to pursue the generation of inducible BioID constructs for
plant expression that would allow for the generation of viable and stable BirA:TIR1 lines
to later study. These lines are currently at the T2 stage and include the generation of stable
transgenic lines of BirA:IBR5 constructs in the ibr5-1 mutant background.
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tir1-1
35S::BirA

tir1-1
35S::BirA:TIR1

tir1-1
35S::BirA:tir1C140A

Figure 4.6. Generation of stable BirA:TIR1 transgenic lines.
Arabidopsis tir1-1 mutants were floral dipped with Agrobacterium lines harbouring
expression constructs for BirA, BirA:TIR1, and BirA:tir1C140A. T2 generation plants are
shown.
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DISCUSSION
A better understanding of the diverse roles of the UPS in plants requires
connecting the ubiquitination machinery with its substrates and interacting partners. In
order to approach this need efficiently, large-scale high-throughput screens need to be
employed. I envision the BioID approach aiding ubiquitin profiling by complementing
other large-scale studies, such as the diglycine-scanning approach described in Chapter 2.
The BirA-tag is expressed and autobiotinylated in the Nicotiana transient
expression system
To my knowledge, this study is the first to employ the BioID system for the study
of protein: protein interactions in plants. The approach required the generation of a plantspecific Gateway®-compatible destination vector. Successful expression of the BirA tag
derived from the mammalian expression construct (Fig. 4.1) allowed for the generation of
the plant-specific vector (Fig. 4.2) with no modification to the coding sequence required.
It has been previously shown that the Nicotiana transient expression system
recapitulates the auxin-mediated degradation system in Arabidopsis [2]. As a proof-ofconcept experiment, we subcloned TIR1 into the pEarleyGateBirA plasmid, and found
that it was successfully expressed in this system (Fig. 4.3A). Furthermore, probing with
HRP-conjugated streptavidin suggested that BirA and BirA:TIR1 were able to
autobiotinylate in planta, with or without the exogenous addition of biotin (Fig. 4.4).
Known interacting-partners can be enriched using BioID in plants
The co-expression of BirA:TIR1 with HA:ASK1, and subsequent enrichment
using streptavidin-conjugated Dynabeads® suggested that the proximity labelling
approach is functional in planta, since ASK1 was enriched with streptavidin beads when
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co-expressed with BirA:TIR1, but not with the BirA-tag alone (Fig. 4.5A). The same
result was obtained when BirA:IBR5 was co-expressed with HA:ASK1, further
supporting our earlier findings that an IBR5–ASK1 interaction exists. I was not, however,
able to enrich for the TIR1 substrate IAA7 when co-expressed with BirA:TIR1 (Fig.
4.5B).
The lack of detection of a TIR1–IAA7 interaction may be due to its rapid
turnover, especially in the presence of ectopically-expressed TIR1 [27]. This lack of
detection might be remedied by the addition of the proteasome inhibitor MG132 in the
growth media and lysis buffers. It is premature to rule-out the identification of substrates
using this approach, primarily because not all ubiquitinated substrates are targeted for
proteasomal degradation, coupled with the fact this approach has been employed in other
systems for the identification of substrates [18]. An alternative possibility is that,
sterically, the BirA-tag might be interfering with the TIR1–IAA7 interaction, which can
further be assessed by performing co-immunoprecipitation assays. Fine-tuning of the
protocol would be best undertaken in the Arabidopsis system when it is ready.
Complications with the generation of a stable tir1-1 BirA:TIR1 Arabidopsis line
Pilot experiments were undertaken in the Nicotiana system primarily because of
its amenability to rapid transient protein expression experiments which could be
performed while the stable transgenic lines of Arabidopsis were being generated.
Through the T2 generation, tir1-1 plants transformed with the BirA, BirA:TIR1, and
BirA:tir1C140A constructs are growing normally (Fig. 4.6). However, the T3 BirA:TIR1
lines were insufficiently viable to produce seeds, and thus I could not generate
homozygous lines for the BirA:TIR1 construct. Interestingly, the tir1-1 BirA:tir1C140A line
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grew normally, suggesting that the strong expression of BirA:TIR1 driven by the
constitutive 35S promoter may have deleterious effects on the health of the plant. Given
that TIR1 plays a central role in integrating auxin response, and that mutants harbouring
the tir1C140 allele are impaired in the normal response to auxin signaling [2], it is not
unreasonable to suggest that overexpression of TIR1 may be contributing to the poor
health of these transgenic lines.
One remedy to this issue is constructing an inducible BioID plant expression
vector which would allow for tight conditional expression of BirA:TIR1 at select
junctures during development of the plant, in support of BioID-based studies of protein–
protein interactions.
The plant BioID approach in its infancy
This study provides a starting point from which to expand the BioID approach in
plants. Ideally, this approach would have been undertaken in Arabidopsis, specifically in
the tir1-1 mutant background, and involve expression constructs under the control of an
inducible or endogenous promoter. Given the complications with the generation of the
stable BirA:TIR1 transgenic line, one thought was to perform the large-scale BioID
experiment in Nicotiana. While showing this approach in a heterologous plant system
would have provided some information as to the amenability of the plant system for the
approach, the primary question would be that of the complete fidelity of the system to
Arabidopsis. Indeed, Nicotiana has served as a model system for Arabidopsis for quite
some time, and many Arabidopsis pathways are recapitulated in Nicotiana, including
auxin-mediated ubiquitination by TIR1 [2]. However, not all dimensions of the auxin
pathway have been shown to be identical between Arabidopsis and Nicotiana. Further,
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proteomics-based experimentation in Nicotiana is all but precluded given the relatively
undeveloped state of the Nicotiana genome and predicted proteome [28]. Further
assessment of the utility of the system will necessarily await the generation of the
suggested stable Arabidopsis lines.
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CONCLUSION
The BioID approach can be a useful tool in profiling protein ubiquitination in
plants. Connecting the UPS machinery with substrates is one way in which to better
understand why UPS components are so prominent in plants. Further, this tool can act to
validate the findings from other large-scale studies, and can be used in conjunction with
other techniques.
The preliminary work presented here suggests that the BioID approach can be
undertaken in the plant system, though further development and optimization is required.
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CHAPTER 5
CONCLUSIONS
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The major thrust of my research has been to bridge the obvious gap between the
genetic complexity of the ubiquitination machinery in Arabidopsis with the
corresponding paucity of information relating to the size and complexity of the known
ubiquitome in this model plant species. It has become clear that this gap exists because
developing high-throughput approaches for identification of ubiquitinated proteins in
plants presents challenges and that further effort in this direction is required.
Thus far, the largest-scale approaches (described in Chapter 2) have identified
approximately 900 candidate ubiquitinated proteins in Arabidopsis, contributing to a
catalogue of only two thousand candidate proteins. However, in many of these surveys
direct ubiquitination has not been demonstrated and the modified Lys residues have yet to
be identified.
An important question that these screens need to address is the biological context
in which these ubiquitination events occur and their significance to the biology of the
organism. Without these elements of the required information set, a survey that presents a
simple list is of modest utility. The diglycine-scanning approach described here has
delivered not only a list of candidate proteins, but more importantly a program of
protocols that with further refinement and development may serve as a platform for
further studies—especially those that aim to perform comparative analyses in order to
identify differentially-ubiquitinated proteins. This approach has already stimulated
additional studies in our lab, including the directed study towards PATL1 ubiquitination.
Through this survey, we identified putative ubiquitination sites on PATL1 distinct from
those reported in the literature, and our results suggest that PATL1 is targeted for
degradation via the 26S proteasome. Elucidating whether this signal is elicited by non228

K63-linked polyUb chains (as is typical for most substrates of the proteasome) or is
directed by K63-linked polyubiquitination will require additional experimentation.
Characterization of PATL1 through BiFC has also revealed a novel homodimerization
event; the function of this higher-order quaternary structure still requires elucidation, but
may serve a regulatory role.
Lastly, I presented preliminary work directed to the adaptation of a highthroughput approach for assessing protein–protein interactions in plants. Though early in
development, the work presented here suggests that plants are amenable to use of the
BioID proximity-based approach, which may serve as an invaluable tool for the
validation of candidate ubiquitinated proteins identified in our large-scale survey, and for
connecting components of the ubiquitination machinery with their substrates.
In closing, this study has revealed the many facets involved in determining the
identity of ubiquitinated proteins in plants, while at the same time providing some
promising technical avenues for expansion of the known ubiquitome in Arabidopsis.
Plant physiology in general, and the proteome in particular, presents a complex
landscape that rapidly undergoes significant changes over short periods of time in
response to the organism’s environment. One can expect that dynamic changes in the
ubiquitome is no different. It is through studies like the ones described in this thesis that
will provide researchers with the necessary tools to provide a more comprehensive
understanding of the role that ubiquitination plays in plant patterning and development,
extending to an improved understanding of the importance of the UPS to the evolutionary
success of the plant kingdom.
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APPENDIX A
TABLES OF MASS SPECTROMETRY RESULTS
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Table A.1. Candidate ubiquitinated proteins identified using the Waters® protocol.
ATG Number
AT4G11280.1

AT1G32990.1
AT1G04480.1

Protein Description
1-aminocyclopropane-1-carboxylate synthase 6
2_3-bisphosphoglycerate-independent phosphoglycerate
mutase 1
2_3-bisphosphoglycerate-independent phosphoglycerate
mutase 1
3-oxoacyl40S ribosomal protein S3a-2
5-methyltetrahydropteroyltriglutamate--homocysteine
methyltransferase 1
5-methyltetrahydropteroyltriglutamate--homocysteine
methyltransferase 1
50S ribosomal protein L11_ chloroplastic
60S ribosomal protein L23

AT3G09630.2

60S ribosomal protein L4-1

AT5G39740.2

60S ribosomal protein L5-2

AT2G18020.1

60S ribosomal protein L8-1

AT2G05710.1
AT2G05710.1

Aconitate hydratase 2_ mitochondrial
Aconitate hydratase 2_ mitochondrial

AT3G18780.2

Actin-2

AT3G23810.1

Adenosylhomocysteinase 2

AT4G28910.3

AFP homolog 2

AT5G43940.1

Alcohol dehydrogenase class-3

AT5G03690.2

Aldolase superfamily protein

AT3G25770.1

Allene oxide cyclase 2_ chloroplastic

AT1G68560.1

Alpha-xylosidase 1

AT1G09780.1
AT1G09780.1
AT5G46290.2
AT4G34670.1
AT5G17920.2
AT5G17920.2

AT5G14740.5

ATP-dependent zinc metalloprotease FTSH 2_
chloroplastic
ATP-dependent zinc metalloprotease FTSH 8_
chloroplastic
Beta carbonic anhydrase 2_ chloroplastic

AT5G16840.3

Binding partner of ACD11 1

AT3G56130.4

biotin/lipoyl attachment domain-containing protein

AT5G50920.1
AT5G50920.1
AT2G04030.2
AT2G04030.2

Chaperone protein ClpC1_ chloroplastic
Chaperone protein ClpC1_ chloroplastic
Chaperone protein htpG family protein
Chaperone protein htpG family protein

AT1G55490.2

Chaperonin 60 subunit beta 1_ chloroplastic

AT1G55490.2

Chaperonin 60 subunit beta 1_ chloroplastic

AT1G55490.2

Chaperonin 60 subunit beta 1_ chloroplastic

AT5G56500.2

Chaperonin 60 subunit beta 3_ chloroplastic

AT5G56500.2

Chaperonin 60 subunit beta 3_ chloroplastic

AT3G23990.1

Chaperonin CPN60_ mitochondrial
Chloroplast stem-loop binding protein of 41 kDa a_
chloroplastic

AT2G30950.1
AT1G06430.1

AT3G63140.1

Peptide Modification(s) Sequence
GlyGly(18)
IASGDGHGENSSYFDGWK
GlyGly(17)

MATSSAWKLDDHPKLPK

GlyGly(7)

ALEIGEK

GlyGly(21)
GlyGly(5)

FPTRFGGQIRGFSSEGYIDGK
TQGTKIASEGLKHR

GlyGly(8)

STAEDLQKVSADLR

AMTVFWSAMAQSMTSRPM
K
GlyGly(10)
ANVSVQFLGK
GlyGly(9)
GRGGTSGNK
AAGKSWYKTMISDSDYTEF
GlyGly(4)
DNFTK
GlyGly(12)
VHAAIRAEPNHK
ASGDYAIVIAHNPDSDTTRI
GlyGly(21)
KLPSGSK
GlyGly(9)
LMNGEVGPKTVHIPSGEK
GlyGly(5);ox+M(3)
DAMNKLGSDSNK
AVFPSVVGRPRHHGVMVG
GlyGly(22);GlyGly(33)
MNQKDAYVGDEAQSK
GlyGly(*);GlyGly(*)
DGLQVDPKKYHK
SNHGGSGTEEFTMRNMSYT
GlyGly(40);ox+M(33)
VPFTVHPQNVVTSMPYSLPT
K
GlyGly(3)
VWKGTAFGGFK
TVPAAVPAVVFLSGGQSEEE
GlyGly(*)
ATVNLNAINQLKGK
GlyGly(18)
VQELSVYEINELDRHSPK
GlyGly(*);GlyGly(*);ox+ LGNGQSTYVDFYASVGNGT
M(*)
MKMWSQVKEGK
DFLKILLGNAGVGLVASGK
GlyGly(19)
ANADEQGVSSSR
QMVTTFGMSEIGPWSLMDS
GlyGly(38);ox+M(2)
SEQSDVIMRMMARNSMSEK
GlyGly(15)
NGSSDSETTLQSASKATK
HGFTSTATAGVASLDQKIGL
GlyGly(17)
SQK
VSPFKNTSYGKPAKLAALEA
GlyGly(14)
SGSTNYVLVTSPAVGK
GlyGly(7);GlyGly(9)
QAMNVPKGK
GlyGly(14)
VPEPTVDETIQILK
GlyGly(17)
EVFLRELVSNASDALDKLR
GlyGly(16)
NYSQFVGFPIYTWQEK
GlyGly(3);GlyGly(34); MSKEVEDSELADVAAVSAG
ox+M(27)
NNDEIGNMIAEAMSK
GlyGly(35);ox+M(2);
KMSKEVEDSELADVAAVSA
ox+M(28)
GNNDEIGNMIAEAMSK
GlyGly(21);ox+M(1);
MASTFTATSSIGSMVAPNGH
ox+M(14)
K
GVVTLEEGKSAENSLYVVE
GlyGly(9)
GMQFDR
VLSSDNPKHGYNAATGKYE
GlyGly(31)
DLMAAGIIDPTK
GlyGly(12)
IGGASEAEVGEK
GlyGly(19);ox+M(18)

GlyGly(*)

MKKPPFNRFSEIVSGGGK

AT3G63140.1

Chloroplast stem-loop binding protein of 41 kDa a

GlyGly(10);ox+M(27)

AT3G63140.1

Chloroplast stem-loop binding protein of 41 kDa a
Chloroplast stem-loop binding protein of 41 kDa b_
chloroplastic

GlyGly(*)

ADAGHVVVEKYLAETFGN
WASFRPQYMIGSGNNK
AIGVDAKKAFLFR

GlyGly(9)

EIFNISGEK

GlyGly(*);ox+M(*);
ox+M(*)

MMMLQQHQPSFSLLTSSLS
DFNGAK

AT1G09340.1
AT1G09340.1

Chloroplast stem-loop binding protein of 41 kDa b
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Table A.1. (cont’d) Waters® protocol.
ATG No.
AT3G59760.3
AT1G65930.1
AT4G34200.1
AT4G34200.1

Protein Description
Chloroplast stem-loop binding protein of 41 kDa b_
chloroplastic
Cysteine synthase_ mitochondrial
Cytosolic isocitrate dehydrogenase
D-3-phosphoglycerate dehydrogenase 1_ chloroplastic
D-3-phosphoglycerate dehydrogenase 1_ chloroplastic

AT5G61410.2

D-ribulose-5-phosphate-3-epimerase

AT1G09340.1

Peptide Modification(s) Peptide Sequence
DQHFFASVEKAKHVLGWKP
GlyGly(18)
EFDLVEGLTDSYNLDFGR
GlyGly(15);ox+M(6)
MVAMIMASRFNREAK
GlyGly(9)
KWPLYLSTK
GlyGly(8)
AGEWKRNK
GlyGly(10)
NVAQADASVK
AGVVLNPGTPLSAIEYVLDM
GlyGly(44);ox+M(20);
VDLVLIMSVNPGFGGQSFIES
ox+M(27)
QVK

AT1G07940.2

Dihydrolipoyllysine-residue acetyltransferase component
GlyGly(5);GlyGly(8)
4 of pyruvate dehydrogenase complex_ chloroplastic
Elongation factor 1-alpha 2
GlyGly(7)

AT4G29060.1

elongation factor Ts family protein

GlyGly(23);GlyGly(33)

AT4G29060.1
AT4G20360.1

elongation factor Ts family protein
Elongation factor Tu_ chloroplastic

GlyGly(13)
GlyGly(13)

AT1G26630.1

Eukaryotic translation initiation factor 5A-2

GlyGly(4);ox+M(15)

AT3G25860.1

AT5G66190.1
AT5G04140.2
AT5G04140.2
AT5G04140.2

Ferredoxin--NADP reductase_ leaf isozyme 1_
chloroplastic
Ferredoxin-dependent glutamate synthase 1_
chloroplastic/mitochondrial
Ferredoxin-dependent glutamate synthase 1_
chloroplastic/mitochondrial

GlyGly(15);ox+M(1)

Ferredoxin-dependent glutamate synthase 1_
chloroplastic/mitochondrial

AFSEDTTKR

GlyGly(8)

GVEGSLQK

GlyGly(*)

VSVKLVAEAGIGTVASGVAK
GNADIIQISGHDGGTGASPISS
IK

GlyGly(8)

AFSEDTTK

AT5G01600.1
AT5G14780.1

Formate dehydrogenase_ mitochondrial

GlyGly(9)

AT3G47800.1

Galactose mutarotase-like superfamily protein

GlyGly(1)

AT3G14210.1

GDSL esterase/lipase ESM1

GlyGly(27);ox+M(19)

AT5G48300.1

Glucose-1-phosphate adenylyltransferase small subunit_
GlyGly(28)
chloroplastic

AT5G63570.1

Glutamate-1-semialdehyde 2_1-aminomutase 1_
chloroplastic

AT5G04140.2

AT5G63570.1
AT1G42970.1
AT2G26080.1
AT3G09440.2
AT4G24280.1
AT4G24280.1
AT5G47210.1
AT5G47210.1
AT1G13930.3
AT1G75280.1
AT3G58610.3
AT1G07890.8
AT1G07890.8
AT2G44060.2
AT2G44060.2
AT2G23120.1

GlyGly(24)
GlyGly(5)

Glutamate-1-semialdehyde 2_1-aminomutase 1
Glyceraldehyde-3-phosphate dehydrogenase GAPB_
chloroplastic
Glycine dehydrogenase (decarboxylating) 2_
mitochondrial

EAAEMNKRSFK
FDETTTQGVVHTATNPFMLA
FRKNEEIAAFLDK
LDSLALLEQPYIK
VTKIMNDKDEESK
DDLKLPTDDGLTAQMRLGF
DEGK
MAAAISAAVSLPSSKSSSLLT
KISSVSPQR

GlyGly(8)

Ferredoxin-dependent glutamate synthase 1_
chloroplastic/mitochondrial
Ferredoxin-dependent glutamate synthase 1_
chloroplastic/mitochondrial
Ferritin-1_ chloroplastic

AT5G04140.2

TEGEKLAK

GlyGly(40);ox+M(39)
GlyGly(16)
GlyGly(10)
GlyGly(6)

SQQAFGYSSEDVQMVIESMA
SQGK
GHAEKFMEYQNQRGGR
LQMAPELEKETGAKFVEDLN
EMLPK
KTAVVTEQVTGR
GVSFAVADASILGAPVESMT
LNQQVVK
IINSDNVQEAARETDGYFIKS
GIVTVIK
GSKMWDIDGNEYIDYVGSW
GPAIIGHADDEVLAALAETM
K
SVGGQPVLIDSVKGSK
VLDEEFGIVKGTMTTTHSYT
GDQR
LVNETKR

DAKMDKNSIDDVVLVGGST
R
Heat shock 70 kDa protein 6_ chloroplastic
GlyGly(19)
RDAIDTKNQADSVVYQTEK
IGSGSTQEIKDAMAALNQEV
Heat shock 70 kDa protein 6_ chloroplastic
GlyGly(10);GlyGly(56) MQIGQSLYNQPGAGGPGAGP
SPGGEGASSGDSSSSK
Hyaluronan / mRNA binding family
GlyGly(3)
AQKEAEEAEAR
GlyGly(17);GlyGly(22); EAEEAEAREMTLEEYEKILEE
Hyaluronan / mRNA binding family
ox+M(10)
K
Involved in response to salt stress. Knockout mutants are GlyGly(14);GlyGly(36); KLSSSTPEEPDHNKPVEGTET
hypersensitive to salt stress.
ox+M(32)
ATRPATNAELMASAK
Isoflavone reductase homolog P3
GlyGly(2)
DKVTILGDGNAK
Ketol-acid reductoisomerase_ chloroplastic
GlyGly(7);GlyGly(13) DSLVEAKSDIVVKIGLR
L-ascorbate peroxidase 1_ cytosolic
GlyGly(*);ox+M(*)
MTKNYPTVSEDYKK
L-ascorbate peroxidase 1_ cytosolic
GlyGly(7)
QMGLSDK
Late embryogenesis abundant protein_ group 2
GlyGly(20)
DFGSALWDMIRGKGTGYTIK
Late embryogenesis abundant protein_ group 2
GlyGly(7)
MSTSEDKPEIISR
DNDLPTDSPYMATGTLEDYK
Late embryogenesis abundant protein_ group 6
GlyGly(*)
LK
Heat shock 70 kDa protein 3

GlyGly(3)

232

Table A.1 (cont’d) Waters® protocol.
ATG No.
AT2G24200.2
AT4G30920.1
AT1G15820.1
AT1G15820.1
AT5G42020.1
AT3G59970.3
AT3G59970.3
AT2G21710.1
AT3G52210.3
AT1G72640.1
AT2G24270.4
AT2G24270.4
AT3G16400.2
AT5G66570.1
AT5G66570.1
AT1G72150.1
AT1G72150.1
AT1G22530.1
AT1G22530.1
AT2G16600.2
AT3G62030.3
AT3G26060.2
AT3G52960.1
AT1G79550.2
AT3G16140.1
AT1G52230.1
AT4G12800.1
AT4G20260.4
AT4G20260.4
AT4G20260.4
AT4G20260.4
AT3G46780.1
AT1G20340.1
AT3G09790.1
AT2G25450.1
AT1G57720.2
AT1G57720.2
AT2G01140.1
AT5G02490.1
AT3G52880.2
AT3G03250.1
AT3G03250.1
AT3G03250.1
AT4G31300.3

Protein Description
Leucine aminopeptidase 1

Peptide Modification(s) Peptide Sequence
GlyGly(20)
ASQSTSAAIVLASSVSDESK
KKAATGFGVATLVEWVQNH
Leucine aminopeptidase 3_ chloroplastic
GlyGly(*)
SSS
light harvesting complex photosystem II subunit 6
GlyGly(12)
NRDGVYEPDFEKLER
HSRLAMVAMLIFYFEAGQG
light harvesting complex photosystem II subunit 6
GlyGly(20)
K
EPNKGVNPDEAVAYGAAVQ
Mediator of RNA polymerase II transcription subunit 37f GlyGly(32)
GGILSGEGGDETK
Methylenetetrahydrofolate reductase 1
GlyGly(7)
SYISRTKGWNDFPHGR
GWNDFPHGRWGDSHSAAYS
Methylenetetrahydrofolate reductase 1
GlyGly(30)
TLSDYQFARPK
Mitochondrial transcription termination factor family
MGMNQNDFGTMVYDYPKII
GlyGly(*)
protein
GFFSFQVMEKK
mRNA cap guanine-N7 methyltransferase 2
GlyGly(13)
NYDVEFFEADPSK
KALEAFGSYVELTTGDASDE
NAD(P)-binding Rossmann-fold superfamily protein
GlyGly(1)
R
NADP-dependent glyceraldehyde-3-phosphate
GlyGly(12);ox+M(6)
DNKAPMAESLVK
dehydrogenase
NADP-dependent glyceraldehyde-3-phosphate
GlyGly(20)
ILGEGKFLLSDSFPGNDRTK
dehydrogenase
Nitrile-specifier protein 1
GlyGly(17)
FEYVNGSQVVVGDEHGK
Oxygen-evolving enhancer protein 1-1_ chloroplastic
GlyGly(16)
ADSVSKNAPPEFQNTK
FKEEDGIDYAAVTVQLPGGE
Oxygen-evolving enhancer protein 1-1_ chloroplastic
GlyGly(2)
RVPFLFTVK
Patellin-1
GlyGly(16)
EGHVVIYSSYGEFQNK
MVFAHGVDKEGHVVIYSSY
Patellin-1
GlyGly(25)
GEFQNK
Patellin-2
GlyGly(7)
AAPGETK
Patellin-2
GlyGly(16)
NALAELKELVREALNK
Peptidyl-prolyl cis-trans isomerase CYP19-1
GlyGly(13)
GNGTGGESIYGSK
Peptidyl-prolyl cis-trans isomerase CYP20-3_
MASSSSMQMVHTSRSIAQIG
GlyGly(24);ox+M(7)
chloroplastic
FGVK
Peroxiredoxin Q_ chloroplastic
GlyGly(3);GlyGly(13) VNKGQAAPDFTLK
YAILADDGVVKVLNLEEGG
Peroxiredoxin-2E_ chloroplastic
GlyGly(11)
AFTNSSAEDMLK
phosphoglycerate kinase
GlyGly(8)
QLAELSGK
Photosystem I reaction center subunit VI-1_
RGLLLKFLILGGGSLLTYVSA
GlyGly(6)
chloroplastic
TSTGEVLPIK
Photosystem I reaction center subunit VI-2_
GlyGly(7);GlyGly(11) AGAVVAKYGDK
chloroplastic
Photosystem I reaction center subunit XI_ chloroplastic GlyGly(13)
QPDQLQTADGWAK
Plasma membrane-associated cation-binding protein 1 GlyGly(4);GlyGly(13) NSAKKAAAAEATK
Plasma membrane-associated cation-binding protein 1 GlyGly(6)
AEEPAKTEEPAKTEGTSGEK
Plasma membrane-associated cation-binding protein 1 GlyGly(5)
ETINKEIEEK
Plasma membrane-associated cation-binding protein 1 GlyGly(12)
GETPETAVVEEK
plastid transcriptionally active 16
GlyGly(6)
AEEEAKVAADK
GEKIVFKNNAGYPHNVVFDE
Plastocyanin major isoform_ chloroplastic
GlyGly(31)
DEIPSGVDVAK
Polyubiquitin 8
GlyGly(9)
TLLDYNIQKGSTIHQLFLQR
DAMEKFGFFQAINHGVPLDV
Probable 2-oxoacid dependent dioxygenase
GlyGly(23);ox+M(24)
MEKMINGIR
Probable elongation factor 1-gamma 2
GlyGly(6);GlyGly(12) SPEFLKMNPIGK
Probable elongation factor 1-gamma 2
GlyGly(*);GlyGly(*)
APQPAKPKEEPKK
Probable fructose-bisphosphate aldolase 3_ chloroplastic GlyGly(11)
YSAEGENEDAKK
Probable mediator of RNA polymerase II transcription
QLWPFTIISGTAEKPMIVVEY
GlyGly(14)
subunit 37c
KGEEK
Probable monodehydroascorbate reductase_ cytoplasmic
GlyGly(6)
ADLSAKSLVSATGDVFK
isoform 3
Probable UTP--glucose-1-phosphate uridylyltransferase
VPLVLMNSFNTHDDTHKIVE
GlyGly(*);ox+M(*)
2
K
Probable UTP--glucose-1-phosphate uridylyltransferase
GlyGly(*)
VTVAAKSGVKLEIPDR
2
Probable UTP--glucose-1-phosphate uridylyltransferase
GlyGly(4);GlyGly(19) IVEKYTNSNVDIHTFNQSK
2
Proteasome subunit beta type-6
GlyGly(14)
TSTGMYVANRASDK
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Table A.1. (cont’d) Waters® protocol.
ATG No.

Protein Description

AT2G21240.2

Protein BASIC PENTACYSTEINE4

AT2G21240.2

Protein BASIC PENTACYSTEINE4

AT1G21750.2

Protein disulfide isomerase-like 1-1

AT2G35410.1

Quinone oxidoreductase-like protein At1g23740_
chloroplastic
Ribosomal protein S5/Elongation factor G/III/V family
protein
Ribosomal protein S5/Elongation factor G/III/V family
protein
Ribosomal protein S5/Elongation factor G/III/V family
protein
Ribulose bisphosphate carboxylase small chain 3B_
chloroplastic
RNA-binding (RRM/RBD/RNP motifs) family protein

AT2G39730.3

Rubisco activase

AT5G26780.3

Serine hydroxymethyltransferase 2_ mitochondrial

AT5G05970.2

Transducin/WD40 repeat-like superfamily protein

AT5G05970.2

Transducin/WD40 repeat-like superfamily protein

AT3G60750.2

Transketolase-1_ chloroplastic

AT2G21170.1
AT3G15950.2

Triosephosphate isomerase_ chloroplastic
TSA1-like protein

AT3G15950.2

TSA1-like protein

AT1G50010.1
AT3G57890.1
AT3G47070.1
AT3G55250.1

Tubulin alpha-4 chain
Tubulin binding cofactor C domain-containing protein
unknown protein
unknown protein

AT1G78900.2

V-type proton ATPase catalytic subunit A

AT1G78900.2
AT3G01390.2

V-type proton ATPase catalytic subunit A
V-type proton ATPase subunit G1

AT1G23740.1
AT1G56070.1
AT3G12915.2
AT3G12915.2
AT5G38410.3

Peptide Modification(s) Peptide Sequence
GlyGly(25);ox+M(8);ox GAQSMWNMIPQHQIKEQHN
+M(23)
ALVMNK
DKALIERDNAYAALQHHENS
GlyGly(29)
LNFALSGGK
GlyGly(1);GlyGly(11);G KQSGPASAEIKSADDASEVV
lyGly(23)
SDK
FVVTSNGDVLKKLNPYIESG
GlyGly(*)
K
GlyGly(16);ox+M(10)

STGISLYYEMTDESLK

GlyGly(15)

GLKLQMTPLSDYEDK

GlyGly(12)

MYASKFGVSESKMMER

GlyGly(1)

KFETLSYLPDLSDVELAK

GlyGly(5)
GlyGly(15);ox+M(22);
ox+M(25)
GlyGly(3)

KPTPKSPNDLPSPAPGDTR
EGPPVFEQPEMTYEKLMEYG
NMLVMEQENVKR
QGKEVMYDYEDR
QFHMHEMEMSKVLSSILENQ
GlyGly(25);GlyGly(28)
AEQMKELK
GlyGly(16);GlyGly(20) SEDSALTPPEAWGGDKFSEK
GlyGly(13);GlyGly(18);
VSIEAASTFGWGKIVGGKGK
GlyGly(20)
GlyGly(17)
IIYGGSVNGGNSAELAK
GlyGly(19)
QNMLDEIEREFEAATSGLK
EFEAATNAKANGENSAKNPS
GlyGly(9)
TISTTVQK
GlyGly(7)
LSVDYGKKSK
GlyGly(12)
SLKEAPLEENRK
GlyGly(*)
GGSGGPKEEK
GlyGly(5)
AYIEKPNSFSTFANK
EDDLNEIVQLVGKDALAEGD
GlyGly(21)
K
GlyGly(15);ox+M(4)
AAGMDGQKITYTLIKHR
GlyGly(3)
QAKEEAEKEIAEYK

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.

Total unique peptides:

139

Total unique proteins:

107
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Table A.2. Candidate ubiquitinated proteins identified using the rice protocol.
ATG No.
AT5G13320.1
AT1G02780.1
AT1G02780.1
AT1G43170.9
AT4G26530.2
AT1G11860.3
ATCG00480.1
AT4G32260.1
AT3G09260.1
AT5G50920.1
AT5G50920.1
AT2G28000.1
AT3G13470.1
AT5G56500.2
AT5G56500.2
AT4G10340.1
AT1G09340.1
AT3G60900.1
AT5G04140.2
AT5G04140.2
AT5G04140.2
AT1G74470.1
AT3G04120.1
AT1G54010.1
AT3G56940.2
AT3G01280.1
AT3G16410.1
AT1G54340.1
AT1G56190.2
AT1G44575.1
ATCG00280.1
AT3G46780.1
AT2G01140.1
AT3G12580.1

Protein Description
Peptide Modification(s)
Sequence
4-substituted benzoates-glutamate
GlyGly(9)
HVKGVEEGKGMMFLFTK
ligase GH3.12
60S ribosomal protein L19-1
carb+C(8);GlyGly(*)
LAASVMKCGKGK
60S ribosomal protein L19-1
GlyGly(2)
EKTLSDQFEAK
60S ribosomal protein L3-1
GlyGly(16);Ox+M(3)
AGMTHIVREVEKPGSK
Aldolase superfamily protein
GlyGly(7)
YIATPGKGILAADESTGTIGKR
Aminomethyltransferase_
GlyGly(9);Ox+M(5)
KNIAMGYVK
mitochondrial
ATP synthase subunit beta_
GlyGly(*)
ATNLEMESKLKK
chloroplastic
ATPase_ F0 complex_ subunit
GlyGly(9)
AEIAAALNK
B/B'_ bacterial/chloroplast
Beta-glucosidase 23
GlyGly(2)
EKGVSQAGVQFYHDLIDELIK
Chaperone protein ClpC1_
GlyGly(10)
GNNALDTLGKSR
chloroplastic
Chaperone protein ClpC1_
GlyGly(15)
AEVSAIQAKGKEMSK
chloroplastic
Chaperonin 60 subunit alpha 1_
GlyGly(3)
QSKLGGGNQQQGQR
chloroplastic
Chaperonin 60 subunit beta 2_
carb+C(8);GlyGly(9);GlyGly(15) MSVEYDNCKLLLVDK
chloroplastic
Chaperonin 60 subunit beta 3_
GlyGly(12)
QLHFNKDGTAIKK
chloroplastic
Chaperonin 60 subunit beta 3_
GlyGly(12)
NAGVNGSVVSEK
chloroplastic
Chlorophyll a-b binding protein
GlyGly(2)
SKAVSETSDELAK
CP26_ chloroplastic
Chloroplast stem-loop binding
GlyGly(10)
DQHFFASVEK
protein of 41 kDa b_ chloroplastic
Fasciclin-like arabinogalactan
GlyGly(3);GlyGly(14)
GGKVGFGSAAPGSK
protein 10
Ferredoxin-dependent glutamate
synthase 1_
GlyGly(1);GlyGly(9)
KGVEGSLQK
chloroplastic/mitochondrial
Ferredoxin-dependent glutamate
synthase 1_
GlyGly(24)
LENFGFIQFRPGGEYHSNNPEMSK
chloroplastic/mitochondrial
Ferredoxin-dependent glutamate
synthase 1_
carb+C(23);GlyGly(18)
GQMEAWDGPALLLFSDGKTVGACLDR
chloroplastic/mitochondrial
Geranylgeranyl diphosphate
GlyGly(13)
VALVGDAAGYVTK
reductase_ chloroplastic
Glyceraldehyde-3-phosphate
GlyGly(9)
AIKEESEGKLK
dehydrogenase GAPC1_ cytosolic
Inactive GDSL esterase/lipase-like
GlyGly(19)
DDPNGKFSDGLIAPDFLAK
protein 23
Magnesium-protoporphyrin IX
GlyGly(5)
NKEFKEAADK
monomethyl ester
Mitochondrial outer membrane
GlyGly(*)
GPGLYTEIGKK
protein porin 1
Nitrile-specifier protein 4
GlyGly(12)
LNTLDSYNIVDK
Peroxisomal isocitrate
GlyGly(13)
AFAESSMYTAYQK
dehydrogenase
Phosphoglycerate kinase 2_
GlyGly(1)
KSVGDLNSVDLK
chloroplastic
Photosystem II 22 kDa protein_
GlyGly(10)
EQGPLFGFTK
chloroplastic
Photosystem II CP43 reaction
GlyGly(11)
GPNGLDLSRLK
center protein
plastid transcriptionally active 16 GlyGly(4)
QMQKLSEK
Probable fructose-bisphosphate
GlyGly(9)
DANIVPGIKVDK
aldolase 3_ chloroplastic
Probable mediator of RNA
polymerase II transcription subunit GlyGly(5)
TTGQKNKITITNDK
37c
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Table A.2. (cont’d) Rice protocol.
ATG No.
AT1G23740.1
AT5G38430.1
AT4G01850.2
AT5G42980.1
AT2G21170.2
AT2G21170.1
AT3G55060.1
AT4G38510.5
AT2G15180.1

Protein Description
Quinone oxidoreductase-like
protein At1g23740_ chloroplastic
Ribulose bisphosphate oxylase
small chain 1B_ chloroplastic
S-adenosylmethionine synthase 2
Thioredoxin H3
Triosephosphate isomerase_
chloroplastic
Triosephosphate isomerase_
chloroplastic
unknown protein
V-type proton ATPase subunit B2
Zinc knuckle (CCHC-type) family
protein

Peptide Modification(s)

Peptide Sequence

GlyGly(11)

FVVTSNGDVLK

GlyGly(1)

KEYPGAFIRIIGFDNTR

GlyGly(7)
GlyGly(*)

ATIDYEKIVR
LKAANESKK

GlyGly(10)

KNVSEEVASK

GlyGly(21)

SPRGVVAMAGSGKFFVGGNWK

GlyGly(*)
GlyGly(1)

NELTTSATKSK
KFVAQGAYDTR

GlyGly(4);GlyGly(9)

SIAKVSGTK

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.

Total unique peptides:

43

Total unique proteins:

37
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Table A.3. Candidate peptides identified through PS/FASP protocol.

Due to space limitations, this list is available in the Appendix_A.xlsx list.
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Table A.4. Candidate digly-modified peptides identified after digly-enrichment of prefractionated peptides (SAX).
ATG No.
AT1G76680.2
AT5G20720.3
AT5G20720.3

Protein Description
12-oxophytodienoate reductase 1
20 kDa chaperonin_ chloroplastic
20 kDa chaperonin_ chloroplastic

Peptide Modification(s)
carb+C(5);GlyGly(8)
GlyGly(10)
GlyGly(12)

AT4G34670.1 40S ribosomal protein S3a-2
AT5G20980.2

GlyGly(22)

5-methyltetrahydropteroyltriglutamate--homocysteine
methyltransferase 3_ chloroplastic

GlyGly(*)

AT3G09820.1 Adenosine kinase 1

GlyGly(*)

AT5G03300.1
AT3G08580.2
AT3G08580.2
AT5G13490.2
AT2G36460.1
AT1G11860.3
AT4G04640.1
AT5G08690.1

GlyGly(19)
GlyGly(9);GlyGly(10)
GlyGly(5)
GlyGly(20);ox+M(11)
carb+C(1);GlyGly(17)
GlyGly(12)
GlyGly(13)
GlyGly(7)

Adenosine kinase 2
ADP_ATP carrier protein 1_ mitochondrial
ADP_ATP carrier protein 1_ mitochondrial
ADP_ATP carrier protein 2_ mitochondrial
Aldolase superfamily protein
Aminomethyltransferase_ mitochondrial
ATP synthase gamma chain 1_ chloroplastic
ATP synthase subunit beta-2_ mitochondrial

AT1G56340.2 Calreticulin-1

GlyGly(22)

AT1G09210.1 Calreticulin-2

carb+C(3);GlyGly(9)

AT4G35090.1 Catalase-2

carb+C(15);GlyGly(29)

AT4G35090.1 Catalase-2

GlyGly(4)

AT1G55490.2 Chaperonin 60 subunit beta 1_ chloroplastic

GlyGly(21)

AT1G55490.2
AT1G55490.2
AT3G13470.1
AT5G01530.1

GlyGly(*)
GlyGly(20);ox+M(13)
GlyGly(8)
GlyGly(6);GlyGly(19)

AT3G63140.1
AT1G09340.1
AT1G47128.1
AT1G65930.1
AT1G65930.1
AT1G65930.1

Chaperonin 60 subunit beta 1_ chloroplastic
Chaperonin 60 subunit beta 1_ chloroplastic
Chaperonin 60 subunit beta 2_ chloroplastic
Chlorophyll a-b binding protein CP29.1_ chloroplastic
Chloroplast stem-loop binding protein of 41 kDa a_
chloroplastic
Chloroplast stem-loop binding protein of 41 kDa b_
chloroplastic
Cysteine proteinase RD21a
Cytosolic isocitrate dehydrogenase
Cytosolic isocitrate dehydrogenase
Cytosolic isocitrate dehydrogenase

AT4G27520.1 Early nodulin-like protein 2
AT1G07940.2 Elongation factor 1-alpha 2
AT1G07940.2 Elongation factor 1-alpha 2
AT4G29060.1
AT4G29060.1
AT4G29060.1
AT3G54400.1

elongation factor Ts family protein
elongation factor Ts family protein
elongation factor Ts family protein
Eukaryotic aspartyl protease family protein

AT2G15620.1 Ferredoxin--nitrite reductase_ chloroplastic
AT5G63570.1
AT5G63570.1
AT1G66200.3
AT1G66200.3
AT1G13440.1
AT1G13440.1

Glutamate-1-semialdehyde 2_1-aminomutase 1_
chloroplastic
Glutamate-1-semialdehyde 2_1-aminomutase 1_
chloroplastic
Glutamine synthetase cytosolic isozyme 1-2
Glutamine synthetase cytosolic isozyme 1-2
Glyceraldehyde-3-phosphate dehydrogenase GAPC2_
cytosolic
Glyceraldehyde-3-phosphate dehydrogenase GAPC2_
cytosolic

AT1G56410.1 Heat shock 70 kDa protein 18

GlyGly(10)
carb+C(7);GlyGly(15)

Peptide Sequence
APISCSDKPLMPQIR
ASSVKFSSLKPGTLR
YAGTEVEFNDVK
AEDVQGRNVLTQFWGMDFT
TDK
TLQTLEDIVGKEK
VAQWMLQVPGATSYMGSIG
KDK
TFSRVHGWETEDVEQIAIK
LANDAKAAKK
SSVSKDVQVGYQRPSMYQR
GFTNFAIDFMMGGVSAAVSK
CKANSEATLGAYKGDAK
DKDLAHIEEHMKAFK
GLGLEYTVISVGK
TYDYGGKGAIGR
DDNTAGEWKHTAGNWSGD
ANDK
LDCGGGYMKLLSGDVDQK
NIDNFFAENEQLAFCPAIIVP
GIHYSDDK
DGMKFPDMVHALKPNPK
VVLTKETSTIVGDGSTQDAV
K
ETSTIVGDGSTQDAVKKR
ASTFTATSSIGSMVAPNGHK
VLANDNVKFGYNAATGK
LYPGGKFFDPLGLAADPEK
ADAGHVVVEKYLAETFGNW
ASFRPQYMIGSGNNK
SDILPHCEEDAVDPK

GlyGly(*)
carb+C(8);GlyGly(1)
carb+C(5);GlyGly(13)
GlyGly(4);GlyGly(12)

VGDELPESIDWRKK
KYNVAIKCATITPDEGR
LEAACVGTVESGK
GPGKLTMTFEGK
KFNVGGSGAWVTNPPENYE
GlyGly(1)
SWSGKNR
GlyGly(3);ox+M(9)
FLKNGDAGMVK
GlyGly(1);GlyGly(8);ox+ KVGYNPDKIPFVPISGFEGDN
M(22)
MIER
GlyGly(15);GlyGly(17)
SQDFAAEVAAQTAAKPK
GlyGly(6);GlyGly(13)
EDLLSKPEQIREKIVDGR
GlyGly(7);GlyGly(13)
QSGGSDKPRSGGKR
carb+C(6);GlyGly(9)
SESINCNEKSHSSDLR
GlyGly(13);GlyGly(22);ox LFMENGIEELAKKSMEELDS
+M(3)
EK
GlyGly(10)

QAGTYEYLDK

carb+C(10);carb+C(11);Gl
VSSSPASNRCCIK
yGly(13)
GlyGly(7)
DTEKEGKGYFEDR
GlyGly(15)
SKARTLPGPVTDPSK
GlyGly(1)

KAIKEESEGK

GlyGly(8)

TVDGPSMKDWRGGR

GlyGly(28)

DAGVIAGLNVLRIINEPTAAA
IAYGLDK

carb+C(1);carb+C(8);GlyG
CMEPVMKCLRDSK
ly(7);ox+M(2)
GlyGly(16);ox+M(10)
FSDASVQSDMKFWPFK

AT1G56410.1 Heat shock 70 kDa protein 18
AT1G56410.1 Heat shock 70 kDa protein 18
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Table A.4. (cont’d) Pre-fractionation.
ATG No.

Protein Description

Peptide Modification(s)

GlyGly(2)

Peptide Sequence
MASSAAQIHVLGGIGFASSSS
SKR
NQADSVVYQTEK
TPVENSLRDAKLSFK
SVSANGKNSMFGKLGYLAR
PFCSRPVGNDVIGIDLGTTNS
CVSVMEGK
YKSESKKPSLK

GlyGly(14)

GPSGSPWYGSDRVK

GlyGly(15)

AASTMALSSPALTGK

GlyGly(5);GlyGly(11)

GSVTKAQTSDK

GlyGly(11)

NALETYVYNMK

GlyGly(3)

HQKDISKDNK

GlyGly(14)

EALEWLDENQNSEK

GlyGly(6)

NQVNDKDK

GlyGly(6)
carb+C(13);GlyGly(3);
GlyGly(21)

AIASFKVPDYNSAK

AT4G24280.1 Heat shock 70 kDa protein 6_ chloroplastic

GlyGly(23);ox+M(1)

AT4G24280.1 Heat shock 70 kDa protein 6_ chloroplastic
AT4G24280.1 Heat shock 70 kDa protein 6_ chloroplastic

GlyGly(12)
GlyGly(15)

AT4G37910.1 Heat shock 70 kDa protein 9_ mitochondrial

carb+C(22);carb+C(41);
GlyGly(*)

AT4G30920.1 Leucine aminopeptidase 3_ chloroplastic
light-harvesting chlorophyll-protein complex II subunit
AT2G34430.1
B1
light-harvesting chlorophyll-protein complex II subunit
AT2G34430.1
B1
AT3G47520.1 Malate dehydrogenase_ chloroplastic
Mediator of RNA polymerase II transcription subunit
AT5G28540.1
37a
Mediator of RNA polymerase II transcription subunit
AT5G28540.1
37a
Mediator of RNA polymerase II transcription subunit
AT5G28540.1
37a
Mediator of RNA polymerase II transcription subunit
AT5G28540.1
37a
AT5G67500.2 Mitochondrial outer membrane protein porin 2
AT1G63940.4 Monodehydroascorbate reductase_ chloroplastic
AT1G63940.4 Monodehydroascorbate reductase_ chloroplastic

GlyGly(22)

AT5G26000.1 Myrosinase 1
Peptidyl-prolyl cis-trans isomerase CYP38_
AT3G01480.1
chloroplastic

GlyGly(12)

AT1G54340.1 Peroxisomal isocitrate dehydrogenase

GlyGly(38)

AT1G79550.2 phosphoglycerate kinase

GlyGly(*)

ATCG00680.1 Photosystem II CP47 reaction center protein

GlyGly(28)

AT3G27690.1 photosystem II light harvesting complex gene 2.3

GlyGly(26)

AT5G23120.1

GlyGly(10);GlyGly(20)

Photosystem II stability/assembly factor HCF136_
chloroplastic
Photosystem II stability/assembly factor HCF136_
chloroplastic
plastid transcriptionally active 16
plastid transcriptionally active 16
Polyubiquitin 8

GlyGly(13)

QLKYGSLIIATGCTASRFPDK
FVKGASINNLEAGSDGRVSA
VK
YYNGLIDGLVAK
KDHGNEMIEKLEAGMQDML
K
TEFEVFNFTGGGVALAMYNT
DESIRAFAESSMYTAYQK
FYAEEEKNDPEFAKK
GGLFRAGSMDNGDGIAVGW
LGHPVFRNK
MATSAIQHSSFAGQTTLKPS
NDLLRK
AADNIAANLYAVK

AT1G67280.1 Probable lactoylglutathione lyase_ chloroplast
Probable mediator of RNA polymerase II transcription
AT5G02500.1
subunit 37e
Probable mediator of RNA polymerase II transcription
AT5G02500.1
subunit 37e
Probable mediator of RNA polymerase II transcription
AT5G02500.1
subunit 37e
Probable monodehydroascorbate reductase_ cytoplasmic
AT3G52880.2
isoform 3
Probable monodehydroascorbate reductase_ cytoplasmic
AT3G52880.2
isoform 3
Probable monodehydroascorbate reductase_ cytoplasmic
AT5G03630.1
isoform 4

GlyGly(15);GlyGly(18)

GGGLYLSKGTGITEEFEEVPV
QSR
KPEKEVRK
ADAVGVTVDGLFNKAK
LIFAGKQLEDGR
ANSLAQLGKYSAEGENEDA
K
AAQATTQDDLLTWVKNDK

GlyGly(5);ox+M(6)

DEIEKMVQEAEK

GlyGly(26)

SINPDEAVAYGAAVQGAILS
GEGNEK

carb+C(12);GlyGly(18)

FEELNMDLFRKCMEPVEK

GlyGly(12)

LTDFGVKGADSK

GlyGly(15)

VVGAFMEGGSGDENK

GlyGly(11)

DQVEEEKGGLK

AT1G21750.1 Protein disulfide isomerase-like 1-1

GlyGly(22)

AT1G21750.1 Protein disulfide isomerase-like 1-1

GlyGly(6)
GlyGly(*);GlyGly(*);
ox+M(*)
GlyGly(7)

AT5G23120.1
AT3G46780.1
AT3G46780.1
AT3G09790.1

GlyGly(8)
GlyGly(8)
GlyGly(14);GlyGly(16)
GlyGly(6)

AT2G01140.1 Probable fructose-bisphosphate aldolase 3_ chloroplastic GlyGly(9)

AT1G21750.1 Protein disulfide isomerase-like 1-1
AT1G21750.1 Protein disulfide isomerase-like 1-1
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QSGPASAEIKSADDASEVVS
DK
DTFDVKGFPTIYFK
FFESTNTKAMLFINFTGEGAE
SLKSK
DTVGEPKK

Table A.4. (cont’d) Pre-fractionation.
ATG No.
Protein Description
AT2G42100.1 Putative actin-5
Ribosomal protein S5/Elongation factor G/III/V family
AT1G56070.1
protein
ATCG00490.1 Ribulose bisphosphate carboxylase large chain

Peptide Modification(s)
GlyGly(16)

Peptide Sequence
MNKEINALAPPSMKIK

carb+C(6);GlyGly(11)

QIIATCMNDQK

GlyGly(9)

AT2G37220.1 RNA-binding protein CP29B_ chloroplastic

GlyGly(22)

AT2G36880.2 S-adenosylmethionine synthase 3

AT3G17390.1 S-adenosylmethionine synthase 4

GlyGly(*);ox+M(*)
carb+C(2);carb+C(13);
carb+C(24);carb+C(27);
GlyGly(29)
GlyGly(3)

SQAETGEIK
NVAITSEFEVEEDGFADVAPP
K
EAFDFRPGMMAINLDLK

AT3G17390.1 S-adenosylmethionine synthase 4

GlyGly(42)

AT3G55800.1
AT3G55800.1
AT4G13930.1
AT5G16830.1

GlyGly(18);ox+M(1)
GlyGly(8)
GlyGly(11)
GlyGly(7)

AT2G36880.2 S-adenosylmethionine synthase 3

Sedoheptulose-1_7-bisphosphatase_ chloroplastic
Sedoheptulose-1_7-bisphosphatase_ chloroplastic
Serine hydroxymethyltransferase 4
Syntaxin-21

AT3G45310.2 Thiol protease aleurain-like

carb+C(20);GlyGly(25)

AT1G15470.1 Transducin/WD40 repeat-like superfamily protein

GlyGly(9)

AT4G18300.1 Trimeric LpxA-like enzyme

GlyGly(23)

AT2G21170.2 Triosephosphate isomerase_ chloroplastic

GlyGly(9)

AT5G15840.2 Zinc finger protein CONSTANS

GlyGly(23);ox+M(14)

LCDQISDAILDACLEQDPESK
VACETCTK
FLKTAAYGHFGR
TQVTIEYINESGAMVPVRVH
TVLISTQHDETVTNDEIAADL
K
MFSPGNLRATFDNSEYSK
TQVAYGSK
DLDQLKADVEK
DFQSVLK
YNGGLDTEEAYPYTGKDGG
CKFSAK
ISEKAAEAK
LAVKSPHNSATELYRNAMG
VITK
NVSEEVASK
VPILPISGNSFSSMTTTHHQSE
K

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.

Total unique peptides:

101

Total unique proteins:

68
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Table A.5. Diglycine-enrichment using the CST PTMScan® kit (CST1).
ATG No.

Protein Description

AT5G09810.1

Actin-7

AT5G09810.1
AT1G52510.1

Actin-7
alpha/beta-Hydrolases superfamily protein

AT1G11860.1

Aminomethyltransferase_ mitochondrial

AT2G31150.1

ATP binding\x3bATPases_ coupled to
transmembrane movement of ions_
phosphorylative mechanism

GlyGly(24);GlyGly(25)

ATCG00480.1

ATP synthase subunit beta_ chloroplastic

GlyGly(21);ox+M(22)

AT5G08690.1

ATP synthase subunit beta-2_ mitochondrial

AT5G08690.1

ATP synthase subunit beta-2_ mitochondrial

AT5G08690.1

ATP synthase subunit beta-2_ mitochondrial

AT5G08690.1

ATP synthase subunit beta-2_ mitochondrial

AT5G64570.1

Beta-D-xylosidase 4

AT2G36530.1
AT1G47128.1
AT1G47128.1
AT1G07940.2

Bifunctional enolase 2/transcriptional activator
Cysteine proteinase RD21a
Cysteine proteinase RD21a
Elongation factor 1-alpha 2

AT1G03220.1

Eukaryotic aspartyl protease family protein

AT1G09750.1

Eukaryotic aspartyl protease family protein

AT5G44130.1

Fasciclin-like arabinogalactan protein 13

AT3G54050.1

Fructose-1_6-bisphosphatase_ chloroplastic

AT1G23310.1

Glutamate--glyoxylate aminotransferase 1
Glyceraldehyde-3-phosphate dehydrogenase
GAPC2_ cytosolic
Glyceraldehyde-3-phosphate dehydrogenase
GAPC2_ cytosolic
Glyceraldehyde-3-phosphate dehydrogenase
GAPC2_ cytosolic
Glycine-rich RNA-binding protein 7

AT1G13440.2
AT1G13440.2
AT1G13440.1
AT2G21660.1
AT1G79620.1
AT1G79620.1
AT1G79620.1
AT5G25980.2
AT5G08530.1
AT5G11670.1
AT3G50820.1
AT1G06680.1
AT1G06680.1

Peptide Modification(s) Peptide Sequence
GlyGly(24);ox+M(14);ox DLYGNIVLSGGSTMFPGIADRMSK
+M(34)
EITALAPSSMK
GlyGly(24)
DLYGNIVLSGGSTMFPGIADRMSK
GlyGly(16)
LIEGAGHLPQEDWPEK
ENGSLFDVAHMCGLSLKGKDCVP
carb+C(12);carb+C(21);
FLETLVVADVAGLAPGTGSLTVFT
GlyGly(50);ox+M(11)
NEK
SQASYSSEAIFDEASSYSVTWTQK
K

NLGRIAQIIGPVLDVAFPPGKMPNI
YNALVVK
TVLIMELINNVAKAHGGFSVFAGV
GlyGly(13)
GER
IGLFGGAGVGKTVLIMELINNVAK
GlyGly(24);ox+M(16)
AHGGFSVFAGVGER
YDDLSEQSFYMVGGIDEVVAKAE
GlyGly(21)
K
GlyGly(15)
TIAMDGTEGLVRGRK
carb+C(2);carb+C(13); SCVVDGNVASVMCSYNQVNGKP
carb+C(24);GlyGly(21) TCADPDLLSGVIR
GlyGly(7)
TYDLNFKEENNNGSQKISGDALK
GlyGly(19)
VVTIDSYEDVPTYSEESLK
GlyGly(10);ox+M(8)
SKYLGAKMEK
GlyGly(8)
LPLQDVYKIGGIGTVPVGR
KFAVCLTSGKGVAFFGNGPYVFLP
carb+C(5);GlyGly(1);
GIQISSLQTTPLLINPVSTASAFSQG
GlyGly(10)
EK
carb+C(20);GlyGly(34); GPMSLVSQTTSLYSGVFSYCLPSF
ox+M(3)
RSFYFSGSLK
carb+C(29);GlyGly(9); AAAPSESEKSGSGEMNTGLGLGL
ox+M(15)
GLVVLCLK
carb+C(16);GlyGly(27); APTGVRNHQYASGVRCMAVAAD
ox+M(17)
AAETK
GlyGly(17);ox+M(18)
FNDEFMTQYDNNFGYSKM
GlyGly(19)

AASFNIIPSSTGAAKAVGK

GlyGly(11)

LEKAATYDEIK

GlyGly(15)

DAPMFVVGVNEHEYK

GlyGly(8);GlyGly(11)

GFGFVTFKDEK
YMELALKCVDETADERPTMSEVV
KEIEIIIQNSGASSSSSASASSSATDF
GEK
LVGSLPDLSDMKSMNYVDLSNNS
GlyGly(12);GlyGly(56);
Leucine-rich repeat protein kinase family protein
FDPSESPLWFSTLPSLTTLVMEYGS
ox+M(11)
LQGPLPNK
Leucine-rich repeat protein kinase family protein GlyGly(19)
AEQAIGLSRPFVSWASSGK
Myrosinase 2
GlyGly(6)
SSLPFKNGDR
QGKPRLKPPFPANAGLYGCPTTVT
NADH dehydrogenase
carb+C(19);GlyGly(3)
NVETVAVSPTILRR
QNYGEKVLVQFEDFANHNAFDLL
GlyGly(6);GlyGly(25);
NADP-dependent malic enzyme 2
SKYSDSHLVFNDDIQGTASVVLAG
GlyGly(53)
LIAAQK
Oxygen-evolving enhancer protein 1-2_
GlyGly(6)
ADSVSKNAPPDFQNTK
chloroplastic
Oxygen-evolving enhancer protein 2-1_
LALTLLVGAAAVGSKVSPADAAY
GlyGly(*);GlyGly(*)
chloroplastic
GEAANVFGKPK
QAYFGETASEGGFDNNAVATANI
Oxygen-evolving enhancer protein 2-1_
GlyGly(34)
LESSSQEVGGKPYYYLSVLTRTAD
chloroplastic
GDEGGK
carb+C(8);GlyGly(24);
Leucine-rich repeat protein kinase family protein
ox+M(2)
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Table A.5. (cont’d) CST1.
ATG No.
AT1G72150.1
AT1G72150.1
AT1G72150.1
AT1G22530.1
AT5G42310.1
AT4G38740.1
AT4G38740.1
AT3G12780.1
AT3G27690.1
AT3G08590.2
AT4G38970.1
AT1G23190.1
AT3G08030.1
AT1G52315.1
AT1G52315.1
AT2G39730.3
AT4G01850.1
AT4G01850.1
AT3G17390.1
AT3G17390.1
AT4G37930.1
AT4G01870.1
AT3G60750.1
AT2G45290.1
AT1G45201.2
AT1G45201.2
AT1G45201.2
AT1G45201.2
AT2G21170.1
AT2G21170.1
AT2G21170.1
AT5G62550.1
AT5G62550.1
AT2G34100.1
AT2G34100.1

Protein Description

Peptide Modification(s) Peptide Sequence
VLGADVSYGAQFEPTTEGSYAVIV
Patellin-1
GlyGly(26)
SKTR
Patellin-1
GlyGly(18)
SADVAAAPVVKEKPITDK
Patellin-1
GlyGly(15)
AVKQFEDNYPEFAAK
Patellin-2
GlyGly(*)
ASEAGKVVITIDNQTFKK
Pentatricopeptide repeat-containing protein
DKLELDVQLVNDIIMGFAKSGDPS
GlyGly(2);GlyGly(19)
At5g42310_ mitochondrial
K
GSKFHRVIPNFMCQGGDFTAGNG
Peptidyl-prolyl cis-trans isomerase CYP18-3
carb+C(13);GlyGly(33)
TGGESIYGSK
MAFPKVYFDMTIDGQPAGRIVME
Peptidyl-prolyl cis-trans isomerase CYP18-3
GlyGly(28);ox+M(1)
LYTDK
GlyGly(36);GlyGly(43); TFNEALDTTQTVIWNGPMGVFEM
Phosphoglycerate kinase 1_ chloroplastic
ox+M(18)
EKFAAGTEAIANKLAELSEK
MATSAIQHSSFAGQTTLKPSNDLL
photosystem II light harvesting complex gene 2.3 GlyGly(26)
RKIGASNGGGR
Probable 2_3-bisphosphoglycerate-independent
GlyGly(13)
APTPAMDSLKDGKPDTWR
phosphoglycerate mutase 2
Probable fructose-bisphosphate aldolase 2_
VWAEVFFYLAQNNVMFEGILLKP
GlyGly(22);ox+M(15)
chloroplastic
SMVTPGAESKDR
carb+C(11);carb+C(14);
FFGNLMDAGMCSVCGEESFGTGS
Probable phosphoglucomutase_ cytoplasmic 1
GlyGly(29);ox+M(6);
DHIREK
ox+M(10)
LVNSTQGVLLPPKQEDLTSPLPGW
Protein of unknown function_ DUF642
GlyGly(13);GlyGly(30)
IIESLKAVK
Regulator of Vps4 activity in the MVB pathway
GlyGly(11)
NYKTDIVNFLKNGQDSEAYR
protein
Regulator of Vps4 activity in the MVB pathway
SFMDEHSDDESVLSESWRIDSLSK
GlyGly(24)
protein
GSLSSSSSSSSSSLR
Ribulose bisphosphate carboxylase/oxygenase
GlyGly(16)
LVVHITKNFLTLPNIK
activase_ chloroplastic
VLVNIEQQSPDIAQGVHGHFTKRP
S-adenosylmethionine synthase 2
GlyGly(22);GlyGly(56) EDIGAGDQGHMFGYATDETPELM
PLSHVLATKIGAR
S-adenosylmethionine synthase 2
GlyGly(*);ox+M(*)
TNMVMVFGEITTKATIDYEK
carb+C(3);carb+C(6);
VACETCTKTNMVMVFGEITTKAN
S-adenosylmethionine synthase 4
GlyGly(21)
VDYEQIVR
VIVQVSYAIGVPEPLSVFVDSYGT
S-adenosylmethionine synthase 4
GlyGly(37)
GKIPDKEILEIVK
ARQWKGLELIPSENFTSVSVMQA
Serine hydroxymethyltransferase 1_ mitochondrial GlyGly(5);GlyGly(31)
VGSVMTNK
tolB protein-related
GlyGly(19)
IAVQIARIKFDPSDLTADK
AKSGHPGLPMGCAPMAHILYDEV
Transketolase-1_ chloroplastic
carb+C(12);GlyGly(29)
MRYNPK
Transketolase-2_ chloroplastic
GlyGly(7)
AFGNFQKATPEER
triacylglycerol lipase-like 1
GlyGly(14)
ISYESKPYITSVVKNTWK
triacylglycerol lipase-like 1
GlyGly(9)
INVGSIEYKSMLSIMASK
triacylglycerol lipase-like 1
GlyGly(14)
ISYESKPYITSVVK
triacylglycerol lipase-like 1
carb+C(9);GlyGly(7)
MSKTNMKFCNSYFLVDPTK
carb+C(18);GlyGly(14);
Triosephosphate isomerase_ chloroplastic
GGAFTGEISVEQLKDLGCK
GlyGly(19)
Triosephosphate isomerase_ chloroplastic
GlyGly(23);ox+M(18)
LVSSSSSSHRSPRGVVAMAGSGK
Triosephosphate isomerase_ chloroplastic
GlyGly(19);GlyGly(20) VASPQQAQEVHVAVRGWLKK
EKDALQDSSVTETSKEEGALQDSS
GlyGly(15);GlyGly(30);
unknown protein
VTETTKEEDALQDSSVTETTKEEQ
GlyGly(45)
ALETVTQGR
unknown protein
GlyGly(3);GlyGly(7)
MEKSMEKSVSSAASGNSINSK
ASKFPESFTQAQGGDDCYENYGD
unknown protein
carb+C(17);GlyGly(3)
GADGIDDDDYDEENSESSLK
unknown protein
GlyGly(2)
EKPSQHWAMR

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.

Total unique peptides:
Total unique proteins:

69
46
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Table A.6. Diglycine-enrichment using the CST PTMScan® kit (CST2).
ATG No.

Peptide Modification(s)

AT1G65350.1

Protein Description
2_3-bisphosphoglycerate-independent
phosphoglycerate mutase 1
3beta-hydroxysteroiddehydrogenase/decarboxylase isoform 2
40S ribosomal protein S10-1

AT3G04120.1

40S ribosomal protein S10-3

GlyGly(9)

AT1G65350.1
AT1G65350.1
AT1G59359.1
AT3G50820.1

40S ribosomal protein S2-2
40S ribosomal protein S2-2
40S ribosomal protein S2-2
40S ribosomal protein S2-2

GlyGly(13)
GlyGly(6)
GlyGly(11)
GlyGly(6);ox+M(2)

AT5G60390.1

40S ribosomal protein S2-3

GlyGly(13)

ATCG00490.1
AT2G41840.1

40S ribosomal protein S4-1
40S ribosomal protein Sa-1

GlyGly(14)
GlyGly(11)

AT3G50820.1

40S ribosomal protein Sa-2

carb+C(20);GlyGly(7)

AT1G65350.1
AT1G65350.1

AT1G67090.1
AT1G59359.1
AT2G36530.1

5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 1
5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 1
5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 2

ATCG00280.1

60S ribosomal protein L28-1

AT3G52930.1

60S ribosomal protein L28-1

AT3G50820.1

Actin-7

AT5G02490.1
AT5G43330.1

ADP_ATP carrier protein 2_ mitochondrial
Alcohol dehydrogenase class-3

AT5G52650.1

Alcohol dehydrogenase class-P

AT3G04120.1

Alcohol dehydrogenase class-P

AT5G09810.1

Alcohol dehydrogenase class-P

AT2G36530.1

Aldolase superfamily protein

AT5G17920.2

Alpha-xylosidase 1

AT5G14040.1

Alpha-xylosidase 1

AT3G17390.1

Aspartate aminotransferase 3_ chloroplastic

AT4G39260.1

Aspartate aminotransferase 3_ chloroplastic

AT1G26630.1

ATP-dependent 6-phosphofructokinase 7

AT5G60390.1

Beta-D-xylosidase 1

AT1G77120.1
AT3G16400.2
AT5G17920.2
AT5G02500.1
AT3G03780.3
AT1G65930.1

carb+C(22);GlyGly(30);ox+M(8)

Peptide Sequence
VNIPNGDMVGHTGDIEATVV
ACEAADLAVK

carb+C(16);GlyGly(*);GlyGly(*)

EQEIDSIVVSFKSFACKHK

GlyGly(*)

TYLNLPSDVVPATLKK
AGGEFGGEKGGAPADYQPSF
QGSGR
SPYQEHTDFLSTKAVSATK
AVSATKVITEGEDQA
TYGFLTPEFWKETR
IMPVQKQTR
SPYQEHTDFLASKALSTSKPD
PVVEDQA
TYPAGFMDVVSIPKTNENFR
NDGIYIFNLGK
TDHQPIKEGALGNIPTIAFCD
TDSPMGFVDIGIPANNK
VNKMLAVLEQNILWVNPDC
GLK

carb+C(19);GlyGly(3)
GlyGly(1)

KSEHAFYLDWAVHSFR

GlyGly(7)

FSYASHKAVNEYK

GNSKVQFSKETNNLTNVHSY
K
KTVTIQAADKDQAVVLATT
GlyGly(1)
K
DLYGNIVLSGGSTMFPGIAD
GlyGly(24);GlyGly(35);ox+M(22)
RMSKEITALAPSSMK
GlyGly(15);GlyGly(16)
GGGERQFNGLVDVYKK
GlyGly(9);GlyGly(16)
TQVPWLVEKYMNKEIK
KGQSVAIFGLGAVGLGAAEG
GlyGly(1)
AR
FSINGKPIYHFLGTSTFSEYTV
GlyGly(30)
VHSGQVAK
EFGVTECVNPKDHDKPIQQV
carb+C(7);GlyGly(11)
IAEMTDGGVDR
GlyGly(8)
ALQQSTLKTWAGK
carb+C(22);carb+C(26);carb+C(34); RFHDLVPIDGLWIDMNEVSN
carb+C(44);carb+C(45);carb+C(48); FCSGLCTIPEGKQCPSGEGPG
GlyGly(32);GlyGly(49)
WVCCLDCK
SVMVEVRGLEMLVGKDFNM
GlyGly(15)
SWK
carb+C(9);carb+C(33);GlyGly(17); MFVADGGECLVAQSYAKNM
GlyGly(34)
GLYGERVGALSIVCK
GLMPFFDSAYQGFASGSLDT
carb+C(35);GlyGly(43)
DAKPIRMFVADGGECLVAQS
YAKNMGLYGER
AINAAHVEAESNENGIGFVK
GlyGly(20)
LMGR
GPVILVLMSGGPIDVTFAKN
GlyGly(19);ox+M(8)
DPR
GlyGly(9)

Bifunctional enolase 2/transcriptional
GlyGly(18);GlyGly(19)
activator
Bifunctional enolase 2/transcriptional
GlyGly(4)
activator
Bifunctional inhibitor/lipid-transfer
protein/seed storage 2S albumin superfamily carb+C(10);carb+C(12);GlyGly(16)
protein
Bifunctional L-3-cyanoalanine
carb+C(13);GlyGly(20)
synthase/cysteine synthase C1_ mitochondrial
Bifunctional L-3-cyanoalanine
GlyGly(22);ox+M(21)
synthase/cysteine synthase C1_ mitochondrial
Calcium sensing receptor_ chloroplastic
GlyGly(20)
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VNQIGSVTESIEAVKMSKK
GVSKAVGNVNNIIGPALIGK
GLVEVEAAACLCTTLK
TPLVFLNKVTEGCEAYVAAK
TTLIEPTSGNMGISLAFMAA
MK
AQEAMQSSGFDSEPVFNAAK

Table A.6. (cont’d) CST2.
ATG No.

Protein Description

Peptide Modification(s)

AT5G35630.3

Calcium sensing receptor_ chloroplastic

GlyGly(*);GlyGly(*)

AT4G25740.2
AT1G59359.1
AT5G11670.1
AT3G09440.2

Catalase-3
Catalase-3
Chaperone protein ClpC2_ chloroplastic
Chaperonin 60 subunit alpha 1_ chloroplastic

GlyGly(1)
GlyGly(5)
GlyGly(12)
GlyGly(19)

AT1G59359.1

Chaperonin 60 subunit alpha 1_ chloroplastic GlyGly(23)

AT1G56070.1

Chaperonin 60 subunit beta 2_ chloroplastic GlyGly(*)

AT1G77120.1

Chaperonin 60 subunit beta 3_ chloroplastic GlyGly(5)
Chlorophyll a-b binding protein CP26_
GlyGly(13)
chloroplastic

AT1G20620.1
AT3G27690.1
AT3G54400.1
AT4G13930.1
AT1G72370.2

Chlorophyll a-b binding protein CP26_
chloroplastic
Cytosolic isocitrate dehydrogenase
D-3-phosphoglycerate dehydrogenase 1_
chloroplastic
Dihydrolipoyl dehydrogenase 2_
mitochondrial

AT1G11580.1

Elongation factor 1-alpha 2

AT2G17360.1

Elongation factor 1-alpha 2

AT3G60750.2

Elongation factor Tu_ chloroplastic

AT3G09440.2
AT1G56070.1
AT4G37930.1
AT1G20620.1
AT5G63570.1
AT1G22530.1
AT1G54340.1
AT1G63770.1
AT4G12800.1
AT4G37930.1
AT3G13470.1
AT4G16515.1
AT5G40370.2
AT4G24280.1
AT4G32520.2
AT1G26630.1
AT3G14310.1
AT5G11520.1
AT2G28000.1
AT5G42310.1
AT4G13930.1
AT3G61440.1

Peptide Sequence
VFQVVGDALKPALDTALPIA
KQAGEEAMK
KENNFKQAGDR
SLGQKLASRLNVRPSI
LTDSKGRTVDFK
QSKLGGGNQQQGQRVSYNK
AVASISAGNDDLIGSMIADAI
DK
LSGGVAVIQVGAQTETELKE
K
VDAIKETLANDEEK
SKAVSETSDELAKWYGPDR

GlyGly(4)

WAMLGAAGFIIPEALNKYGA
NCGPEAVWFKTGALLLDGN
TLNYFGK
VHQKGGETSTNSIASIFAWTR

GlyGly(3)

DSKLVQHER

GlyGly(6);ox+M(2)

FMLKTKVVGVDSSGDGVK

carb+C(16);carb+C(17);
carb+C(18);GlyGly(12)
carb+C(4);carb+C(5);carb+C(6);
GlyGly(8);ox+M(9)

EHALLAFTLGVKQMICCCNK
MDATTPK

carb+C(22);GlyGly(46)

QMICCCNKMDATTPKYSK

HSPFFAGYRPQFYMRTTDVT
GK
Elongation factor Tu_ mitochondrial
carb+C(9);GlyGly(13)
QVGVPSLVCFLNK
carb+C(8);GlyGly(12);
VFHINSLCSPFKTSVSWADTL
Eukaryotic aspartyl protease family protein
GlyGly(25)
LQDK
Eukaryotic translation initiation factor 5A-2 carb+C(12);GlyGly(1)
KLEDIVPSSHNCDVPHVNR
LGFDEGKDIVVSVMSSMGEE
Eukaryotic translation initiation factor 5A-2 carb+C(23);GlyGly(26);ox+M(14)
QICAVKEVGGGK
Ferredoxin-dependent glutamate synthase 1_
MGISLLSSYCGAQIFEIYGLG
carb+C(10);GlyGly(35);ox+M(1)
chloroplastic/mitochondrial
QDVVDLAFTGSVSK
Ferredoxin-dependent glutamate synthase 1_
SQQAFGYSSEDVQMVIESMA
GlyGly(24)
chloroplastic/mitochondrial
SQGK
Ferredoxin-dependent glutamate synthase 1_
GlyGly(13);ox+M(5)
EGLVMSLEVNIGK
chloroplastic/mitochondrial
FEGCYHGHANAFLVKAGSG
Glutamate-1-semialdehyde 2_1-aminomutase
carb+C(4);GlyGly(15)
VATLGLPDSPGVPKAATSDT
1_ chloroplastic
LTAPYNDLEAVEK
IFSHPDVAKEEPWYGIEQEYT
Glutamine synthetase cytosolic isozyme 1-3 GlyGly(9);ox+M(23)
LMQK
Glutamine synthetase_
RLTGKHETASIDQFSWGVAN
GlyGly(5)
chloroplastic/mitochondrial
R
TVPNVFIGGNHIGGCDATSN
Glutaredoxin-C2
carb+C(15);GlyGly(23)
LHK
Glyceraldehyde-3-phosphate dehydrogenase
GlyGly(15)
AASFNIIPSSTGAAKAVGK
GAPC1_ cytosolic
Glyceraldehyde-3-phosphate dehydrogenase
VVLQRDDVELVAVNDPFITT
GlyGly(28)
GAPC1_ cytosolic
EYMTYMFKYDSVHGQWK
Glycine-rich RNA-binding protein 8
GlyGly(8)
GFGFVTFKDEKAMR
Heat shock 70 kDa protein 3
GlyGly(14);GlyGly(18)
SGPAEKPMIVVNYKGEDK
Heat shock 70 kDa protein 3
carb+C(15);GlyGly(12)
VQQLLVDFFNGKELCK
QDITITGASTLPKDEVDQMV
Heat shock 70 kDa protein 6_ chloroplastic GlyGly(13)
QEAER
Heat shock protein 90-4
GlyGly(14)
EGQNEIFYITGESKK
Heat shock protein 90-4
GlyGly(*);ox+M(*)
AQALKDSNTGGYMSSKK
heat shock protein 90.1
GlyGly(2);GlyGly(17)
SKLDGQPELFIRLVPDK
GSVGPKSAEFTLAPDEYITAL
Jacalin-related lectin 34
GlyGly(26)
SAYGK
Malate dehydrogenase_ cytoplasmic 2
GlyGly(11);GlyGly(19);ox+M(3) DVMSKNVSIYKSQASALEK
GlyGly(22);ox+M(14)
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Table A.6. (cont’d) CST2.
ATG No.

Protein Description

AT5G54500.1

Mitochondrial phosphate carrier protein 3_
mitochondrial

AT3G17240.3

Mitochondrial Rho GTPase 2

AT1G77120.1

NAD(P)H dehydrogenase (quinone) FQR1

AT3G08590.2

NADP-dependent malic enzyme 2

AT4G20360.1

Nitrile-specifier protein 1

AT1G68560.1
AT3G14790.1
AT2G10940.2
AT3G19170.1

Nucleoside diphosphate kinase III_
chloroplastic/mitochondrial
Oxygen-evolving enhancer protein 1-2_
chloroplastic
Oxygen-evolving enhancer protein 1-2_
chloroplastic
Oxygen-evolving enhancer protein 1-2_
chloroplastic

AT5G11520.1

Patellin-2

AT5G04140.2

Patellin-2

AT4G10340.1
AT1G23190.1

Pectinesterase/pectinesterase inhibitor 18
Pectinesterase/pectinesterase inhibitor 18

AT3G17820.1

Pectinesterase/pectinesterase inhibitor 3

AT4G26410.1

Pentatricopeptide repeat-containing protein
At1g12620

Peptide Modification(s)

Peptide Sequence
GIEMYSPAFYAACTFGGILSC
carb+C(13);carb+C(21);carb+C(36);
GLTHMTVTPLDLVKCNMQI
GlyGly(44);GlyGly(46);ox+M(38)
DPAKYK
carb+C(8);GlyGly(*)
TERNVFQCFVFGPKK
AQALAGKPAGIFYSTGSQGG
GlyGly(7);ox+M(38)
GQETTALTAITQLVHHGMLF
VPIGYTFGAGMFEMENVK
GlyGly(3);GlyGly(10)
YNKGLAFTDKER
LDKFGGEEETPSSRGWTAST
GlyGly(3);GlyGly(27)
TATIDGK
NARFFSEGRAIGAAAAVSAS
GlyGly(22)
GK
NAPPDFQNTKLMTRLTYTLD
GlyGly(10)
EIEGPFEVGSDGSVK
GlyGly(10)

NAPPDFQNTKLMTR

GlyGly(16)

ADSVSKNAPPDFQNTK

YVAPEVVPVKYGGLSKDSPF
TVEDGVTEAVVK
EILQSESFKEEGYLASELQEA
GlyGly(23)
EK
carb+C(1);GlyGly(2)
CKITASSDLAPVK
GlyGly(12)
DSKEAEQFTVAK
VGSDFSAFYNCDMLAYQDT
carb+C(11);carb+C(32);carb+C(52);
LYVHSNRQFFVKCLIAGTVD
GlyGly(31);ox+M(13)
FIFGNAAVVLQDCDIHAR
LGYEPDTVTFSTLINGLCLEG
carb+C(18);carb+C(53);GlyGly(*);o
RVSEALELVDRMVEMGHKP
x+M(*)
TLITLNALVNGLCLNGK
GlyGly(16);GlyGly(32)

AT5G49360.1

Pentatricopeptide repeat-containing protein
At1g12620
Pentatricopeptide repeat-containing protein
At5g42310_ mitochondrial
Peptidase M1 family protein

AT2G19730.3

Peptidase M1 family protein

GlyGly(35);GlyGly(43);ox+M(3)

AT3G61440.1

Peroxidase 33

carb+C(4);GlyGly(25);ox+M(7)

AT3G48870.2

Peroxisomal isocitrate dehydrogenase

GlyGly(24);ox+M(23)

AT4G26410.1
AT1G12620.1

AT3G16460.1
AT4G32520.2

Phosphoserine aminotransferase 2_
chloroplastic
Photosystem I reaction center subunit XI_
chloroplastic

carb+C(11);GlyGly(12)

TKQYDLVLDLCKQMELK

GlyGly(17)

LELDVQLVNDIIMGFAK

GlyGly(13);ox+M(11)

ITFYQDRPDIMAK
AAMKWDEDVFGLEYDLDLF
NIVAVPDFNMGAMENKSLNI
FNSK
TVSCADMLTIAAQQSVTLAG
GPSWK
SKYEAAGIWYEHRLIDDMV
AYAMK

GlyGly(6);GlyGly(20)

SEKYTKVPTFDGLEQSSDAK

GlyGly(1);GlyGly(15)

KKQPDQLQTADGWAK

AT4G34200.1

Photosystem II CP43 reaction center protein GlyGly(20)

ALYFGGVYDTWAPGGGDVR
K

AT1G09780.1

photosystem II light harvesting complex gene
GlyGly(4)
2.3

NGVKFGEAVWFK

AT3G49110.1

Presequence protease 1_
chloroplastic/mitochondrial

GlyGly(41);ox+M(16)

LRGSGHGIAAARMDAMLNI
AGWMSEQMGGLSYLEFLHT
LEK

AT2G10965.1

Probable 2_3-bisphosphoglycerateindependent phosphoglycerate mutase 2

GlyGly(11)

DGKPDTWRLIK

AT4G10340.1

Probable aquaporin PIP2-4

GlyGly(25)

AT3G18130.1

Probable fructokinase-1
GlyGly(7);GlyGly(11)
Probable mediator of RNA polymerase II
carb+C(8);GlyGly(*)
transcription subunit 37c
Probable mediator of RNA polymerase II
GlyGly(12)
transcription subunit 37e
Probable phosphoglucomutase_ cytoplasmic 1 GlyGly(8)
Protein BTR1
GlyGly(10)

AT4G26410.1
AT2G28000.1
AT2G26260.1
AT2G19730.3

245

GTGLGAEIIGTFVLVYTVFSA
TDPKR
EPLWPSKEEAK
GVPQITVCFDIDANGILNVSA
EDKTTGK
DEIEKMVQEAEK
DAVQIIIK
AIQQAETMIK

Table A.6. (cont’d) CST2.
ATG No.

Protein Description

Peptide Modification(s)

AT5G56500.2

Receptor for activated C kinase 1C

carb+C(22);GlyGly(27)

AT5G56630.1

Ribosomal protein S5/Elongation factor
G/III/V family protein

GlyGly(11);GlyGly(12);ox+M(2)

IMGPNYIPGEKKDLYTK

AT5G56000.1

Ribosomal protein S5/Elongation factor
G/III/V family protein

carb+C(4);GlyGly(47)

MDRCFLELQVDGEEAYQTFS
RVIENANVIMATYEDPLLGD
VQVYPEK

GlyGly(15)

TFQGPPHGIQVERDK

AT2G31390.1
AT4G02930.1

Ribulose bisphosphate carboxylase large
chain
Ribulose bisphosphate carboxylase small
chain 1A_ chloroplastic

carb+C(6);carb+C(19);GlyGly(14) LPLFGCTDSAQVLKEVEECK

AT5G13490.2

Root meristem growth factor 6

GlyGly(*)

AT5G23060.1

S-adenosylmethionine synthase 4

GlyGly(11)

AT5G43940.1

Selenium-binding protein 2

GlyGly(5)

AT4G11010.1

GlyGly(18)

AT3G04770.2
AT5G04140.2
AT5G04430.2

Selenium-binding protein 2
Serine hydroxymethyltransferase 1_
mitochondrial
Serine hydroxymethyltransferase 1_
mitochondrial
Serine hydroxymethyltransferase 3_
chloroplastic
Serine hydroxymethyltransferase 3_
chloroplastic
Serine hydroxymethyltransferase 4
Serine hydroxymethyltransferase 4
Subtilase family protein

AT3G63150.1

Transketolase-1_ chloroplastic

GlyGly(21);ox+M(2);ox+M(7)

AT1G11580.1
AT2G10965.1
AT1G22530.1
AT5G52640.1

AT5G56000.1
AT2G05920.1
AT5G60660.1
AT1G12620.1

Trifunctional UDP-glucose 4_6dehydratase/UDP-4-keto-6-deoxy-D-glucose
3_5-epimerase/UDP-4-keto-L-rhamnosereductase RHM3
Trifunctional UDP-glucose 4_6dehydratase/UDP-4-keto-6-deoxy-D-glucose
3_5-epimerase/UDP-4-keto-L-rhamnosereductase RHM3
ubiquitin 13
ubiquitin 13
ubiquitin 13
ubiquitin 13

AT4G14040.1

ubiquitin 13

AT1G63770.1

AT5G23060.1

AT2G17630.1
AT5G04140.2
AT3G14790.1
AT1G68560.1
AT4G14040.1

GlyGly(18);GlyGly(25);ox+M(1)
GlyGly(3);ox+M(26)
GlyGly(22)
carb+C(22);GlyGly(26)
GlyGly(5)
GlyGly(14)
GlyGly(13)

ALGGVETGEEVVVMDYPQP
HRKPPIHNEKS
DDADFTWEVVKPLKSNK
GSPYKAVGEDGNTYQFDVP
QIK
SGPGYATPLAAMAGPREK
MGTPALTSRGFVEEDFAKVA
EYFDK
QWKGLELIPSENFTSVSVMQ
AVGSVMTNK
RNLVSEMRASSVSLPNVEISS
K
SLELIASENFTSRAVMEAVGS
CLTNKYSEGLPGK
GLVEKDFEQIGEFLSR
KGQPEGAVYDFEDK
GFQMASGGGFSSKR
AMPNTLMFRPADGNETAGA
YKIAVTKR

GlyGly(11)

WSNFNLEEQAK

carb+C(12);GlyGly(10)

TGWLGGLLGKLCEKQGIPYE
YGK

GlyGly(9)
GlyGly(5)
GlyGly(6)
GlyGly(6);ox+M(1)
GlyGly(6)

Uncharacterised conserved protein
UCP022280
Uncharacterised conserved protein
UCP022280
Uncharacterised conserved protein
UCP022280
unknown protein
unknown protein

Peptide Sequence
NSLVGHSGYLNTVAVSPDGS
LCASGGK

TLADYNIQKESTLHLVLR
TLTGKTITLEVESSDTIDNVK
LIFAGKQLEDGR
MQIFVKTLTGK
LIFAGKQLEDGRTLADYNIQ
K

GlyGly(13);ox+M(12)

HVQELNMSVDLMK

GlyGly(*);ox+M(*)

HVQELNMSVDLMKKESR

ENSTSQFRSIQDFIPHALTQY
KTYENAFFSK
carb+C(2);GlyGly(19);GlyGly(20) ECSLLGGHILPMSENTASKK
GlyGly(5)
SSTNKVVDESMVTVK
GlyGly(22);GlyGly(31)

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.

Total unique peptides:

136

Total unique proteins:

95

246

Table A.7. Digly-modified peptides identified in the first-pass diglycine-enrichment.
ATG No.
AT1G05010.1
AT1G09780.1
AT5G06290.1
AT5G20720.3
AT4G27150.1
AT4G13430.1
AT2G43090.1
AT2G33150.1
AT4G24220.2
AT1G74960.1
AT5G41520.1
AT5G18380.3
AT1G34030.1
AT2G41840.1
AT2G31610.1
AT4G34670.1
AT4G31700.1
AT5G10360.1
AT5G16130.1
AT1G72370.2
AT3G04770.1
AT5G17920.1
AT1G14320.1
AT1G04480.1
AT1G33140.1
AT1G59870.1
AT4G35830.1
AT4G26970.1
AT2G37620.2
AT3G08580.2
AT5G13490.2
AT2G35040.1
AT5G43940.1
AT1G77120.1
AT3G48000.1
AT3G52930.1
AT5G13420.1
AT3G22850.1
AT1G11860.3
AT4G10720.2
AT4G31990.4
AT1G62800.2
AT1G11910.1
AT1G62290.2
AT1G09620.1
AT5G49460.1
AT2G30950.1

Protein Description
1-aminocyclopropane-1-carboxylate oxidase 4
2_3-bisphosphoglycerate-independent
phosphoglycerate mutase 1

Peptide Modification(s) Peptide Sequence
carb+C(1);GlyGly(11) CMEERFKESIK
EGKLQILTSHTLKPVPIAIGGPGLAQ
GlyGly(13)
GVR
SVDETMRTLQALQYVQENPDEVCP
2-Cys peroxiredoxin BAS1-like_ chloroplastic carb+C(23);GlyGly(*)
AGWKPGEKSMKPDPK
20 kDa chaperonin_ chloroplastic
GlyGly(3)
DLKPLNDR
2S seed storage protein 2
carb+C(2);GlyGly(4)
ACQKLMRMQMR
3-isopropylmalate dehydratase large subunit
GlyGly(4)
ILLKVPPTMR
3-isopropylmalate dehydratase small subunit 3 GlyGly(11)
FNSTSVASNFKPLVSREASSSFVTR
LKPVFKKDGTTTAGNSSQVSDGAG
3-ketoacyl-CoA thiolase 2_ peroxisomal
GlyGly(*);ox+M(*)
AVLLMK
3-oxo-Delta(4_5)-steroid 5-beta-reductase
GlyGly(7)
VWEEMVKENQLQEK
3-oxoacylGlyGly(1)
KPPTEQR
40S ribosomal protein S10-2
GlyGly(8)
SGGEYGDKAGAPADYQPGFR
40S ribosomal protein S16-3
carb+C(12);GlyGly(*) MATQPATESVQCFGRKK
40S ribosomal protein S18
GlyGly(3)
DGKYSQVVSNALDMK
SPYQEHTDFLASKALSTSKPDPVVE
40S ribosomal protein S2-3
GlyGly(19)
DQA
40S ribosomal protein S3-1
GlyGly(11)
ATRTQNVLGEKGR
40S ribosomal protein S3a-2
GlyGly(15);ox+M(9)
NVLTQFWGMDFTTDKLR
40S ribosomal protein S6-1
carb+C(12);GlyGly(2) MKFNVANPTTGCQK
40S ribosomal protein S6-2
GlyGly(12)
YVNTYRRTFTNK
40S ribosomal protein S7-3
GlyGly(6);ox+M(10)
NNTEYKLETMVGVYRK
40S ribosomal protein Sa-1
GlyGly(15)
MATNGSASSAQLSQK
EGALGNIPTIAFCDTDSPMGFVDIGIP
40S ribosomal protein Sa-2
carb+C(13);GlyGly(*)
ANNKGK
5-methyltetrahydropteroyltriglutamate-VVEVNALAKALAGQKDEALFSANA
GlyGly(9);GlyGly(15)
homocysteine methyltransferase 1
AALASR
60S ribosomal protein L10-1
GlyGly(8)
FNRADFTKLR
60S ribosomal protein L23
GlyGly(7)
GGTSGNKFR
60S ribosomal protein L9-1
GlyGly(1)
KFLDGIYVSEK
ABC transporter G family member 36
GlyGly(4)
VGIKLPTVEVR
Aconitate hydratase 1
GlyGly(11)
MFVDYSEPESK
YATMASEHSYKDILTSLPKPGGGEY
Aconitate hydratase 3_ mitochondrial
GlyGly(19)
GK
carb+C(1);carb+C(29);G CPEVLYQPSMIGMENAGIHETTYNSI
Actin-1
lyGly(28);ox+M(27)
MKCDVDIRK
ADP_ATP carrier protein 1_ mitochondrial
GlyGly(3)
AAKKGGGGR
GAGANILRAVAGAGVLAGYDKLQL
ADP_ATP carrier protein 2_ mitochondrial
GlyGly(*)
IVFGK
AICARFT/IMPCHase bienzyme family protein GlyGly(22)
SPTDGETRMFYEIVVAPKYTAK
Alcohol dehydrogenase class-3
GlyGly(13)
SATGVGIMMNDRKSR
Alcohol dehydrogenase class-P
GlyGly(5)
DDAFKTHPMNFLNER
Aldehyde dehydrogenase family 2 member B4_
GlyGly(10)
YGLAAGVFTKNLDTANR
mitochondrial
Aldolase superfamily protein
GlyGly(8)
ALQQSTLKTWAGK
Aldolase-type TIM barrel family protein
GlyGly(1)
KQRLLWASTSVK
Aluminium induced protein with YGL and
GlyGly(14)
EAMPRVGSVQNWSK
LRDR motifs
SHSEVHDESGNKIGEITSGGFSPNLK
Aminomethyltransferase_ mitochondrial
GlyGly(*)
K
Ankyrin repeat family protein
GlyGly(4)
WGGKSGNSLPK
Aspartate aminotransferase_ chloroplastic
GlyGly(16)
AQSDNMTDKWHVYMTK
Aspartate aminotransferase_ cytoplasmic
carb+C(9);GlyGly(17);o
MFVADGGECLIAQSYAK
isozyme 2
x+M(1)
Aspartic proteinase A1
GlyGly(10)
AAPVWYNMLK
carb+C(3);carb+C(9);Gl KICSQIGLCAYDGTHGVSMGIESVV
Aspartic proteinase A2
yGly(1);GlyGly(27)
DKENTR
ATP binding\x3bleucine-tRNA
ligases\x3baminoacyl-tRNA
GlyGly(1)
KPALQDKYGVK
ligases\x3bnucleotide binding\x3bATP
binding\x3baminoacyl-tRNA ligases
SAAASSMAALKQPTIKVVAIIAEGVP
ATP-citrate synthase beta chain protein 2
GlyGly(*)
ESDTK
ATP-dependent zinc metalloprotease FTSH 2_
GlyGly(21)
SGGGMGGPGGPGNPLQFGQSK
chloroplastic
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Table A.7. (cont’d) First-pass enrichment.
ATG No.
AT2G18960.1
AT2G07698.1
AT3G07390.1
AT1G15050.1
AT3G01500.1

Protein Description
ATP-dependent zinc metalloprotease FTSH 8_
chloroplastic
ATPase 1_ plasma membrane-type
ATPase_ F1 complex_ alpha subunit protein
auxin-responsive family protein
Auxin-responsive protein IAA34
Beta carbonic anhydrase 1_ chloroplastic

AT3G09260.1

Beta-glucosidase 23

AT3G18070.1
AT3G18080.1

AT3G12290.1

Beta-glucosidase 43
Beta-glucosidase 44
Bifunctional dTDP-4-dehydrorhamnose 3_5epimerase/dTDP-4-dehydrorhamnose reductase
Bifunctional enolase 2/transcriptional activator
Bifunctional inhibitor/lipid-transfer protein/seed
storage 2S albumin superfamily protein
Bifunctional L-3-cyanoalanine synthase/cysteine
synthase C1_ mitochondrial
Bifunctional protein FolD 2

AT5G34850.1

Bifunctional purple acid phosphatase 26

GlyGly(6)

AT5G35360.1
AT5G23060.1
AT5G61790.1

Biotin carboxylase_ chloroplastic
Calcium sensing receptor_ chloroplastic
Calnexin homolog 1

carb+C(4);GlyGly(11)
GlyGly(11)
GlyGly(9)

AT5G07340.2

Calnexin homolog 2

GlyGly(*)

AT1G09210.1

Calreticulin-2

GlyGly(15)

AT1G20630.1

Catalase-1

GlyGly(49);ox+M(32)

AT4G35090.1

Catalase-2

AT1G20620.1

Catalase-3

AT2G04030.2
AT3G13470.1
AT5G56500.1
AT3G23990.1

Chaperone protein htpG family protein
Chaperonin 60 subunit beta 2_ chloroplastic
Chaperonin 60 subunit beta 3_ chloroplastic
Chaperonin CPN60_ mitochondrial
Chlorophyll a-b binding protein CP26_
chloroplastic
Chloroplast stem-loop binding protein of 41 kDa
a_ chloroplastic
Citrate synthase 5_ mitochondrial
Class I glutamine amidotransferase-like
superfamily protein
Class II aaRS and biotin synthetases superfamily
protein

AT1G06430.1

AT1G63000.1
AT2G36530.1
AT1G55260.2
AT3G61440.1

AT4G10340.1
AT3G63140.1
AT3G60100.1
AT4G30530.1
AT3G44740.1
AT4G36020.1

Cold shock protein 1

Peptide Modification(s) Peptide Sequence
GlyGly(2)

GKTAISSKEIDDSIDR

GlyGly(3)
GlyGly(12)
GlyGly(14)
GlyGly(1);GlyGly(17)
GlyGly(13)

DGKWSEQEAAILVPGDIVSIK
VVDAMGVPIDGK
TYNISSYSSLVEGK
KPTMDSDPLGVFPNSPK
YETNPALYGELAK
LPLIGLLLLLTIVASPANADGPVCPPS
carb+C(24);GlyGly(29)
NKLSR
GlyGly(21)
SGEESPSGDAVPLATGGLNRK
GlyGly(2)
NKLHTGGLSR
GlyGly(9)

NFTLEEQAKVIVAPRSNNELDATK

GlyGly(9);GlyGly(13)

DGGSDYLGKGVSK

GlyGly(5)

AEPVKSNGWK

GlyGly(3)

YLKSKNPNVK

GlyGly(7)

NTVDGAKRVFGE
YPVPDKSAPVYITVGDGGNQEGLAG
R
SSLCNLMMPSK
TVTDVAQQTSK
ELDEPLNLK
SKIMELIEKAETQPNLTIGVLISIVIVF
LSLFFK
AEETKSVDSEETSEK
VGGANHSHATKDLYDSIAAGNYPQ
WNLFVQVMDPAHEDKFDFDPLDVT
K

GlyGly(18);ox+M(2);ox
+M(11)
carb+C(16);GlyGly(10);
GlyGly(19)
GlyGly(20);ox+M(15)
GlyGly(8);GlyGly(17)
GlyGly(*)
GlyGly(11)

HMDGSGVNTYMLINKAGK
DEEINYYPSKFDPVRCAEK
NEEELTSLDDYIENMGENQK
VLANDNVKFGYNAATGK
ETLANDEEKVGADIVKK
DRVTDALNATK

GlyGly(17)

AVSRSSAPLASSPSTFK

GlyGly(5)

LSPQKFTVK

GlyGly(10)

WLHSSELDLKSQMQEIIPEQQDR

GlyGly(1);GlyGly(7)

KIDEMKK

carb+C(2);carb+C(15);G
DCAVKSNVLSFWRQCGR
lyGly(5)
carb+C(2);GlyGly(5);Gl
DCTQKSVGNGDQRGAVK
yGly(17)

AT3G12490.2

Curculin-like (mannose-binding) lectin family
protein
Cysteine proteinase inhibitor 6

AT3G59760.3

Cysteine synthase_ mitochondrial

GlyGly(*)

AT1G65930.1

Cytosolic isocitrate dehydrogenase
D-3-phosphoglycerate dehydrogenase 3_
chloroplastic
D-mannose binding lectin protein with Applelike carbohydrate-binding domain

GlyGly(*)

HVAEQAVK
EGLMVGISSGAAAAAAIKVAKRPEN
AGK
FKDIFQEVYEASWKSK

GlyGly(10);ox+M(7)

QVDQPGMIGK

AT1G78830.1

AT3G19480.1
AT1G78850.1
AT3G53110.1

DEAD-box ATP-dependent RNA helicase 38

AT1G20440.1

Dehydrin COR47

carb+C(24);GlyGly(25) IVGVEHFTGPYVNDGQGPTSVNDCK
GlyGly(8)

carb+C(22);carb+C(26); IEGADSFMTKYNGGSSTTESACGDK
GlyGly(25)
CTR
ELANQNMEVLQKMGKFTGITAELA
GlyGly(12)
VPDSTR
TEEDEENKPSVIEKLHRSNSSSSSSSD
GlyGly(33)
EEGEEK
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Table A.7. (cont’d) First-pass enrichment.
ATG No.

AT5G60390.1
AT1G62750.1
AT4G29060.1

Protein Description
Delta-aminolevulinic acid dehydratase 1_
chloroplastic
Diaminopimelate decarboxylase 1_ chloroplastic
Dihydrolipoyl dehydrogenase 1_ mitochondrial
Dolichyl-diphosphooligosaccharide—protein
glycosyltransferase 48 kDa subunit
Dolichyl-diphosphooligosaccharide—protein
glycosyltransferase subunit 2
Elongation factor 1-alpha 2
Elongation factor G_ chloroplastic
elongation factor Ts family protein

AT4G20360.1

Elongation factor Tu_ chloroplastic

AT4G24190.2
AT2G05990.2

Endoplasmin homolog
Enoyl-

AT1G03230.1

Eukaryotic aspartyl protease family protein

AT1G13020.1

eukaryotic initiation factor 4B2

AT3G11400.2

eukaryotic translation initiation factor 3G1

AT1G69410.1

Eukaryotic translation initiation factor 5A-3

AT3G13460.3

evolutionarily conserved C-terminal region 2
Ferredoxin—NADP reductase_ leaf isozyme 1_
chloroplastic
Ferredoxin—nitrite reductase_ chloroplastic
Ferredoxin-dependent glutamate synthase 1_
chloroplastic/mitochondrial
Flavone 3’-O-methyltransferase 1
Formate dehydrogenase_ mitochondrial
Formate—tetrahydrofolate ligase
Fructose-1_6-bisphosphatase_ chloroplastic
Fumarate hydratase 2_ chloroplastic

AT1G69740.2
AT3G14390.1
AT1G48030.2
AT5G66680.1
AT4G21150.3

AT5G66190.1
AT2G15620.1
AT5G04140.2
AT5G54160.1
AT5G14780.1
AT1G50480.1
AT3G54050.2
AT5G50950.2
AT5G66530.2
AT3G22200.1
AT5G28840.2
AT1G33811.1
AT5G19220.1
AT4G24620.1
AT1G65960.2
AT5G53460.3
AT1G23310.2
AT5G63570.1
AT3G48730.1
AT1G48470.1
AT1G19570.1
AT4G19880.2
AT3G26650.1
AT1G42970.1
AT1G68010.2
AT1G29880.1

Peptide Modification(s) Peptide Sequence
GlyGly(9)

HGLVQEVAKARAVGVNSIVLFPK

GlyGly(9)
GlyGly(10)

LQWFLDQVK
FPFMANSRAK

GlyGly(11)

VPDVYGVFQFKVEYEK

GlyGly(13)

DGAVSLSANHLQK

GlyGly(7)
VGYNPDK
GlyGly(13)
FEPLEAGSGYEFK
GlyGly(1)
KGEGFNSKFAK
carb+C(3);carb+C(13);G
ILCSYSSPSPSLCPAISTSGK
lyGly(21)
carb+C(10);GlyGly(16) ISNRLADTPCVVVTSK
carb+C(20);GlyGly(17) AGTYIVGANPGNASWDKLSCTR
HNIGLPLQFAAAFSFNRKFAVCLTSG
carb+C(22);GlyGly(18)
R
YGGGGGSFGGGGGGGAGSYGGGG
GlyGly(36)
AGAGSGGGGGFSK
GlyGly(*)
QVIGPDENGLKTTIEYKFNDEENK
carb+C(23);GlyGly(26); NGFEEGKDIVVSVMSAMGEEQMCA
ox+M(17);ox+M(22)
LK
GlyGly(12)
TNGRGWAATDNK
GlyGly(20)
GlyGly(*);GlyGly(*)

FNGLAWLFLGVPTSSSLLYK

EPMKLFMENGIEELAKK
FAQVTNPAIDPLREGLVMSLEVNIG
GlyGly(26)
K
carb+C(11);GlyGly(17) NEDGVSIAALCLMNQDK
GlyGly(9)
LQMAPELEK
GlyGly(12);ox+M(6)
ERLGKMVIGNSK
carb+C(1);GlyGly(12) CMAVAADAAETKTAARK
GlyGly(9)
NLHSSLESKSFEFKDIVK
DFVCVENAKLGDVKLEPGQSWTAT
Galactose mutarotase-like superfamily protein carb+C(4);GlyGly(9)
QLLSIS
Gamma-aminobutyrate transaminase POP2_
EGPETIGAFIAEPVMGAGGVIPPPAT
GlyGly(30)
mitochondrial
YFEK
GDP-mannose 3_5-epimerase
GlyGly(*)
EKAKGSDVSLYGSSK
YLSRCIFYSGMGSNDYLNNYFMPDF
GDSL esterase/lipase At1g33811
carb+C(5);GlyGly(35)
YSTSTNYNDK
Glucose-1-phosphate adenylyltransferase large
AYNSNGLGFGDGYVEVLAATQTPG
GlyGly(28)
subunit 1_ chloroplastic
ESGKR
MASLSGLYSSSPSLKPAKNHSFKALP
Glucose-6-phosphate isomerase 1_ chloroplastic GlyGly(15);GlyGly(23)
AQSR
carb+C(26);GlyGly(43); EVNLSEGYYVMDPDKAAEMVDENT
Glutamate decarboxylase 2
ox+M(19)
ICVAAILGSTLNGEFEDVK
Glutamate synthase 1
GlyGly(18)
LQEAARTNSVAAYKEYSK
carb+C(21);GlyGly(10);
Glutamate—glyoxylate aminotransferase 1
LPTGALQAAKQAGKVPDVFYCLK
GlyGly(23)
Glutamate-1-semialdehyde 2_1-aminomutase 1_
TGHPMCGGYISGMFGFFFAEGPVYN
carb+C(6);GlyGly(30)
chloroplastic
FADSK
Glutamate-1-semialdehyde 2_1-aminomutase 2_
GlyGly(12)
LSQPGTYEYLDKITK
chloroplastic
Glutamine synthetase cytosolic isozyme 1-5
GlyGly(11)
TLPGPVSNPTK
Glutathione S-transferase DHAR1_
GlyGly(*)
TLFSLDSFEKTK
mitochondrial
Glutathione S-transferase family protein
GlyGly(1)
KQGPYEEAVEQVYEALDR
Glyceraldehyde-3-phosphate dehydrogenase
GlyGly(25)
AAALNIVPTSTGAAKAVALVLPNLK
GAPA1_ chloroplastic
Glyceraldehyde-3-phosphate dehydrogenase
carb+C(14);GlyGly(17) LQSKSAIHSFPAQCSSKR
GAPB_ chloroplastic
Glycerate dehydrogenase HPR_ peroxisomal
GlyGly(19)
AFSNMAVGYNNVDVEAANK
Glycine—tRNA ligase 1_ mitochondrial
GlyGly(18)
LEFLMFPREEQMSGQSAK
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Table A.7. (cont’d) First-pass enrichment.
ATG No.
AT4G39260.1
AT1G11840.6
z
AT5G20010.1
AT5G09590.1
AT1G79920.2
AT3G09440.2
AT1G16030.1
AT4G24280.1
AT5G49910.1
AT4G37910.1
AT5G56010.1
AT5G56000.1
AT5G52640.1
AT1G12270.1
AT3G10850.1
AT1G51760.1
AT1G16350.1
AT1G13930.3
AT3G16460.2
AT3G15356.1
AT1G33590.1
AT3G45140.1
AT4G23850.1
AT2G45670.1
AT4G25080.5
AT4G18480.1
AT5G45930.1
AT3G56940.1
AT3G47520.1
AT5G28540.1
AT3G59970.3
AT2G44160.1
AT5G23010.1
AT3G15660.2
AT5G26000.1
AT5G22290.1
AT5G37510.2
AT5G11670.1
AT5G13850.1
AT2G01410.1
AT3G16400.2
AT4G09320.1
AT4G11010.1

Protein Description

Peptide Modification(s) Peptide Sequence
CFVGGLAWATNDEDLQRTFSQFGD
Glycine-rich RNA-binding protein 8
carb+C(1);GlyGly(29)
VIDSK
glyoxalase I homolog
GlyGly(9)
IVNQELGGKITR
GTP binding
GlyGly(5)
FEDLKELGNEPAVKAAGK
GTP-binding nuclear protein Ran-1
carb+C(3);GlyGly(11) FYCWDTAGQEKFGGLR
AFSSKPAGNDVIGIDLGTTNSCVAV
Heat shock 70 kDa protein 10_ mitochondrial
carb+C(22);GlyGly(29)
MEGK
MDTDKASAEAAPASGDSDVNMQD
Heat shock 70 kDa protein 15
GlyGly(5)
AK
Heat shock 70 kDa protein 3
GlyGly(4)
IGEKLAGDDKK
Heat shock 70 kDa protein 5
GlyGly(1)
KEQVFSTYADNQPGVLIQVYEGER
Heat shock 70 kDa protein 6_ chloroplastic
GlyGly(1)
KQDITITGASTLPK
Heat shock 70 kDa protein 7_ chloroplastic
GlyGly(26)
MASSAAQIHILGGIGFPTSSSSSSTK
Heat shock 70 kDa protein 9_ mitochondrial
GlyGly(22);ox+M(2)
GMPQIEVTFDIDANGITTVSAK
Heat shock protein 90-3
carb+C(2);GlyGly(13) KCLELFFEIAENK
Heat shock protein 90-4
GlyGly(*)
EGQNEIFYITGESKK
heat shock protein 90.1
GlyGly(*)
KENEGEVEEVDEEKEK
Hsp70-Hsp90 organizing protein 1
GlyGly(9)
LNDAERAKK
Hydroxyacylglutathione hydrolase cytoplasmic carb+C(3);GlyGly(4)
LGCKSPIDTMREVR
EHEEELQGTVVLVFQPAEEGGGGAK
IAA-amino acid hydrolase ILR1-like 4
GlyGly(*)
K
YVKNTYPELDVVGGNVVTMYQAE
Inosine-5’-monophosphate dehydrogenase 2
GlyGly(27)
NLIK
Involved in response to salt stress. Knockout
GlyGly(9)
SSTGQYLDK
mutants are hypersensitive to salt stress.
Jacalin-related lectin 34
GlyGly(14)
VYVGQGQDGVAAVK
Lectin-like protein LEC
GlyGly(5)
VWSFKDVNLSSGER
carb+C(11);carb+C(13);
Leucine-rich repeat (LRR) family protein
FPASAFVGNDCLCGSPLSPCK
carb+C(20);GlyGly(21)
Lipoxygenase 2_ chloroplastic
GlyGly(12)
FDQEGLPADLIKR
carb+C(18);GlyGly(5);o
Long chain acyl-CoA synthetase 4
SIFAKDGFPDPIEGMDSCWDVFR
x+M(15)
Lysophospholipid acyltransferase LPEAT2
GlyGly(5);ox+M(13)
ATELKLENPSNYMVEMAR
Magnesium protoporphyrin IX
GlyGly(10)
AQLPSENLPK
methyltransferase_ chloroplastic
Magnesium-chelatase subunit ChlI-1_
GlyGly(14)
IGGVMIMGDRGTGK
chloroplastic
Magnesium-chelatase subunit ChlI-2_
GlyGly(5)
EKVQKGEELSVIETK
chloroplastic
carb+C(7);carb+C(18);G
Magnesium-protoporphyrin IX monomethyl ester
ENPEFQCYPIFKYFENWCQDENR
lyGly(12)
GlyGly(6);GlyGly(42);o INASYKVAVLGAAGGIGQPLSLLIK
Malate dehydrogenase_ chloroplastic
x+M(26)
MSPLVSTLHLYDIANVK
Mediator of RNA polymerase II transcription
DFFEGKEPNKGVNPDEAVAYGAAV
GlyGly(6);GlyGly(38)
subunit 37a
QGGILSGEGGDETK
SVTEQGQTAFSFEFFPPKTEDGVENL
Methylenetetrahydrofolate reductase 1
GlyGly(18)
FER
Methylenetetrahydrofolate reductase 2
GlyGly(16);ox+M(11) SALAILMNLGMIDESK
Methylthioalkylmalate synthase 1_ chloroplastic GlyGly(21)
ALVTSSDEISLEKLNGANGLK
Monothiol glutaredoxin-S15_ mitochondrial
GlyGly(8)
DIVENDVK
GlyGly(4);ox+M(6);ox+
Myrosinase 1
DDQKGMIGPVMITR
M(11)
VQNGATSSGSPSDWDNLVDFYLAG
NAC domain-containing protein 89
GlyGly(29)
ESGEK
carb+C(11);GlyGly(12);
NADH dehydrogenase
VEAAMVNARICK
ox+M(5)
NADP-dependent malic enzyme 2
carb+C(15);GlyGly(18) ATGQEYAEFLHEFMCAVKQNYGEK
Nascent polypeptide-associated complex subunit
IDLDKPEVEDDDDNDEDDSEDDDEA
GlyGly(5)
alpha-like protein 3
EGHDGEAGGR
NHL domain-containing protein
GlyGly(10)
DGTVMVVSQK
Nitrile-specifier protein 1
GlyGly(1)
KGLVMHGGKAPTNDR
Nucleoside diphosphate kinase family protein
GlyGly(1)
KIIGATNPAASEPGTIR
Nucleoside diphosphate kinase III_
FFSEGRAIGAAAAVSASGKIPLYASN
GlyGly(19)
chloroplastic/mitochondrial
FAR
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Table A.7. (cont’d) First-pass enrichment.
ATG No.
AT3G48990.1

AT1G22530.1

Protein Description
Oxalate—CoA ligase
Oxygen-evolving enhancer protein 1-2_
chloroplastic
Oxygen-evolving enhancer protein 2-1_
chloroplastic
P-loop containing nucleoside triphosphate
hydrolases superfamily protein
Patellin-2

AT5G45280.2

Pectin acetylesterase 11

AT4G19410.2

Pectin acetylesterase 7

AT1G11580.1

Pectinesterase/pectinesterase inhibitor 18

GlyGly(*)
carb+C(6);carb+C(15);
GlyGly(23)
carb+C(7);carb+C(11);
GlyGly(23)
carb+C(14);GlyGly(15)

AT3G14310.1

Pectinesterase/pectinesterase inhibitor 3

GlyGly(2);GlyGly(3)

AT3G50820.1
AT1G06680.1
AT1G43910.1

AT1G23440.1
AT1G63770.5
AT4G34870.1
AT3G56070.2
AT4G11290.1

Pentatricopeptide repeat-containing protein
At2g01390
Pentatricopeptide repeat-containing protein
At5g42310_ mitochondrial
Peptidase C15_ pyroglutamyl peptidase I-like
Peptidase M1 family protein
Peptidyl-prolyl cis-trans isomerase CYP18-4
Peptidyl-prolyl cis-trans isomerase CYP19-3
Peroxidase 39

AT3G52960.1

Peroxiredoxin-2E_ chloroplastic

AT2G01390.1
AT5G42310.1

AT4G37870.1
AT2G42600.2
AT3G14940.1
AT3G18000.1

Phospho-2-dehydro-3-deoxyheptonate aldolase
2_ chloroplastic
Phosphoenolpyruvate carboxykinase
Phosphoenolpyruvate carboxylase 2
Phosphoenolpyruvate carboxylase 3
Phosphoethanolamine N-methyltransferase 1

AT1G73600.2

Phosphoethanolamine N-methyltransferase 3

AT1G56190.2
AT2G45790.1

Phosphoglycerate kinase 2_ chloroplastic
Phosphomannomutase
Phosphomethylethanolamine Nmethyltransferase

AT4G33510.1

AT1G48600.2
AT1G32060.1

Phosphoribulokinase_ chloroplastic

Peptide Modification(s) Peptide Sequence
GlyGly(9)
GEIQEPNNK
carb+C(8);GlyGly(21)

GTGTANQCPTIDGGSETFSFK

GlyGly(*)

VSPADAAYGEAANVFGKPK

GlyGly(1)

KEEDGGEDDGEPQKR
TEETEEKK
SLPASCTSSMKPDLCFFPQYVAK
GLFLDSCHAHCQGGSAASWSGDK
EDQNQNTAISIQKCK
NKKLVLLSAAVALLFVAAVAGISAG
ASK

carb+C(1);GlyGly(20)

CEEALDIFFKMQEIGVQPDK

GlyGly(13)

RDAEAFAVLQYMK

GlyGly(10)
GlyGly(22);ox+M(11)
GlyGly(*)
GlyGly(9)
GlyGly(20)
carb+C(26);GlyGly(11);
GlyGly(12)

AITIHVTGFK
IYQFPQDAGPMAHPVRPHSYIK
HVVFGQVVKGLDVVK
VVDGYNVVK
RFAGGSEQEFFAEFSNSMEK
TVTVSSLTAGKKTILFAVPGAFTPTC
SQK
DTFRVLLQMGVVLMFGGQLPVIKV
GR
GSFITSNGALATLSGAK
IRDCLTQLYAK
GDFVDESSATTESDIEETFKR
FTGELAQK

GlyGly(23)

GlyGly(17)
carb+C(4);GlyGly(11)
GlyGly(20)
GlyGly(8)
carb+C(5);carb+C(22);G
LFKECHMNDEDGNSYELSLVSCK
lyGly(3)
GlyGly(4)
EEEKNEPDFAK
GlyGly(18)
ELINFTLHYIADLDIPIKR
carb+C(14);GlyGly(15) DASGNSFELSMVGCK

carb+C(8);carb+C(23);G
RFNTLITCAQETIVIGLAADSGCGK
lyGly(25)

AT1G60680.1
AT1G60710.1
AT4G39330.1
AT3G59480.1

Photosystem I reaction center subunit V_
GlyGly(14)
chloroplastic
Photosystem II D2 protein
GlyGly(3);ox+M(9)
photosystem II light harvesting complex gene 2.1 GlyGly(3);GlyGly(17)
Plasma membrane-associated cation-binding
GlyGly(6);GlyGly(16)
protein 1
Polyadenylate-binding protein 2
GlyGly(23);ox+M(15)
Polyadenylate-binding protein 8
GlyGly(19)
Polyketide cyclase/dehydrase and lipid transport carb+C(5);carb+C(7);Gl
superfamily protein
yGly(8);GlyGly(15)
Porphobilinogen deaminase_ chloroplastic
carb+C(10);GlyGly(8)
Presequence protease 1_
GlyGly(3)
chloroplastic/mitochondrial
Probable 2_3-bisphosphoglycerate-independent
GlyGly(3);GlyGly(11)
phosphoglycerate mutase 2
Probable 2-oxoacid dependent dioxygenase
carb+C(8);GlyGly(*)
Probable ADP-ribosylation factor GTPaseGlyGly(8)
activating protein AGD9
Probable aldo-keto reductase 2
GlyGly(10)
Probable aldo-keto reductase 4
GlyGly(10)
Probable cinnamyl alcohol dehydrogenase 9
GlyGly(3)
Probable fructokinase-4
GlyGly(18)

AT5G51830.1

Probable fructokinase-7

GlyGly(34)

AT2G21330.3

Probable fructose-bisphosphate aldolase 1_
chloroplastic

carb+C(22);GlyGly(24) TAKTIASPGHGIMAMDESNATCGK

AT1G55670.1
ATCG00270.1
AT2G05100.1
AT4G20260.4
AT4G34110.1
AT1G49760.2
AT4G23670.1
AT5G08280.1
AT3G19170.1
AT3G08590.2
AT2G25450.1
AT5G46750.1
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ENVAKQGLPEQNGK
DEKDLFDIMDDWLRR
TVKSTPQSIWYGPDRPK
TFDESKETINKEIEEK
EIFSPFGTVTSSKVMRDPNGTSK
GYGFVQYDTDEAAQGAIDK
SEDSCVCKITMIWEKR
QSSSGFVKACVAVEQK
DFKDFAQAIDVVRDK
DGKPDTWRLIK
AQDLPEVCGEIMLEYSKEVMK
ATENLTDK
FQQENVDHNKILFEKVSAMAEK
FQEENLDHNK
MAKSPETEHPNK
KGAIPALPTESEVQSLLK
VGGVKVKPVDTTGAGDAFVSGLLN
SLASDLTLLK

Table A.7. (cont’d) First-pass enrichment.
ATG No.

Peptide Modification(s) Peptide Sequence

AT1G23190.1
AT2G47060.4

Protein Description
Probable mannose-1-phosphate
guanylyltransferase 2
Probable mediator of RNA polymerase II
transcription subunit 37c
Probable mediator of RNA polymerase II
transcription subunit 37e
Probable methyltransferase PMT25
Probable mitochondrial-processing peptidase
subunit beta
Probable monodehydroascorbate reductase_
cytoplasmic isoform 3
Probable phosphoglucomutase_ cytoplasmic 1
Probable receptor-like protein kinase At2g47060

AT5G42630.2

Probable transcription factor KAN4

GlyGly(26)

AT3G55590.1
AT3G12580.1
AT5G02500.1
AT2G34300.2
AT3G02090.1
AT3G52880.2

GlyGly(6)

LFVGNKINAGIYLLNPSVLDR

GlyGly(4)

VDAKNALENYAYNMRNTIK

GlyGly(2);GlyGly(3)

SKKDITGNPR

GlyGly(12)
EKIWYNNVPHTK
GlyGly(*);ox+M(*);ox+ MIDDDLPLAQFAVAFEGASWTDPDS
M(*)
VALMVMQTMLGSWNK
GlyGly(16)

GTVASGFTAQPNGEVK

GlyGly(16);ox+M(3)
GlyGly(12)

YNMENGGPAPESITDK
GQQSLVTWATPK
IEDNNNNEEADEGTDTNSPNSSSVQ
K
LLSLSLDKSSGSGFQSNQEFLYGKAE
VQMK

AT1G09310.1

Probable xyloglucan
endotransglucosylase/hydrolase protein 18
Probable xyloglucan
endotransglucosylase/hydrolase protein 6
Proteasome subunit beta type-6
Protein BTR1
Protein disulfide isomerase-like 1-1
Protein disulfide isomerase-like 1-2
Protein disulfide isomerase-like 1-4
Protein disulfide-isomerase like 2-1
Protein DJ-1 homolog A
Protein of unknown function DUF2359_
transmembrane
Protein of unknown function_ DUF538

AT2G35350.1

Protein phosphatase 2C 29

GlyGly(28)

AT2G24820.1

Protein TIC 55_ chloroplastic
Pyrophosphate—fructose 6-phosphate 1phosphotransferase subunit alpha 1

carb+C(3);GlyGly(5)

EEPAKEEPAK
GSGSSEQLHTGFRAISGASVSANTSN
SK
AACVKTYEVK

GlyGly(2)

GKAYDLLRQNAQK

AT4G30280.1
AT5G65730.1
AT4G31300.3
AT5G04430.1
AT1G21750.1
AT1G77510.1
AT5G60640.1
AT2G47470.4
AT3G14990.1
AT1G70770.2

AT1G20950.1
AT5G54960.1

Pyruvate decarboxylase 2

AT3G52990.1

Pyruvate kinase family protein

AT1G23740.1

Quinone oxidoreductase-like protein
At1g23740_ chloroplastic

AT4G18430.1

Ras-related protein RABA1e

AT1G07410.1
AT4G39990.1
AT5G03530.1
AT5G03520.1
AT3G16100.1
AT3G18820.1
AT1G18080.1
AT3G08920.1
AT1G56070.1
AT2G39730.1
AT2G37220.1
AT3G17390.1
AT2G41530.1
AT2G35780.1
AT4G37930.1
AT5G26780.3

GlyGly(8)
carb+C(18);GlyGly(6)

QMEDGKAIQLVLDQSTGCGFASKR

GlyGly(9)
GlyGly(17)
GlyGly(16)
GlyGly(5)
GlyGly(15)
GlyGly(16)
GlyGly(*)

EEAEQLVVKAVSLAIAR
MESTESYAAGSPEELAK
VVVSDSLDDIVLNSGK
NSEKKPTSHGEESTK
VETTETKESPDSTTK
YEGPRNAEALAEYVNK
ANVVIAAVGNSLEVEGSRKAK

carb+C(2);GlyGly(3)

SCKTISGR

GlyGly(5)

carb+C(3);GlyGly(9);
GlyGly(19)
GlyGly(4);GlyGly(5);
ox+M(2)
GlyGly(28);ox+M(27)

carb+C(20);carb+C(21);
GlyGly(16)
Ras-related protein RABA2b
GlyGly(15)
Ras-related protein RABA4b
GlyGly(13)
Ras-related protein RABC2a
GlyGly(6);ox+M(1)
carb+C(18);carb+C(19);
Ras-related protein RABE1d
GlyGly(3)
Ras-related protein RABG3c
carb+C(11);GlyGly(14)
Ras-related protein RABG3f
GlyGly(1);GlyGly(7)
Receptor for activated C kinase 1A
carb+C(11);GlyGly(3)
Rhodanese-like domain-containing protein 10
GlyGly(24)
Ribosomal protein S5/Elongation factor G/III/V carb+C(18);GlyGly(19);
family protein
ox+M(13);ox+M(17)
Ribulose bisphosphate carboxylase/oxygenase
GlyGly(20)
activase_ chloroplastic
RNA-binding protein CP29B_ chloroplastic
GlyGly(9)
S-adenosylmethionine synthase 4
GlyGly(4)
S-formylglutathione hydrolase
GlyGly(12);ox+M(13)
Serine carboxypeptidase-like 26
carb+C(22);GlyGly(23)
Serine hydroxymethyltransferase 1_
carb+C(4);GlyGly(17)
mitochondrial
Serine hydroxymethyltransferase 2_
GlyGly(15);ox+M(2)
mitochondrial
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VRCEEELVKAINTATNEEK
EMLKKLGDLSQTQIFAK
FLKISASSQSASAAVNVTADASIPKE
MK
GQTIDIGNKDDVTAVKSSGCCSG
DHADSNIVIMMAGNK
MAGGGGYGGASGK
MLVGNKVDR
ITKQDTAASSSTAEKSACCSYV
DGVNVDAAFECIAK
KFSNQYK
TIKLWNTLGECK
FATIGGVSFYLLKLLVLLPSFGQKSR
IWAFGPETTGPNMVVDMCKGVQYL
NEIK
QYNLDNMMDGFYIAPAFMDK
EQSFSADLK
QAAKSIVASGLAR
MASGLSEIGSTKMFDGYNK
AMEAADLEQGNIDPYSIYTVTCK
STSCYMSSLPSEAVDEK
FMSSLSTAAMAESEKSR

Table A.7. (cont’d) First-pass enrichment
ATG No.
AT4G32520.2
AT4G13930.1
AT2G05920.1
AT5G58830.1
AT2G18450.1
AT4G26500.1
AT4G27960.2
AT5G26360.1
AT2G43910.1
AT1G03680.1
AT4G03520.1
AT4G09010.1
AT5G42290.1
AT2G45290.1
AT1G45201.1
AT3G14790.1
AT2G21170.1
AT5G07350.2
AT5G61780.1
AT1G51710.2
AT5G38470.2
AT1G23410.1
AT2G47110.1
AT2G30110.1
AT2G36060.3
AT1G31340.1
AT2G27860.1
AT3G29360.2
AT5G15490.1
AT2G37660.1
AT2G07724.1
AT4G16807.1
AT2G36835.1
AT5G24165.1
AT1G32520.1
AT5G06590.1
AT4G19620.1
AT3G14930.3
AT5G17310.2
AT1G78900.2
AT1G76030.1
AT4G38510.5

Protein Description
Serine hydroxymethyltransferase 3_
chloroplastic
Serine hydroxymethyltransferase 4
Subtilase family protein
Subtilisin-like serine endopeptidase family
protein

Peptide Modification(s) Peptide Sequence
carb+C(9);GlyGly(13)

AVMEAVGSCLTNK

GlyGly(13)
GlyGly(14)
carb+C(8);GlyGly(15);
GlyGly(18)
carb+C(22);GlyGly(32);
ox+M(12);ox+M(25)

ANAVALGNYLMSK
VTVNGAPSVGISVKPSK
TDHISFLCGMNYTSKTLK

SMIWNSDLIETMELENLLVNACITM
HSAEARK
KALHLEVKGEEDSSSGESSESSFVSIP
SufE-like protein 1_ chloroplastic/mitochondrial GlyGly(30)
ETK
VFHPNINSNGSICLDILKEQWSPALTI
SUMO-conjugating enzyme UBC9
carb+C(13);GlyGly(18)
SK
VPGGQFEDSEVLKGVMFNKDVVAP
T-complex protein 1 subunit gamma
GlyGly(19);ox+M(16)
GK
Thiocyanate methyltransferase 1
GlyGly(*)
AVSVEENPHAIPTRKGK
Thioredoxin M1_ chloroplastic
GlyGly(23)
QMFSVLPESSGLRTRVSLSSLSK
FYKLNTDESPNTPGQYGVRSIPTIMIF
Thioredoxin M2_ chloroplastic
GlyGly(3)
VGGEK
CGGNEEKGNLLYTAYGSAGQWGLF
Thylakoid lumenal 29 kDa protein_ chloroplastic carb+C(1);GlyGly(7)
DR
transcription activator-related
GlyGly(3)
EPKQEPEEGRDK
AKSGHPGLPMGCAPMSHILYDEVM
Transketolase-2_ chloroplastic
carb+C(12);GlyGly(25)
K
triacylglycerol lipase-like 1
GlyGly(6)
ALGLQKDGWPK
Trifunctional UDP-glucose 4_6-dehydratase
carb+C(2);GlyGly(13) LCEKQGIPYEYGK
Triosephosphate isomerase_ chloroplastic
carb+C(14);GlyGly(18) AAYALSEGLGVIACIGEK
GlyGly(11);ox+M(8);ox
TUDOR-SN protein 1
TITFSSLMAPKMAR
+M(12)
TUDOR-SN protein 2
GlyGly(25)
VASIQNQLAALSLKDAPIIGSFNPK
Ubiquitin carboxyl-terminal hydrolase 6
GlyGly(4)
DGQKLMMMGTADEIVK
Ubiquitin receptor RAD23d
GlyGly(12)
TLSGSNFEIEVKPADK
Ubiquitin-40S ribosomal protein S27a-1
GlyGly(9)
TLADYNIQKESTLHLVLR
Ubiquitin-40S ribosomal protein S27a-2
GlyGly(9)
TLADYNIQKESTLHLVLR
Ubiquitin-activating enzyme E1 1
GlyGly(23)
QLIYTFPEDAATSTGAPFWSAPKR
carb+C(9);GlyGly(19);G
Ubiquitin-conjugating enzyme E2 variant 1C
FHSRINMTCVNHDTGVDSKK
lyGly(20)
Ubiquitin-NEDD8-like protein RUB1
GlyGly(6)
LIYAGKQLADDK
UDP-D-apiose/UDP-D-xylose synthase 1
GlyGly(17)
VSGEGAIESPTVDVSSK
UDP-glucose 6-dehydrogenase 2
GlyGly(14)
EADIVFVSVNTPTKTR
DLTMNKFDWDHPLHLQPMSPTTVK
UDP-glucose 6-dehydrogenase 3
GlyGly(24);ox+M(18)
QVSVAWDAYTATK
Uncharacterized protein At2g37660_
GlyGly(21)
AMMTTTTTTFFHPLLPANTYK
chloroplastic
carb+C(1);GlyGly(24);o
unknown protein
CLNPKMPSKSMFGGSVSENLFLSK
x+M(6);ox+M(11)
unknown protein
GlyGly(9);GlyGly(21) ENIATDTAKEVSLDNAVSDQK
unknown protein
GlyGly(4);ox+M(13)
MLGKFMDNAVELMNK
NVTASSDVPAAPKNTADGGKASLQP
unknown protein
GlyGly(13)
K
unknown protein
GlyGly(10)
ASIDGFGATK
unknown protein
GlyGly(14)
SLASWEDLLSAVQK
MSSSDDSDFPDISAESVTSPPPLPDVE
unknown protein
GlyGly(30)
TLK
Uroporphyrinogen decarboxylase 1_
GlyGly(15)
TEEDMKRLHPIDFEK
chloroplastic
UTP--glucose-1-phosphate uridylyltransferase 1 GlyGly(6)
ANAGTKLEIPDNAVLENK
V-type proton ATPase catalytic subunit A
GlyGly(9)
LTTFEDDEKESEYGYVR
TVDLLEDHGEDNFAIVFAAMGVNM
V-type proton ATPase subunit B1
GlyGly(31)
ETAQFFK
V-type proton ATPase subunit B2
GlyGly(12)
YTTVQFTGEVLK
Succinate dehydrogenase

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.
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Table A.8. Digly-modified peptides identified in the second-pass diglycine-enrichment.
ATG No.

Protein Description
26S proteasome non-ATPase regulatory subunit
3 homolog A
2S seed storage protein 2
3-ketoacyl-CoA thiolase 2_ peroxisomal
3-oxo-5-alpha-steroid 4-dehydrogenase family
protein

Peptide Modification(s) Peptide Sequence

AT1G24360.1

3-oxoacyl-

carb+C(13);GlyGly(31)

AT1G79850.1
AT5G07090.1
AT5G10360.2
AT5G15200.1

30S ribosomal protein S17_ chloroplastic
4-hydroxy-3-methylbut-2-en-1-yl diphosphate
synthase (ferredoxin)_ chloroplastic
40S ribosomal protein S4-2
40S ribosomal protein S6-2
40S ribosomal protein S9-1

AT3G04770.1

40S ribosomal protein Sa-2

AT3G53740.4
AT4G10450.1
AT1G16880.1
AT3G46000.1
AT3G09820.1

AT4G35450.5
AT3G53420.2

60S ribosomal protein L36-2
60S ribosomal protein L9-2
ACT domain-containing protein ACR11
Actin-depolymerizing factor 2
Adenosine kinase 1
ADP-ribosylation factor GTPase-activating
protein AGD7
AGAMOUS-like 87
Aldehyde dehydrogenase family 2 member B4_
mitochondrial
Ankyrin repeat domain-containing protein 2
Aquaporin PIP2-1

AT1G11910.1

Aspartic proteinase A1

AT5G08690.1

ATP synthase subunit beta-2_ mitochondrial

AT3G06650.1

ATP-citrate synthase beta chain protein 1

AT1G20200.1
AT4G27150.1
AT2G33150.1
AT5G16010.1

AT5G60600.1

AT2G37550.2
AT1G22590.1
AT3G48000.1

AT5G35360.3
AT4G23650.1

Calcium-dependent protein kinase 3

AT1G17880.1
AT5G24540.1
AT2G36530.1
AT3G61440.1

SIFTQKGMEK

carb+C(3);GlyGly(*)
carb+C(8);GlyGly(1)

QKCQKEFQQSQHLR
KFAQAQNCLLPMGVTSENVAQR

GlyGly(20)

GNHLKYSKFGVSSSSPQPQK

EGASRNINVNVVCPGFIASDMTAEL
GEDMEK
carb+C(11);GlyGly(16) AMKTMQGRVVCATSDK

ATP-dependent zinc metalloprotease FTSH 2_
chloroplastic
basic transcription factor 3
Beta-glucosidase 31
Bifunctional enolase 2/transcriptional activator
Bifunctional L-3-cyanoalanine synthase/cysteine
synthase C1_ mitochondrial
Biotin carboxylase_ chloroplastic

AT2G30950.1

GlyGly(6);ox+M(8)

GlyGly(11)

LDYHNFVFSMK

GlyGly(3)
carb+C(10);GlyGly(12)
GlyGly(4)
carb+C(2);carb+C(17);
carb+C(21);GlyGly(9)
GlyGly(10)
GlyGly(3)
GlyGly(13)
GlyGly(9)
GlyGly(10)

TDKTYPAGFMDVVSIPKTNENFR
GYVFKIMGGCDKQGFPMK
RNEKSASK
TCVSPTPDKDLDLFLLCRWICFSTGS
PK
EVAGQAPYEKR
DFKHLNLDFQLIKDQVTGK
IRASNATAVENGK
DKMIYASSK
KPENWALVEK

GlyGly(7)

ETDIISKYNSNAASVYR

carb+C(2);GlyGly(10)

RCFKTNESTK

GlyGly(12)

KGIEQGPQIDLK

carb+C(1);GlyGly(*)
GlyGly(5)

CAQVLIDAGASVNAVDKNK
ASGSKSLGSFRSAANV
AAAIHYGTGAIAGFFSNDAVTVGDL
GlyGly(28)
VVK
GlyGly(9)
EMIESGVIKLGEKQSESK
LFKSEVQFGHAGAKSGGEMESAQA
GlyGly(14);GlyGly(25)
K
GlyGly(23)

AKFQMEPNTGVTFDDVAGVDEAK

GlyGly(*)
GlyGly(7)
GlyGly(22)

VQASIAANTWVVSGSPQTKK
RIEYHQKHLQELQK
QIFDSRGNPTVEVDIHTSNGIK

carb+C(8);GlyGly(11)

QEHFQPTCSIK

AT5G11880.1
AT3G17240.3
AT1G55250.3
AT5G12110.1
AT2G18110.1
AT1G62750.1

GlyGly(18)
GlyGly(1);GlyGly(4);
ox+M(2)
Calreticulin-1
GlyGly(*)
Chaperone protein ClpC1_ chloroplastic
GlyGly(13)
Chaperonin 60 subunit alpha 1_ chloroplastic
GlyGly(9)
Chaperonin 60 subunit beta 3_ chloroplastic
GlyGly(5)
Chlorophyll a-b binding protein 4_ chloroplastic GlyGly(*)
Citrate synthase 5_ mitochondrial
GlyGly(4)
Class II aaRS and biotin synthetases superfamily
GlyGly(11)
protein
Coproporphyrinogen-III oxidase 1_ chloroplastic GlyGly(2)
Delta-1-pyrroline-5-carboxylate dehydrogenase
carb+C(7);GlyGly(1)
12A1_ mitochondrial
Diaminopimelate decarboxylase 2_ chloroplastic GlyGly(12)
Dihydrolipoyl dehydrogenase 2_ mitochondrial GlyGly(6)
E3 ubiquitin-protein ligase BRE1-like 2
carb+C(8);GlyGly(9)
Elongation factor 1-beta 1
GlyGly(18)
Elongation factor 1-delta 2
GlyGly(10)
Elongation factor G_ chloroplastic
GlyGly(5)

AT1G13020.1

eukaryotic initiation factor 4B2

AT1G56340.2
AT5G50920.1
AT2G28000.1
AT5G56500.2
AT3G47470.1
AT3G60100.1
AT5G52520.1
AT1G03475.1
AT5G62530.1

AT5G44320.1
AT5G57870.1

GlyGly(9)

Eukaryotic translation initiation factor 3 subunit
GlyGly(7)
7 (eIF-3)
Eukaryotic translation initiation factor isoform
carb+C(22);GlyGly(9)
4G-1
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ALNDTIITGVPTTINYHK
KMLKYDPK
DAEKAAFDEAEKK
HAQVPEEARELEK
AALQAGIDK
VDAIKETLANDEEK
TSSFKVEAKK
EQLKDYVWK
EALQTAGVRVK
RKDMEFTEQHK
KFLENFCGDQVR
NEKLQWFLDEVK
FMLKTKVVGVDSSGDGVK
LQEEVKNCK
VYAAVLENPGDGFPNASK
AAEERAASVK
VYSGKISAGSYVLNANK
EAAIAPESKESQQESDSNHQNLPDLI
REKEK
FKNRSFK
IVESSEQGKSLLASQAADIEACR

Table A.8. (cont’d) Second-pass enrichment.
ATG No.

Protein Description
Far-red impaired responsive (FAR1) family
protein
FKBP-like peptidyl-prolyl cis-trans isomerase
family protein

Peptide Modification(s) Peptide Sequence

AT5G54160.1

Flavone 3’-O-methyltransferase 1

GlyGly(36)

AT1G50480.1

GlyGly(10)
GlyGly(10)

LRSSTNFSQK

GlyGly(*)
GlyGly(*)

EFSDKIRSGSWVGATGKPLK
ALDYDTLNENVKK

GlyGly(7)

KSFSLQK

GlyGly(*)

TLFSLDSFEKTK

GlyGly(11)
GlyGly(9)

TPPEFASVGSK
RVLIALHEKNLDFELVHVELK

GlyGly(*)

GGRGASQNIIPSSTGAAKAVGK

GlyGly(4)
GlyGly(20)

AGGKAFSNMAVGYNNVDVEAANK
AHSDKSGTPLVAEEKFAEPK

GlyGly(9);ox+M(4)

SSLMGIFEKR

AT4G16660.1

Formate—tetrahydrofolate ligase
Glucose-1-phosphate adenylyltransferase large
subunit 1_ chloroplastic
Glucose-6-phosphate isomerase_ cytosolic
Glutamate—glyoxylate aminotransferase 1
Glutamate-1-semialdehyde 2_1-aminomutase 1_
chloroplastic
Glutathione S-transferase DHAR1_
mitochondrial
Glutathione S-transferase DHAR2
Glutathione S-transferase F2
Glyceraldehyde-3-phosphate dehydrogenase
GAPCP1_ chloroplastic
Glycerate dehydrogenase HPR_ peroxisomal
Glycine—tRNA ligase 1_ mitochondrial
Guanosine nucleotide diphosphate dissociation
inhibitor 2
Heat shock 70 kDa protein 17

GSTAETQLTPVQVTDDEAALFAMQL
ASASVLPMALK
IFHETSQSDKALFNR

GlyGly(24)

AT1G56410.1

Heat shock 70 kDa protein 18

GlyGly(28)

AT4G24280.1
AT3G07770.1
AT5G56010.1
AT5G52640.1
AT4G36740.1
AT3G44330.1
AT5G14590.1
AT4G35260.1
AT3G16460.2
AT3G15356.1
AT4G30910.1
AT3G45140.1

GlyGly(10)
GlyGly(13)
GlyGly(9)
GlyGly(10)
GlyGly(2)
GlyGly(*)
GlyGly(2)
carb+C(1);GlyGly(22)
GlyGly(*)
GlyGly(14)
GlyGly(*)
GlyGly(2)
GlyGly(8)

ARFDSNPKDFR

GlyGly(22)

LQEQITTARSNLSAVQIDQDLK

AT5G43330.1

Heat shock 70 kDa protein 6_ chloroplastic
HEAT SHOCK PROTEIN 89.1
Heat shock protein 90-3
heat shock protein 90.1
Homeobox-leucine zipper protein ATHB-40
INVOLVED IN\x3a protein processing
Isocitrate dehydrogenase
Isocitrate dehydrogenase
Jacalin-related lectin 34
Lectin-like protein LEC
Leucine aminopeptidase 2_ chloroplastic
Lipoxygenase 2_ chloroplastic
Magnesium-chelatase subunit ChlI-1_
chloroplastic
Magnesium-chelatase subunit ChlI-2_
chloroplastic
Malate dehydrogenase_ cytoplasmic 2

WDLGLGGQSMEMRLVEHFADEFNK
DAGVIAGLNVLRIINEPTAAAIAYGL
DK
TTPSVVAYTK
SILYVPPVSPSGK
DVLGDKVEK
DIFYITGESK
TKGSVASADGGNGLFRK
YNLLFALTSGGPYNYEGTQKWLK
FKDIFQEVYEANWK
CRTKDLGGTSTTQEVVDAVIAK
TSKNKTAGPFGIVSGTK
DSRNTITIAPENVK
SESKKPSLKSVVFIGFGTGPELENK
GKLQYLEGVIDER

GlyGly(6)

AT1G79340.1

Metacaspase-4

GlyGly(12)

AT3G59970.3
AT3G01280.1
AT5G15090.2
AT5G44720.1

Methylenetetrahydrofolate reductase 1
Mitochondrial outer membrane protein porin 1
Mitochondrial outer membrane protein porin 3
Molybdenum cofactor sulfurase family protein

GlyGly(*)
GlyGly(15)
GlyGly(12)
GlyGly(11)

AT1G63940.1

Monodehydroascorbate reductase_ chloroplastic GlyGly(10)

AT5G37510.2
AT5G08530.1
AT3G16400.2
AT1G03810.1

NADH dehydrogenase
NADH dehydrogenase
Nitrile-specifier protein 1
Nucleic acid-binding_ OB-fold-like protein
Oxygen-evolving enhancer protein 1-1_
chloroplastic
Oxygen-evolving enhancer protein 3-1_
chloroplastic

NVSIYKSQASALEK
QQTGNDNIEVGKIRPSLFDAFGDDSS
PKVK
SIEDVQEKFK
SGNFTKINAGLSFTK
DLLYRDYQGDQK
FRSDNVLMPDK
VFEYEGSPRKVWWQFFGDNVGETV
EVGNFDPK
VHFSNPEDAIEVFVDGYAVK
DREIMRHDPHK
GWTASTTATIDGKKGLVMHGGK
MSTTANTNATTAPK
QLDASGKPDSFTGKFLVPSYRGSSFL
DPK

AT4G12850.3
AT1G26550.1

AT5G19220.1
AT5G42740.1
AT1G23310.1
AT5G63570.1
AT1G19570.2
AT1G75270.1
AT4G02520.1
AT1G79530.1
AT1G68010.1
AT1G29880.1
AT3G59920.1

AT4G18480.1
AT5G45930.1

AT5G66570.1
AT4G21280.2
AT1G11580.1

Pectinesterase/pectinesterase inhibitor 18

AT3G14310.1
AT1G23440.1

Pectinesterase/pectinesterase inhibitor 3
Peptidase C15_ pyroglutamyl peptidase I-like

GlyGly(8)

FESEEEAKDFYVEYSK

GlyGly(12)

KLQDGWLSNGDKVPPAEFAK

GlyGly(20)
GlyGly(11)
GlyGly(*)
GlyGly(14);ox+M(1)
GlyGly(29)
GlyGly(10)
GlyGly(1);GlyGly(2);
GlyGly(11)
carb+C(9);GlyGly(17)
GlyGly(1)
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YDLNTIISSKPKDEKK
KKNLMLVGDGK
GQIHVEHMCSNALAMIK
KFLGVSENPTEK

Table A.8. (cont’d) Second-pass enrichment.
ATG No.
AT3G06050.1
AT2G42600.2
AT2G42600.1
AT3G18000.1
AT1G79550.2
AT2G17630.1
AT3G27690.1
AT5G08280.1
AT2G25450.1
AT4G23400.1
AT4G34370.2
AT2G01140.1
AT5G02500.1
AT3G52880.1
AT4G37800.1
AT1G50380.1
AT5G60640.1
AT3G14990.3
AT3G13870.1
AT3G18890.1
AT2G30790.1
AT3G16420.3
AT5G08570.1
AT3G52990.1
AT3G16100.1
AT3G20390.1
AT1G18080.1
AT4G20830.2
AT1G14210.1
AT3G12915.1
AT3G55800.1
AT5G26780.3
AT4G32520.2
AT5G05540.1
AT1G23820.2
AT5G20830.2
AT5G04590.1
AT5G42980.1
AT5G66040.1
AT1G78570.1

AT3G14790.1
AT5G61780.1
AT3G02540.3
AT1G23410.1

Protein Description

Peptide Modification(s) Peptide Sequence
KVVIFGLPGAYTGVCSQQHVPSYKS
Peroxiredoxin-2F_ mitochondrial
carb+C(15);GlyGly(1)
HIDK
Phosphoenolpyruvate carboxylase 2
GlyGly(5);ox+M(8)
EYGVKLTMFHGR
Phosphoenolpyruvate carboxylase 2
GlyGly(5);ox+M(8)
EYGVKLTMFHGR
Phosphoethanolamine N-methyltransferase 1
GlyGly(2)
RKSNPTHYR
phosphoglycerate kinase
GlyGly(10)
TFSEALDTTK
Phosphoserine aminotransferase 2_ chloroplastic GlyGly(20)
SEKYTKVPTFDGLEQSSDAK
photosystem II light harvesting complex gene 2.3 GlyGly(18)
MATSAIQHSSFAGQTTLKPSNDLLR
Porphobilinogen deaminase_ chloroplastic
GlyGly(9)
KQSSSGFVK
Probable 2-oxoacid dependent dioxygenase
carb+C(8);GlyGly(21) AQDLPEVCGEIMLEYSKEVMK
Probable aquaporin PIP1-5
GlyGly(*)
FPERQPIGTAAQTESKDYK
Probable E3 ubiquitin-protein ligase ARI1
GlyGly(14)
YLLESYIEDNRMVK
Probable fructose-bisphosphate aldolase 3_
GlyGly(17)
NKASPETVADFTLTMLK
chloroplastic
Probable mediator of RNA polymerase II
GlyGly(19)
NAVVTVPAYFNDSQRQATK
transcription subunit 37e
Probable monodehydroascorbate reductase_
GlyGly(12)
LTDFGVKGADSKNILYLR
cytoplasmic isoform 3
Probable xyloglucan
GlyGly(5)
GGIEKINWSR
endotransglucosylase/hydrolase protein 7
ENGLQKITVHRLPAEGQPLEGLQGG
Prolyl oligopeptidase family protein
GlyGly(6)
R
Protein disulfide isomerase-like 1-4
GlyGly(7)
SSQSDSKDEL
QAEANKPYGGICASPAYVFEPNGLL
Protein DJ-1 homolog A
carb+C(12);GlyGly(*)
KGKK
Protein ROOT HAIR DEFECTIVE 3
GlyGly(18)
TRTPLENLEPVLREDIQK
Protein TIC 62_ chloroplastic
GlyGly(9)
AGSLVQSVK
Putative oxygen-evolving enhancer protein 2-2 GlyGly(1)
KFVENAATSFSVA
MAQKVEAQGGKGANLWDDGSTHD
PYK10-binding protein 1
GlyGly(11)
AVTK
Pyruvate kinase family protein
carb+C(6);GlyGly(4)
VMAKICIEAESSLDYNTIFK
Pyruvate kinase family protein
GlyGly(12)
LGDLSQTQIFAK
Ras-related protein RABG3c
carb+C(11);GlyGly(14) DGVNVDAAFECIAK
Reactive Intermediate Deaminase A_
GlyGly(11)
ASGADYSSVVK
chloroplastic
Receptor for activated C kinase 1A
GlyGly(8)
MAEGLVLKGTMR
Reticuline oxidase-like protein
GlyGly(8)
IQYSVNWK
carb+C(5);carb+C(15);G
Ribonuclease T2 family protein
NAIKCAIGFAPGIECNEDVK
lyGly(20)
Ribosomal protein S5/Elongation factor G/III/V
GlyGly(12)
MYASKFGVSESK
family protein
Sedoheptulose-1_7-bisphosphatase_
GlyGly(16)
TIINLDDRTQVAYGSKNEIIR
chloroplastic
Serine hydroxymethyltransferase 2_
GlyGly(7);ox+M(15)
AESQGTKLKDFVATMQSNEK
mitochondrial
Serine hydroxymethyltransferase 3_
carb+C(9);GlyGly(13) AVMEAVGSCLTNK
chloroplastic
Small RNA degrading nuclease 2
GlyGly(1)
KDDLVAFLTTLK
spermidine synthase 1
carb+C(14);GlyGly(18) EVARHASIEQIDMCEIDK
Sucrose synthase 1
GlyGly(9)
GGLQRIEEK
Sulfite reductase
GlyGly(10)
QTFQLHGVLK
Thioredoxin H3
GlyGly(25)
VDVDELNTVAEEFKVQAMPTFIFMK
Thiosulfate sulfurtransferase 16_ chloroplastic GlyGly(14)
ATTDLLHAGFTGVK
Trifunctional UDP-glucose 4_6dehydratase/UDP-4-keto-6-deoxy-D-glucose
carb+C(13);GlyGly(14) NNIYGTHVLLEACKVTGQIRR
3_5-epimerase/UDP-4-keto-L-rhamnosereductase RHM1
Trifunctional UDP-glucose 4_6dehydratase/UDP-4-keto-6-deoxy-D-glucose
carb+C(13);carb+C(27); VNVAGTLTLADVCRENDLLMMNFA
3_5-epimerase/UDP-4-keto-L-rhamnoseGlyGly(44)
TGCIFEYDAAHPEGSGIGFK
reductase RHM3
TUDOR-SN protein 2
GlyGly(15)
IPEAHILEMAERSAK
Ubiquitin receptor RAD23c
GlyGly(24)
KNIESVQGADVYPAAKQMLIHQGK
Ubiquitin-40S ribosomal protein S27a-1
GlyGly(6);ox+M(1)
MQIFVKTLTGK
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Table A.8. (cont’d) Second-pass enrichment.
ATG No.
AT3G62250.1
AT2G30110.1
AT3G46440.1
AT3G52480.1
AT2G07775.1
AT5G17310.2
AT5G24770.2
AT3G57410.1
AT4G30270.1

Protein Description
Ubiquitin-40S ribosomal protein S27a-3
Ubiquitin-activating enzyme E1 1
UDP-glucuronic acid decarboxylase 5
unknown protein
unknown protein
UTP--glucose-1-phosphate uridylyltransferase 1
Vegetative storage protein 2
Villin-3
Xyloglucan endotransglucosylase/hydrolase
protein 24

Peptide Modification(s) Peptide Sequence
GlyGly(6)
LIFAGKQLEDGR
GlyGly(9)
NYSIPEVDKLKAK
GlyGly(10)
ELINPSIEIK
GlyGly(10)
GSIFTEDHVK
GlyGly(9)
GSIFSGESK
GlyGly(12)
SNVDIHTFNQSK
GlyGly(16)
NVTLDNLEAAGVTYWK
GlyGly(9)
EIQGHESDK
GlyGly(9)

SSGSGFQSK

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.
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Table A.9. Digly-modified peptides identified in unenriched peptide preparations.

Due to space limitations, this list is available in the Appendix_A.xlsx file.
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Table A.10. LRGG-modified peptides identified by diglycine-enrichment (first-pass).
First-Pass Enrichment
ATG No.
Protein Description
1-aminocyclopropane-1-carboxylate
AT1G05010.1
oxidase 4
2-Cys peroxiredoxin BAS1-like_
AT5G06290.1
chloroplastic

Peptide Modification(s)
LRGG(8)
LRGG(21)

Peptide Sequence
VSGLQLLKDGEWVDVPPVKHSIVVNLG
DQLEVITNGK
SFGVLIPDQGIALRGLFIIDKEGVIQHSTI
NNLGIGR

AT1G79850.1 30S ribosomal protein S17_ chloroplastic

carb+C(11);GlyGly(3);
LRGG(16);ox+M(2)

AMKTMQGRVVCATSDK

4-hydroxy-3-methylbut-2-en-1-yl
AT5G60600.1 diphosphate synthase (ferredoxin)_
chloroplastic

GlyGly(12);LRGG(12)

GDEPYEELEILKNIDATMILHDVPFTEDK

AT5G52650.1 40S ribosomal protein S10-3

LRGG(13)

AT5G02960.1 40S ribosomal protein S23-2

GlyGly(12);LRGG(12)
carb+C(10);GlyGly(17);
LRGG(17)

AT5G35530.1 40S ribosomal protein S3-3
AT3G03780.3
AT3G03780.3
AT5G20980.2
AT3G02360.2
AT3G02360.2
AT2G27710.3
AT3G05590.1
AT2G19730.3
AT1G59870.1

5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 2
5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 2
5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 3_
chloroplastic
6-phosphogluconate dehydrogenase_
decarboxylating 3
6-phosphogluconate dehydrogenase_
decarboxylating 3
60S acidic ribosomal protein P2-2
60S ribosomal protein L18-2
60S ribosomal protein L28-1
ABC transporter G family member 36

FVMESGAKGCEVIVSGK

carb+C(29);LRGG(31)

NDMVEYFGEQLSGFAFTANGWVQSYGS
RCVKPPVIYGDVSRPKPMTVFWSSTAQS
MTK

LRGG(7)

AMVDAAKLIRSQLGSAK

LRGG(11)

SALSNMVAAAKLIR

carb+C(11);LRGG(8)

TLSAYLEKGDCIVDGGNEWYENTER

LRGG(33)

LRGG(3)
LRGG(12)
LRGG(7)
GlyGly(17);LRGG(1)
carb+C(22);carb+C(27);
AT5G48230.2 Acetyl-CoA acetyltransferase_ cytosolic 1
carb+C(31);LRGG(12)
Adenine nucleotide alpha hydrolases-like
AT3G11930.4
LRGG(2)
superfamily protein
AT4G13940.1 Adenosylhomocysteinase 1

AGPRAGGEFGGEKGGAPADYQPSFQGS
GR
QYKKSHLGNEWK

carb+C(10);LRGG(51)

GlyGly(10);LRGG(10);
ox+M(19)
GlyGly(10);LRGG(10);
AT5G13490.2 ADP_ATP carrier protein 2_ mitochondrial
ox+M(19)
AT1G70490.3 ADP-ribosylation factor 2-B
LRGG(14)
AT1G35720.1 Annexin D1
LRGG(17)
AT5G06120.4 ARM repeat superfamily protein
carb+C(14);LRGG(18)
AT4G31990.4 Aspartate aminotransferase_ chloroplastic LRGG(16)
AT1G11910.1 Aspartic proteinase A1
LRGG(9)
ATCG00480.1 ATP synthase subunit beta_ chloroplastic LRGG(10)
AT5G49460.1 ATP-citrate synthase beta chain protein 2 carb+C(13);LRGG(3)
AT3G08580.2 ADP_ATP carrier protein 1_ mitochondrial

AT2G18960.1 ATPase 1_ plasma membrane-type

LRGG(18)

ATPase_ F1 complex_ alpha subunit
AT2G07698.1
protein

LRGG(7)

AT4G17090.1 Beta-amylase 3_ chloroplastic

LRGG(10)

AT3G09260.1 Beta-glucosidase 23
Bifunctional inhibitor/lipid-transfer
AT1G55260.2 protein/seed storage 2S albumin
superfamily protein
AT5G35360.1 Biotin carboxylase_ chloroplastic

LRGG(22)

AT5G61790.1 Calnexin homolog 1

GlyGly(32);LRGG(32)

carb+C(6);carb+C(7);
LRGG(4);LRGG(16)
LRGG(11)
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IGLAGLAVMGQNLALNIAEKGFPISVYN
RTTSK
EEKEESDDDMGFSLFE
RTNSKFNGVILK
HSGLANK
KAGLLPEEENEDADQGK
FGHDSLVDGMLKDGLWDVYNDCGMGS
CAELCAEK
AKQIRTETLVLEGEAK
VIVTEIDPICALQALMEGLQVLTLEDVVS
EADIFVTTTGNKDIIMVDHMRK
TAAAPIERVKLLIQNQDEMIK
TAAAPIERVKLLIQNQDEMLK
NISFTVWDVGGQDK
KSLEEDVAHHTTGDFRK
MQSFVIASLIQLLCRLTK
AQSDNMTDKWHVYMTK
DQEFIEATKEPGITFVVAK
EGNDLYMEMKESGVINEQNLAESK
VNKPVVAWVSGTCAR
LGMGTNMYPSAALLGTDKDSNIASIPVE
ELIEK
AIPNSVKPELLQALKGGLTNERK
AMNASLMALKGAGVEGVMVDAWWGL
VEK
KEKGVSQAGVQFYHDLIDELIK
APTKDCCAGFGQVIRK
QRTQTLKVSQK
ITELIEKAEQQPNLTIGVLVAIVVVFFSLF
LKLIFGGK

Table A.10. (cont’d) First-pass LRGG-modified peptides.
ATG No.

Protein Description

Peptide Modification(s)

AT1G09210.1 Calreticulin-2

GlyGly(33);LRGG(7)

AT1G20620.1 Catalase-3
AT1G20620.1 Catalase-3
Chaperone DnaJ-domain superfamily
AT2G17880.1
protein
AT5G50920.1 Chaperone protein ClpC1_ chloroplastic

carb+C(1);LRGG(4)
LRGG(15)

Peptide Sequence
NEEEESKDAPAESDAEDEPEDDEGGDDS
DSESK
CAEKVPTPTNSYTGIRTK
HMEGFGVHTYTLIAKSGK

LRGG(23)

FSATASLYEILEIPVGSTSQEIK

LRGG(6)
carb+C(6);GlyGly(2);
LRGG(2)
AT2G04030.1 Chaperone protein htpG family protein
GlyGly(5);LRGG(4)
AT2G04030.2 Chaperone protein htpG family protein
LRGG(20)
AT5G56500.2 Chaperonin 60 subunit beta 3_ chloroplastic LRGG(5)
AT5G56500.1 Chaperonin 60 subunit beta 3_ chloroplastic GlyGly(5);LRGG(17)
Chlorophyll a-b binding protein CP26_
GlyGly(1);GlyGly(34);
AT4G10340.1
chloroplastic
LRGG(1)
Chloroplast stem-loop binding protein of 41
AT3G63140.1
LRGG(9)
kDa a_ chloroplastic
carb+C(9);carb+C(12);
AT2G21060.1 Cold shock domain-containing protein 4
GlyGly(11);LRGG(11)
CONTAINS InterPro DOMAIN/s\x3a NLI GlyGly(7);GlyGly(12);
AT2G36550.1
interacting factor
LRGG(12)
Cysteine synthase_
AT2G43750.2
LRGG(33)
chloroplastic/chromoplastic
ATCG00540.1 Cytochrome f
GlyGly(13);LRGG(14)
AT1G65930.1 Cytosolic isocitrate dehydrogenase
carb+C(12);LRGG(20)
D-mannose binding lectin protein with
carb+C(22);carb+C(26);
AT1G78850.1
Apple-like carbohydrate-binding domain LRGG(10)
Dihydrolipoyl dehydrogenase 2_
AT3G17240.3
LRGG(43)
mitochondrial
AT1G03230.1 Eukaryotic aspartyl protease family protein LRGG(21)
AT5G50920.1 Chaperone protein ClpC1_ chloroplastic

AT1G13020.1 eukaryotic initiation factor 4B2
AT5G57870.1
AT5G66190.1
AT5G04140.2
AT5G54160.1
AT5G66510.1
AT5G48300.1
AT1G65960.2
AT4G02520.1
AT1G42970.1
AT1G42970.1
AT1G29880.1
AT1G29880.1

LRGG(36)

Eukaryotic translation initiation factor
GlyGly(5);GlyGly(20);
isoform 4G-1
LRGG(5)
Ferredoxin--NADP reductase_ leaf isozyme
LRGG(9)
1_ chloroplastic
Ferredoxin-dependent glutamate synthase
GlyGly(25);LRGG(11)
1_ chloroplastic/mitochondrial
Flavone 3'-O-methyltransferase 1
carb+C(7);LRGG(17)
Gamma carbonic anhydrase 3_
LRGG(23)
mitochondrial
Glucose-1-phosphate adenylyltransferase
carb+C(2);LRGG(26)
small subunit_ chloroplastic
Glutamate decarboxylase 2
GlyGly(5);LRGG(13)
Glutathione S-transferase F2
GlyGly(15);LRGG(15)
Glyceraldehyde-3-phosphate
carb+C(13);carb+C(24);
dehydrogenase GAPB_ chloroplastic
GlyGly(45);LRGG(45)
Glyceraldehyde-3-phosphate
LRGG(17)
dehydrogenase GAPB_ chloroplastic
GlyGly(17);GlyGly(29);
Glycine--tRNA ligase 1_ mitochondrial
LRGG(29)
Glycine--tRNA ligase 1_ mitochondrial
carb+C(9);LRGG(15)

AT1G02710.1 glycine-rich protein

LRGG(*)

AT3G60210.1 GroES-like family protein
AT1G79920.2 Heat shock 70 kDa protein 15

GlyGly(12);LRGG(12)
LRGG(15)
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LAEEGK
TKNNPCLIGEPGVGKTAIAEGLAQR
EDYKKFWENFGR
SILYIPGMGPLNNEDVTNPK
VDAIKETLANDEEKVGADIVK
VEQIKNLIEAAEQDYEK
KPENFAKYQAFELIHARWAMLGAAGFII
PEALNK
AVTLDGMAK
GGGGGDNSCFKCGEPGHMAR
TLENSDKPLFFK
QLALQEGLLVGISSGAAAAAAIQVAKRP
ENAGK
IGNLSFQNYRPNKKNILVIGPVPGQK
LLDFTEKLEAACVGTVESGK
IEGADSFMTKYNGGSSTTESACGDKCTR
LIVEPAEGGEQTTLEADVVLVSAGRTPF
TSGLDLEKIGVETDK
NVGVTRLGYAVPEIQLVLHSKDVVWR
YGGGGGSFGGGGGGGAGSYGGGGAGA
GSGGGGGFSK
YDLLKGQLIESGITSADILK
EQTNEKGEKMYIQTR
VTAPAGELQLKSLIEAHVEKTGSSK
QVVHVDCIMLAHNPGGKER
VFFSSSAVEYSNLAQAHATENAK
SCISEGAIIEDSLLMGADYYETATEK
LPLVKSINVSGHK
NPFGQVPAFEDGDLK
AANGPMKGILDVCDAPLVSVDFRCSDV
STTIDSSLTMVMGDDMVK
ARAAALNIVPTSTGAAKAVSLVLPQLK
DVLAVMEDFSPEQLGAKIREYGITAPDT
K
ADHLLKDYCTEKLEK
GQWLHGGGGEGGGGEGGGGEGGGGQ
KISK
RNSFRINAVSTK
FIGTAGAASTMMNPK

Table A.10. (cont’d) First-pass LRGG-modified peptides.
AT1G79920.1 Heat shock 70 kDa protein 15

LRGG(18);LRGG(32)

AT3G09440.2 Heat shock 70 kDa protein 3
GlyGly(13);LRGG(13)
Heat shock 70 kDa protein 6_
AT4G24280.1
GlyGly(10);LRGG(10)
chloroplastic
Heat shock 70 kDa protein 6_
AT4G24280.1
LRGG(10)
chloroplastic
AT3G07770.1 HEAT SHOCK PROTEIN 89.1
GlyGly(18);LRGG(18)
AT5G56030.2 Heat shock protein 90-2
carb+C(11);LRGG(12)
AT5G56000.1 Heat shock protein 90-4
GlyGly(16);LRGG(5);ox+M(13)
AT5G52640.1 heat shock protein 90.1
LRGG(14)
AT4G17520.1 Hyaluronan / mRNA binding family GlyGly(9);LRGG(16)
AT4G17520.1 Hyaluronan / mRNA binding family LRGG(15)
IAA-amino acid hydrolase ILR1-like
AT1G51760.1
LRGG(24)
4
AT5G14590.1 Isocitrate dehydrogenase
LRGG(11)
AT2G24200.2 Leucine aminopeptidase 1
LRGG(12);ox+M(10);ox+M(11)
light-harvesting chlorophyll-protein
AT2G34430.1
LRGG(20)
complex II subunit B1
LL-diaminopimelate
AT4G33680.1
LRGG(8)
aminotransferase_ chloroplastic
Lysophospholipid acyltransferase
AT2G45670.1
carb+C(18);LRGG(14)
LPEAT2
Mannose-1-phosphate
AT2G39770.2
GlyGly(9);LRGG(7);LRGG(15)
guanylyltransferase 1
Mediator of RNA polymerase II
AT5G28540.1
GlyGly(12);LRGG(12)
transcription subunit 37a
Methylthioalkylmalate synthase 1_
AT5G23010.1
LRGG(10)
chloroplastic
Microtubule-associated protein
AT5G67270.1
GlyGly(3);LRGG(11);LRGG(16)
RP/EB family member 1C
Microtubule-associated protein
AT5G67270.1
GlyGly(9);LRGG(9)
RP/EB family member 1C
Mitochondrial outer membrane
AT5G15090.2
LRGG(10)
protein porin 3
Monothiol glutaredoxin-S15_
AT3G15660.2
carb+C(8);LRGG(37)
mitochondrial
AT5G22290.1 NAC domain-containing protein 89 LRGG(*)
NADPH-dependent thioredoxin
AT2G17420.1
LRGG(22)
reductase A
AT3G16400.2 Nitrile-specifier protein 1

DTSDATGTDNGVPESAEKPVQMETDSK
AEAPK
ARFEELNIDLFRK
KMNEVDEESKQVSYR
DEGIDLLKDKQALQR
IAAAASTSRSSPSATDVKR
EELKEKFEGLCK
AQALKDSNTGGYMSSK
KENEGEVEEVDEEK
VVAPVQTAKSGKMPTKPPPPSQAVR
NETPAEKAEEKPEDK
IHENPELGYEEVETSKLVRAELEK
LILPYLDLDIKYFDLGILNR
MPLEESYWEMMK
KASKPTGPSGSPWYGSDRVK
LGWTVIPK
NNTPGVSGLYEAIKLVICLPIALIRLVLFA
ASLAVGYLATK
VEKFVEKPKLYVGNK
DRKLVPYQIVNK
NAATSSTDLKPVVERWPEYIPNK
QSKPVPAYDEKITELK
AAATQQSGKSSSSSAPPRPSSSNGTRK
HFNAGFNFTK

GVPESPQCGFSSLAVRVLQQYNVPISSR
NILEDQELK
GKKYPHGSQNR
NKPLVVIGGGDSAMEEANFLTKYGSKV
YIIHR
QYNGFYSFDTTTNEWKLLTPVEEGPTPR
GlyGly(16);LRGG(16);ox+M(33)
SFHSMAADEENVYVFGGVSATAR
GlyGly(24);LRGG(24)
FGGEEETPSSRGWTASTTATIGGK
carb+C(8);carb+C(12);carb+C(22)
KNIAFSDCISICSGFRHSRPSCLDLVTK
;GlyGly(28);LRGG(1)

AT3G16410.1 Nitrile-specifier protein 4
Nitrogen regulatory protein P-II
AT4G01900.1
homolog
Oxygen-evolving enhancer protein 2AT1G06680.2
LRGG(5)
1_ chloroplastic
Oxygen-evolving enhancer protein 3AT4G21280.1
LRGG(8)
1_ chloroplastic
Pectinesterase/pectinesterase
AT1G11580.1
LRGG(10)
inhibitor 18
Pectinesterase/pectinesterase
AT1G11580.1
GlyGly(12);LRGG(3)
inhibitor 18
Pectinesterase/pectinesterase
AT3G14310.1
GlyGly(1);LRGG(1);LRGG(26)
inhibitor 3
carb+C(15);carb+C(18);LRGG(25
AT1G63770.5 Peptidase M1 family protein
)
AT4G08770.1 Peroxidase 37
LRGG(14);ox+M(2)
AT3G26060.1 Peroxiredoxin Q_ chloroplastic
LRGG(13)
Peroxisomal (S)-2-hydroxy-acid
AT3G14420.6
LRGG(*)
oxidase GLO1
Peroxisomal (S)-2-hydroxy-acid
AT3G14420.6
GlyGly(7);LRGG(18);ox+M(30)
oxidase GLO1
Phospho-2-dehydro-3AT4G39980.1 deoxyheptonate aldolase 1_
GlyGly(*);LRGG(*)
chloroplastic
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WNPSKEIEYPGQVLR
KSPSQAEKYYAETVSALNEVLAK
KNLMLVGDGKDATIITGSLNVIDGSTTF
R
DSKEAEQFTVAK
KLVLLSAAVALLFVAAVAGISAGASKA
NEK
NTSLEGLYKSSGNFCTQCEAEGFRK
AMIRMSSLSPLTGKQGEIR
VNKGQAAPDFTLK
DVQWLQTITKLPILVKGVLTGEDAR
ILIDVSKIDMTTTVLGFKISMPIMVAPTA
MQK
VSNKMDPFELVKLVEILNPNNKPGR

Table A.10. (cont’d) First-pass LRGG-modified peptides.
ATG No.

Protein Description
Peptide Modification(s)
Phospho-2-dehydro-3-deoxyheptonate
carb+C(22);GlyGly(27);
AT4G33510.1
aldolase 2_ chloroplastic
LRGG(27)
AT2G42600.2 Phosphoenolpyruvate carboxylase 2
GlyGly(23);LRGG(23)
AT2G42600.2 Phosphoenolpyruvate carboxylase 2
LRGG(1)
Phosphoethanolamine N-methyltransferase carb+C(7);LRGG(1);
AT3G18000.1
1
LRGG(12)
Phosphoethanolamine N-methyltransferase
AT3G18000.1
GlyGly(9);LRGG(9)
1
Phosphoethanolamine N-methyltransferase carb+C(7);LRGG(1);
AT1G73600.2
3
LRGG(12)
Phosphoethanolamine N-methyltransferase
AT1G73600.2
GlyGly(4);LRGG(26)
3
AT3G12780.1 Phosphoglycerate kinase 1_ chloroplastic LRGG(3)
Phosphomethylethanolamine NAT1G48600.2
GlyGly(7);LRGG(15)
methyltransferase
Phosphomethylethanolamine NAT1G48600.2
LRGG(8)
methyltransferase
Photosystem I reaction center subunit VI-1_
AT3G16140.1
LRGG(*)
chloroplastic
Photosystem II 22 kDa protein_
AT1G44575.1
LRGG(*)
chloroplastic
ATCG00680.1 Photosystem II CP47 reaction center proteinLRGG(18)
AT1G49760.2 Polyadenylate-binding protein 8
GlyGly(2);LRGG(2)
Polyketide cyclase/dehydrase and lipid
AT4G23670.1
LRGG(2)
transport superfamily protein
Polyketide cyclase/dehydrase and lipid
AT4G23680.1
LRGG(23)
transport superfamily protein
AT3G09790.1 Polyubiquitin 8

GlyGly(33);LRGG(33)

AT5G08280.1 Porphobilinogen deaminase_ chloroplastic carb+C(10);LRGG(16)
GlyGly(*);LRGG(*);
AT5G51830.1 Probable fructokinase-7
LRGG(*)
Probable fructose-bisphosphate aldolase 2_
AT4G38970.1
carb+C(32);LRGG(*)
chloroplastic
Probable fructose-bisphosphate aldolase 3_
AT2G01140.1
GlyGly(14);LRGG(14)
chloroplastic
Probable fructose-bisphosphate aldolase 3_
AT2G01140.1
LRGG(11)
chloroplastic
Probable mediator of RNA polymerase II
AT3G12580.1
LRGG(5);ox+M(6)
transcription subunit 37c
Probable mediator of RNA polymerase II
AT5G02500.2
LRGG(26)
transcription subunit 37e
AT2G34300.2 Probable methyltransferase PMT25
GlyGly(1);LRGG(1)
AT2G34300.2 Probable methyltransferase PMT25
LRGG(10)
Probable mitochondrial-processing
AT1G51980.1
LRGG(*)
peptidase subunit alpha-1
Probable mitochondrial-processing
AT3G16480.1
LRGG(16)
peptidase subunit alpha-2
Probable xyloglucan
AT4G30280.1
LRGG(12)
endotransglucosylase/hydrolase protein 18

Peptide Sequence
KLEDKLGQAAMGQAFMLQGGDCAESF
K
QESERHSDVLDAITTHLGIGSYK
KPSGGIESLRAIPWIFAWTQTR
KNQNQICWIWQK
DTILHIQDKPALFRTFFK
KNQNQICWLWQK
NYWKEHSVGLSVEAMMLDSKASDLDK
FLKPSVAGFLLQK
TASGEQKWGLFIADK
FTGELAQKAGEVIALDFIESAIQK
MASLATVAAVKPSAAIKGLGGSSLAGA
K
QSFVPLALFKPKTKAAPK
RVSAGLAENQSLSEAWAK
SKGFGFVNFENSDDAAR
EKREIDDENK
EIDDETKTLTLRGLEGHVMEQLK
ESTLHLVLGMQIFVKLFGGKIITLEVLSS
DTIK
QSSSGFVKACVAVEQKTR
STQLVAMKIAKAAGSLLSYDPNLR
MVDVLVEQNIVPGIKVDKGLVPLVGSN
NESWCQGLDGLSSR
TWQGKPEKIEASQKALLVR
YSAEGENEDAK
EEIEKMVQEAEKYK
IEDSIEQAIQWLEGNQLAEADEFEDK
KEEGDRDPK
SEDGNGNEEKAEENASETEESTEK
SVDQLTLKDIADFTSKVISKPLTMGSFGD
VLAVPSYDTISSK
QILTYGERKPVDQFLKTVDQLTLK
DVQIHWGDGRGK

AT5G04430.1 Protein BTR1

LRGG(14)

AT5G60640.2 Protein disulfide isomerase-like 1-4

LRGG(1)
GlyGly(27);LRGG(27);
ox+M(21)
LRGG(4)

FLVSNAAAGSVIGKGGSTITEFQAKSGA
R
KEEEKISHFDGEFVK
NHQYIPEDTSSPNYHHEYAFMGVRNGK
FYGTK
DTLKVPHTSVGGGHVK

LRGG(*)

DDLVLGDPTAPRFVLWNGKLRPVPSK

LRGG(22);LRGG(23)

QLTAFGSDDGTVWDDGAYVGVKKVYV
GQAQDGISAVK

AT2G44240.1 Protein of Unknown Function (DUF239)
AT3G08030.1 Protein of unknown function_ DUF642
Protoporphyrinogen oxidase 1_
AT4G01690.1
chloroplastic
AT3G16420.3 PYK10-binding protein 1
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Table A.10. (cont’d) First-pass LRGG-modified peptides.
ATG No.
AT4G39990.1
AT5G03530.1
AT1G18080.1
AT1G48630.1
AT3G18130.1

Protein Description
Ras-related protein RABA4b
Ras-related protein RABC2a
Receptor for activated C kinase 1A
Receptor for activated C kinase 1B
Receptor for activated C kinase 1C
Rhodanese-like domain-containing
AT3G08920.1
protein 10
Ribulose bisphosphate carboxylase
ATCG00490.1
large chain
RNA-binding (RRM/RBD/RNP
AT4G09040.1
motifs) family protein
AT3G17390.1 S-adenosylmethionine synthase 4
Serine hydroxymethyltransferase 2_
AT5G26780.3
mitochondrial
Serine hydroxymethyltransferase 3_
AT4G32520.2
chloroplastic
AT1G21850.1 SKU5 similar 8
AT1G41830.1 SKU5-similar 6
AT2G05920.1
AT5G67360.1
AT5G40570.2
AT5G40570.2
AT5G40570.2
AT5G26360.1
AT5G60360.1
AT2G45290.1
AT2G45290.1
AT3G14790.1
AT2G47110.1
AT2G30110.1
AT1G64230.5
AT3G29360.2
AT3G29360.2
AT5G02240.1
AT1G65090.1
AT5G24165.1
AT5G17310.2
AT1G52340.1

Peptide Modification(s)
LRGG(15)
GlyGly(3);LRGG(3)
carb+C(8);carb+C(25);LRGG(9)
LRGG(10)
carb+C(10);GlyGly(3);LRGG(11)

Peptide Sequence
SDLEDQRAVPTEDAK
RLKLTIWDTAGQER
LWNTLGECKYTISEGGEGHRDWVSCVR
TDGSTGIGNK
TVKVWNLQNCK

LRGG(13)

FATIGGVSFYLLKLLVLLPSFGQK

carb+C(18);LRGG(19)

NEGRDLAVEGNEIIREACK

LRGG(*)

TKKQAEAALIEFQGK

carb+C(3);carb+C(6);LRGG(8)

VACETCTKTNMVMVFGEITTK

carb+C(15);GlyGly(17);LRGG(5) TPEYKAYQDQVLRNCSK
LRGG(20);ox+M(2);ox+M(17)

IMGLDLPHGGHLSHGFMTAK

LRGG(3)
LRGG(12)

TIKLASSAGNINGK
SNGATLNVEQGK
SDSKPTALLVFKGTVLDVKPSPVVAAFS
Subtilase family protein
LRGG(19)
SR
EANEKKSYTVTFTVDSSKPSGSNSFGSIE
Subtilisin-like protease SBT1.7
GlyGly(*);LRGG(*)
WSDGK
HNKEDSGSEESDFWMPKSSSDSELDEET
Surfeit locus protein 2 (SURF2)
carb+C(33);GlyGly(17);LRGG(3)
DEENCK
carb+C(16);carb+C(21);
SSSDSELDEETDEENCKGSHCDDKESEE
Surfeit locus protein 2 (SURF2)
LRGG(24)
LSER
carb+C(16);carb+C(21);
Surfeit locus protein 2 (SURF2)
SSSDSELDEETDEENCKGSHCDDK
LRGG(17)
TMTALQGKHANGENAWTGIDGNTGAIA
T-complex protein 1 subunit gamma LRGG(8)
DMK
carb+C(17);carb+C(20);
DWREDGIVSPVKDQGGCGSCWTFSTTG
Thiol protease aleurain
LRGG(39)
ALEAAYHQAFGK
NASTISHSLRPLVRAAAVEAIVTSSDSSL
Transketolase-2_ chloroplastic
LRGG(32)
VDKSVNTIR
Transketolase-2_ chloroplastic
GlyGly(*);LRGG(*)
EAKAVTDKPTLIKVTTTIGYGSPNK
Trifunctional UDP-glucose 4_6carb+C(4);LRGG(14)
LDYCSNLKNLNPSK
dehydratase
Ubiquitin-40S ribosomal protein
LRGG(6)
LIFAGKQLEDGR
S27a-2
Ubiquitin-activating enzyme E1 1
LRGG(21)
EAAEAVDRVIVPDFEPRQDAK
Ubiquitin-conjugating enzyme E2 28 LRGG(3)
ILKELKDLQK
UDP-glucose 6-dehydrogenase 2
GlyGly(16);LRGG(17)
FVNRVVSSMFNSVSNKK
UDP-glucose 6-dehydrogenase 2
LRGG(17)
HVREADIVFVSVNTPTK
Uncharacterized protein At5g02240 GlyGly(9);GlyGly(18);LRGG(9) NKAFDLGSKPEGTSTPTK
unknown protein
LRGG(15)
SQTMEEYQSNESEDK
unknown protein
LRGG(7)
NTADGGKASLQPK
UTP--glucose-1-phosphate
LRGG(*)
TNPTNPAIELGPEFKKVASFLSR
uridylyltransferase 1
Xanthoxin dehydrogenase
carb+C(15);LRGG(21)
YISGDNLMIDGGFTCTNHSFK

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.
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Table A.11. LRGG-modified peptides identified by diglycine-enrichment (second-pass).
Second-Pass Enrichment
ATG No.
Protein Description
Peptide Modification(s)
5methyltetrahydropteroyltriglutam
AT5G17920.2
GlyGly(14);LRGG(14)
ate--homocysteine
methyltransferase 1
carb+C(3);GlyGly(*);GlyGly(*);
AT4G35830.1 Aconitate hydratase 1
LRGG(*)
AT1G35720.1 Annexin D1
LRGG(8)
ATP binding\x3bleucine-tRNA
ligases\x3baminoacyl-tRNA
ligases\x3bnucleotide
AT1G09620.1
LRGG(13)
binding\x3bATP
binding\x3baminoacyl-tRNA
ligases
AT5G35360.3 Biotin carboxylase_ chloroplastic carb+C(18);LRGG(22)
Cell division protein FtsZ
AT3G52750.1
LRGG(19)
homolog 2-2_ chloroplastic
Chaperonin CPN60_
AT3G23990.1
LRGG(12)
mitochondrial
Chlorophyll a-b binding protein
AT5G01530.1
LRGG(17)
CP29.1_ chloroplastic
Diaminopimelate decarboxylase
AT5G11880.1
LRGG(16)
2_ chloroplastic
Diaminopimelate decarboxylase
AT5G11880.1
LRGG(12)
2_ chloroplastic
elongation factor Ts family
AT4G29060.1
LRGG(11)
protein
FKBP-like peptidyl-prolyl cisAT1G26550.1
LRGG(14)
trans isomerase family protein
Glycine-rich RNA-binding
AT2G21660.2
LRGG(3);ox+M(2)
protein 7
AT5G56010.1 Heat shock protein 90-3
LRGG(14)
AT5G56000.1 Heat shock protein 90-4
LRGG(2)
Monodehydroascorbate
AT1G63940.1
LRGG(19);LRGG(32)
reductase_ chloroplastic
NADPH-dependent thioredoxin
AT2G41680.1
LRGG(20)
reductase 3
NADPH-dependent thioredoxin
AT2G17420.1
carb+C(13);LRGG(32)
reductase A
Phospho-2-dehydro-3AT4G39980.1 deoxyheptonate aldolase 1_
LRGG(12)
chloroplastic
Probable monodehydroascorbate
AT3G52880.2
LRGG(7)
reductase_ cytoplasmic isoform 3
Probable phosphoglucomutase_
AT1G23190.1
LRGG(10)
cytoplasmic 1
Putative transcription factor
AT5G37800.1
LRGG(5)
bHLH086
AT4G20830.2 Reticuline oxidase-like protein GlyGly(13);LRGG(13)
AT5G05540.1 Small RNA degrading nuclease 2 LRGG(8)
AT2G45290.1 Transketolase-2_ chloroplastic carb+C(10);LRGG(23)
AT5G61780.1 TUDOR-SN protein 2
GlyGly(25);GlyGly(26);LRGG(14)
Ubiquitin carboxyl-terminal
AT1G51710.1
LRGG(12)
hydrolase 6
Uncharacterized protein
AT2G37660.1
LRGG(19)
At2g37660_ chloroplastic

Peptide Sequence
RATNVSARLDAQQK
KACDLGLEVKPWIKTSLAPGSGVVTK
RNSIPLEKAITK

LPFGEIEVLQSNK

LLQQAKSEAAAAFGNDGCYLEK
GLGAGGNPEIGMNAATESK
DKIKNVGASLVK
NLAGDVIGTRTEAADAK
MRPPEYWVEEDGSITKIRHAETFDDHLR
NEKLQWFLDEVK
AKEEPKAEEAK
STHGYHIILSEGRKN
AMKDAIEGMNGQDLDGR
EGQNDIFYITGESK
MKEGQNEIFYITGESK
LADGSTIEADTVVIGIGAKPAIGPFETLAM
NK
YLTSNNLLVEFHQPQTEEAK
KYRQAITAAGTGCMAALDAEHYLQEIGS
QEGK
GDNINGDTFDEK
GQVEEDKGGIKTDAFFK
NKGNIDGNAK
LAGNKRPFTGENTQLSK
KFGLSVDYVEDAKIVDVNGR
DSRGLSQKQIFLEPSSSEPR
SGHPGLPMGCAPMSHILYDEVMK
VASIQNQLAALSLKDAPIIGSFNPKK
LGLQTSAKSGSK
ALDLASKPEGTGTPTKDFKALFTQVTTK

Number in parentheses indicates location of assigned modified residue(s). Asterisks (*) indicate unassigned
modification. Carb+C: Cys carbamidomethyl; ox+M: Met oxidation.
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Table A.12. Peptides captured by protein G agarose.
ATG No.
AT2G37270.2
AT3G14415.3
AT3G09260.1
AT2G13360.2
AT1G74050.1
ATCG00490.1
AT3G09260.1
AT5G60390.3
AT2G13360.2
AT3G53430.1
AT5G14670.1
AT3G14415.3

Protein Description
ribosomal protein 5B
Aldolase-type TIM barrel family
protein
Glycosyl hydrolase superfamily
protein
alanine:glyoxylate aminotransferase
Ribosomal protein L6 family protein
ribulose-bisphosphate carboxylases
Glycosyl hydrolase superfamily
protein
GTP binding Elongation factor Tu
family protein
alanine:glyoxylate aminotransferase
Ribosomal protein L11 family
protein
ADP-ribosylation factor A1B
Aldolase-type TIM barrel family
protein

AT3G16420.3

PYK10-binding protein 1

AT1G31020.1

thioredoxin O2
Ribosomal protein L16p/L10e
family protein
ribosomal protein 5B
rubisco activase
60S acidic ribosomal protein family

AT1G26910.1
AT2G37270.2
AT2G39730.3
AT2G27710.4

Peptide Sequence
AQCPIVER
FFQLYVYK
FGLYYVDFK
YNLSLGLGLNK
ASITPGTVLIILAGR
DNGLLLHIHR
FGLYYVDFK
FHINIVVIGHVDSGK
HHLFVPGPVNIPEPVIR
HNGNISFDDVTEIAR
HYFQNTQGLIFVVDSNDR
IAIQAGAAGIIVSNHGAR
IIGFHGSAGGNLNSLGAYFAPL
TTTTPLTPAK
LNVSAVPTLQFFK
VAIGQVLLSVR
VNQAIFLLTTGAR
VPLILGIWGGK
VVAAYLLAVLSGK

Note: none of the peptides identified in screen were found to be modified.
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Table B.1. Gene ontology assignments for candidate ubiquitinated proteins, distributed
by pathway.
Pathway
DPP signaling pathway
DPP-SCW signaling pathway
BMP/activin signaling pathway-drosophila
De novo pyrimidine deoxyribonucleotide biosynthesis
Apoptosis signaling pathway
De novo purine biosynthesis
Cysteine biosynthesis
Alzheimer disease-presenilin pathway
Integrin signalling pathway
5-Hydroxytryptamine degredation
Chorismate biosynthesis
Phenylalanine biosynthesis
Inflammation mediated by chemokine and cytokine signaling pathway
Pentose phosphate pathway
Asparagine and aspartate biosynthesis
Ubiquitin proteasome pathway
Huntington disease
Ascorbate degradation
Arginine biosynthesis
Pyridoxal-5-phosphate biosynthesis
Wnt signaling pathway
Aminobutyrate degradation
Vasopressin synthesis
O-antigen biosynthesis
Glycolysis
Vitamin B6 metabolism
Methylcitrate cycle
FGF signaling pathway
Valine biosynthesis
ATP synthesis
Tyrosine biosynthesis
TCA cycle
Mannose metabolism
Tryptophan biosynthesis
Lysine biosynthesis
Threonine biosynthesis
EGF receptor signaling pathway
Parkinson disease
Leucine biosynthesis
Cytoskeletal regulation by Rho GTPase
Isoleucine biosynthesis
Histidine biosynthesis
Cholesterol biosynthesis
Sulfate assimilation
Heme biosynthesis
Cell cycle
Gamma-aminobutyric acid synthesis
Nicotinic acetylcholine receptor signaling pathway
Glutamine glutamate conversion
Cadherin signaling pathway
Serine glycine biosynthesis
Fructose galactose metabolism
Formyltetrahydroformate biosynthesis
S-adenosylmethionine biosynthesis
CCKR signaling map
Pyruvate metabolism
De novo pyrimidine ribonucleotides biosythesis
Pyrimidine Metabolism
SCW signaling pathway
GBB signaling pathway
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Distribution
0.50%
0.50%
0.50%
1.40%
3.70%
2.30%
1.90%
1.40%
0.90%
2.30%
0.50%
0.50%
1.40%
0.50%
3.70%
2.80%
5.10%
0.90%
0.50%
0.90%
0.90%
0.50%
0.50%
0.90%
5.10%
0.90%
1.40%
1.90%
0.50%
1.90%
1.40%
2.30%
1.40%
0.90%
2.80%
1.40%
1.90%
8.30%
2.80%
1.90%
0.50%
0.90%
0.50%
0.50%
3.70%
0.50%
0.50%
1.40%
1.40%
1.90%
4.20%
3.20%
0.90%
1.40%
0.90%
2.30%
2.80%
0.50%
0.50%
0.50%
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Trypsin optimization: Trypsin digest of synthetic mono-ubiquitin 1:100
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Figure C.1. Optimization of monoubiquitin trypsinolysis.
Recombinant Arabidopsis monoubiquitin was subjected to trypsinolysis at the indicated
trypsin:protein ratio. Tryptic peptides were submitted to MALDI-TOF-MS analysis.
Peptide sequences and corresponding amino acid residue positions are indicated.
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Figure C.2. Digest of human recombinant K48- and K63-linked polyubiquitin chains.
Human recombinant (A) K48- and (B) K63-linked polyUb chains were subjected to
proteolysis with 1:50 (trypsin:protein). Tryptic fragments were subjected to MALDITOF-MS. The location of the digly-modification is indicated by (GG), where applicable.
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DMSO-treated plants
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Figure C.3. Enrichment of digly-modified polyubiquitin-derived peptides in DMSO- and
MG132-treated seedlings.
14-day-old Arabidopsis seedlings were treated with (A) DMSO or (B) MG132. Wholecell lysates were subjected to trypsinolysis, and tryptic peptides were submitted to
MALDI-TOF-MS analysis. The peptide comprising residues 43–54 includes the diglymodified K48-residue (m/z 1460), and 55–72 includes the digly-modified K63-residue
(m/z 2228).
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